BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 610997 FC(F)(F)c1cnc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)cn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143742 US8969352, 1::US9611277, Example 1::US10183953, Example 1::US9845333, 1 Orexin/Hypocretin receptor type 1 Rat 74.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143742 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143742&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271691 251972329 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 610998 FC(F)(F)c1cnc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)cn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143742 US8969352, 1::US9611277, Example 1::US10183953, Example 1::US9845333, 1 Orexin/Hypocretin receptor type 1 Human 120 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143742 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143742&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271691 251972329 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 610999 FC(F)(F)c1cnc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)cn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143742 US8969352, 1::US9611277, Example 1::US10183953, Example 1::US9845333, 1 Orexin receptor type 2 Human 4700 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143742 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143742&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271691 251972329 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611000 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3cnc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C20H18F3N7O2/c1-11-2-3-13(30-26-4-5-27-30)18(28-11)19(31)29-10-12-6-14(29)15(7-12)32-17-9-24-16(8-25-17)20(21,22)23/h2-5,8-9,12,14-15H,6-7,10H2,1H3 CKWUPZSHHCLQII-UHFFFAOYSA-N 143743 US8969352, 2::US9611277, Example 125::US10183953, Example 2::US9845333, 2 Orexin/Hypocretin receptor type 1 Rat 200 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143743 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143743&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271695 251972330 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611001 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3cnc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C20H18F3N7O2/c1-11-2-3-13(30-26-4-5-27-30)18(28-11)19(31)29-10-12-6-14(29)15(7-12)32-17-9-24-16(8-25-17)20(21,22)23/h2-5,8-9,12,14-15H,6-7,10H2,1H3 CKWUPZSHHCLQII-UHFFFAOYSA-N 143743 US8969352, 2::US9611277, Example 125::US10183953, Example 2::US9845333, 2 Orexin/Hypocretin receptor type 1 Human 342 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143743 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143743&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271695 251972330 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611002 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3cnc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C20H18F3N7O2/c1-11-2-3-13(30-26-4-5-27-30)18(28-11)19(31)29-10-12-6-14(29)15(7-12)32-17-9-24-16(8-25-17)20(21,22)23/h2-5,8-9,12,14-15H,6-7,10H2,1H3 CKWUPZSHHCLQII-UHFFFAOYSA-N 143743 US8969352, 2::US9611277, Example 125::US10183953, Example 2::US9845333, 2 Orexin receptor type 2 Human 10000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143743 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143743&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271695 251972330 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611003 CCOc1ncc2ccccc2c1C(=O)N1CC2CC(Oc3cnc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H21F3N4O3/c1-2-32-21-20(15-6-4-3-5-14(15)9-29-21)22(31)30-12-13-7-16(30)17(8-13)33-19-11-27-18(10-28-19)23(24,25)26/h3-6,9-11,13,16-17H,2,7-8,12H2,1H3 VCKIIVINGOZJPM-UHFFFAOYSA-N 143744 US8969352, 3::US9611277, Example 3::US10183953, Example 3::US9845333, 3 Orexin/Hypocretin receptor type 1 Rat 63.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143744 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143744&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271692 251972331 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611004 CCOc1ncc2ccccc2c1C(=O)N1CC2CC(Oc3cnc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H21F3N4O3/c1-2-32-21-20(15-6-4-3-5-14(15)9-29-21)22(31)30-12-13-7-16(30)17(8-13)33-19-11-27-18(10-28-19)23(24,25)26/h3-6,9-11,13,16-17H,2,7-8,12H2,1H3 VCKIIVINGOZJPM-UHFFFAOYSA-N 143744 US8969352, 3::US9611277, Example 3::US10183953, Example 3::US9845333, 3 Orexin/Hypocretin receptor type 1 Human 123 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143744 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143744&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271692 251972331 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611005 CCOc1ncc2ccccc2c1C(=O)N1CC2CC(Oc3cnc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H21F3N4O3/c1-2-32-21-20(15-6-4-3-5-14(15)9-29-21)22(31)30-12-13-7-16(30)17(8-13)33-19-11-27-18(10-28-19)23(24,25)26/h3-6,9-11,13,16-17H,2,7-8,12H2,1H3 VCKIIVINGOZJPM-UHFFFAOYSA-N 143744 US8969352, 3::US9611277, Example 3::US10183953, Example 3::US9845333, 3 Orexin receptor type 2 Human 8900 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143744 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143744&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271692 251972331 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611006 Cc1cnc(C(=O)N2CC3CC(Oc4cnc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C20H18F3N7O2/c1-11-4-14(30-27-2-3-28-30)18(26-7-11)19(31)29-10-12-5-13(29)15(6-12)32-17-9-24-16(8-25-17)20(21,22)23/h2-4,7-9,12-13,15H,5-6,10H2,1H3 YLFJSQKDYGUXAW-UHFFFAOYSA-N 143745 US8969352, 4::US9611277, Example 4::US10183953, Example 4::US9845333, 4 Orexin/Hypocretin receptor type 1 Rat 837 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143745 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143745&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271696 251972332 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611007 Cc1cnc(C(=O)N2CC3CC(Oc4cnc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C20H18F3N7O2/c1-11-4-14(30-27-2-3-28-30)18(26-7-11)19(31)29-10-12-5-13(29)15(6-12)32-17-9-24-16(8-25-17)20(21,22)23/h2-4,7-9,12-13,15H,5-6,10H2,1H3 YLFJSQKDYGUXAW-UHFFFAOYSA-N 143745 US8969352, 4::US9611277, Example 4::US10183953, Example 4::US9845333, 4 Orexin receptor type 2 Human >10000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143745 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143745&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271696 251972332 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611008 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143746 US8969352, 36::US8969352, 7::US9611277, Example 36::US10183953, Example 36::US9845333, 36 Orexin/Hypocretin receptor type 1 Rat 21.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143746 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143746&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271693 251972333 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611009 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143746 US8969352, 36::US8969352, 7::US9611277, Example 36::US10183953, Example 36::US9845333, 36 Orexin/Hypocretin receptor type 1 Human 12.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143746 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143746&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271693 251972333 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611010 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143746 US8969352, 36::US8969352, 7::US9611277, Example 36::US10183953, Example 36::US9845333, 36 Orexin receptor type 2 Human 800 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143746 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143746&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271693 251972333 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611011 CCOc1ncc2ccccc2c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C24H22F3N3O3/c1-2-32-22-21(17-6-4-3-5-15(17)11-29-22)23(31)30-13-14-9-18(30)19(10-14)33-20-8-7-16(12-28-20)24(25,26)27/h3-8,11-12,14,18-19H,2,9-10,13H2,1H3 WORAHSUSUFAEIQ-UHFFFAOYSA-N 143747 US8969352, 8::US9611277, Example 8::US10183953, Example 8::US9845333, 8 Orexin/Hypocretin receptor type 1 Rat 16.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143747 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143747&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271785 251972334 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611012 CCOc1ncc2ccccc2c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C24H22F3N3O3/c1-2-32-22-21(17-6-4-3-5-15(17)11-29-22)23(31)30-13-14-9-18(30)19(10-14)33-20-8-7-16(12-28-20)24(25,26)27/h3-8,11-12,14,18-19H,2,9-10,13H2,1H3 WORAHSUSUFAEIQ-UHFFFAOYSA-N 143747 US8969352, 8::US9611277, Example 8::US10183953, Example 8::US9845333, 8 Orexin/Hypocretin receptor type 1 Human 15.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143747 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143747&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271785 251972334 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611013 CCOc1ncc2ccccc2c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C24H22F3N3O3/c1-2-32-22-21(17-6-4-3-5-15(17)11-29-22)23(31)30-13-14-9-18(30)19(10-14)33-20-8-7-16(12-28-20)24(25,26)27/h3-8,11-12,14,18-19H,2,9-10,13H2,1H3 WORAHSUSUFAEIQ-UHFFFAOYSA-N 143747 US8969352, 8::US9611277, Example 8::US10183953, Example 8::US9845333, 8 Orexin receptor type 2 Human 1450 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143747 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143747&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271785 251972334 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611014 Cc1cnc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H19F3N6O2/c1-12-6-16(30-27-4-5-28-30)19(26-9-12)20(31)29-11-13-7-15(29)17(8-13)32-18-3-2-14(10-25-18)21(22,23)24/h2-6,9-10,13,15,17H,7-8,11H2,1H3 OAQRBSBYWFGTPG-UHFFFAOYSA-N 143748 US8969352, 28::US8969352, 9::US9611277, Example 28::US10183953, Example 28::US9845333, 28 Orexin/Hypocretin receptor type 1 Rat 56.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143748 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143748&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271971 251972335 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611015 Cc1cnc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H19F3N6O2/c1-12-6-16(30-27-4-5-28-30)19(26-9-12)20(31)29-11-13-7-15(29)17(8-13)32-18-3-2-14(10-25-18)21(22,23)24/h2-6,9-10,13,15,17H,7-8,11H2,1H3 OAQRBSBYWFGTPG-UHFFFAOYSA-N 143748 US8969352, 28::US8969352, 9::US9611277, Example 28::US10183953, Example 28::US9845333, 28 Orexin/Hypocretin receptor type 1 Human 101 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143748 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143748&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271971 251972335 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611016 Cc1cnc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H19F3N6O2/c1-12-6-16(30-27-4-5-28-30)19(26-9-12)20(31)29-11-13-7-15(29)17(8-13)32-18-3-2-14(10-25-18)21(22,23)24/h2-6,9-10,13,15,17H,7-8,11H2,1H3 OAQRBSBYWFGTPG-UHFFFAOYSA-N 143748 US8969352, 28::US8969352, 9::US9611277, Example 28::US10183953, Example 28::US9845333, 28 Orexin receptor type 2 Human 2554 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143748 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143748&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271971 251972335 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611017 CCOc1ccc2cccnc2c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C24H22F3N3O3/c1-2-32-18-7-5-15-4-3-9-28-22(15)21(18)23(31)30-13-14-10-17(30)19(11-14)33-20-8-6-16(12-29-20)24(25,26)27/h3-9,12,14,17,19H,2,10-11,13H2,1H3 TWCLRHNSMBRHHR-UHFFFAOYSA-N 143749 US8969352, 10::US9611277, Example 10::US10183953, Example 10::US9845333, 10 Orexin/Hypocretin receptor type 1 Rat 18.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143749 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143749&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271786 251972336 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611018 CCOc1ccc2cccnc2c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C24H22F3N3O3/c1-2-32-18-7-5-15-4-3-9-28-22(15)21(18)23(31)30-13-14-10-17(30)19(11-14)33-20-8-6-16(12-29-20)24(25,26)27/h3-9,12,14,17,19H,2,10-11,13H2,1H3 TWCLRHNSMBRHHR-UHFFFAOYSA-N 143749 US8969352, 10::US9611277, Example 10::US10183953, Example 10::US9845333, 10 Orexin/Hypocretin receptor type 1 Human 27.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143749 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143749&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271786 251972336 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611019 CCOc1ccc2cccnc2c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C24H22F3N3O3/c1-2-32-18-7-5-15-4-3-9-28-22(15)21(18)23(31)30-13-14-10-17(30)19(11-14)33-20-8-6-16(12-29-20)24(25,26)27/h3-9,12,14,17,19H,2,10-11,13H2,1H3 TWCLRHNSMBRHHR-UHFFFAOYSA-N 143749 US8969352, 10::US9611277, Example 10::US10183953, Example 10::US9845333, 10 Orexin receptor type 2 Human 526 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143749 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143749&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271786 251972336 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611020 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C23H18F4N4O2/c24-16-4-1-3-15(20(16)21-28-7-2-8-29-21)22(32)31-12-13-9-17(31)18(10-13)33-19-6-5-14(11-30-19)23(25,26)27/h1-8,11,13,17-18H,9-10,12H2 HUKWIAXQBOHZIX-UHFFFAOYSA-N 143750 US8969352, 27::US8969352, 11::US9611277, Example 86::US10183953, Example 86::US9845333, 27 Orexin/Hypocretin receptor type 1 Rat 11.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143750 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143750&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271787 251972337 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611021 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C23H18F4N4O2/c24-16-4-1-3-15(20(16)21-28-7-2-8-29-21)22(32)31-12-13-9-17(31)18(10-13)33-19-6-5-14(11-30-19)23(25,26)27/h1-8,11,13,17-18H,9-10,12H2 HUKWIAXQBOHZIX-UHFFFAOYSA-N 143750 US8969352, 27::US8969352, 11::US9611277, Example 86::US10183953, Example 86::US9845333, 27 Orexin/Hypocretin receptor type 1 Human 8.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143750 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143750&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271787 251972337 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611022 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C23H18F4N4O2/c24-16-4-1-3-15(20(16)21-28-7-2-8-29-21)22(32)31-12-13-9-17(31)18(10-13)33-19-6-5-14(11-30-19)23(25,26)27/h1-8,11,13,17-18H,9-10,12H2 HUKWIAXQBOHZIX-UHFFFAOYSA-N 143750 US8969352, 27::US8969352, 11::US9611277, Example 86::US10183953, Example 86::US9845333, 27 Orexin receptor type 2 Human 1475 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143750 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143750&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271787 251972337 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611023 COc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C24H21F3N4O3/c1-33-16-4-5-17(18(11-16)22-28-7-2-8-29-22)23(32)31-13-14-9-19(31)20(10-14)34-21-6-3-15(12-30-21)24(25,26)27/h2-8,11-12,14,19-20H,9-10,13H2,1H3 DSTQNGFYZOHDRW-UHFFFAOYSA-N 143751 US8969352, 12::US9611277, Example 12::US10183953, Example 12::US9845333, 12 Orexin/Hypocretin receptor type 1 Rat 44.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143751 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143751&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271788 251972338 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611024 COc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C24H21F3N4O3/c1-33-16-4-5-17(18(11-16)22-28-7-2-8-29-22)23(32)31-13-14-9-19(31)20(10-14)34-21-6-3-15(12-30-21)24(25,26)27/h2-8,11-12,14,19-20H,9-10,13H2,1H3 DSTQNGFYZOHDRW-UHFFFAOYSA-N 143751 US8969352, 12::US9611277, Example 12::US10183953, Example 12::US9845333, 12 Orexin/Hypocretin receptor type 1 Human 59.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143751 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143751&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271788 251972338 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611025 COc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C24H21F3N4O3/c1-33-16-4-5-17(18(11-16)22-28-7-2-8-29-22)23(32)31-13-14-9-19(31)20(10-14)34-21-6-3-15(12-30-21)24(25,26)27/h2-8,11-12,14,19-20H,9-10,13H2,1H3 DSTQNGFYZOHDRW-UHFFFAOYSA-N 143751 US8969352, 12::US9611277, Example 12::US10183953, Example 12::US9845333, 12 Orexin receptor type 2 Human >10000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143751 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143751&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271788 251972338 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611026 COc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C22H20F3N5O3/c1-32-15-3-4-16(17(10-15)30-27-6-7-28-30)21(31)29-12-13-8-18(29)19(9-13)33-20-5-2-14(11-26-20)22(23,24)25/h2-7,10-11,13,18-19H,8-9,12H2,1H3 JAACBBVXXQKQLD-UHFFFAOYSA-N 143752 US8969352, 13::US9611277, Example 13::US10183953, Example 13::US9845333, 13 Orexin/Hypocretin receptor type 1 Rat 52.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143752 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143752&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271789 251972339 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611027 COc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C22H20F3N5O3/c1-32-15-3-4-16(17(10-15)30-27-6-7-28-30)21(31)29-12-13-8-18(29)19(9-13)33-20-5-2-14(11-26-20)22(23,24)25/h2-7,10-11,13,18-19H,8-9,12H2,1H3 JAACBBVXXQKQLD-UHFFFAOYSA-N 143752 US8969352, 13::US9611277, Example 13::US10183953, Example 13::US9845333, 13 Orexin/Hypocretin receptor type 1 Human 109 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143752 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143752&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271789 251972339 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611028 COc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C22H20F3N5O3/c1-32-15-3-4-16(17(10-15)30-27-6-7-28-30)21(31)29-12-13-8-18(29)19(9-13)33-20-5-2-14(11-26-20)22(23,24)25/h2-7,10-11,13,18-19H,8-9,12H2,1H3 JAACBBVXXQKQLD-UHFFFAOYSA-N 143752 US8969352, 13::US9611277, Example 13::US10183953, Example 13::US9845333, 13 Orexin receptor type 2 Human >10000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143752 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143752&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271789 251972339 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611029 Fc1ccc(c(c1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H17F4N5O2/c22-14-2-3-16(30-27-5-6-28-30)15(9-14)20(31)29-11-12-7-17(29)18(8-12)32-19-4-1-13(10-26-19)21(23,24)25/h1-6,9-10,12,17-18H,7-8,11H2 PSMGZVKVWYLIHB-UHFFFAOYSA-N 143753 US8969352, 43::US8969352, 14::US9611277, Example 43::US10183953, Example 43::US9845333, 43 Orexin/Hypocretin receptor type 1 Rat 16.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143753 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143753&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271790 251972340 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611030 Fc1ccc(c(c1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H17F4N5O2/c22-14-2-3-16(30-27-5-6-28-30)15(9-14)20(31)29-11-12-7-17(29)18(8-12)32-19-4-1-13(10-26-19)21(23,24)25/h1-6,9-10,12,17-18H,7-8,11H2 PSMGZVKVWYLIHB-UHFFFAOYSA-N 143753 US8969352, 43::US8969352, 14::US9611277, Example 43::US10183953, Example 43::US9845333, 43 Orexin/Hypocretin receptor type 1 Human 21.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143753 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143753&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271790 251972340 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611031 Fc1ccc(c(c1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H17F4N5O2/c22-14-2-3-16(30-27-5-6-28-30)15(9-14)20(31)29-11-12-7-17(29)18(8-12)32-19-4-1-13(10-26-19)21(23,24)25/h1-6,9-10,12,17-18H,7-8,11H2 PSMGZVKVWYLIHB-UHFFFAOYSA-N 143753 US8969352, 43::US8969352, 14::US9611277, Example 43::US10183953, Example 43::US9845333, 43 Orexin receptor type 2 Human 855 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143753 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143753&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271790 251972340 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611032 COc1cccc(c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:15:14:10.11:27,8:10:14.13:27| InChI=1S/C22H20F3N5O3/c1-32-17-4-2-3-15(30-27-7-8-28-30)20(17)21(31)29-12-13-9-16(29)18(10-13)33-19-6-5-14(11-26-19)22(23,24)25/h2-8,11,13,16,18H,9-10,12H2,1H3 XSMDMCQWMREAHT-UHFFFAOYSA-N 143754 US8969352, 15::US9611277, Example 15::US10183953, Example 15::US9845333, 15 Orexin/Hypocretin receptor type 1 Rat 17.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143754 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143754&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271881 251972341 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611033 COc1cccc(c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:15:14:10.11:27,8:10:14.13:27| InChI=1S/C22H20F3N5O3/c1-32-17-4-2-3-15(30-27-7-8-28-30)20(17)21(31)29-12-13-9-16(29)18(10-13)33-19-6-5-14(11-26-19)22(23,24)25/h2-8,11,13,16,18H,9-10,12H2,1H3 XSMDMCQWMREAHT-UHFFFAOYSA-N 143754 US8969352, 15::US9611277, Example 15::US10183953, Example 15::US9845333, 15 Orexin/Hypocretin receptor type 1 Human 40.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143754 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143754&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271881 251972341 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611034 COc1cccc(c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:15:14:10.11:27,8:10:14.13:27| InChI=1S/C22H20F3N5O3/c1-32-17-4-2-3-15(30-27-7-8-28-30)20(17)21(31)29-12-13-9-16(29)18(10-13)33-19-6-5-14(11-26-19)22(23,24)25/h2-8,11,13,16,18H,9-10,12H2,1H3 XSMDMCQWMREAHT-UHFFFAOYSA-N 143754 US8969352, 15::US9611277, Example 15::US10183953, Example 15::US9845333, 15 Orexin receptor type 2 Human 229 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143754 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143754&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271881 251972341 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611035 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C21H17F4N5O2/c22-15-3-1-2-14(19(15)30-27-6-7-28-30)20(31)29-11-12-8-16(29)17(9-12)32-18-5-4-13(10-26-18)21(23,24)25/h1-7,10,12,16-17H,8-9,11H2 VEJWAVKRPRJLDD-UHFFFAOYSA-N 143755 US8969352, 35::US8969352, 16::US9611277, Example 35::US10183953, Example 35::US9845333, 35 Orexin/Hypocretin receptor type 1 Rat 8.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143755 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143755&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271882 251972342 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611036 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C21H17F4N5O2/c22-15-3-1-2-14(19(15)30-27-6-7-28-30)20(31)29-11-12-8-16(29)17(9-12)32-18-5-4-13(10-26-18)21(23,24)25/h1-7,10,12,16-17H,8-9,11H2 VEJWAVKRPRJLDD-UHFFFAOYSA-N 143755 US8969352, 35::US8969352, 16::US9611277, Example 35::US10183953, Example 35::US9845333, 35 Orexin/Hypocretin receptor type 1 Human 7.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143755 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143755&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271882 251972342 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611037 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C21H17F4N5O2/c22-15-3-1-2-14(19(15)30-27-6-7-28-30)20(31)29-11-12-8-16(29)17(9-12)32-18-5-4-13(10-26-18)21(23,24)25/h1-7,10,12,16-17H,8-9,11H2 VEJWAVKRPRJLDD-UHFFFAOYSA-N 143755 US8969352, 35::US8969352, 16::US9611277, Example 35::US10183953, Example 35::US9845333, 35 Orexin receptor type 2 Human 1000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143755 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143755&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271882 251972342 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611038 Cc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C22H20F3N5O2/c1-13-3-2-4-16(20(13)30-27-7-8-28-30)21(31)29-12-14-9-17(29)18(10-14)32-19-6-5-15(11-26-19)22(23,24)25/h2-8,11,14,17-18H,9-10,12H2,1H3 VMCVDMDKIAUUAU-UHFFFAOYSA-N 143756 US8969352, 17::US9611277, Example 17::US10183953, Example 17::US9845333, 17 Orexin/Hypocretin receptor type 1 Rat 8.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143756 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143756&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271883 251972343 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611039 Cc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C22H20F3N5O2/c1-13-3-2-4-16(20(13)30-27-7-8-28-30)21(31)29-12-14-9-17(29)18(10-14)32-19-6-5-15(11-26-19)22(23,24)25/h2-8,11,14,17-18H,9-10,12H2,1H3 VMCVDMDKIAUUAU-UHFFFAOYSA-N 143756 US8969352, 17::US9611277, Example 17::US10183953, Example 17::US9845333, 17 Orexin/Hypocretin receptor type 1 Human 3.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143756 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143756&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271883 251972343 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611040 Cc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C22H20F3N5O2/c1-13-3-2-4-16(20(13)30-27-7-8-28-30)21(31)29-12-14-9-17(29)18(10-14)32-19-6-5-15(11-26-19)22(23,24)25/h2-8,11,14,17-18H,9-10,12H2,1H3 VMCVDMDKIAUUAU-UHFFFAOYSA-N 143756 US8969352, 17::US9611277, Example 17::US10183953, Example 17::US9845333, 17 Orexin receptor type 2 Human 234 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143756 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143756&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271883 251972343 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611041 Fc1cccc(c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H17F4N5O2/c22-14-2-1-3-15(30-27-6-7-28-30)19(14)20(31)29-11-12-8-16(29)17(9-12)32-18-5-4-13(10-26-18)21(23,24)25/h1-7,10,12,16-17H,8-9,11H2 SGBSAQGVDFRKJX-UHFFFAOYSA-N 143757 US8969352, 46::US8969352, 18::US9611277, Example 46::US10183953, Example 46::US9845333, 46 Orexin/Hypocretin receptor type 1 Rat 25.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143757 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143757&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271884 251972344 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611042 Fc1cccc(c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H17F4N5O2/c22-14-2-1-3-15(30-27-6-7-28-30)19(14)20(31)29-11-12-8-16(29)17(9-12)32-18-5-4-13(10-26-18)21(23,24)25/h1-7,10,12,16-17H,8-9,11H2 SGBSAQGVDFRKJX-UHFFFAOYSA-N 143757 US8969352, 46::US8969352, 18::US9611277, Example 46::US10183953, Example 46::US9845333, 46 Orexin/Hypocretin receptor type 1 Human 23.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143757 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143757&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271884 251972344 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611043 Fc1cccc(c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H17F4N5O2/c22-14-2-1-3-15(30-27-6-7-28-30)19(14)20(31)29-11-12-8-16(29)17(9-12)32-18-5-4-13(10-26-18)21(23,24)25/h1-7,10,12,16-17H,8-9,11H2 SGBSAQGVDFRKJX-UHFFFAOYSA-N 143757 US8969352, 46::US8969352, 18::US9611277, Example 46::US10183953, Example 46::US9845333, 46 Orexin receptor type 2 Human 1800 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143757 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143757&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271884 251972344 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611044 Fc1ccc(-c2ncccn2)c(c1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H18F4N4O2/c24-15-3-4-16(21-28-6-1-7-29-21)17(10-15)22(32)31-12-13-8-18(31)19(9-13)33-20-5-2-14(11-30-20)23(25,26)27/h1-7,10-11,13,18-19H,8-9,12H2 MSBDPMYPBOZFHI-UHFFFAOYSA-N 143758 US8969352, 19::US9611277, Example 19::US10183953, Example 19::US9845333, 19 Orexin/Hypocretin receptor type 1 Rat 18.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143758 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143758&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 90416120 251972345 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611045 Fc1ccc(-c2ncccn2)c(c1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H18F4N4O2/c24-15-3-4-16(21-28-6-1-7-29-21)17(10-15)22(32)31-12-13-8-18(31)19(9-13)33-20-5-2-14(11-30-20)23(25,26)27/h1-7,10-11,13,18-19H,8-9,12H2 MSBDPMYPBOZFHI-UHFFFAOYSA-N 143758 US8969352, 19::US9611277, Example 19::US10183953, Example 19::US9845333, 19 Orexin/Hypocretin receptor type 1 Human 9.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143758 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143758&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 90416120 251972345 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611046 Fc1ccc(-c2ncccn2)c(c1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H18F4N4O2/c24-15-3-4-16(21-28-6-1-7-29-21)17(10-15)22(32)31-12-13-8-18(31)19(9-13)33-20-5-2-14(11-30-20)23(25,26)27/h1-7,10-11,13,18-19H,8-9,12H2 MSBDPMYPBOZFHI-UHFFFAOYSA-N 143758 US8969352, 19::US9611277, Example 19::US10183953, Example 19::US9845333, 19 Orexin receptor type 2 Human 945 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143758 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143758&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 90416120 251972345 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611047 Fc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C23H18F4N4O2/c24-15-3-4-16(17(10-15)21-28-6-1-7-29-21)22(32)31-12-13-8-18(31)19(9-13)33-20-5-2-14(11-30-20)23(25,26)27/h1-7,10-11,13,18-19H,8-9,12H2 AXZNZGVQOXKZLA-UHFFFAOYSA-N 143759 US8969352, 26::US8969352, 27::US8969352, 20::US9611277, Example 26::US10183953, Example 26::US9845333, 26 Orexin/Hypocretin receptor type 1 Rat 15.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143759 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143759&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271886 251972346 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611048 Fc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C23H18F4N4O2/c24-15-3-4-16(17(10-15)21-28-6-1-7-29-21)22(32)31-12-13-8-18(31)19(9-13)33-20-5-2-14(11-30-20)23(25,26)27/h1-7,10-11,13,18-19H,8-9,12H2 AXZNZGVQOXKZLA-UHFFFAOYSA-N 143759 US8969352, 26::US8969352, 27::US8969352, 20::US9611277, Example 26::US10183953, Example 26::US9845333, 26 Orexin/Hypocretin receptor type 1 Human 15.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143759 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143759&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271886 251972346 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611049 Fc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C23H18F4N4O2/c24-15-3-4-16(17(10-15)21-28-6-1-7-29-21)22(32)31-12-13-8-18(31)19(9-13)33-20-5-2-14(11-30-20)23(25,26)27/h1-7,10-11,13,18-19H,8-9,12H2 AXZNZGVQOXKZLA-UHFFFAOYSA-N 143759 US8969352, 26::US8969352, 27::US8969352, 20::US9611277, Example 26::US10183953, Example 26::US9845333, 26 Orexin receptor type 2 Human 2700 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143759 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143759&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271886 251972346 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611050 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2cnnc2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143760 US8969352, 21::US9611277, Example 21::US10183953, Example 21::US9845333, 21 Orexin/Hypocretin receptor type 1 Rat >10000 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143760 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143760&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271970 251972347 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611051 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2cnnc2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143760 US8969352, 21::US9611277, Example 21::US10183953, Example 21::US9845333, 21 Orexin receptor type 2 Human >10000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143760 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143760&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271970 251972347 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611052 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H19F3N6O2/c1-12-2-4-15(30-26-6-7-27-30)19(28-12)20(31)29-11-13-8-16(29)17(9-13)32-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,16-17H,8-9,11H2,1H3 DIVFYQCMVDWPOD-UHFFFAOYSA-N 143761 US8969352, 23::US8969352, 24::US8969352, 25::US8969352, 22::US9611277, Example 25::US10183953, Example 25::US9845333, 25 Orexin/Hypocretin receptor type 1 Rat 25.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143761 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143761&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271694 251972348 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611053 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H19F3N6O2/c1-12-2-4-15(30-26-6-7-27-30)19(28-12)20(31)29-11-13-8-16(29)17(9-13)32-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,16-17H,8-9,11H2,1H3 DIVFYQCMVDWPOD-UHFFFAOYSA-N 143761 US8969352, 23::US8969352, 24::US8969352, 25::US8969352, 22::US9611277, Example 25::US10183953, Example 25::US9845333, 25 Orexin/Hypocretin receptor type 1 Human 23.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143761 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143761&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271694 251972348 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611054 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H19F3N6O2/c1-12-2-4-15(30-26-6-7-27-30)19(28-12)20(31)29-11-13-8-16(29)17(9-13)32-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,16-17H,8-9,11H2,1H3 DIVFYQCMVDWPOD-UHFFFAOYSA-N 143761 US8969352, 23::US8969352, 24::US8969352, 25::US8969352, 22::US9611277, Example 25::US10183953, Example 25::US9845333, 25 Orexin receptor type 2 Human 1000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143761 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143761&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271694 251972348 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611055 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H19F3N6O2/c1-12-2-4-15(30-26-6-7-27-30)19(28-12)20(31)29-11-13-8-16(29)17(9-13)32-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,16-17H,8-9,11H2,1H3 DIVFYQCMVDWPOD-UHFFFAOYSA-N 143761 US8969352, 23::US8969352, 24::US8969352, 25::US8969352, 22::US9611277, Example 25::US10183953, Example 25::US9845333, 25 Orexin/Hypocretin receptor type 1 Rat >10000 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143761 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143761&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271694 251972348 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611056 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H19F3N6O2/c1-12-2-4-15(30-26-6-7-27-30)19(28-12)20(31)29-11-13-8-16(29)17(9-13)32-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,16-17H,8-9,11H2,1H3 DIVFYQCMVDWPOD-UHFFFAOYSA-N 143761 US8969352, 23::US8969352, 24::US8969352, 25::US8969352, 22::US9611277, Example 25::US10183953, Example 25::US9845333, 25 Orexin receptor type 2 Human >10000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143761 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143761&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271694 251972348 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611057 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H19F3N6O2/c1-12-2-4-15(30-26-6-7-27-30)19(28-12)20(31)29-11-13-8-16(29)17(9-13)32-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,16-17H,8-9,11H2,1H3 DIVFYQCMVDWPOD-UHFFFAOYSA-N 143761 US8969352, 23::US8969352, 24::US8969352, 25::US8969352, 22::US9611277, Example 25::US10183953, Example 25::US9845333, 25 Orexin/Hypocretin receptor type 1 Rat 20.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143761 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143761&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271694 251972348 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611058 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H19F3N6O2/c1-12-2-4-15(30-26-6-7-27-30)19(28-12)20(31)29-11-13-8-16(29)17(9-13)32-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,16-17H,8-9,11H2,1H3 DIVFYQCMVDWPOD-UHFFFAOYSA-N 143761 US8969352, 23::US8969352, 24::US8969352, 25::US8969352, 22::US9611277, Example 25::US10183953, Example 25::US9845333, 25 Orexin/Hypocretin receptor type 1 Human 16.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143761 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143761&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271694 251972348 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611059 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H19F3N6O2/c1-12-2-4-15(30-26-6-7-27-30)19(28-12)20(31)29-11-13-8-16(29)17(9-13)32-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,16-17H,8-9,11H2,1H3 DIVFYQCMVDWPOD-UHFFFAOYSA-N 143761 US8969352, 23::US8969352, 24::US8969352, 25::US8969352, 22::US9611277, Example 25::US10183953, Example 25::US9845333, 25 Orexin receptor type 2 Human 692 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143761 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143761&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271694 251972348 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611060 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H19F3N6O2/c1-12-2-4-15(30-26-6-7-27-30)19(28-12)20(31)29-11-13-8-16(29)17(9-13)32-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,16-17H,8-9,11H2,1H3 DIVFYQCMVDWPOD-UHFFFAOYSA-N 143761 US8969352, 23::US8969352, 24::US8969352, 25::US8969352, 22::US9611277, Example 25::US10183953, Example 25::US9845333, 25 Orexin/Hypocretin receptor type 1 Rat 17.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143761 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143761&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271694 251972348 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611061 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H19F3N6O2/c1-12-2-4-15(30-26-6-7-27-30)19(28-12)20(31)29-11-13-8-16(29)17(9-13)32-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,16-17H,8-9,11H2,1H3 DIVFYQCMVDWPOD-UHFFFAOYSA-N 143761 US8969352, 23::US8969352, 24::US8969352, 25::US8969352, 22::US9611277, Example 25::US10183953, Example 25::US9845333, 25 Orexin/Hypocretin receptor type 1 Human 15.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143761 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143761&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271694 251972348 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611062 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H19F3N6O2/c1-12-2-4-15(30-26-6-7-27-30)19(28-12)20(31)29-11-13-8-16(29)17(9-13)32-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,16-17H,8-9,11H2,1H3 DIVFYQCMVDWPOD-UHFFFAOYSA-N 143761 US8969352, 23::US8969352, 24::US8969352, 25::US8969352, 22::US9611277, Example 25::US10183953, Example 25::US9845333, 25 Orexin receptor type 2 Human 466 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143761 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143761&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271694 251972348 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611063 Fc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C23H18F4N4O2/c24-15-3-4-16(17(10-15)21-28-6-1-7-29-21)22(32)31-12-13-8-18(31)19(9-13)33-20-5-2-14(11-30-20)23(25,26)27/h1-7,10-11,13,18-19H,8-9,12H2 AXZNZGVQOXKZLA-UHFFFAOYSA-N 143759 US8969352, 26::US8969352, 27::US8969352, 20::US9611277, Example 26::US10183953, Example 26::US9845333, 26 Orexin/Hypocretin receptor type 1 Rat 12.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143759 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143759&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271886 251972346 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611064 Fc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C23H18F4N4O2/c24-15-3-4-16(17(10-15)21-28-6-1-7-29-21)22(32)31-12-13-8-18(31)19(9-13)33-20-5-2-14(11-30-20)23(25,26)27/h1-7,10-11,13,18-19H,8-9,12H2 AXZNZGVQOXKZLA-UHFFFAOYSA-N 143759 US8969352, 26::US8969352, 27::US8969352, 20::US9611277, Example 26::US10183953, Example 26::US9845333, 26 Orexin/Hypocretin receptor type 1 Human 15.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143759 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143759&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271886 251972346 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611065 Fc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C23H18F4N4O2/c24-15-3-4-16(17(10-15)21-28-6-1-7-29-21)22(32)31-12-13-8-18(31)19(9-13)33-20-5-2-14(11-30-20)23(25,26)27/h1-7,10-11,13,18-19H,8-9,12H2 AXZNZGVQOXKZLA-UHFFFAOYSA-N 143759 US8969352, 26::US8969352, 27::US8969352, 20::US9611277, Example 26::US10183953, Example 26::US9845333, 26 Orexin receptor type 2 Human 2100 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143759 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143759&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271886 251972346 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611066 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C23H18F4N4O2/c24-16-4-1-3-15(20(16)21-28-7-2-8-29-21)22(32)31-12-13-9-17(31)18(10-13)33-19-6-5-14(11-30-19)23(25,26)27/h1-8,11,13,17-18H,9-10,12H2 HUKWIAXQBOHZIX-UHFFFAOYSA-N 143750 US8969352, 27::US8969352, 11::US9611277, Example 86::US10183953, Example 86::US9845333, 27 Orexin/Hypocretin receptor type 1 Rat 4.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143750 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143750&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271787 251972337 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611067 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C23H18F4N4O2/c24-16-4-1-3-15(20(16)21-28-7-2-8-29-21)22(32)31-12-13-9-17(31)18(10-13)33-19-6-5-14(11-30-19)23(25,26)27/h1-8,11,13,17-18H,9-10,12H2 HUKWIAXQBOHZIX-UHFFFAOYSA-N 143750 US8969352, 27::US8969352, 11::US9611277, Example 86::US10183953, Example 86::US9845333, 27 Orexin/Hypocretin receptor type 1 Human 4.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143750 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143750&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271787 251972337 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611068 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C23H18F4N4O2/c24-16-4-1-3-15(20(16)21-28-7-2-8-29-21)22(32)31-12-13-9-17(31)18(10-13)33-19-6-5-14(11-30-19)23(25,26)27/h1-8,11,13,17-18H,9-10,12H2 HUKWIAXQBOHZIX-UHFFFAOYSA-N 143750 US8969352, 27::US8969352, 11::US9611277, Example 86::US10183953, Example 86::US9845333, 27 Orexin receptor type 2 Human 767 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143750 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143750&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271787 251972337 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611069 Cc1cnc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H19F3N6O2/c1-12-6-16(30-27-4-5-28-30)19(26-9-12)20(31)29-11-13-7-15(29)17(8-13)32-18-3-2-14(10-25-18)21(22,23)24/h2-6,9-10,13,15,17H,7-8,11H2,1H3 OAQRBSBYWFGTPG-UHFFFAOYSA-N 143748 US8969352, 28::US8969352, 9::US9611277, Example 28::US10183953, Example 28::US9845333, 28 Orexin/Hypocretin receptor type 1 Rat 32.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143748 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143748&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271971 251972335 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611070 Cc1cnc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H19F3N6O2/c1-12-6-16(30-27-4-5-28-30)19(26-9-12)20(31)29-11-13-7-15(29)17(8-13)32-18-3-2-14(10-25-18)21(22,23)24/h2-6,9-10,13,15,17H,7-8,11H2,1H3 OAQRBSBYWFGTPG-UHFFFAOYSA-N 143748 US8969352, 28::US8969352, 9::US9611277, Example 28::US10183953, Example 28::US9845333, 28 Orexin/Hypocretin receptor type 1 Human 21.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143748 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143748&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271971 251972335 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611071 Cc1cnc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H19F3N6O2/c1-12-6-16(30-27-4-5-28-30)19(26-9-12)20(31)29-11-13-7-15(29)17(8-13)32-18-3-2-14(10-25-18)21(22,23)24/h2-6,9-10,13,15,17H,7-8,11H2,1H3 OAQRBSBYWFGTPG-UHFFFAOYSA-N 143748 US8969352, 28::US8969352, 9::US9611277, Example 28::US10183953, Example 28::US9845333, 28 Orexin receptor type 2 Human 1600 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143748 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143748&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271971 251972335 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611072 Cc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(n1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H19F3N6O2/c1-12-2-4-15(19(28-12)30-26-6-7-27-30)20(31)29-11-13-8-16(29)17(9-13)32-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,16-17H,8-9,11H2,1H3 FTIPLKXQDISZMV-UHFFFAOYSA-N 143768 US8969352, 29::US9611277, Example 29::US10183953, Example 29::US9845333, 29 Orexin/Hypocretin receptor type 1 Rat 55.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143768 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143768&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271972 251972349 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611073 Cc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(n1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H19F3N6O2/c1-12-2-4-15(19(28-12)30-26-6-7-27-30)20(31)29-11-13-8-16(29)17(9-13)32-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,16-17H,8-9,11H2,1H3 FTIPLKXQDISZMV-UHFFFAOYSA-N 143768 US8969352, 29::US9611277, Example 29::US10183953, Example 29::US9845333, 29 Orexin/Hypocretin receptor type 1 Human 47.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143768 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143768&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271972 251972349 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611074 Cc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(n1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H19F3N6O2/c1-12-2-4-15(19(28-12)30-26-6-7-27-30)20(31)29-11-13-8-16(29)17(9-13)32-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,16-17H,8-9,11H2,1H3 FTIPLKXQDISZMV-UHFFFAOYSA-N 143768 US8969352, 29::US9611277, Example 29::US10183953, Example 29::US9845333, 29 Orexin receptor type 2 Human >10000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143768 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143768&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271972 251972349 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611075 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2ncccc2-n2nccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143769 US8969352, 30::US9611277, Example 30::US10183953, Example 30::US9845333, 30 Orexin/Hypocretin receptor type 1 Rat 19.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143769 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143769&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271973 251972350 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611076 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2ncccc2-n2nccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143769 US8969352, 30::US9611277, Example 30::US10183953, Example 30::US9845333, 30 Orexin/Hypocretin receptor type 1 Human 22.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143769 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143769&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271973 251972350 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611077 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2ncccc2-n2nccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143769 US8969352, 30::US9611277, Example 30::US10183953, Example 30::US9845333, 30 Orexin receptor type 2 Human 1700 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143769 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143769&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271973 251972350 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611078 COc1c(F)cccc1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:16:15:11.12:28,9:11:15.14:28| InChI=1S/C20H18F4N2O3/c1-28-18-13(3-2-4-14(18)21)19(27)26-10-11-7-15(26)16(8-11)29-17-6-5-12(9-25-17)20(22,23)24/h2-6,9,11,15-16H,7-8,10H2,1H3 RYMOHHYAOSEKIU-UHFFFAOYSA-N 143770 US8969352, 31::US9611277, Example 31::US10183953, Example 31::US9845333, 31 Orexin/Hypocretin receptor type 1 Rat 707 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143770 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143770&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271974 251972351 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611079 COc1c(F)cccc1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:16:15:11.12:28,9:11:15.14:28| InChI=1S/C20H18F4N2O3/c1-28-18-13(3-2-4-14(18)21)19(27)26-10-11-7-15(26)16(8-11)29-17-6-5-12(9-25-17)20(22,23)24/h2-6,9,11,15-16H,7-8,10H2,1H3 RYMOHHYAOSEKIU-UHFFFAOYSA-N 143770 US8969352, 31::US9611277, Example 31::US10183953, Example 31::US9845333, 31 Orexin receptor type 2 Human >10000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143770 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143770&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271974 251972351 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611080 Cc1ccc(OC2CC3CC2N(C3)C(=O)c2cccc(C)c2-c2ncco2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 314847 (3-methyl-2-(oxazol-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 32 Orexin/Hypocretin receptor type 1 Rat 3.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314847 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314847&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 90452177 383541669 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611081 Cc1ccc(OC2CC3CC2N(C3)C(=O)c2cccc(C)c2-c2ncco2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 314847 (3-methyl-2-(oxazol-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 32 Orexin/Hypocretin receptor type 1 Human 4.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314847 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314847&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 90452177 383541669 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611082 Cc1ccc(OC2CC3CC2N(C3)C(=O)c2cccc(C)c2-c2ncco2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 314847 (3-methyl-2-(oxazol-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 32 Orexin receptor type 2 Human 143 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314847 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314847&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 90452177 383541669 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611083 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-n1ccnn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C21H17F4N5O2/c22-15-3-1-2-14(19(15)30-7-6-27-28-30)20(31)29-11-12-8-16(29)17(9-12)32-18-5-4-13(10-26-18)21(23,24)25/h1-7,10,12,16-17H,8-9,11H2 RNUWTSJVSRFNSZ-UHFFFAOYSA-N 143772 US8969352, 33::US9611277, Example 33::US10183953, Example 33::US9845333, 33 Orexin/Hypocretin receptor type 1 Rat 74.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143772 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143772&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270572 251972353 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611084 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-n1ccnn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C21H17F4N5O2/c22-15-3-1-2-14(19(15)30-7-6-27-28-30)20(31)29-11-12-8-16(29)17(9-12)32-18-5-4-13(10-26-18)21(23,24)25/h1-7,10,12,16-17H,8-9,11H2 RNUWTSJVSRFNSZ-UHFFFAOYSA-N 143772 US8969352, 33::US9611277, Example 33::US10183953, Example 33::US9845333, 33 Orexin/Hypocretin receptor type 1 Human 86.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143772 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143772&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270572 251972353 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611085 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-n1ccnn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C21H17F4N5O2/c22-15-3-1-2-14(19(15)30-7-6-27-28-30)20(31)29-11-12-8-16(29)17(9-12)32-18-5-4-13(10-26-18)21(23,24)25/h1-7,10,12,16-17H,8-9,11H2 RNUWTSJVSRFNSZ-UHFFFAOYSA-N 143772 US8969352, 33::US9611277, Example 33::US10183953, Example 33::US9845333, 33 Orexin receptor type 2 Human 3500 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143772 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143772&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270572 251972353 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611086 Cc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(n1)-n1ccnn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H19F3N6O2/c1-12-2-4-15(19(27-12)30-7-6-26-28-30)20(31)29-11-13-8-16(29)17(9-13)32-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,16-17H,8-9,11H2,1H3 ICOFMFLOEJHBPA-UHFFFAOYSA-N 143773 US8969352, 34::US9611277, Example 34::US10183953, Example 34::US9845333, 34 Orexin/Hypocretin receptor type 1 Rat 117 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143773 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143773&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 90454381 251972354 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611087 Cc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(n1)-n1ccnn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H19F3N6O2/c1-12-2-4-15(19(27-12)30-7-6-26-28-30)20(31)29-11-13-8-16(29)17(9-13)32-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,16-17H,8-9,11H2,1H3 ICOFMFLOEJHBPA-UHFFFAOYSA-N 143773 US8969352, 34::US9611277, Example 34::US10183953, Example 34::US9845333, 34 Orexin/Hypocretin receptor type 1 Human 462 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143773 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143773&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 90454381 251972354 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611088 Cc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(n1)-n1ccnn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H19F3N6O2/c1-12-2-4-15(19(27-12)30-7-6-26-28-30)20(31)29-11-13-8-16(29)17(9-13)32-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,16-17H,8-9,11H2,1H3 ICOFMFLOEJHBPA-UHFFFAOYSA-N 143773 US8969352, 34::US9611277, Example 34::US10183953, Example 34::US9845333, 34 Orexin receptor type 2 Human 1100 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143773 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143773&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 90454381 251972354 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611089 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C21H17F4N5O2/c22-15-3-1-2-14(19(15)30-27-6-7-28-30)20(31)29-11-12-8-16(29)17(9-12)32-18-5-4-13(10-26-18)21(23,24)25/h1-7,10,12,16-17H,8-9,11H2 VEJWAVKRPRJLDD-UHFFFAOYSA-N 143755 US8969352, 35::US8969352, 16::US9611277, Example 35::US10183953, Example 35::US9845333, 35 Orexin/Hypocretin receptor type 1 Rat 8.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143755 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143755&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271882 251972342 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611090 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C21H17F4N5O2/c22-15-3-1-2-14(19(15)30-27-6-7-28-30)20(31)29-11-12-8-16(29)17(9-12)32-18-5-4-13(10-26-18)21(23,24)25/h1-7,10,12,16-17H,8-9,11H2 VEJWAVKRPRJLDD-UHFFFAOYSA-N 143755 US8969352, 35::US8969352, 16::US9611277, Example 35::US10183953, Example 35::US9845333, 35 Orexin/Hypocretin receptor type 1 Human 3.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143755 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143755&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271882 251972342 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611091 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C21H17F4N5O2/c22-15-3-1-2-14(19(15)30-27-6-7-28-30)20(31)29-11-12-8-16(29)17(9-12)32-18-5-4-13(10-26-18)21(23,24)25/h1-7,10,12,16-17H,8-9,11H2 VEJWAVKRPRJLDD-UHFFFAOYSA-N 143755 US8969352, 35::US8969352, 16::US9611277, Example 35::US10183953, Example 35::US9845333, 35 Orexin receptor type 2 Human 542 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143755 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143755&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271882 251972342 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611092 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143746 US8969352, 36::US8969352, 7::US9611277, Example 36::US10183953, Example 36::US9845333, 36 Orexin/Hypocretin receptor type 1 Rat 5.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143746 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143746&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271693 251972333 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611093 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143746 US8969352, 36::US8969352, 7::US9611277, Example 36::US10183953, Example 36::US9845333, 36 Orexin/Hypocretin receptor type 1 Human 11.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143746 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143746&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271693 251972333 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611094 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143746 US8969352, 36::US8969352, 7::US9611277, Example 36::US10183953, Example 36::US9845333, 36 Orexin receptor type 2 Human 322 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143746 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143746&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271693 251972333 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611095 CCOc1ccc(C)nc1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:17:16:12.13:29,10:12:16.15:29| InChI=1S/C21H22F3N3O3/c1-3-29-16-6-4-12(2)26-19(16)20(28)27-11-13-8-15(27)17(9-13)30-18-7-5-14(10-25-18)21(22,23)24/h4-7,10,13,15,17H,3,8-9,11H2,1-2H3 HBQVLSLDECXOPX-UHFFFAOYSA-N 143776 US8969352, 37::US9611277, Example 37::US10183953, Example 37::US9845333, 37 Orexin/Hypocretin receptor type 1 Rat 170 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143776 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143776&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270574 251972355 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611096 CCOc1ccc(C)nc1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:17:16:12.13:29,10:12:16.15:29| InChI=1S/C21H22F3N3O3/c1-3-29-16-6-4-12(2)26-19(16)20(28)27-11-13-8-15(27)17(9-13)30-18-7-5-14(10-25-18)21(22,23)24/h4-7,10,13,15,17H,3,8-9,11H2,1-2H3 HBQVLSLDECXOPX-UHFFFAOYSA-N 143776 US8969352, 37::US9611277, Example 37::US10183953, Example 37::US9845333, 37 Orexin/Hypocretin receptor type 1 Human 265 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143776 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143776&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270574 251972355 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611097 CCOc1ccc(C)nc1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:17:16:12.13:29,10:12:16.15:29| InChI=1S/C21H22F3N3O3/c1-3-29-16-6-4-12(2)26-19(16)20(28)27-11-13-8-15(27)17(9-13)30-18-7-5-14(10-25-18)21(22,23)24/h4-7,10,13,15,17H,3,8-9,11H2,1-2H3 HBQVLSLDECXOPX-UHFFFAOYSA-N 143776 US8969352, 37::US9611277, Example 37::US10183953, Example 37::US9845333, 37 Orexin receptor type 2 Human 1800 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143776 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143776&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270574 251972355 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611098 Fc1cccc(-c2ncccn2)c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H18F4N4O2/c24-16-4-1-3-15(21-28-7-2-8-29-21)20(16)22(32)31-12-13-9-17(31)18(10-13)33-19-6-5-14(11-30-19)23(25,26)27/h1-8,11,13,17-18H,9-10,12H2 IGPUBGBQVDTOBH-UHFFFAOYSA-N 143777 US8969352, 38::US9611277, Example 38::US10183953, Example 38::US9845333, 38 Orexin/Hypocretin receptor type 1 Rat 8.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143777 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143777&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271885 251972356 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611099 Fc1cccc(-c2ncccn2)c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H18F4N4O2/c24-16-4-1-3-15(21-28-7-2-8-29-21)20(16)22(32)31-12-13-9-17(31)18(10-13)33-19-6-5-14(11-30-19)23(25,26)27/h1-8,11,13,17-18H,9-10,12H2 IGPUBGBQVDTOBH-UHFFFAOYSA-N 143777 US8969352, 38::US9611277, Example 38::US10183953, Example 38::US9845333, 38 Orexin/Hypocretin receptor type 1 Human 8.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143777 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143777&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271885 251972356 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611100 Fc1cccc(-c2ncccn2)c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H18F4N4O2/c24-16-4-1-3-15(21-28-7-2-8-29-21)20(16)22(32)31-12-13-9-17(31)18(10-13)33-19-6-5-14(11-30-19)23(25,26)27/h1-8,11,13,17-18H,9-10,12H2 IGPUBGBQVDTOBH-UHFFFAOYSA-N 143777 US8969352, 38::US9611277, Example 38::US10183953, Example 38::US9845333, 38 Orexin receptor type 2 Human 690 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143777 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143777&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271885 251972356 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611101 COc1cccc(-c2ccn[nH]2)c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H21F3N4O3/c1-32-18-4-2-3-15(16-7-8-28-29-16)21(18)22(31)30-12-13-9-17(30)19(10-13)33-20-6-5-14(11-27-20)23(24,25)26/h2-8,11,13,17,19H,9-10,12H2,1H3,(H,28,29) CTMWEIJXXSCTJH-UHFFFAOYSA-N 143778 US8969352, 39::US9611277, Example 39::US10183953, Example 39::US9845333, 39 Orexin/Hypocretin receptor type 1 Rat 132 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143778 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143778&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270575 251972357 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611102 COc1cccc(-c2ccn[nH]2)c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H21F3N4O3/c1-32-18-4-2-3-15(16-7-8-28-29-16)21(18)22(31)30-12-13-9-17(30)19(10-13)33-20-6-5-14(11-27-20)23(24,25)26/h2-8,11,13,17,19H,9-10,12H2,1H3,(H,28,29) CTMWEIJXXSCTJH-UHFFFAOYSA-N 143778 US8969352, 39::US9611277, Example 39::US10183953, Example 39::US9845333, 39 Orexin/Hypocretin receptor type 1 Human 17.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143778 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143778&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270575 251972357 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611103 COc1cccc(-c2ccn[nH]2)c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H21F3N4O3/c1-32-18-4-2-3-15(16-7-8-28-29-16)21(18)22(31)30-12-13-9-17(30)19(10-13)33-20-6-5-14(11-27-20)23(24,25)26/h2-8,11,13,17,19H,9-10,12H2,1H3,(H,28,29) CTMWEIJXXSCTJH-UHFFFAOYSA-N 143778 US8969352, 39::US9611277, Example 39::US10183953, Example 39::US9845333, 39 Orexin receptor type 2 Human 108 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143778 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143778&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270575 251972357 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611104 COc1cccc(-c2ncccn2)c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:21:20:16.17:33,14:16:20.19:33| InChI=1S/C24H21F3N4O3/c1-33-18-5-2-4-16(22-28-8-3-9-29-22)21(18)23(32)31-13-14-10-17(31)19(11-14)34-20-7-6-15(12-30-20)24(25,26)27/h2-9,12,14,17,19H,10-11,13H2,1H3 YREUWZWUXFUQNJ-UHFFFAOYSA-N 143779 US8969352, 40::US9611277, Example 40::US10183953, Example 40::US9845333, 40 Orexin/Hypocretin receptor type 1 Rat 16.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143779 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143779&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270576 251972358 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611105 COc1cccc(-c2ncccn2)c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:21:20:16.17:33,14:16:20.19:33| InChI=1S/C24H21F3N4O3/c1-33-18-5-2-4-16(22-28-8-3-9-29-22)21(18)23(32)31-13-14-10-17(31)19(11-14)34-20-7-6-15(12-30-20)24(25,26)27/h2-9,12,14,17,19H,10-11,13H2,1H3 YREUWZWUXFUQNJ-UHFFFAOYSA-N 143779 US8969352, 40::US9611277, Example 40::US10183953, Example 40::US9845333, 40 Orexin/Hypocretin receptor type 1 Human 9.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143779 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143779&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270576 251972358 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611106 COc1cccc(-c2ncccn2)c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:21:20:16.17:33,14:16:20.19:33| InChI=1S/C24H21F3N4O3/c1-33-18-5-2-4-16(22-28-8-3-9-29-22)21(18)23(32)31-13-14-10-17(31)19(11-14)34-20-7-6-15(12-30-20)24(25,26)27/h2-9,12,14,17,19H,10-11,13H2,1H3 YREUWZWUXFUQNJ-UHFFFAOYSA-N 143779 US8969352, 40::US9611277, Example 40::US10183953, Example 40::US9845333, 40 Orexin receptor type 2 Human 340 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143779 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143779&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270576 251972358 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611107 Cc1cnn(C)c1-c1ccccc1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32,(.61,-1.24,;1.38,-2.58,;.9,-4.04,;2.15,-4.95,;3.4,-4.04,;4.73,-4.81,;2.92,-2.58,;4.01,-1.49,;5.5,-1.89,;6.59,-.8,;6.19,.69,;4.7,1.09,;3.61,-0,;2.12,.4,;1.03,-.69,;1.72,1.88,;2.5,3.22,;1.01,3.62,;-.48,3.22,;-1.25,1.88,;-1.25,.34,;-2.58,-.43,;-2.58,-1.97,;-3.92,-2.74,;-5.35,-1.98,;-5.25,-.43,;-3.92,.34,;-6.69,-2.74,;-8.03,-3.49,;-7.44,-1.4,;-5.93,-4.08,;.24,2.28,;.24,4.95,)| InChI=1S/C24H23F3N4O2/c1-14-11-29-30(2)22(14)17-5-3-4-6-18(17)23(32)31-13-15-9-19(31)20(10-15)33-21-8-7-16(12-28-21)24(25,26)27/h3-8,11-12,15,19-20H,9-10,13H2,1-2H3 JHIBIGDVURAFGJ-UHFFFAOYSA-N 143780 US8969352, 41::US9611277, Example 41::US10183953, Example 41::US9845333, 41 Orexin/Hypocretin receptor type 1 Rat 4399 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143780 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143780&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 90454374 251972359 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611108 Cc1cnn(C)c1-c1ccccc1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32,(.61,-1.24,;1.38,-2.58,;.9,-4.04,;2.15,-4.95,;3.4,-4.04,;4.73,-4.81,;2.92,-2.58,;4.01,-1.49,;5.5,-1.89,;6.59,-.8,;6.19,.69,;4.7,1.09,;3.61,-0,;2.12,.4,;1.03,-.69,;1.72,1.88,;2.5,3.22,;1.01,3.62,;-.48,3.22,;-1.25,1.88,;-1.25,.34,;-2.58,-.43,;-2.58,-1.97,;-3.92,-2.74,;-5.35,-1.98,;-5.25,-.43,;-3.92,.34,;-6.69,-2.74,;-8.03,-3.49,;-7.44,-1.4,;-5.93,-4.08,;.24,2.28,;.24,4.95,)| InChI=1S/C24H23F3N4O2/c1-14-11-29-30(2)22(14)17-5-3-4-6-18(17)23(32)31-13-15-9-19(31)20(10-15)33-21-8-7-16(12-28-21)24(25,26)27/h3-8,11-12,15,19-20H,9-10,13H2,1-2H3 JHIBIGDVURAFGJ-UHFFFAOYSA-N 143780 US8969352, 41::US9611277, Example 41::US10183953, Example 41::US9845333, 41 Orexin receptor type 2 Human >10000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143780 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143780&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 90454374 251972359 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611109 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2cccc3cc[nH]c23)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143781 US8969352, 42::US9611277, Example 42::US10183953, Example 42::US9845333, 42 Orexin/Hypocretin receptor type 1 Rat 184 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143781 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143781&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270656 251972360 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611110 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2cccc3cc[nH]c23)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143781 US8969352, 42::US9611277, Example 42::US10183953, Example 42::US9845333, 42 Orexin/Hypocretin receptor type 1 Human 175 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143781 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143781&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270656 251972360 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611111 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2cccc3cc[nH]c23)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143781 US8969352, 42::US9611277, Example 42::US10183953, Example 42::US9845333, 42 Orexin receptor type 2 Human 5800 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143781 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143781&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270656 251972360 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611112 Fc1ccc(c(c1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H17F4N5O2/c22-14-2-3-16(30-27-5-6-28-30)15(9-14)20(31)29-11-12-7-17(29)18(8-12)32-19-4-1-13(10-26-19)21(23,24)25/h1-6,9-10,12,17-18H,7-8,11H2 PSMGZVKVWYLIHB-UHFFFAOYSA-N 143753 US8969352, 43::US8969352, 14::US9611277, Example 43::US10183953, Example 43::US9845333, 43 Orexin/Hypocretin receptor type 1 Rat 16.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143753 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143753&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271790 251972340 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611113 Fc1ccc(c(c1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H17F4N5O2/c22-14-2-3-16(30-27-5-6-28-30)15(9-14)20(31)29-11-12-7-17(29)18(8-12)32-19-4-1-13(10-26-19)21(23,24)25/h1-6,9-10,12,17-18H,7-8,11H2 PSMGZVKVWYLIHB-UHFFFAOYSA-N 143753 US8969352, 43::US8969352, 14::US9611277, Example 43::US10183953, Example 43::US9845333, 43 Orexin/Hypocretin receptor type 1 Human 8.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143753 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143753&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271790 251972340 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611114 Fc1ccc(c(c1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H17F4N5O2/c22-14-2-3-16(30-27-5-6-28-30)15(9-14)20(31)29-11-12-7-17(29)18(8-12)32-19-4-1-13(10-26-19)21(23,24)25/h1-6,9-10,12,17-18H,7-8,11H2 PSMGZVKVWYLIHB-UHFFFAOYSA-N 143753 US8969352, 43::US8969352, 14::US9611277, Example 43::US10183953, Example 43::US9845333, 43 Orexin receptor type 2 Human 557 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143753 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143753&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271790 251972340 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611115 Fc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H17F4N5O2/c22-14-2-3-15(16(9-14)30-27-5-6-28-30)20(31)29-11-12-7-17(29)18(8-12)32-19-4-1-13(10-26-19)21(23,24)25/h1-6,9-10,12,17-18H,7-8,11H2 NOXUACCAWHVGCM-UHFFFAOYSA-N 143783 US8969352, 44::US9611277, Example 44::US10183953, Example 44::US9845333, 44 Orexin/Hypocretin receptor type 1 Rat 22.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143783 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143783&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270657 251972361 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611116 Fc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H17F4N5O2/c22-14-2-3-15(16(9-14)30-27-5-6-28-30)20(31)29-11-12-7-17(29)18(8-12)32-19-4-1-13(10-26-19)21(23,24)25/h1-6,9-10,12,17-18H,7-8,11H2 NOXUACCAWHVGCM-UHFFFAOYSA-N 143783 US8969352, 44::US9611277, Example 44::US10183953, Example 44::US9845333, 44 Orexin/Hypocretin receptor type 1 Human 42.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143783 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143783&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270657 251972361 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611117 Fc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H17F4N5O2/c22-14-2-3-15(16(9-14)30-27-5-6-28-30)20(31)29-11-12-7-17(29)18(8-12)32-19-4-1-13(10-26-19)21(23,24)25/h1-6,9-10,12,17-18H,7-8,11H2 NOXUACCAWHVGCM-UHFFFAOYSA-N 143783 US8969352, 44::US9611277, Example 44::US10183953, Example 44::US9845333, 44 Orexin receptor type 2 Human 2198 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143783 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143783&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270657 251972361 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611118 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1Br |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C19H15BrF4N2O2/c20-17-12(2-1-3-13(17)21)18(27)26-9-10-6-14(26)15(7-10)28-16-5-4-11(8-25-16)19(22,23)24/h1-5,8,10,14-15H,6-7,9H2 QSCWUOPMXMROKO-UHFFFAOYSA-N 143784 US8969352, 45::US9611277, Example 45::US10183953, Example 45::US9845333, 45 Orexin/Hypocretin receptor type 1 Rat 60.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143784&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270658 251972362 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611119 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1Br |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C19H15BrF4N2O2/c20-17-12(2-1-3-13(17)21)18(27)26-9-10-6-14(26)15(7-10)28-16-5-4-11(8-25-16)19(22,23)24/h1-5,8,10,14-15H,6-7,9H2 QSCWUOPMXMROKO-UHFFFAOYSA-N 143784 US8969352, 45::US9611277, Example 45::US10183953, Example 45::US9845333, 45 Orexin/Hypocretin receptor type 1 Human 55.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143784&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270658 251972362 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611120 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1Br |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C19H15BrF4N2O2/c20-17-12(2-1-3-13(17)21)18(27)26-9-10-6-14(26)15(7-10)28-16-5-4-11(8-25-16)19(22,23)24/h1-5,8,10,14-15H,6-7,9H2 QSCWUOPMXMROKO-UHFFFAOYSA-N 143784 US8969352, 45::US9611277, Example 45::US10183953, Example 45::US9845333, 45 Orexin receptor type 2 Human 1500 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143784&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270658 251972362 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611121 Fc1cccc(c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H17F4N5O2/c22-14-2-1-3-15(30-27-6-7-28-30)19(14)20(31)29-11-12-8-16(29)17(9-12)32-18-5-4-13(10-26-18)21(23,24)25/h1-7,10,12,16-17H,8-9,11H2 SGBSAQGVDFRKJX-UHFFFAOYSA-N 143757 US8969352, 46::US8969352, 18::US9611277, Example 46::US10183953, Example 46::US9845333, 46 Orexin/Hypocretin receptor type 1 Rat 10.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143757 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143757&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271884 251972344 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611122 Fc1cccc(c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H17F4N5O2/c22-14-2-1-3-15(30-27-6-7-28-30)19(14)20(31)29-11-12-8-16(29)17(9-12)32-18-5-4-13(10-26-18)21(23,24)25/h1-7,10,12,16-17H,8-9,11H2 SGBSAQGVDFRKJX-UHFFFAOYSA-N 143757 US8969352, 46::US8969352, 18::US9611277, Example 46::US10183953, Example 46::US9845333, 46 Orexin/Hypocretin receptor type 1 Human 12.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143757 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143757&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271884 251972344 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611123 Fc1cccc(c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H17F4N5O2/c22-14-2-1-3-15(30-27-6-7-28-30)19(14)20(31)29-11-12-8-16(29)17(9-12)32-18-5-4-13(10-26-18)21(23,24)25/h1-7,10,12,16-17H,8-9,11H2 SGBSAQGVDFRKJX-UHFFFAOYSA-N 143757 US8969352, 46::US8969352, 18::US9611277, Example 46::US10183953, Example 46::US9845333, 46 Orexin receptor type 2 Human 650 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143757 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143757&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271884 251972344 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611124 Fc1cccc(-c2ncccn2)c1C(=O)N1CC2CC(Oc3ccc(Br)cn3)C1C2 |TLB:20:19:15.16:29,13:15:19.18:29| InChI=1S/C22H18BrFN4O2/c23-14-5-6-19(27-11-14)30-18-10-13-9-17(18)28(12-13)22(29)20-15(3-1-4-16(20)24)21-25-7-2-8-26-21/h1-8,11,13,17-18H,9-10,12H2 DZJNFUJQJJPNEW-UHFFFAOYSA-N 143786 US8969352, 47::US9611277, Example 47::US10183953, Example 47::US9845333, 47 Orexin/Hypocretin receptor type 1 Rat 7.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143786 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143786&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 90452188 251972363 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611125 Fc1cccc(-c2ncccn2)c1C(=O)N1CC2CC(Oc3ccc(Br)cn3)C1C2 |TLB:20:19:15.16:29,13:15:19.18:29| InChI=1S/C22H18BrFN4O2/c23-14-5-6-19(27-11-14)30-18-10-13-9-17(18)28(12-13)22(29)20-15(3-1-4-16(20)24)21-25-7-2-8-26-21/h1-8,11,13,17-18H,9-10,12H2 DZJNFUJQJJPNEW-UHFFFAOYSA-N 143786 US8969352, 47::US9611277, Example 47::US10183953, Example 47::US9845333, 47 Orexin/Hypocretin receptor type 1 Human 11.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143786 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143786&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 90452188 251972363 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611126 Fc1cccc(-c2ncccn2)c1C(=O)N1CC2CC(Oc3ccc(Br)cn3)C1C2 |TLB:20:19:15.16:29,13:15:19.18:29| InChI=1S/C22H18BrFN4O2/c23-14-5-6-19(27-11-14)30-18-10-13-9-17(18)28(12-13)22(29)20-15(3-1-4-16(20)24)21-25-7-2-8-26-21/h1-8,11,13,17-18H,9-10,12H2 DZJNFUJQJJPNEW-UHFFFAOYSA-N 143786 US8969352, 47::US9611277, Example 47::US10183953, Example 47::US9845333, 47 Orexin receptor type 2 Human 503 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143786 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143786&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 90452188 251972363 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611127 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(Br)cn4)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:22,6:8:12.11:22| InChI=1S/C22H18BrFN4O2/c23-14-5-6-19(27-11-14)30-18-10-13-9-17(18)28(12-13)22(29)15-3-1-4-16(24)20(15)21-25-7-2-8-26-21/h1-8,11,13,17-18H,9-10,12H2 WHPVXNLPYOHPJB-UHFFFAOYSA-N 143787 US8969352, 48::US9611277, Example 48::US10183953, Example 48::US9845333, 48 Orexin/Hypocretin receptor type 1 Rat 3.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143787 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143787&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270659 251972364 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611128 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(Br)cn4)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:22,6:8:12.11:22| InChI=1S/C22H18BrFN4O2/c23-14-5-6-19(27-11-14)30-18-10-13-9-17(18)28(12-13)22(29)15-3-1-4-16(24)20(15)21-25-7-2-8-26-21/h1-8,11,13,17-18H,9-10,12H2 WHPVXNLPYOHPJB-UHFFFAOYSA-N 143787 US8969352, 48::US9611277, Example 48::US10183953, Example 48::US9845333, 48 Orexin/Hypocretin receptor type 1 Human 6.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143787 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143787&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270659 251972364 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611129 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(Br)cn4)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:22,6:8:12.11:22| InChI=1S/C22H18BrFN4O2/c23-14-5-6-19(27-11-14)30-18-10-13-9-17(18)28(12-13)22(29)15-3-1-4-16(24)20(15)21-25-7-2-8-26-21/h1-8,11,13,17-18H,9-10,12H2 WHPVXNLPYOHPJB-UHFFFAOYSA-N 143787 US8969352, 48::US9611277, Example 48::US10183953, Example 48::US9845333, 48 Orexin receptor type 2 Human 972 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143787 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143787&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270659 251972364 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611130 Brc1ccc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 143788 US8969352, 49::US9611277, Example 49::US10183953, Example 49::US9845333, 49 Orexin/Hypocretin receptor type 1 Rat 6.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143788 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143788&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270660 251972365 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611131 Brc1ccc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 143788 US8969352, 49::US9611277, Example 49::US10183953, Example 49::US9845333, 49 Orexin/Hypocretin receptor type 1 Human 6.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143788 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143788&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270660 251972365 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611132 Brc1ccc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 143788 US8969352, 49::US9611277, Example 49::US10183953, Example 49::US9845333, 49 Orexin receptor type 2 Human 507 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143788 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143788&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270660 251972365 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611133 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc(Br)cn3)C1C2)-n1nccn1 |TLB:14:13:9.10:23,7:9:13.12:23| InChI=1S/C20H19BrN6O2/c1-12-2-4-15(27-23-6-7-24-27)19(25-12)20(28)26-11-13-8-16(26)17(9-13)29-18-5-3-14(21)10-22-18/h2-7,10,13,16-17H,8-9,11H2,1H3 GOUAQCADINSCHG-UHFFFAOYSA-N 143789 US8969352, 50::US9611277, Example 50::US10183953, Example 50::US9845333, 50 Orexin/Hypocretin receptor type 1 Rat 7.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143789 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143789&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270661 251972366 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611134 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc(Br)cn3)C1C2)-n1nccn1 |TLB:14:13:9.10:23,7:9:13.12:23| InChI=1S/C20H19BrN6O2/c1-12-2-4-15(27-23-6-7-24-27)19(25-12)20(28)26-11-13-8-16(26)17(9-13)29-18-5-3-14(21)10-22-18/h2-7,10,13,16-17H,8-9,11H2,1H3 GOUAQCADINSCHG-UHFFFAOYSA-N 143789 US8969352, 50::US9611277, Example 50::US10183953, Example 50::US9845333, 50 Orexin/Hypocretin receptor type 1 Human 9.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143789 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143789&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270661 251972366 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611135 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc(Br)cn3)C1C2)-n1nccn1 |TLB:14:13:9.10:23,7:9:13.12:23| InChI=1S/C20H19BrN6O2/c1-12-2-4-15(27-23-6-7-24-27)19(25-12)20(28)26-11-13-8-16(26)17(9-13)29-18-5-3-14(21)10-22-18/h2-7,10,13,16-17H,8-9,11H2,1H3 GOUAQCADINSCHG-UHFFFAOYSA-N 143789 US8969352, 50::US9611277, Example 50::US10183953, Example 50::US9845333, 50 Orexin receptor type 2 Human 670 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143789 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143789&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270661 251972366 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611136 FC(F)(F)c1cccnc1OC1CC2CC1N(C2)C(=O)c1ccccc1-n1nccn1 |TLB:18:16:11.12:14,THB:10:11:16.17:14| 143790 US8969352, 51::US9611277, Example 51::US10183953, Example 51::US9845333, 51 Orexin/Hypocretin receptor type 1 Rat 294 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143790 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143790&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270750 251972367 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611137 FC(F)(F)c1cccnc1OC1CC2CC1N(C2)C(=O)c1ccccc1-n1nccn1 |TLB:18:16:11.12:14,THB:10:11:16.17:14| 143790 US8969352, 51::US9611277, Example 51::US10183953, Example 51::US9845333, 51 Orexin receptor type 2 Human 676 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143790 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143790&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270750 251972367 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611138 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ncccc3C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H19F3N6O2/c1-12-4-5-15(30-26-7-8-27-30)18(28-12)20(31)29-11-13-9-16(29)17(10-13)32-19-14(21(22,23)24)3-2-6-25-19/h2-8,13,16-17H,9-11H2,1H3 ZAUBOSKPBRXIFA-UHFFFAOYSA-N 143791 US8969352, 52::US9611277, Example 52::US10183953, Example 52::US9845333, 52 Orexin/Hypocretin receptor type 1 Rat 550 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143791 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143791&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270751 251972368 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611139 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ncccc3C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H19F3N6O2/c1-12-4-5-15(30-26-7-8-27-30)18(28-12)20(31)29-11-13-9-16(29)17(10-13)32-19-14(21(22,23)24)3-2-6-25-19/h2-8,13,16-17H,9-11H2,1H3 ZAUBOSKPBRXIFA-UHFFFAOYSA-N 143791 US8969352, 52::US9611277, Example 52::US10183953, Example 52::US9845333, 52 Orexin receptor type 2 Human 4000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143791 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143791&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270751 251972368 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611140 FC(F)(F)c1ccc(NC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143792 US8969352, 53::US9611277, Example 53::US10183953, Example 53::US9845333, 53 Orexin/Hypocretin receptor type 1 Rat 3.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143792 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143792&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270752 251972369 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611141 FC(F)(F)c1ccc(NC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143792 US8969352, 53::US9611277, Example 53::US10183953, Example 53::US9845333, 53 Orexin/Hypocretin receptor type 1 Human 3.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143792 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143792&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270752 251972369 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611142 FC(F)(F)c1ccc(NC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143792 US8969352, 53::US9611277, Example 53::US10183953, Example 53::US9845333, 53 Orexin receptor type 2 Human 165 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143792 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143792&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270752 251972369 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611143 Cc1ccc(c(n1)C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H20F3N7O/c1-12-2-4-16(31-26-6-7-27-31)19(28-12)20(32)30-11-13-8-15(17(30)9-13)29-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,15,17H,8-9,11H2,1H3,(H,25,29) DUSWDGIUZGEZMC-UHFFFAOYSA-N 143793 US8969352, 54::US9611277, Example 54::US9845333, 54 Orexin/Hypocretin receptor type 1 Rat 5.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143793 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143793&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270753 251972370 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611144 Cc1ccc(c(n1)C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H20F3N7O/c1-12-2-4-16(31-26-6-7-27-31)19(28-12)20(32)30-11-13-8-15(17(30)9-13)29-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,15,17H,8-9,11H2,1H3,(H,25,29) DUSWDGIUZGEZMC-UHFFFAOYSA-N 143793 US8969352, 54::US9611277, Example 54::US9845333, 54 Orexin/Hypocretin receptor type 1 Human 6.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143793 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143793&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270753 251972370 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611145 Cc1ccc(c(n1)C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H20F3N7O/c1-12-2-4-16(31-26-6-7-27-31)19(28-12)20(32)30-11-13-8-15(17(30)9-13)29-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,15,17H,8-9,11H2,1H3,(H,25,29) DUSWDGIUZGEZMC-UHFFFAOYSA-N 143793 US8969352, 54::US9611277, Example 54::US9845333, 54 Orexin receptor type 2 Human 132 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143793 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143793&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270753 251972370 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611146 Cc1cccc(C(=O)N2CC3CC(Nc4ccc(cn4)C(F)(F)F)C2C3)c1-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C22H21F3N6O/c1-13-3-2-4-16(20(13)31-27-7-8-28-31)21(32)30-12-14-9-17(18(30)10-14)29-19-6-5-15(11-26-19)22(23,24)25/h2-8,11,14,17-18H,9-10,12H2,1H3,(H,26,29) TWMWEJVSFZPUFN-UHFFFAOYSA-N 143794 US8969352, 55::US9611277, Example 55::US10183953, Example 55::US9845333, 55 Orexin/Hypocretin receptor type 1 Rat 3.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143794 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143794&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270754 251972371 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611147 Cc1cccc(C(=O)N2CC3CC(Nc4ccc(cn4)C(F)(F)F)C2C3)c1-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C22H21F3N6O/c1-13-3-2-4-16(20(13)31-27-7-8-28-31)21(32)30-12-14-9-17(18(30)10-14)29-19-6-5-15(11-26-19)22(23,24)25/h2-8,11,14,17-18H,9-10,12H2,1H3,(H,26,29) TWMWEJVSFZPUFN-UHFFFAOYSA-N 143794 US8969352, 55::US9611277, Example 55::US10183953, Example 55::US9845333, 55 Orexin/Hypocretin receptor type 1 Human 3.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143794 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143794&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270754 251972371 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611148 Cc1cccc(C(=O)N2CC3CC(Nc4ccc(cn4)C(F)(F)F)C2C3)c1-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C22H21F3N6O/c1-13-3-2-4-16(20(13)31-27-7-8-28-31)21(32)30-12-14-9-17(18(30)10-14)29-19-6-5-15(11-26-19)22(23,24)25/h2-8,11,14,17-18H,9-10,12H2,1H3,(H,26,29) TWMWEJVSFZPUFN-UHFFFAOYSA-N 143794 US8969352, 55::US9611277, Example 55::US10183953, Example 55::US9845333, 55 Orexin receptor type 2 Human 46.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143794 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143794&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270754 251972371 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611149 CCOc1ccc2cccnc2c1C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C24H23F3N4O2/c1-2-33-19-7-5-15-4-3-9-28-22(15)21(19)23(32)31-13-14-10-17(18(31)11-14)30-20-8-6-16(12-29-20)24(25,26)27/h3-9,12,14,17-18H,2,10-11,13H2,1H3,(H,29,30) UODSZXVZFBKAGJ-UHFFFAOYSA-N 143795 US8969352, 56::US9611277, Example 56::US10183953, Example 56::US9845333, 56 Orexin/Hypocretin receptor type 1 Rat 8.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143795 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143795&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270755 251972372 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611150 CCOc1ccc2cccnc2c1C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C24H23F3N4O2/c1-2-33-19-7-5-15-4-3-9-28-22(15)21(19)23(32)31-13-14-10-17(18(31)11-14)30-20-8-6-16(12-29-20)24(25,26)27/h3-9,12,14,17-18H,2,10-11,13H2,1H3,(H,29,30) UODSZXVZFBKAGJ-UHFFFAOYSA-N 143795 US8969352, 56::US9611277, Example 56::US10183953, Example 56::US9845333, 56 Orexin/Hypocretin receptor type 1 Human 10.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143795 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143795&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270755 251972372 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611151 CCOc1ccc2cccnc2c1C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C24H23F3N4O2/c1-2-33-19-7-5-15-4-3-9-28-22(15)21(19)23(32)31-13-14-10-17(18(31)11-14)30-20-8-6-16(12-29-20)24(25,26)27/h3-9,12,14,17-18H,2,10-11,13H2,1H3,(H,29,30) UODSZXVZFBKAGJ-UHFFFAOYSA-N 143795 US8969352, 56::US9611277, Example 56::US10183953, Example 56::US9845333, 56 Orexin receptor type 2 Human 192 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143795 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143795&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270755 251972372 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611152 Fc1ccc(c(c1)C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H18F4N6O/c22-14-2-3-17(31-27-5-6-28-31)15(9-14)20(32)30-11-12-7-16(18(30)8-12)29-19-4-1-13(10-26-19)21(23,24)25/h1-6,9-10,12,16,18H,7-8,11H2,(H,26,29) DMOGSWQIKPEGKH-UHFFFAOYSA-N 143796 US8969352, 57::US9611277, Example 57::US10183953, Example 57::US9845333, 57 Orexin/Hypocretin receptor type 1 Rat 6.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143796 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143796&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270842 251972373 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611153 Fc1ccc(c(c1)C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H18F4N6O/c22-14-2-3-17(31-27-5-6-28-31)15(9-14)20(32)30-11-12-7-16(18(30)8-12)29-19-4-1-13(10-26-19)21(23,24)25/h1-6,9-10,12,16,18H,7-8,11H2,(H,26,29) DMOGSWQIKPEGKH-UHFFFAOYSA-N 143796 US8969352, 57::US9611277, Example 57::US10183953, Example 57::US9845333, 57 Orexin/Hypocretin receptor type 1 Human 5.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143796 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143796&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270842 251972373 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611154 Fc1ccc(c(c1)C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H18F4N6O/c22-14-2-3-17(31-27-5-6-28-31)15(9-14)20(32)30-11-12-7-16(18(30)8-12)29-19-4-1-13(10-26-19)21(23,24)25/h1-6,9-10,12,16,18H,7-8,11H2,(H,26,29) DMOGSWQIKPEGKH-UHFFFAOYSA-N 143796 US8969352, 57::US9611277, Example 57::US10183953, Example 57::US9845333, 57 Orexin receptor type 2 Human 252 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143796 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143796&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270842 251972373 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611155 Fc1ccc(-c2ncccn2)c(c1)C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H19F4N5O/c24-15-3-4-16(21-28-6-1-7-29-21)17(10-15)22(33)32-12-13-8-18(19(32)9-13)31-20-5-2-14(11-30-20)23(25,26)27/h1-7,10-11,13,18-19H,8-9,12H2,(H,30,31) CKIBODIXGNACEX-UHFFFAOYSA-N 143797 US8969352, 58::US9611277, Example 58::US10183953, Example 58::US9845333, 58 Orexin/Hypocretin receptor type 1 Rat 4.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143797 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143797&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270843 251972374 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611156 Fc1ccc(-c2ncccn2)c(c1)C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H19F4N5O/c24-15-3-4-16(21-28-6-1-7-29-21)17(10-15)22(33)32-12-13-8-18(19(32)9-13)31-20-5-2-14(11-30-20)23(25,26)27/h1-7,10-11,13,18-19H,8-9,12H2,(H,30,31) CKIBODIXGNACEX-UHFFFAOYSA-N 143797 US8969352, 58::US9611277, Example 58::US10183953, Example 58::US9845333, 58 Orexin/Hypocretin receptor type 1 Human 2.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143797 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143797&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270843 251972374 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611157 Fc1ccc(-c2ncccn2)c(c1)C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H19F4N5O/c24-15-3-4-16(21-28-6-1-7-29-21)17(10-15)22(33)32-12-13-8-18(19(32)9-13)31-20-5-2-14(11-30-20)23(25,26)27/h1-7,10-11,13,18-19H,8-9,12H2,(H,30,31) CKIBODIXGNACEX-UHFFFAOYSA-N 143797 US8969352, 58::US9611277, Example 58::US10183953, Example 58::US9845333, 58 Orexin receptor type 2 Human 181 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143797 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143797&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270843 251972374 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611158 FC(F)(F)c1cnc(NC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)cn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143798 US8969352, 59::US9611277, Example 59::US10183953, Example 59::US9845333, 59 Orexin/Hypocretin receptor type 1 Rat 6.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143798 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143798&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270844 251972375 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611159 FC(F)(F)c1cnc(NC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)cn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143798 US8969352, 59::US9611277, Example 59::US10183953, Example 59::US9845333, 59 Orexin/Hypocretin receptor type 1 Human 9.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143798 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143798&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270844 251972375 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611160 FC(F)(F)c1cnc(NC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)cn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143798 US8969352, 59::US9611277, Example 59::US10183953, Example 59::US9845333, 59 Orexin receptor type 2 Human 213 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143798 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143798&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270844 251972375 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611161 FC(F)(F)c1cnc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)cn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143742 US8969352, 1::US9611277, Example 1::US10183953, Example 1::US9845333, 1 Orexin/Hypocretin receptor type 1 Rat 74.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143742 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143742&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271691 251972329 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611162 FC(F)(F)c1cnc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)cn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143742 US8969352, 1::US9611277, Example 1::US10183953, Example 1::US9845333, 1 Orexin/Hypocretin receptor type 1 Human 120 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143742 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143742&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271691 251972329 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611163 FC(F)(F)c1cnc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)cn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143742 US8969352, 1::US9611277, Example 1::US10183953, Example 1::US9845333, 1 Orexin receptor type 2 Human 4700 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143742 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143742&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271691 251972329 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611164 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3cnc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C20H18F3N7O2/c1-11-2-3-13(30-26-4-5-27-30)18(28-11)19(31)29-10-12-6-14(29)15(7-12)32-17-9-24-16(8-25-17)20(21,22)23/h2-5,8-9,12,14-15H,6-7,10H2,1H3 CKWUPZSHHCLQII-UHFFFAOYSA-N 143743 US8969352, 2::US9611277, Example 125::US10183953, Example 2::US9845333, 2 Orexin/Hypocretin receptor type 1 Rat 200 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143743 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143743&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271695 251972330 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611165 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3cnc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C20H18F3N7O2/c1-11-2-3-13(30-26-4-5-27-30)18(28-11)19(31)29-10-12-6-14(29)15(7-12)32-17-9-24-16(8-25-17)20(21,22)23/h2-5,8-9,12,14-15H,6-7,10H2,1H3 CKWUPZSHHCLQII-UHFFFAOYSA-N 143743 US8969352, 2::US9611277, Example 125::US10183953, Example 2::US9845333, 2 Orexin/Hypocretin receptor type 1 Human 342 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143743 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143743&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271695 251972330 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611166 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3cnc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C20H18F3N7O2/c1-11-2-3-13(30-26-4-5-27-30)18(28-11)19(31)29-10-12-6-14(29)15(7-12)32-17-9-24-16(8-25-17)20(21,22)23/h2-5,8-9,12,14-15H,6-7,10H2,1H3 CKWUPZSHHCLQII-UHFFFAOYSA-N 143743 US8969352, 2::US9611277, Example 125::US10183953, Example 2::US9845333, 2 Orexin receptor type 2 Human 10000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143743 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143743&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271695 251972330 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611167 CCOc1ncc2ccccc2c1C(=O)N1CC2CC(Oc3cnc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H21F3N4O3/c1-2-32-21-20(15-6-4-3-5-14(15)9-29-21)22(31)30-12-13-7-16(30)17(8-13)33-19-11-27-18(10-28-19)23(24,25)26/h3-6,9-11,13,16-17H,2,7-8,12H2,1H3 VCKIIVINGOZJPM-UHFFFAOYSA-N 143744 US8969352, 3::US9611277, Example 3::US10183953, Example 3::US9845333, 3 Orexin/Hypocretin receptor type 1 Rat 63.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143744 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143744&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271692 251972331 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611168 CCOc1ncc2ccccc2c1C(=O)N1CC2CC(Oc3cnc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H21F3N4O3/c1-2-32-21-20(15-6-4-3-5-14(15)9-29-21)22(31)30-12-13-7-16(30)17(8-13)33-19-11-27-18(10-28-19)23(24,25)26/h3-6,9-11,13,16-17H,2,7-8,12H2,1H3 VCKIIVINGOZJPM-UHFFFAOYSA-N 143744 US8969352, 3::US9611277, Example 3::US10183953, Example 3::US9845333, 3 Orexin/Hypocretin receptor type 1 Human 123 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143744 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143744&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271692 251972331 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611169 CCOc1ncc2ccccc2c1C(=O)N1CC2CC(Oc3cnc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H21F3N4O3/c1-2-32-21-20(15-6-4-3-5-14(15)9-29-21)22(31)30-12-13-7-16(30)17(8-13)33-19-11-27-18(10-28-19)23(24,25)26/h3-6,9-11,13,16-17H,2,7-8,12H2,1H3 VCKIIVINGOZJPM-UHFFFAOYSA-N 143744 US8969352, 3::US9611277, Example 3::US10183953, Example 3::US9845333, 3 Orexin receptor type 2 Human 8900 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143744 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143744&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271692 251972331 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611170 Cc1cnc(C(=O)N2CC3CC(Oc4cnc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C20H18F3N7O2/c1-11-4-14(30-27-2-3-28-30)18(26-7-11)19(31)29-10-12-5-13(29)15(6-12)32-17-9-24-16(8-25-17)20(21,22)23/h2-4,7-9,12-13,15H,5-6,10H2,1H3 YLFJSQKDYGUXAW-UHFFFAOYSA-N 143745 US8969352, 4::US9611277, Example 4::US10183953, Example 4::US9845333, 4 Orexin/Hypocretin receptor type 1 Rat 837 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143745 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143745&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271696 251972332 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611171 Cc1cnc(C(=O)N2CC3CC(Oc4cnc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C20H18F3N7O2/c1-11-4-14(30-27-2-3-28-30)18(26-7-11)19(31)29-10-12-5-13(29)15(6-12)32-17-9-24-16(8-25-17)20(21,22)23/h2-4,7-9,12-13,15H,5-6,10H2,1H3 YLFJSQKDYGUXAW-UHFFFAOYSA-N 143745 US8969352, 4::US9611277, Example 4::US10183953, Example 4::US9845333, 4 Orexin receptor type 2 Human >10000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143745 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143745&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271696 251972332 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611172 Cc1nc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(s1)-c1ccc(F)cc1 |TLB:11:10:6.7:23,4:6:10.9:23| InChI=1S/C23H19F4N3O2S/c1-12-29-20(21(33-12)14-2-5-16(24)6-3-14)22(31)30-11-13-8-17(30)18(9-13)32-19-7-4-15(10-28-19)23(25,26)27/h2-7,10,13,17-18H,8-9,11H2,1H3 HLYSNEDIOWGXAK-UHFFFAOYSA-N 314883 US10183953, Example 5::(R/S)-(5-(4-fluorophenyl)-2-methylthiazol-4-yl)(6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 5 Orexin/Hypocretin receptor type 1 Rat 25.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314883 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314883&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637427 383541702 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611173 Cc1nc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(s1)-c1ccc(F)cc1 |TLB:11:10:6.7:23,4:6:10.9:23| InChI=1S/C23H19F4N3O2S/c1-12-29-20(21(33-12)14-2-5-16(24)6-3-14)22(31)30-11-13-8-17(30)18(9-13)32-19-7-4-15(10-28-19)23(25,26)27/h2-7,10,13,17-18H,8-9,11H2,1H3 HLYSNEDIOWGXAK-UHFFFAOYSA-N 314883 US10183953, Example 5::(R/S)-(5-(4-fluorophenyl)-2-methylthiazol-4-yl)(6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 5 Orexin/Hypocretin receptor type 1 Human 18.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314883 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314883&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637427 383541702 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611174 Cc1nc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(s1)-c1ccc(F)cc1 |TLB:11:10:6.7:23,4:6:10.9:23| InChI=1S/C23H19F4N3O2S/c1-12-29-20(21(33-12)14-2-5-16(24)6-3-14)22(31)30-11-13-8-17(30)18(9-13)32-19-7-4-15(10-28-19)23(25,26)27/h2-7,10,13,17-18H,8-9,11H2,1H3 HLYSNEDIOWGXAK-UHFFFAOYSA-N 314883 US10183953, Example 5::(R/S)-(5-(4-fluorophenyl)-2-methylthiazol-4-yl)(6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 5 Orexin receptor type 2 Human 779 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314883 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314883&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637427 383541702 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611175 Cc1nc2sccn2c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:16:15:11.12:28,9:11:15.14:28| InChI=1S/C19H17F3N4O2S/c1-10-16(25-4-5-29-18(25)24-10)17(27)26-9-11-6-13(26)14(7-11)28-15-3-2-12(8-23-15)19(20,21)22/h2-5,8,11,13-14H,6-7,9H2,1H3 LTYZBHJDWAJSOP-UHFFFAOYSA-N 314884 US10183953, Example 6::(R/S)-(6-methylimidazo[2,1-b]thiazol-5-yl)(6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 6 Orexin/Hypocretin receptor type 1 Rat >10000 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314884 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314884&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117631574 383541703 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611176 Cc1nc2sccn2c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:16:15:11.12:28,9:11:15.14:28| InChI=1S/C19H17F3N4O2S/c1-10-16(25-4-5-29-18(25)24-10)17(27)26-9-11-6-13(26)14(7-11)28-15-3-2-12(8-23-15)19(20,21)22/h2-5,8,11,13-14H,6-7,9H2,1H3 LTYZBHJDWAJSOP-UHFFFAOYSA-N 314884 US10183953, Example 6::(R/S)-(6-methylimidazo[2,1-b]thiazol-5-yl)(6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 6 Orexin receptor type 2 Human >10000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314884 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314884&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117631574 383541703 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611177 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143746 US8969352, 36::US8969352, 7::US9611277, Example 36::US10183953, Example 36::US9845333, 36 Orexin/Hypocretin receptor type 1 Rat 21.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143746 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143746&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271693 251972333 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611178 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143746 US8969352, 36::US8969352, 7::US9611277, Example 36::US10183953, Example 36::US9845333, 36 Orexin/Hypocretin receptor type 1 Human 12.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143746 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143746&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271693 251972333 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611179 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143746 US8969352, 36::US8969352, 7::US9611277, Example 36::US10183953, Example 36::US9845333, 36 Orexin receptor type 2 Human 800 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143746 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143746&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271693 251972333 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611180 CCOc1ncc2ccccc2c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C24H22F3N3O3/c1-2-32-22-21(17-6-4-3-5-15(17)11-29-22)23(31)30-13-14-9-18(30)19(10-14)33-20-8-7-16(12-28-20)24(25,26)27/h3-8,11-12,14,18-19H,2,9-10,13H2,1H3 WORAHSUSUFAEIQ-UHFFFAOYSA-N 143747 US8969352, 8::US9611277, Example 8::US10183953, Example 8::US9845333, 8 Orexin/Hypocretin receptor type 1 Rat 16.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143747 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143747&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271785 251972334 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611181 CCOc1ncc2ccccc2c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C24H22F3N3O3/c1-2-32-22-21(17-6-4-3-5-15(17)11-29-22)23(31)30-13-14-9-18(30)19(10-14)33-20-8-7-16(12-28-20)24(25,26)27/h3-8,11-12,14,18-19H,2,9-10,13H2,1H3 WORAHSUSUFAEIQ-UHFFFAOYSA-N 143747 US8969352, 8::US9611277, Example 8::US10183953, Example 8::US9845333, 8 Orexin/Hypocretin receptor type 1 Human 15.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143747 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143747&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271785 251972334 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611182 CCOc1ncc2ccccc2c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C24H22F3N3O3/c1-2-32-22-21(17-6-4-3-5-15(17)11-29-22)23(31)30-13-14-9-18(30)19(10-14)33-20-8-7-16(12-28-20)24(25,26)27/h3-8,11-12,14,18-19H,2,9-10,13H2,1H3 WORAHSUSUFAEIQ-UHFFFAOYSA-N 143747 US8969352, 8::US9611277, Example 8::US10183953, Example 8::US9845333, 8 Orexin receptor type 2 Human 1450 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143747 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143747&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271785 251972334 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611183 Cc1cnc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H19F3N6O2/c1-12-6-16(30-27-4-5-28-30)19(26-9-12)20(31)29-11-13-7-15(29)17(8-13)32-18-3-2-14(10-25-18)21(22,23)24/h2-6,9-10,13,15,17H,7-8,11H2,1H3 OAQRBSBYWFGTPG-UHFFFAOYSA-N 143748 US8969352, 28::US8969352, 9::US9611277, Example 28::US10183953, Example 28::US9845333, 28 Orexin/Hypocretin receptor type 1 Rat 56.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143748 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143748&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271971 251972335 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611184 Cc1cnc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H19F3N6O2/c1-12-6-16(30-27-4-5-28-30)19(26-9-12)20(31)29-11-13-7-15(29)17(8-13)32-18-3-2-14(10-25-18)21(22,23)24/h2-6,9-10,13,15,17H,7-8,11H2,1H3 OAQRBSBYWFGTPG-UHFFFAOYSA-N 143748 US8969352, 28::US8969352, 9::US9611277, Example 28::US10183953, Example 28::US9845333, 28 Orexin/Hypocretin receptor type 1 Human 102 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143748 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143748&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271971 251972335 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611185 Cc1cnc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H19F3N6O2/c1-12-6-16(30-27-4-5-28-30)19(26-9-12)20(31)29-11-13-7-15(29)17(8-13)32-18-3-2-14(10-25-18)21(22,23)24/h2-6,9-10,13,15,17H,7-8,11H2,1H3 OAQRBSBYWFGTPG-UHFFFAOYSA-N 143748 US8969352, 28::US8969352, 9::US9611277, Example 28::US10183953, Example 28::US9845333, 28 Orexin receptor type 2 Human 2575 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143748 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143748&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271971 251972335 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611186 CCOc1ccc2cccnc2c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C24H22F3N3O3/c1-2-32-18-7-5-15-4-3-9-28-22(15)21(18)23(31)30-13-14-10-17(30)19(11-14)33-20-8-6-16(12-29-20)24(25,26)27/h3-9,12,14,17,19H,2,10-11,13H2,1H3 TWCLRHNSMBRHHR-UHFFFAOYSA-N 143749 US8969352, 10::US9611277, Example 10::US10183953, Example 10::US9845333, 10 Orexin/Hypocretin receptor type 1 Rat 18.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143749 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143749&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271786 251972336 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611187 CCOc1ccc2cccnc2c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C24H22F3N3O3/c1-2-32-18-7-5-15-4-3-9-28-22(15)21(18)23(31)30-13-14-10-17(30)19(11-14)33-20-8-6-16(12-29-20)24(25,26)27/h3-9,12,14,17,19H,2,10-11,13H2,1H3 TWCLRHNSMBRHHR-UHFFFAOYSA-N 143749 US8969352, 10::US9611277, Example 10::US10183953, Example 10::US9845333, 10 Orexin/Hypocretin receptor type 1 Human 27.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143749 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143749&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271786 251972336 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611188 CCOc1ccc2cccnc2c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C24H22F3N3O3/c1-2-32-18-7-5-15-4-3-9-28-22(15)21(18)23(31)30-13-14-10-17(30)19(11-14)33-20-8-6-16(12-29-20)24(25,26)27/h3-9,12,14,17,19H,2,10-11,13H2,1H3 TWCLRHNSMBRHHR-UHFFFAOYSA-N 143749 US8969352, 10::US9611277, Example 10::US10183953, Example 10::US9845333, 10 Orexin receptor type 2 Human 526 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143749 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143749&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271786 251972336 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611189 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C23H18F4N4O2/c24-16-4-1-3-15(20(16)21-28-7-2-8-29-21)22(32)31-12-13-9-17(31)18(10-13)33-19-6-5-14(11-30-19)23(25,26)27/h1-8,11,13,17-18H,9-10,12H2 HUKWIAXQBOHZIX-UHFFFAOYSA-N 143750 US8969352, 27::US8969352, 11::US9611277, Example 86::US10183953, Example 86::US9845333, 27 Orexin/Hypocretin receptor type 1 Rat 11.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143750 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143750&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271787 251972337 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611190 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C23H18F4N4O2/c24-16-4-1-3-15(20(16)21-28-7-2-8-29-21)22(32)31-12-13-9-17(31)18(10-13)33-19-6-5-14(11-30-19)23(25,26)27/h1-8,11,13,17-18H,9-10,12H2 HUKWIAXQBOHZIX-UHFFFAOYSA-N 143750 US8969352, 27::US8969352, 11::US9611277, Example 86::US10183953, Example 86::US9845333, 27 Orexin/Hypocretin receptor type 1 Human 9.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143750 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143750&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271787 251972337 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611191 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C23H18F4N4O2/c24-16-4-1-3-15(20(16)21-28-7-2-8-29-21)22(32)31-12-13-9-17(31)18(10-13)33-19-6-5-14(11-30-19)23(25,26)27/h1-8,11,13,17-18H,9-10,12H2 HUKWIAXQBOHZIX-UHFFFAOYSA-N 143750 US8969352, 27::US8969352, 11::US9611277, Example 86::US10183953, Example 86::US9845333, 27 Orexin receptor type 2 Human 1475 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143750 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143750&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271787 251972337 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611192 COc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C24H21F3N4O3/c1-33-16-4-5-17(18(11-16)22-28-7-2-8-29-22)23(32)31-13-14-9-19(31)20(10-14)34-21-6-3-15(12-30-21)24(25,26)27/h2-8,11-12,14,19-20H,9-10,13H2,1H3 DSTQNGFYZOHDRW-UHFFFAOYSA-N 143751 US8969352, 12::US9611277, Example 12::US10183953, Example 12::US9845333, 12 Orexin/Hypocretin receptor type 1 Rat 44.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143751 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143751&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271788 251972338 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611193 COc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C24H21F3N4O3/c1-33-16-4-5-17(18(11-16)22-28-7-2-8-29-22)23(32)31-13-14-9-19(31)20(10-14)34-21-6-3-15(12-30-21)24(25,26)27/h2-8,11-12,14,19-20H,9-10,13H2,1H3 DSTQNGFYZOHDRW-UHFFFAOYSA-N 143751 US8969352, 12::US9611277, Example 12::US10183953, Example 12::US9845333, 12 Orexin/Hypocretin receptor type 1 Human 59.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143751 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143751&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271788 251972338 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611194 COc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C24H21F3N4O3/c1-33-16-4-5-17(18(11-16)22-28-7-2-8-29-22)23(32)31-13-14-9-19(31)20(10-14)34-21-6-3-15(12-30-21)24(25,26)27/h2-8,11-12,14,19-20H,9-10,13H2,1H3 DSTQNGFYZOHDRW-UHFFFAOYSA-N 143751 US8969352, 12::US9611277, Example 12::US10183953, Example 12::US9845333, 12 Orexin receptor type 2 Human >10000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143751 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143751&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271788 251972338 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611195 COc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C22H20F3N5O3/c1-32-15-3-4-16(17(10-15)30-27-6-7-28-30)21(31)29-12-13-8-18(29)19(9-13)33-20-5-2-14(11-26-20)22(23,24)25/h2-7,10-11,13,18-19H,8-9,12H2,1H3 JAACBBVXXQKQLD-UHFFFAOYSA-N 143752 US8969352, 13::US9611277, Example 13::US10183953, Example 13::US9845333, 13 Orexin/Hypocretin receptor type 1 Rat 52.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143752 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143752&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271789 251972339 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611196 COc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C22H20F3N5O3/c1-32-15-3-4-16(17(10-15)30-27-6-7-28-30)21(31)29-12-13-8-18(29)19(9-13)33-20-5-2-14(11-26-20)22(23,24)25/h2-7,10-11,13,18-19H,8-9,12H2,1H3 JAACBBVXXQKQLD-UHFFFAOYSA-N 143752 US8969352, 13::US9611277, Example 13::US10183953, Example 13::US9845333, 13 Orexin/Hypocretin receptor type 1 Human 109 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143752 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143752&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271789 251972339 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611197 COc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C22H20F3N5O3/c1-32-15-3-4-16(17(10-15)30-27-6-7-28-30)21(31)29-12-13-8-18(29)19(9-13)33-20-5-2-14(11-26-20)22(23,24)25/h2-7,10-11,13,18-19H,8-9,12H2,1H3 JAACBBVXXQKQLD-UHFFFAOYSA-N 143752 US8969352, 13::US9611277, Example 13::US10183953, Example 13::US9845333, 13 Orexin receptor type 2 Human >10000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143752 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143752&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271789 251972339 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611198 Fc1ccc(c(c1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H17F4N5O2/c22-14-2-3-16(30-27-5-6-28-30)15(9-14)20(31)29-11-12-7-17(29)18(8-12)32-19-4-1-13(10-26-19)21(23,24)25/h1-6,9-10,12,17-18H,7-8,11H2 PSMGZVKVWYLIHB-UHFFFAOYSA-N 143753 US8969352, 43::US8969352, 14::US9611277, Example 43::US10183953, Example 43::US9845333, 43 Orexin/Hypocretin receptor type 1 Rat 17.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143753 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143753&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271790 251972340 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611199 Fc1ccc(c(c1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H17F4N5O2/c22-14-2-3-16(30-27-5-6-28-30)15(9-14)20(31)29-11-12-7-17(29)18(8-12)32-19-4-1-13(10-26-19)21(23,24)25/h1-6,9-10,12,17-18H,7-8,11H2 PSMGZVKVWYLIHB-UHFFFAOYSA-N 143753 US8969352, 43::US8969352, 14::US9611277, Example 43::US10183953, Example 43::US9845333, 43 Orexin/Hypocretin receptor type 1 Human 23.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143753 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143753&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271790 251972340 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611200 Fc1ccc(c(c1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H17F4N5O2/c22-14-2-3-16(30-27-5-6-28-30)15(9-14)20(31)29-11-12-7-17(29)18(8-12)32-19-4-1-13(10-26-19)21(23,24)25/h1-6,9-10,12,17-18H,7-8,11H2 PSMGZVKVWYLIHB-UHFFFAOYSA-N 143753 US8969352, 43::US8969352, 14::US9611277, Example 43::US10183953, Example 43::US9845333, 43 Orexin receptor type 2 Human 882 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143753 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143753&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271790 251972340 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611201 COc1cccc(c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:15:14:10.11:27,8:10:14.13:27| InChI=1S/C22H20F3N5O3/c1-32-17-4-2-3-15(30-27-7-8-28-30)20(17)21(31)29-12-13-9-16(29)18(10-13)33-19-6-5-14(11-26-19)22(23,24)25/h2-8,11,13,16,18H,9-10,12H2,1H3 XSMDMCQWMREAHT-UHFFFAOYSA-N 143754 US8969352, 15::US9611277, Example 15::US10183953, Example 15::US9845333, 15 Orexin/Hypocretin receptor type 1 Rat 17.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143754 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143754&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271881 251972341 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611202 COc1cccc(c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:15:14:10.11:27,8:10:14.13:27| InChI=1S/C22H20F3N5O3/c1-32-17-4-2-3-15(30-27-7-8-28-30)20(17)21(31)29-12-13-9-16(29)18(10-13)33-19-6-5-14(11-26-19)22(23,24)25/h2-8,11,13,16,18H,9-10,12H2,1H3 XSMDMCQWMREAHT-UHFFFAOYSA-N 143754 US8969352, 15::US9611277, Example 15::US10183953, Example 15::US9845333, 15 Orexin/Hypocretin receptor type 1 Human 40.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143754 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143754&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271881 251972341 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611203 COc1cccc(c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:15:14:10.11:27,8:10:14.13:27| InChI=1S/C22H20F3N5O3/c1-32-17-4-2-3-15(30-27-7-8-28-30)20(17)21(31)29-12-13-9-16(29)18(10-13)33-19-6-5-14(11-26-19)22(23,24)25/h2-8,11,13,16,18H,9-10,12H2,1H3 XSMDMCQWMREAHT-UHFFFAOYSA-N 143754 US8969352, 15::US9611277, Example 15::US10183953, Example 15::US9845333, 15 Orexin receptor type 2 Human 229 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143754 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143754&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271881 251972341 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611204 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C21H17F4N5O2/c22-15-3-1-2-14(19(15)30-27-6-7-28-30)20(31)29-11-12-8-16(29)17(9-12)32-18-5-4-13(10-26-18)21(23,24)25/h1-7,10,12,16-17H,8-9,11H2 VEJWAVKRPRJLDD-UHFFFAOYSA-N 143755 US8969352, 35::US8969352, 16::US9611277, Example 35::US10183953, Example 35::US9845333, 35 Orexin/Hypocretin receptor type 1 Rat 8.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143755 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143755&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271882 251972342 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611205 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C21H17F4N5O2/c22-15-3-1-2-14(19(15)30-27-6-7-28-30)20(31)29-11-12-8-16(29)17(9-12)32-18-5-4-13(10-26-18)21(23,24)25/h1-7,10,12,16-17H,8-9,11H2 VEJWAVKRPRJLDD-UHFFFAOYSA-N 143755 US8969352, 35::US8969352, 16::US9611277, Example 35::US10183953, Example 35::US9845333, 35 Orexin/Hypocretin receptor type 1 Human 7.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143755 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143755&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271882 251972342 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611206 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C21H17F4N5O2/c22-15-3-1-2-14(19(15)30-27-6-7-28-30)20(31)29-11-12-8-16(29)17(9-12)32-18-5-4-13(10-26-18)21(23,24)25/h1-7,10,12,16-17H,8-9,11H2 VEJWAVKRPRJLDD-UHFFFAOYSA-N 143755 US8969352, 35::US8969352, 16::US9611277, Example 35::US10183953, Example 35::US9845333, 35 Orexin receptor type 2 Human 1000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143755 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143755&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271882 251972342 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611207 Cc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C22H20F3N5O2/c1-13-3-2-4-16(20(13)30-27-7-8-28-30)21(31)29-12-14-9-17(29)18(10-14)32-19-6-5-15(11-26-19)22(23,24)25/h2-8,11,14,17-18H,9-10,12H2,1H3 VMCVDMDKIAUUAU-UHFFFAOYSA-N 143756 US8969352, 17::US9611277, Example 17::US10183953, Example 17::US9845333, 17 Orexin/Hypocretin receptor type 1 Rat 8.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143756 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143756&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271883 251972343 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611208 Cc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C22H20F3N5O2/c1-13-3-2-4-16(20(13)30-27-7-8-28-30)21(31)29-12-14-9-17(29)18(10-14)32-19-6-5-15(11-26-19)22(23,24)25/h2-8,11,14,17-18H,9-10,12H2,1H3 VMCVDMDKIAUUAU-UHFFFAOYSA-N 143756 US8969352, 17::US9611277, Example 17::US10183953, Example 17::US9845333, 17 Orexin/Hypocretin receptor type 1 Human 3.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143756 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143756&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271883 251972343 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611209 Cc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C22H20F3N5O2/c1-13-3-2-4-16(20(13)30-27-7-8-28-30)21(31)29-12-14-9-17(29)18(10-14)32-19-6-5-15(11-26-19)22(23,24)25/h2-8,11,14,17-18H,9-10,12H2,1H3 VMCVDMDKIAUUAU-UHFFFAOYSA-N 143756 US8969352, 17::US9611277, Example 17::US10183953, Example 17::US9845333, 17 Orexin receptor type 2 Human 234 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143756 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143756&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271883 251972343 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611210 Fc1cccc(c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H17F4N5O2/c22-14-2-1-3-15(30-27-6-7-28-30)19(14)20(31)29-11-12-8-16(29)17(9-12)32-18-5-4-13(10-26-18)21(23,24)25/h1-7,10,12,16-17H,8-9,11H2 SGBSAQGVDFRKJX-UHFFFAOYSA-N 143757 US8969352, 46::US8969352, 18::US9611277, Example 46::US10183953, Example 46::US9845333, 46 Orexin/Hypocretin receptor type 1 Rat 25.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143757 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143757&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271884 251972344 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611211 Fc1cccc(c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H17F4N5O2/c22-14-2-1-3-15(30-27-6-7-28-30)19(14)20(31)29-11-12-8-16(29)17(9-12)32-18-5-4-13(10-26-18)21(23,24)25/h1-7,10,12,16-17H,8-9,11H2 SGBSAQGVDFRKJX-UHFFFAOYSA-N 143757 US8969352, 46::US8969352, 18::US9611277, Example 46::US10183953, Example 46::US9845333, 46 Orexin/Hypocretin receptor type 1 Human 23.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143757 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143757&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271884 251972344 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611212 Fc1cccc(c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H17F4N5O2/c22-14-2-1-3-15(30-27-6-7-28-30)19(14)20(31)29-11-12-8-16(29)17(9-12)32-18-5-4-13(10-26-18)21(23,24)25/h1-7,10,12,16-17H,8-9,11H2 SGBSAQGVDFRKJX-UHFFFAOYSA-N 143757 US8969352, 46::US8969352, 18::US9611277, Example 46::US10183953, Example 46::US9845333, 46 Orexin receptor type 2 Human 1800 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143757 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143757&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271884 251972344 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611213 Fc1ccc(-c2ncccn2)c(c1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H18F4N4O2/c24-15-3-4-16(21-28-6-1-7-29-21)17(10-15)22(32)31-12-13-8-18(31)19(9-13)33-20-5-2-14(11-30-20)23(25,26)27/h1-7,10-11,13,18-19H,8-9,12H2 MSBDPMYPBOZFHI-UHFFFAOYSA-N 143758 US8969352, 19::US9611277, Example 19::US10183953, Example 19::US9845333, 19 Orexin/Hypocretin receptor type 1 Rat 18.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143758 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143758&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 90416120 251972345 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611214 Fc1ccc(-c2ncccn2)c(c1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H18F4N4O2/c24-15-3-4-16(21-28-6-1-7-29-21)17(10-15)22(32)31-12-13-8-18(31)19(9-13)33-20-5-2-14(11-30-20)23(25,26)27/h1-7,10-11,13,18-19H,8-9,12H2 MSBDPMYPBOZFHI-UHFFFAOYSA-N 143758 US8969352, 19::US9611277, Example 19::US10183953, Example 19::US9845333, 19 Orexin/Hypocretin receptor type 1 Human 9.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143758 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143758&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 90416120 251972345 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611215 Fc1ccc(-c2ncccn2)c(c1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H18F4N4O2/c24-15-3-4-16(21-28-6-1-7-29-21)17(10-15)22(32)31-12-13-8-18(31)19(9-13)33-20-5-2-14(11-30-20)23(25,26)27/h1-7,10-11,13,18-19H,8-9,12H2 MSBDPMYPBOZFHI-UHFFFAOYSA-N 143758 US8969352, 19::US9611277, Example 19::US10183953, Example 19::US9845333, 19 Orexin receptor type 2 Human 945 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143758 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143758&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 90416120 251972345 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611216 Fc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C23H18F4N4O2/c24-15-3-4-16(17(10-15)21-28-6-1-7-29-21)22(32)31-12-13-8-18(31)19(9-13)33-20-5-2-14(11-30-20)23(25,26)27/h1-7,10-11,13,18-19H,8-9,12H2 AXZNZGVQOXKZLA-UHFFFAOYSA-N 143759 US8969352, 26::US8969352, 27::US8969352, 20::US9611277, Example 26::US10183953, Example 26::US9845333, 26 Orexin/Hypocretin receptor type 1 Rat 15.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143759 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143759&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271886 251972346 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611217 Fc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C23H18F4N4O2/c24-15-3-4-16(17(10-15)21-28-6-1-7-29-21)22(32)31-12-13-8-18(31)19(9-13)33-20-5-2-14(11-30-20)23(25,26)27/h1-7,10-11,13,18-19H,8-9,12H2 AXZNZGVQOXKZLA-UHFFFAOYSA-N 143759 US8969352, 26::US8969352, 27::US8969352, 20::US9611277, Example 26::US10183953, Example 26::US9845333, 26 Orexin/Hypocretin receptor type 1 Human 15.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143759 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143759&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271886 251972346 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611218 Fc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C23H18F4N4O2/c24-15-3-4-16(17(10-15)21-28-6-1-7-29-21)22(32)31-12-13-8-18(31)19(9-13)33-20-5-2-14(11-30-20)23(25,26)27/h1-7,10-11,13,18-19H,8-9,12H2 AXZNZGVQOXKZLA-UHFFFAOYSA-N 143759 US8969352, 26::US8969352, 27::US8969352, 20::US9611277, Example 26::US10183953, Example 26::US9845333, 26 Orexin receptor type 2 Human 2700 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143759 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143759&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271886 251972346 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611219 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2cnnc2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143760 US8969352, 21::US9611277, Example 21::US10183953, Example 21::US9845333, 21 Orexin/Hypocretin receptor type 1 Rat >10000 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143760 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143760&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271970 251972347 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611220 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2cnnc2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143760 US8969352, 21::US9611277, Example 21::US10183953, Example 21::US9845333, 21 Orexin receptor type 2 Human >10000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143760 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143760&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271970 251972347 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611221 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H19F3N6O2/c1-12-2-4-15(30-26-6-7-27-30)19(28-12)20(31)29-11-13-8-16(29)17(9-13)32-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,16-17H,8-9,11H2,1H3 DIVFYQCMVDWPOD-UHFFFAOYSA-N 143761 US8969352, 23::US8969352, 24::US8969352, 25::US8969352, 22::US9611277, Example 25::US10183953, Example 25::US9845333, 25 Orexin/Hypocretin receptor type 1 Rat 25.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143761 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143761&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271694 251972348 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611222 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H19F3N6O2/c1-12-2-4-15(30-26-6-7-27-30)19(28-12)20(31)29-11-13-8-16(29)17(9-13)32-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,16-17H,8-9,11H2,1H3 DIVFYQCMVDWPOD-UHFFFAOYSA-N 143761 US8969352, 23::US8969352, 24::US8969352, 25::US8969352, 22::US9611277, Example 25::US10183953, Example 25::US9845333, 25 Orexin/Hypocretin receptor type 1 Human 23.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143761 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143761&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271694 251972348 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611223 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H19F3N6O2/c1-12-2-4-15(30-26-6-7-27-30)19(28-12)20(31)29-11-13-8-16(29)17(9-13)32-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,16-17H,8-9,11H2,1H3 DIVFYQCMVDWPOD-UHFFFAOYSA-N 143761 US8969352, 23::US8969352, 24::US8969352, 25::US8969352, 22::US9611277, Example 25::US10183953, Example 25::US9845333, 25 Orexin receptor type 2 Human 1000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143761 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143761&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271694 251972348 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611224 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H19F3N6O2/c1-12-2-4-15(30-26-6-7-27-30)19(28-12)20(31)29-11-13-8-16(29)17(9-13)32-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,16-17H,8-9,11H2,1H3 DIVFYQCMVDWPOD-UHFFFAOYSA-N 143761 US8969352, 23::US8969352, 24::US8969352, 25::US8969352, 22::US9611277, Example 25::US10183953, Example 25::US9845333, 25 Orexin/Hypocretin receptor type 1 Rat >10000 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143761 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143761&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271694 251972348 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611225 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H19F3N6O2/c1-12-2-4-15(30-26-6-7-27-30)19(28-12)20(31)29-11-13-8-16(29)17(9-13)32-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,16-17H,8-9,11H2,1H3 DIVFYQCMVDWPOD-UHFFFAOYSA-N 143761 US8969352, 23::US8969352, 24::US8969352, 25::US8969352, 22::US9611277, Example 25::US10183953, Example 25::US9845333, 25 Orexin receptor type 2 Human >10000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143761 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143761&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271694 251972348 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611226 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H19F3N6O2/c1-12-2-4-15(30-26-6-7-27-30)19(28-12)20(31)29-11-13-8-16(29)17(9-13)32-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,16-17H,8-9,11H2,1H3 DIVFYQCMVDWPOD-UHFFFAOYSA-N 143761 US8969352, 23::US8969352, 24::US8969352, 25::US8969352, 22::US9611277, Example 25::US10183953, Example 25::US9845333, 25 Orexin/Hypocretin receptor type 1 Rat 20.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143761 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143761&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271694 251972348 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611227 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H19F3N6O2/c1-12-2-4-15(30-26-6-7-27-30)19(28-12)20(31)29-11-13-8-16(29)17(9-13)32-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,16-17H,8-9,11H2,1H3 DIVFYQCMVDWPOD-UHFFFAOYSA-N 143761 US8969352, 23::US8969352, 24::US8969352, 25::US8969352, 22::US9611277, Example 25::US10183953, Example 25::US9845333, 25 Orexin/Hypocretin receptor type 1 Human 16.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143761 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143761&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271694 251972348 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611228 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H19F3N6O2/c1-12-2-4-15(30-26-6-7-27-30)19(28-12)20(31)29-11-13-8-16(29)17(9-13)32-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,16-17H,8-9,11H2,1H3 DIVFYQCMVDWPOD-UHFFFAOYSA-N 143761 US8969352, 23::US8969352, 24::US8969352, 25::US8969352, 22::US9611277, Example 25::US10183953, Example 25::US9845333, 25 Orexin receptor type 2 Human 692 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143761 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143761&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271694 251972348 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611229 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H19F3N6O2/c1-12-2-4-15(30-26-6-7-27-30)19(28-12)20(31)29-11-13-8-16(29)17(9-13)32-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,16-17H,8-9,11H2,1H3 DIVFYQCMVDWPOD-UHFFFAOYSA-N 143761 US8969352, 23::US8969352, 24::US8969352, 25::US8969352, 22::US9611277, Example 25::US10183953, Example 25::US9845333, 25 Orexin/Hypocretin receptor type 1 Rat 14.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143761 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143761&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271694 251972348 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611230 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H19F3N6O2/c1-12-2-4-15(30-26-6-7-27-30)19(28-12)20(31)29-11-13-8-16(29)17(9-13)32-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,16-17H,8-9,11H2,1H3 DIVFYQCMVDWPOD-UHFFFAOYSA-N 143761 US8969352, 23::US8969352, 24::US8969352, 25::US8969352, 22::US9611277, Example 25::US10183953, Example 25::US9845333, 25 Orexin/Hypocretin receptor type 1 Human 15.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143761 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143761&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271694 251972348 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611231 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H19F3N6O2/c1-12-2-4-15(30-26-6-7-27-30)19(28-12)20(31)29-11-13-8-16(29)17(9-13)32-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,16-17H,8-9,11H2,1H3 DIVFYQCMVDWPOD-UHFFFAOYSA-N 143761 US8969352, 23::US8969352, 24::US8969352, 25::US8969352, 22::US9611277, Example 25::US10183953, Example 25::US9845333, 25 Orexin receptor type 2 Human 483 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143761 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143761&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271694 251972348 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611232 Fc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C23H18F4N4O2/c24-15-3-4-16(17(10-15)21-28-6-1-7-29-21)22(32)31-12-13-8-18(31)19(9-13)33-20-5-2-14(11-30-20)23(25,26)27/h1-7,10-11,13,18-19H,8-9,12H2 AXZNZGVQOXKZLA-UHFFFAOYSA-N 143759 US8969352, 26::US8969352, 27::US8969352, 20::US9611277, Example 26::US10183953, Example 26::US9845333, 26 Orexin/Hypocretin receptor type 1 Rat 12.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143759 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143759&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271886 251972346 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611233 Fc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C23H18F4N4O2/c24-15-3-4-16(17(10-15)21-28-6-1-7-29-21)22(32)31-12-13-8-18(31)19(9-13)33-20-5-2-14(11-30-20)23(25,26)27/h1-7,10-11,13,18-19H,8-9,12H2 AXZNZGVQOXKZLA-UHFFFAOYSA-N 143759 US8969352, 26::US8969352, 27::US8969352, 20::US9611277, Example 26::US10183953, Example 26::US9845333, 26 Orexin/Hypocretin receptor type 1 Human 15.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143759 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143759&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271886 251972346 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611234 Fc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C23H18F4N4O2/c24-15-3-4-16(17(10-15)21-28-6-1-7-29-21)22(32)31-12-13-8-18(31)19(9-13)33-20-5-2-14(11-30-20)23(25,26)27/h1-7,10-11,13,18-19H,8-9,12H2 AXZNZGVQOXKZLA-UHFFFAOYSA-N 143759 US8969352, 26::US8969352, 27::US8969352, 20::US9611277, Example 26::US10183953, Example 26::US9845333, 26 Orexin receptor type 2 Human 2100 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143759 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143759&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271886 251972346 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611235 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C23H18F4N4O2/c24-16-4-1-3-15(20(16)21-28-7-2-8-29-21)22(32)31-12-13-9-17(31)18(10-13)33-19-6-5-14(11-30-19)23(25,26)27/h1-8,11,13,17-18H,9-10,12H2 HUKWIAXQBOHZIX-UHFFFAOYSA-N 143750 US8969352, 27::US8969352, 11::US9611277, Example 86::US10183953, Example 86::US9845333, 27 Orexin/Hypocretin receptor type 1 Rat 6.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143750 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143750&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271787 251972337 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611236 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C23H18F4N4O2/c24-16-4-1-3-15(20(16)21-28-7-2-8-29-21)22(32)31-12-13-9-17(31)18(10-13)33-19-6-5-14(11-30-19)23(25,26)27/h1-8,11,13,17-18H,9-10,12H2 HUKWIAXQBOHZIX-UHFFFAOYSA-N 143750 US8969352, 27::US8969352, 11::US9611277, Example 86::US10183953, Example 86::US9845333, 27 Orexin/Hypocretin receptor type 1 Human 5.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143750 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143750&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271787 251972337 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611237 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C23H18F4N4O2/c24-16-4-1-3-15(20(16)21-28-7-2-8-29-21)22(32)31-12-13-9-17(31)18(10-13)33-19-6-5-14(11-30-19)23(25,26)27/h1-8,11,13,17-18H,9-10,12H2 HUKWIAXQBOHZIX-UHFFFAOYSA-N 143750 US8969352, 27::US8969352, 11::US9611277, Example 86::US10183953, Example 86::US9845333, 27 Orexin receptor type 2 Human 725 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143750 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143750&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271787 251972337 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611238 Cc1cnc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H19F3N6O2/c1-12-6-16(30-27-4-5-28-30)19(26-9-12)20(31)29-11-13-7-15(29)17(8-13)32-18-3-2-14(10-25-18)21(22,23)24/h2-6,9-10,13,15,17H,7-8,11H2,1H3 OAQRBSBYWFGTPG-UHFFFAOYSA-N 143748 US8969352, 28::US8969352, 9::US9611277, Example 28::US10183953, Example 28::US9845333, 28 Orexin/Hypocretin receptor type 1 Rat 32.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143748 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143748&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271971 251972335 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611239 Cc1cnc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H19F3N6O2/c1-12-6-16(30-27-4-5-28-30)19(26-9-12)20(31)29-11-13-7-15(29)17(8-13)32-18-3-2-14(10-25-18)21(22,23)24/h2-6,9-10,13,15,17H,7-8,11H2,1H3 OAQRBSBYWFGTPG-UHFFFAOYSA-N 143748 US8969352, 28::US8969352, 9::US9611277, Example 28::US10183953, Example 28::US9845333, 28 Orexin/Hypocretin receptor type 1 Human 21.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143748 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143748&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271971 251972335 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611240 Cc1cnc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H19F3N6O2/c1-12-6-16(30-27-4-5-28-30)19(26-9-12)20(31)29-11-13-7-15(29)17(8-13)32-18-3-2-14(10-25-18)21(22,23)24/h2-6,9-10,13,15,17H,7-8,11H2,1H3 OAQRBSBYWFGTPG-UHFFFAOYSA-N 143748 US8969352, 28::US8969352, 9::US9611277, Example 28::US10183953, Example 28::US9845333, 28 Orexin receptor type 2 Human 1600 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143748 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143748&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271971 251972335 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611241 Cc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(n1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H19F3N6O2/c1-12-2-4-15(19(28-12)30-26-6-7-27-30)20(31)29-11-13-8-16(29)17(9-13)32-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,16-17H,8-9,11H2,1H3 FTIPLKXQDISZMV-UHFFFAOYSA-N 143768 US8969352, 29::US9611277, Example 29::US10183953, Example 29::US9845333, 29 Orexin/Hypocretin receptor type 1 Rat 55.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143768 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143768&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271972 251972349 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611242 Cc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(n1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H19F3N6O2/c1-12-2-4-15(19(28-12)30-26-6-7-27-30)20(31)29-11-13-8-16(29)17(9-13)32-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,16-17H,8-9,11H2,1H3 FTIPLKXQDISZMV-UHFFFAOYSA-N 143768 US8969352, 29::US9611277, Example 29::US10183953, Example 29::US9845333, 29 Orexin/Hypocretin receptor type 1 Human 47.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143768 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143768&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271972 251972349 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611243 Cc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(n1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H19F3N6O2/c1-12-2-4-15(19(28-12)30-26-6-7-27-30)20(31)29-11-13-8-16(29)17(9-13)32-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,16-17H,8-9,11H2,1H3 FTIPLKXQDISZMV-UHFFFAOYSA-N 143768 US8969352, 29::US9611277, Example 29::US10183953, Example 29::US9845333, 29 Orexin receptor type 2 Human >10000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143768 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143768&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271972 251972349 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611244 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2ncccc2-n2nccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143769 US8969352, 30::US9611277, Example 30::US10183953, Example 30::US9845333, 30 Orexin/Hypocretin receptor type 1 Rat 19.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143769 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143769&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271973 251972350 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611245 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2ncccc2-n2nccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143769 US8969352, 30::US9611277, Example 30::US10183953, Example 30::US9845333, 30 Orexin/Hypocretin receptor type 1 Human 22.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143769 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143769&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271973 251972350 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611246 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2ncccc2-n2nccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143769 US8969352, 30::US9611277, Example 30::US10183953, Example 30::US9845333, 30 Orexin receptor type 2 Human 1700 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143769 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143769&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271973 251972350 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611247 COc1c(F)cccc1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:16:15:11.12:28,9:11:15.14:28| InChI=1S/C20H18F4N2O3/c1-28-18-13(3-2-4-14(18)21)19(27)26-10-11-7-15(26)16(8-11)29-17-6-5-12(9-25-17)20(22,23)24/h2-6,9,11,15-16H,7-8,10H2,1H3 RYMOHHYAOSEKIU-UHFFFAOYSA-N 143770 US8969352, 31::US9611277, Example 31::US10183953, Example 31::US9845333, 31 Orexin/Hypocretin receptor type 1 Rat 707 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143770 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143770&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271974 251972351 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611248 COc1c(F)cccc1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:16:15:11.12:28,9:11:15.14:28| InChI=1S/C20H18F4N2O3/c1-28-18-13(3-2-4-14(18)21)19(27)26-10-11-7-15(26)16(8-11)29-17-6-5-12(9-25-17)20(22,23)24/h2-6,9,11,15-16H,7-8,10H2,1H3 RYMOHHYAOSEKIU-UHFFFAOYSA-N 143770 US8969352, 31::US9611277, Example 31::US10183953, Example 31::US9845333, 31 Orexin receptor type 2 Human >10000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143770 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143770&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271974 251972351 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611249 Cc1ccc(OC2CC3CC2N(C3)C(=O)c2cccc(C)c2-c2ncco2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 314847 (3-methyl-2-(oxazol-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 32 Orexin/Hypocretin receptor type 1 Rat 3.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314847 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314847&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 90452177 383541669 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611250 Cc1ccc(OC2CC3CC2N(C3)C(=O)c2cccc(C)c2-c2ncco2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 314847 (3-methyl-2-(oxazol-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 32 Orexin/Hypocretin receptor type 1 Human 6.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314847 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314847&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 90452177 383541669 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611251 Cc1ccc(OC2CC3CC2N(C3)C(=O)c2cccc(C)c2-c2ncco2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 314847 (3-methyl-2-(oxazol-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 32 Orexin receptor type 2 Human 149 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314847 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314847&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 90452177 383541669 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611252 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-n1ccnn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C21H17F4N5O2/c22-15-3-1-2-14(19(15)30-7-6-27-28-30)20(31)29-11-12-8-16(29)17(9-12)32-18-5-4-13(10-26-18)21(23,24)25/h1-7,10,12,16-17H,8-9,11H2 RNUWTSJVSRFNSZ-UHFFFAOYSA-N 143772 US8969352, 33::US9611277, Example 33::US10183953, Example 33::US9845333, 33 Orexin/Hypocretin receptor type 1 Rat 74.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143772 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143772&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270572 251972353 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611253 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-n1ccnn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C21H17F4N5O2/c22-15-3-1-2-14(19(15)30-7-6-27-28-30)20(31)29-11-12-8-16(29)17(9-12)32-18-5-4-13(10-26-18)21(23,24)25/h1-7,10,12,16-17H,8-9,11H2 RNUWTSJVSRFNSZ-UHFFFAOYSA-N 143772 US8969352, 33::US9611277, Example 33::US10183953, Example 33::US9845333, 33 Orexin/Hypocretin receptor type 1 Human 86.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143772 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143772&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270572 251972353 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611254 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-n1ccnn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C21H17F4N5O2/c22-15-3-1-2-14(19(15)30-7-6-27-28-30)20(31)29-11-12-8-16(29)17(9-12)32-18-5-4-13(10-26-18)21(23,24)25/h1-7,10,12,16-17H,8-9,11H2 RNUWTSJVSRFNSZ-UHFFFAOYSA-N 143772 US8969352, 33::US9611277, Example 33::US10183953, Example 33::US9845333, 33 Orexin receptor type 2 Human 3500 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143772 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143772&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270572 251972353 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611255 Cc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(n1)-n1ccnn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H19F3N6O2/c1-12-2-4-15(19(27-12)30-7-6-26-28-30)20(31)29-11-13-8-16(29)17(9-13)32-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,16-17H,8-9,11H2,1H3 ICOFMFLOEJHBPA-UHFFFAOYSA-N 143773 US8969352, 34::US9611277, Example 34::US10183953, Example 34::US9845333, 34 Orexin/Hypocretin receptor type 1 Rat 162 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143773 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143773&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 90454381 251972354 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611256 Cc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(n1)-n1ccnn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H19F3N6O2/c1-12-2-4-15(19(27-12)30-7-6-26-28-30)20(31)29-11-13-8-16(29)17(9-13)32-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,16-17H,8-9,11H2,1H3 ICOFMFLOEJHBPA-UHFFFAOYSA-N 143773 US8969352, 34::US9611277, Example 34::US10183953, Example 34::US9845333, 34 Orexin/Hypocretin receptor type 1 Human 368 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143773 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143773&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 90454381 251972354 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611257 Cc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(n1)-n1ccnn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H19F3N6O2/c1-12-2-4-15(19(27-12)30-7-6-26-28-30)20(31)29-11-13-8-16(29)17(9-13)32-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,16-17H,8-9,11H2,1H3 ICOFMFLOEJHBPA-UHFFFAOYSA-N 143773 US8969352, 34::US9611277, Example 34::US10183953, Example 34::US9845333, 34 Orexin receptor type 2 Human 1050 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143773 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143773&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 90454381 251972354 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611258 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C21H17F4N5O2/c22-15-3-1-2-14(19(15)30-27-6-7-28-30)20(31)29-11-12-8-16(29)17(9-12)32-18-5-4-13(10-26-18)21(23,24)25/h1-7,10,12,16-17H,8-9,11H2 VEJWAVKRPRJLDD-UHFFFAOYSA-N 143755 US8969352, 35::US8969352, 16::US9611277, Example 35::US10183953, Example 35::US9845333, 35 Orexin/Hypocretin receptor type 1 Rat 8.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143755 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143755&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271882 251972342 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611259 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C21H17F4N5O2/c22-15-3-1-2-14(19(15)30-27-6-7-28-30)20(31)29-11-12-8-16(29)17(9-12)32-18-5-4-13(10-26-18)21(23,24)25/h1-7,10,12,16-17H,8-9,11H2 VEJWAVKRPRJLDD-UHFFFAOYSA-N 143755 US8969352, 35::US8969352, 16::US9611277, Example 35::US10183953, Example 35::US9845333, 35 Orexin/Hypocretin receptor type 1 Human 3.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143755 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143755&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271882 251972342 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611260 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C21H17F4N5O2/c22-15-3-1-2-14(19(15)30-27-6-7-28-30)20(31)29-11-12-8-16(29)17(9-12)32-18-5-4-13(10-26-18)21(23,24)25/h1-7,10,12,16-17H,8-9,11H2 VEJWAVKRPRJLDD-UHFFFAOYSA-N 143755 US8969352, 35::US8969352, 16::US9611277, Example 35::US10183953, Example 35::US9845333, 35 Orexin receptor type 2 Human 546 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143755 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143755&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271882 251972342 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611261 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143746 US8969352, 36::US8969352, 7::US9611277, Example 36::US10183953, Example 36::US9845333, 36 Orexin/Hypocretin receptor type 1 Rat 5.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143746 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143746&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271693 251972333 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611262 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143746 US8969352, 36::US8969352, 7::US9611277, Example 36::US10183953, Example 36::US9845333, 36 Orexin/Hypocretin receptor type 1 Human 13.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143746 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143746&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271693 251972333 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611263 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143746 US8969352, 36::US8969352, 7::US9611277, Example 36::US10183953, Example 36::US9845333, 36 Orexin receptor type 2 Human 343 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143746 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143746&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271693 251972333 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611264 CCOc1ccc(C)nc1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:17:16:12.13:29,10:12:16.15:29| InChI=1S/C21H22F3N3O3/c1-3-29-16-6-4-12(2)26-19(16)20(28)27-11-13-8-15(27)17(9-13)30-18-7-5-14(10-25-18)21(22,23)24/h4-7,10,13,15,17H,3,8-9,11H2,1-2H3 HBQVLSLDECXOPX-UHFFFAOYSA-N 143776 US8969352, 37::US9611277, Example 37::US10183953, Example 37::US9845333, 37 Orexin/Hypocretin receptor type 1 Rat 170 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143776 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143776&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270574 251972355 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611265 CCOc1ccc(C)nc1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:17:16:12.13:29,10:12:16.15:29| InChI=1S/C21H22F3N3O3/c1-3-29-16-6-4-12(2)26-19(16)20(28)27-11-13-8-15(27)17(9-13)30-18-7-5-14(10-25-18)21(22,23)24/h4-7,10,13,15,17H,3,8-9,11H2,1-2H3 HBQVLSLDECXOPX-UHFFFAOYSA-N 143776 US8969352, 37::US9611277, Example 37::US10183953, Example 37::US9845333, 37 Orexin/Hypocretin receptor type 1 Human 265 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143776 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143776&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270574 251972355 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611266 CCOc1ccc(C)nc1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:17:16:12.13:29,10:12:16.15:29| InChI=1S/C21H22F3N3O3/c1-3-29-16-6-4-12(2)26-19(16)20(28)27-11-13-8-15(27)17(9-13)30-18-7-5-14(10-25-18)21(22,23)24/h4-7,10,13,15,17H,3,8-9,11H2,1-2H3 HBQVLSLDECXOPX-UHFFFAOYSA-N 143776 US8969352, 37::US9611277, Example 37::US10183953, Example 37::US9845333, 37 Orexin receptor type 2 Human 1800 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143776 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143776&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270574 251972355 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611267 Fc1cccc(-c2ncccn2)c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H18F4N4O2/c24-16-4-1-3-15(21-28-7-2-8-29-21)20(16)22(32)31-12-13-9-17(31)18(10-13)33-19-6-5-14(11-30-19)23(25,26)27/h1-8,11,13,17-18H,9-10,12H2 IGPUBGBQVDTOBH-UHFFFAOYSA-N 143777 US8969352, 38::US9611277, Example 38::US10183953, Example 38::US9845333, 38 Orexin/Hypocretin receptor type 1 Rat 8.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143777 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143777&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271885 251972356 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611268 Fc1cccc(-c2ncccn2)c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H18F4N4O2/c24-16-4-1-3-15(21-28-7-2-8-29-21)20(16)22(32)31-12-13-9-17(31)18(10-13)33-19-6-5-14(11-30-19)23(25,26)27/h1-8,11,13,17-18H,9-10,12H2 IGPUBGBQVDTOBH-UHFFFAOYSA-N 143777 US8969352, 38::US9611277, Example 38::US10183953, Example 38::US9845333, 38 Orexin/Hypocretin receptor type 1 Human 8.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143777 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143777&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271885 251972356 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611269 Fc1cccc(-c2ncccn2)c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H18F4N4O2/c24-16-4-1-3-15(21-28-7-2-8-29-21)20(16)22(32)31-12-13-9-17(31)18(10-13)33-19-6-5-14(11-30-19)23(25,26)27/h1-8,11,13,17-18H,9-10,12H2 IGPUBGBQVDTOBH-UHFFFAOYSA-N 143777 US8969352, 38::US9611277, Example 38::US10183953, Example 38::US9845333, 38 Orexin receptor type 2 Human 633 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143777 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143777&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271885 251972356 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611270 COc1cccc(-c2ccn[nH]2)c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H21F3N4O3/c1-32-18-4-2-3-15(16-7-8-28-29-16)21(18)22(31)30-12-13-9-17(30)19(10-13)33-20-6-5-14(11-27-20)23(24,25)26/h2-8,11,13,17,19H,9-10,12H2,1H3,(H,28,29) CTMWEIJXXSCTJH-UHFFFAOYSA-N 143778 US8969352, 39::US9611277, Example 39::US10183953, Example 39::US9845333, 39 Orexin/Hypocretin receptor type 1 Rat 72.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143778 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143778&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270575 251972357 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611271 COc1cccc(-c2ccn[nH]2)c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H21F3N4O3/c1-32-18-4-2-3-15(16-7-8-28-29-16)21(18)22(31)30-12-13-9-17(30)19(10-13)33-20-6-5-14(11-27-20)23(24,25)26/h2-8,11,13,17,19H,9-10,12H2,1H3,(H,28,29) CTMWEIJXXSCTJH-UHFFFAOYSA-N 143778 US8969352, 39::US9611277, Example 39::US10183953, Example 39::US9845333, 39 Orexin/Hypocretin receptor type 1 Human 17.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143778 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143778&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270575 251972357 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611272 COc1cccc(-c2ccn[nH]2)c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H21F3N4O3/c1-32-18-4-2-3-15(16-7-8-28-29-16)21(18)22(31)30-12-13-9-17(30)19(10-13)33-20-6-5-14(11-27-20)23(24,25)26/h2-8,11,13,17,19H,9-10,12H2,1H3,(H,28,29) CTMWEIJXXSCTJH-UHFFFAOYSA-N 143778 US8969352, 39::US9611277, Example 39::US10183953, Example 39::US9845333, 39 Orexin receptor type 2 Human 104 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143778 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143778&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270575 251972357 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611273 COc1cccc(-c2ncccn2)c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:21:20:16.17:33,14:16:20.19:33| InChI=1S/C24H21F3N4O3/c1-33-18-5-2-4-16(22-28-8-3-9-29-22)21(18)23(32)31-13-14-10-17(31)19(11-14)34-20-7-6-15(12-30-20)24(25,26)27/h2-9,12,14,17,19H,10-11,13H2,1H3 YREUWZWUXFUQNJ-UHFFFAOYSA-N 143779 US8969352, 40::US9611277, Example 40::US10183953, Example 40::US9845333, 40 Orexin/Hypocretin receptor type 1 Rat 15.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143779 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143779&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270576 251972358 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611274 COc1cccc(-c2ncccn2)c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:21:20:16.17:33,14:16:20.19:33| InChI=1S/C24H21F3N4O3/c1-33-18-5-2-4-16(22-28-8-3-9-29-22)21(18)23(32)31-13-14-10-17(31)19(11-14)34-20-7-6-15(12-30-20)24(25,26)27/h2-9,12,14,17,19H,10-11,13H2,1H3 YREUWZWUXFUQNJ-UHFFFAOYSA-N 143779 US8969352, 40::US9611277, Example 40::US10183953, Example 40::US9845333, 40 Orexin/Hypocretin receptor type 1 Human 9.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143779 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143779&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270576 251972358 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611275 COc1cccc(-c2ncccn2)c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:21:20:16.17:33,14:16:20.19:33| InChI=1S/C24H21F3N4O3/c1-33-18-5-2-4-16(22-28-8-3-9-29-22)21(18)23(32)31-13-14-10-17(31)19(11-14)34-20-7-6-15(12-30-20)24(25,26)27/h2-9,12,14,17,19H,10-11,13H2,1H3 YREUWZWUXFUQNJ-UHFFFAOYSA-N 143779 US8969352, 40::US9611277, Example 40::US10183953, Example 40::US9845333, 40 Orexin receptor type 2 Human 333 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143779 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143779&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270576 251972358 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611276 Cc1cnn(C)c1-c1ccccc1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32,(.61,-1.24,;1.38,-2.58,;.9,-4.04,;2.15,-4.95,;3.4,-4.04,;4.73,-4.81,;2.92,-2.58,;4.01,-1.49,;5.5,-1.89,;6.59,-.8,;6.19,.69,;4.7,1.09,;3.61,-0,;2.12,.4,;1.03,-.69,;1.72,1.88,;2.5,3.22,;1.01,3.62,;-.48,3.22,;-1.25,1.88,;-1.25,.34,;-2.58,-.43,;-2.58,-1.97,;-3.92,-2.74,;-5.35,-1.98,;-5.25,-.43,;-3.92,.34,;-6.69,-2.74,;-8.03,-3.49,;-7.44,-1.4,;-5.93,-4.08,;.24,2.28,;.24,4.95,)| InChI=1S/C24H23F3N4O2/c1-14-11-29-30(2)22(14)17-5-3-4-6-18(17)23(32)31-13-15-9-19(31)20(10-15)33-21-8-7-16(12-28-21)24(25,26)27/h3-8,11-12,15,19-20H,9-10,13H2,1-2H3 JHIBIGDVURAFGJ-UHFFFAOYSA-N 143780 US8969352, 41::US9611277, Example 41::US10183953, Example 41::US9845333, 41 Orexin/Hypocretin receptor type 1 Rat 4400 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143780 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143780&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 90454374 251972359 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611277 Cc1cnn(C)c1-c1ccccc1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32,(.61,-1.24,;1.38,-2.58,;.9,-4.04,;2.15,-4.95,;3.4,-4.04,;4.73,-4.81,;2.92,-2.58,;4.01,-1.49,;5.5,-1.89,;6.59,-.8,;6.19,.69,;4.7,1.09,;3.61,-0,;2.12,.4,;1.03,-.69,;1.72,1.88,;2.5,3.22,;1.01,3.62,;-.48,3.22,;-1.25,1.88,;-1.25,.34,;-2.58,-.43,;-2.58,-1.97,;-3.92,-2.74,;-5.35,-1.98,;-5.25,-.43,;-3.92,.34,;-6.69,-2.74,;-8.03,-3.49,;-7.44,-1.4,;-5.93,-4.08,;.24,2.28,;.24,4.95,)| InChI=1S/C24H23F3N4O2/c1-14-11-29-30(2)22(14)17-5-3-4-6-18(17)23(32)31-13-15-9-19(31)20(10-15)33-21-8-7-16(12-28-21)24(25,26)27/h3-8,11-12,15,19-20H,9-10,13H2,1-2H3 JHIBIGDVURAFGJ-UHFFFAOYSA-N 143780 US8969352, 41::US9611277, Example 41::US10183953, Example 41::US9845333, 41 Orexin receptor type 2 Human >10000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143780 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143780&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 90454374 251972359 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611278 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2cccc3cc[nH]c23)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143781 US8969352, 42::US9611277, Example 42::US10183953, Example 42::US9845333, 42 Orexin/Hypocretin receptor type 1 Rat 184 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143781 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143781&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270656 251972360 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611279 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2cccc3cc[nH]c23)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143781 US8969352, 42::US9611277, Example 42::US10183953, Example 42::US9845333, 42 Orexin/Hypocretin receptor type 1 Human 175 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143781 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143781&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270656 251972360 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611280 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2cccc3cc[nH]c23)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143781 US8969352, 42::US9611277, Example 42::US10183953, Example 42::US9845333, 42 Orexin receptor type 2 Human 5800 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143781 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143781&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270656 251972360 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611281 Fc1ccc(c(c1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H17F4N5O2/c22-14-2-3-16(30-27-5-6-28-30)15(9-14)20(31)29-11-12-7-17(29)18(8-12)32-19-4-1-13(10-26-19)21(23,24)25/h1-6,9-10,12,17-18H,7-8,11H2 PSMGZVKVWYLIHB-UHFFFAOYSA-N 143753 US8969352, 43::US8969352, 14::US9611277, Example 43::US10183953, Example 43::US9845333, 43 Orexin/Hypocretin receptor type 1 Rat 24.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143753 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143753&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271790 251972340 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611282 Fc1ccc(c(c1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H17F4N5O2/c22-14-2-3-16(30-27-5-6-28-30)15(9-14)20(31)29-11-12-7-17(29)18(8-12)32-19-4-1-13(10-26-19)21(23,24)25/h1-6,9-10,12,17-18H,7-8,11H2 PSMGZVKVWYLIHB-UHFFFAOYSA-N 143753 US8969352, 43::US8969352, 14::US9611277, Example 43::US10183953, Example 43::US9845333, 43 Orexin/Hypocretin receptor type 1 Human 16.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143753 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143753&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271790 251972340 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611283 Fc1ccc(c(c1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H17F4N5O2/c22-14-2-3-16(30-27-5-6-28-30)15(9-14)20(31)29-11-12-7-17(29)18(8-12)32-19-4-1-13(10-26-19)21(23,24)25/h1-6,9-10,12,17-18H,7-8,11H2 PSMGZVKVWYLIHB-UHFFFAOYSA-N 143753 US8969352, 43::US8969352, 14::US9611277, Example 43::US10183953, Example 43::US9845333, 43 Orexin receptor type 2 Human 550 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143753 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143753&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271790 251972340 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611284 Fc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H17F4N5O2/c22-14-2-3-15(16(9-14)30-27-5-6-28-30)20(31)29-11-12-7-17(29)18(8-12)32-19-4-1-13(10-26-19)21(23,24)25/h1-6,9-10,12,17-18H,7-8,11H2 NOXUACCAWHVGCM-UHFFFAOYSA-N 143783 US8969352, 44::US9611277, Example 44::US10183953, Example 44::US9845333, 44 Orexin/Hypocretin receptor type 1 Rat 21.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143783 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143783&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270657 251972361 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611285 Fc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H17F4N5O2/c22-14-2-3-15(16(9-14)30-27-5-6-28-30)20(31)29-11-12-7-17(29)18(8-12)32-19-4-1-13(10-26-19)21(23,24)25/h1-6,9-10,12,17-18H,7-8,11H2 NOXUACCAWHVGCM-UHFFFAOYSA-N 143783 US8969352, 44::US9611277, Example 44::US10183953, Example 44::US9845333, 44 Orexin/Hypocretin receptor type 1 Human 39.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143783 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143783&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270657 251972361 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611286 Fc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H17F4N5O2/c22-14-2-3-15(16(9-14)30-27-5-6-28-30)20(31)29-11-12-7-17(29)18(8-12)32-19-4-1-13(10-26-19)21(23,24)25/h1-6,9-10,12,17-18H,7-8,11H2 NOXUACCAWHVGCM-UHFFFAOYSA-N 143783 US8969352, 44::US9611277, Example 44::US10183953, Example 44::US9845333, 44 Orexin receptor type 2 Human 2333 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143783 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143783&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270657 251972361 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611287 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1Br |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C19H15BrF4N2O2/c20-17-12(2-1-3-13(17)21)18(27)26-9-10-6-14(26)15(7-10)28-16-5-4-11(8-25-16)19(22,23)24/h1-5,8,10,14-15H,6-7,9H2 QSCWUOPMXMROKO-UHFFFAOYSA-N 143784 US8969352, 45::US9611277, Example 45::US10183953, Example 45::US9845333, 45 Orexin/Hypocretin receptor type 1 Rat 60.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143784&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270658 251972362 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611288 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1Br |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C19H15BrF4N2O2/c20-17-12(2-1-3-13(17)21)18(27)26-9-10-6-14(26)15(7-10)28-16-5-4-11(8-25-16)19(22,23)24/h1-5,8,10,14-15H,6-7,9H2 QSCWUOPMXMROKO-UHFFFAOYSA-N 143784 US8969352, 45::US9611277, Example 45::US10183953, Example 45::US9845333, 45 Orexin/Hypocretin receptor type 1 Human 55.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143784&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270658 251972362 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611289 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1Br |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C19H15BrF4N2O2/c20-17-12(2-1-3-13(17)21)18(27)26-9-10-6-14(26)15(7-10)28-16-5-4-11(8-25-16)19(22,23)24/h1-5,8,10,14-15H,6-7,9H2 QSCWUOPMXMROKO-UHFFFAOYSA-N 143784 US8969352, 45::US9611277, Example 45::US10183953, Example 45::US9845333, 45 Orexin receptor type 2 Human 1500 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143784&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270658 251972362 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611290 Fc1cccc(c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H17F4N5O2/c22-14-2-1-3-15(30-27-6-7-28-30)19(14)20(31)29-11-12-8-16(29)17(9-12)32-18-5-4-13(10-26-18)21(23,24)25/h1-7,10,12,16-17H,8-9,11H2 SGBSAQGVDFRKJX-UHFFFAOYSA-N 143757 US8969352, 46::US8969352, 18::US9611277, Example 46::US10183953, Example 46::US9845333, 46 Orexin/Hypocretin receptor type 1 Rat 10.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143757 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143757&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271884 251972344 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611291 Fc1cccc(c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H17F4N5O2/c22-14-2-1-3-15(30-27-6-7-28-30)19(14)20(31)29-11-12-8-16(29)17(9-12)32-18-5-4-13(10-26-18)21(23,24)25/h1-7,10,12,16-17H,8-9,11H2 SGBSAQGVDFRKJX-UHFFFAOYSA-N 143757 US8969352, 46::US8969352, 18::US9611277, Example 46::US10183953, Example 46::US9845333, 46 Orexin/Hypocretin receptor type 1 Human 12.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143757 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143757&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271884 251972344 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611292 Fc1cccc(c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H17F4N5O2/c22-14-2-1-3-15(30-27-6-7-28-30)19(14)20(31)29-11-12-8-16(29)17(9-12)32-18-5-4-13(10-26-18)21(23,24)25/h1-7,10,12,16-17H,8-9,11H2 SGBSAQGVDFRKJX-UHFFFAOYSA-N 143757 US8969352, 46::US8969352, 18::US9611277, Example 46::US10183953, Example 46::US9845333, 46 Orexin receptor type 2 Human 650 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143757 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143757&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271884 251972344 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611293 Fc1cccc(-c2ncccn2)c1C(=O)N1CC2CC(Oc3ccc(Br)cn3)C1C2 |TLB:20:19:15.16:29,13:15:19.18:29| InChI=1S/C22H18BrFN4O2/c23-14-5-6-19(27-11-14)30-18-10-13-9-17(18)28(12-13)22(29)20-15(3-1-4-16(20)24)21-25-7-2-8-26-21/h1-8,11,13,17-18H,9-10,12H2 DZJNFUJQJJPNEW-UHFFFAOYSA-N 143786 US8969352, 47::US9611277, Example 47::US10183953, Example 47::US9845333, 47 Orexin/Hypocretin receptor type 1 Rat 6.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143786 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143786&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 90452188 251972363 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611294 Fc1cccc(-c2ncccn2)c1C(=O)N1CC2CC(Oc3ccc(Br)cn3)C1C2 |TLB:20:19:15.16:29,13:15:19.18:29| InChI=1S/C22H18BrFN4O2/c23-14-5-6-19(27-11-14)30-18-10-13-9-17(18)28(12-13)22(29)20-15(3-1-4-16(20)24)21-25-7-2-8-26-21/h1-8,11,13,17-18H,9-10,12H2 DZJNFUJQJJPNEW-UHFFFAOYSA-N 143786 US8969352, 47::US9611277, Example 47::US10183953, Example 47::US9845333, 47 Orexin/Hypocretin receptor type 1 Human 9.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143786 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143786&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 90452188 251972363 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611295 Fc1cccc(-c2ncccn2)c1C(=O)N1CC2CC(Oc3ccc(Br)cn3)C1C2 |TLB:20:19:15.16:29,13:15:19.18:29| InChI=1S/C22H18BrFN4O2/c23-14-5-6-19(27-11-14)30-18-10-13-9-17(18)28(12-13)22(29)20-15(3-1-4-16(20)24)21-25-7-2-8-26-21/h1-8,11,13,17-18H,9-10,12H2 DZJNFUJQJJPNEW-UHFFFAOYSA-N 143786 US8969352, 47::US9611277, Example 47::US10183953, Example 47::US9845333, 47 Orexin receptor type 2 Human 524 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143786 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143786&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 90452188 251972363 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611296 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(Br)cn4)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:22,6:8:12.11:22| InChI=1S/C22H18BrFN4O2/c23-14-5-6-19(27-11-14)30-18-10-13-9-17(18)28(12-13)22(29)15-3-1-4-16(24)20(15)21-25-7-2-8-26-21/h1-8,11,13,17-18H,9-10,12H2 WHPVXNLPYOHPJB-UHFFFAOYSA-N 143787 US8969352, 48::US9611277, Example 48::US10183953, Example 48::US9845333, 48 Orexin/Hypocretin receptor type 1 Rat 4.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143787 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143787&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270659 251972364 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611297 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(Br)cn4)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:22,6:8:12.11:22| InChI=1S/C22H18BrFN4O2/c23-14-5-6-19(27-11-14)30-18-10-13-9-17(18)28(12-13)22(29)15-3-1-4-16(24)20(15)21-25-7-2-8-26-21/h1-8,11,13,17-18H,9-10,12H2 WHPVXNLPYOHPJB-UHFFFAOYSA-N 143787 US8969352, 48::US9611277, Example 48::US10183953, Example 48::US9845333, 48 Orexin/Hypocretin receptor type 1 Human 5.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143787 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143787&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270659 251972364 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611298 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(Br)cn4)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:22,6:8:12.11:22| InChI=1S/C22H18BrFN4O2/c23-14-5-6-19(27-11-14)30-18-10-13-9-17(18)28(12-13)22(29)15-3-1-4-16(24)20(15)21-25-7-2-8-26-21/h1-8,11,13,17-18H,9-10,12H2 WHPVXNLPYOHPJB-UHFFFAOYSA-N 143787 US8969352, 48::US9611277, Example 48::US10183953, Example 48::US9845333, 48 Orexin receptor type 2 Human 903 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143787 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143787&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270659 251972364 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611299 Brc1ccc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 143788 US8969352, 49::US9611277, Example 49::US10183953, Example 49::US9845333, 49 Orexin/Hypocretin receptor type 1 Rat 6.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143788 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143788&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270660 251972365 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611300 Brc1ccc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 143788 US8969352, 49::US9611277, Example 49::US10183953, Example 49::US9845333, 49 Orexin/Hypocretin receptor type 1 Human 5.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143788 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143788&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270660 251972365 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611301 Brc1ccc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 143788 US8969352, 49::US9611277, Example 49::US10183953, Example 49::US9845333, 49 Orexin receptor type 2 Human 443 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143788 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143788&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270660 251972365 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611302 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc(Br)cn3)C1C2)-n1nccn1 |TLB:14:13:9.10:23,7:9:13.12:23| InChI=1S/C20H19BrN6O2/c1-12-2-4-15(27-23-6-7-24-27)19(25-12)20(28)26-11-13-8-16(26)17(9-13)29-18-5-3-14(21)10-22-18/h2-7,10,13,16-17H,8-9,11H2,1H3 GOUAQCADINSCHG-UHFFFAOYSA-N 143789 US8969352, 50::US9611277, Example 50::US10183953, Example 50::US9845333, 50 Orexin/Hypocretin receptor type 1 Rat 7.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143789 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143789&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270661 251972366 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611303 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc(Br)cn3)C1C2)-n1nccn1 |TLB:14:13:9.10:23,7:9:13.12:23| InChI=1S/C20H19BrN6O2/c1-12-2-4-15(27-23-6-7-24-27)19(25-12)20(28)26-11-13-8-16(26)17(9-13)29-18-5-3-14(21)10-22-18/h2-7,10,13,16-17H,8-9,11H2,1H3 GOUAQCADINSCHG-UHFFFAOYSA-N 143789 US8969352, 50::US9611277, Example 50::US10183953, Example 50::US9845333, 50 Orexin/Hypocretin receptor type 1 Human 10.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143789 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143789&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270661 251972366 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611304 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc(Br)cn3)C1C2)-n1nccn1 |TLB:14:13:9.10:23,7:9:13.12:23| InChI=1S/C20H19BrN6O2/c1-12-2-4-15(27-23-6-7-24-27)19(25-12)20(28)26-11-13-8-16(26)17(9-13)29-18-5-3-14(21)10-22-18/h2-7,10,13,16-17H,8-9,11H2,1H3 GOUAQCADINSCHG-UHFFFAOYSA-N 143789 US8969352, 50::US9611277, Example 50::US10183953, Example 50::US9845333, 50 Orexin receptor type 2 Human 578 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143789 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143789&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270661 251972366 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611305 FC(F)(F)c1cccnc1OC1CC2CC1N(C2)C(=O)c1ccccc1-n1nccn1 |TLB:18:16:11.12:14,THB:10:11:16.17:14| 143790 US8969352, 51::US9611277, Example 51::US10183953, Example 51::US9845333, 51 Orexin/Hypocretin receptor type 1 Rat 294 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143790 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143790&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270750 251972367 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611306 FC(F)(F)c1cccnc1OC1CC2CC1N(C2)C(=O)c1ccccc1-n1nccn1 |TLB:18:16:11.12:14,THB:10:11:16.17:14| 143790 US8969352, 51::US9611277, Example 51::US10183953, Example 51::US9845333, 51 Orexin receptor type 2 Human 676 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143790 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143790&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270750 251972367 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611307 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ncccc3C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H19F3N6O2/c1-12-4-5-15(30-26-7-8-27-30)18(28-12)20(31)29-11-13-9-16(29)17(10-13)32-19-14(21(22,23)24)3-2-6-25-19/h2-8,13,16-17H,9-11H2,1H3 ZAUBOSKPBRXIFA-UHFFFAOYSA-N 143791 US8969352, 52::US9611277, Example 52::US10183953, Example 52::US9845333, 52 Orexin/Hypocretin receptor type 1 Rat 550 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143791 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143791&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270751 251972368 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611308 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ncccc3C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H19F3N6O2/c1-12-4-5-15(30-26-7-8-27-30)18(28-12)20(31)29-11-13-9-16(29)17(10-13)32-19-14(21(22,23)24)3-2-6-25-19/h2-8,13,16-17H,9-11H2,1H3 ZAUBOSKPBRXIFA-UHFFFAOYSA-N 143791 US8969352, 52::US9611277, Example 52::US10183953, Example 52::US9845333, 52 Orexin receptor type 2 Human 4000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143791 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143791&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270751 251972368 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611309 FC(F)(F)c1ccc(NC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143792 US8969352, 53::US9611277, Example 53::US10183953, Example 53::US9845333, 53 Orexin/Hypocretin receptor type 1 Rat 3.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143792 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143792&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270752 251972369 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611310 FC(F)(F)c1ccc(NC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143792 US8969352, 53::US9611277, Example 53::US10183953, Example 53::US9845333, 53 Orexin/Hypocretin receptor type 1 Human 4.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143792 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143792&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270752 251972369 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611311 FC(F)(F)c1ccc(NC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143792 US8969352, 53::US9611277, Example 53::US10183953, Example 53::US9845333, 53 Orexin receptor type 2 Human 169 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143792 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143792&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270752 251972369 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611312 Cc1ccc(c(n1)C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H20F3N7O/c1-12-2-4-16(31-26-6-7-27-31)19(28-12)20(32)30-11-13-8-15(17(30)9-13)29-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,15,17H,8-9,11H2,1H3,(H,25,29) DUSWDGIUZGEZMC-UHFFFAOYSA-N 143793 US8969352, 54::US9611277, Example 54::US9845333, 54 Orexin/Hypocretin receptor type 1 Rat 6.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143793 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143793&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270753 251972370 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611313 Cc1ccc(c(n1)C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H20F3N7O/c1-12-2-4-16(31-26-6-7-27-31)19(28-12)20(32)30-11-13-8-15(17(30)9-13)29-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,15,17H,8-9,11H2,1H3,(H,25,29) DUSWDGIUZGEZMC-UHFFFAOYSA-N 143793 US8969352, 54::US9611277, Example 54::US9845333, 54 Orexin/Hypocretin receptor type 1 Human 5.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143793 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143793&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270753 251972370 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611314 Cc1ccc(c(n1)C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H20F3N7O/c1-12-2-4-16(31-26-6-7-27-31)19(28-12)20(32)30-11-13-8-15(17(30)9-13)29-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,15,17H,8-9,11H2,1H3,(H,25,29) DUSWDGIUZGEZMC-UHFFFAOYSA-N 143793 US8969352, 54::US9611277, Example 54::US9845333, 54 Orexin receptor type 2 Human 126 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143793 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143793&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270753 251972370 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611315 Cc1cccc(C(=O)N2CC3CC(Nc4ccc(cn4)C(F)(F)F)C2C3)c1-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C22H21F3N6O/c1-13-3-2-4-16(20(13)31-27-7-8-28-31)21(32)30-12-14-9-17(18(30)10-14)29-19-6-5-15(11-26-19)22(23,24)25/h2-8,11,14,17-18H,9-10,12H2,1H3,(H,26,29) TWMWEJVSFZPUFN-UHFFFAOYSA-N 143794 US8969352, 55::US9611277, Example 55::US10183953, Example 55::US9845333, 55 Orexin/Hypocretin receptor type 1 Rat 3.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143794 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143794&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270754 251972371 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611316 Cc1cccc(C(=O)N2CC3CC(Nc4ccc(cn4)C(F)(F)F)C2C3)c1-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C22H21F3N6O/c1-13-3-2-4-16(20(13)31-27-7-8-28-31)21(32)30-12-14-9-17(18(30)10-14)29-19-6-5-15(11-26-19)22(23,24)25/h2-8,11,14,17-18H,9-10,12H2,1H3,(H,26,29) TWMWEJVSFZPUFN-UHFFFAOYSA-N 143794 US8969352, 55::US9611277, Example 55::US10183953, Example 55::US9845333, 55 Orexin/Hypocretin receptor type 1 Human 3.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143794 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143794&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270754 251972371 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611317 Cc1cccc(C(=O)N2CC3CC(Nc4ccc(cn4)C(F)(F)F)C2C3)c1-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C22H21F3N6O/c1-13-3-2-4-16(20(13)31-27-7-8-28-31)21(32)30-12-14-9-17(18(30)10-14)29-19-6-5-15(11-26-19)22(23,24)25/h2-8,11,14,17-18H,9-10,12H2,1H3,(H,26,29) TWMWEJVSFZPUFN-UHFFFAOYSA-N 143794 US8969352, 55::US9611277, Example 55::US10183953, Example 55::US9845333, 55 Orexin receptor type 2 Human 46.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143794 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143794&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270754 251972371 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611318 CCOc1ccc2cccnc2c1C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C24H23F3N4O2/c1-2-33-19-7-5-15-4-3-9-28-22(15)21(19)23(32)31-13-14-10-17(18(31)11-14)30-20-8-6-16(12-29-20)24(25,26)27/h3-9,12,14,17-18H,2,10-11,13H2,1H3,(H,29,30) UODSZXVZFBKAGJ-UHFFFAOYSA-N 143795 US8969352, 56::US9611277, Example 56::US10183953, Example 56::US9845333, 56 Orexin/Hypocretin receptor type 1 Rat 8.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143795 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143795&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270755 251972372 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611319 CCOc1ccc2cccnc2c1C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C24H23F3N4O2/c1-2-33-19-7-5-15-4-3-9-28-22(15)21(19)23(32)31-13-14-10-17(18(31)11-14)30-20-8-6-16(12-29-20)24(25,26)27/h3-9,12,14,17-18H,2,10-11,13H2,1H3,(H,29,30) UODSZXVZFBKAGJ-UHFFFAOYSA-N 143795 US8969352, 56::US9611277, Example 56::US10183953, Example 56::US9845333, 56 Orexin/Hypocretin receptor type 1 Human 10.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143795 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143795&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270755 251972372 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611320 CCOc1ccc2cccnc2c1C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C24H23F3N4O2/c1-2-33-19-7-5-15-4-3-9-28-22(15)21(19)23(32)31-13-14-10-17(18(31)11-14)30-20-8-6-16(12-29-20)24(25,26)27/h3-9,12,14,17-18H,2,10-11,13H2,1H3,(H,29,30) UODSZXVZFBKAGJ-UHFFFAOYSA-N 143795 US8969352, 56::US9611277, Example 56::US10183953, Example 56::US9845333, 56 Orexin receptor type 2 Human 192 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143795 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143795&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270755 251972372 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611321 Fc1ccc(c(c1)C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H18F4N6O/c22-14-2-3-17(31-27-5-6-28-31)15(9-14)20(32)30-11-12-7-16(18(30)8-12)29-19-4-1-13(10-26-19)21(23,24)25/h1-6,9-10,12,16,18H,7-8,11H2,(H,26,29) DMOGSWQIKPEGKH-UHFFFAOYSA-N 143796 US8969352, 57::US9611277, Example 57::US10183953, Example 57::US9845333, 57 Orexin/Hypocretin receptor type 1 Rat 5.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143796 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143796&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270842 251972373 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611322 Fc1ccc(c(c1)C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H18F4N6O/c22-14-2-3-17(31-27-5-6-28-31)15(9-14)20(32)30-11-12-7-16(18(30)8-12)29-19-4-1-13(10-26-19)21(23,24)25/h1-6,9-10,12,16,18H,7-8,11H2,(H,26,29) DMOGSWQIKPEGKH-UHFFFAOYSA-N 143796 US8969352, 57::US9611277, Example 57::US10183953, Example 57::US9845333, 57 Orexin/Hypocretin receptor type 1 Human 5.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143796 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143796&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270842 251972373 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611323 Fc1ccc(c(c1)C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H18F4N6O/c22-14-2-3-17(31-27-5-6-28-31)15(9-14)20(32)30-11-12-7-16(18(30)8-12)29-19-4-1-13(10-26-19)21(23,24)25/h1-6,9-10,12,16,18H,7-8,11H2,(H,26,29) DMOGSWQIKPEGKH-UHFFFAOYSA-N 143796 US8969352, 57::US9611277, Example 57::US10183953, Example 57::US9845333, 57 Orexin receptor type 2 Human 225 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143796 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143796&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270842 251972373 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611324 Fc1ccc(-c2ncccn2)c(c1)C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H19F4N5O/c24-15-3-4-16(21-28-6-1-7-29-21)17(10-15)22(33)32-12-13-8-18(19(32)9-13)31-20-5-2-14(11-30-20)23(25,26)27/h1-7,10-11,13,18-19H,8-9,12H2,(H,30,31) CKIBODIXGNACEX-UHFFFAOYSA-N 143797 US8969352, 58::US9611277, Example 58::US10183953, Example 58::US9845333, 58 Orexin/Hypocretin receptor type 1 Rat 5.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143797 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143797&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270843 251972374 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611325 Fc1ccc(-c2ncccn2)c(c1)C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H19F4N5O/c24-15-3-4-16(21-28-6-1-7-29-21)17(10-15)22(33)32-12-13-8-18(19(32)9-13)31-20-5-2-14(11-30-20)23(25,26)27/h1-7,10-11,13,18-19H,8-9,12H2,(H,30,31) CKIBODIXGNACEX-UHFFFAOYSA-N 143797 US8969352, 58::US9611277, Example 58::US10183953, Example 58::US9845333, 58 Orexin/Hypocretin receptor type 1 Human 3.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143797 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143797&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270843 251972374 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611326 Fc1ccc(-c2ncccn2)c(c1)C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H19F4N5O/c24-15-3-4-16(21-28-6-1-7-29-21)17(10-15)22(33)32-12-13-8-18(19(32)9-13)31-20-5-2-14(11-30-20)23(25,26)27/h1-7,10-11,13,18-19H,8-9,12H2,(H,30,31) CKIBODIXGNACEX-UHFFFAOYSA-N 143797 US8969352, 58::US9611277, Example 58::US10183953, Example 58::US9845333, 58 Orexin receptor type 2 Human 193 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143797 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143797&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270843 251972374 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611327 FC(F)(F)c1cnc(NC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)cn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143798 US8969352, 59::US9611277, Example 59::US10183953, Example 59::US9845333, 59 Orexin/Hypocretin receptor type 1 Rat 6.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143798 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143798&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270844 251972375 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611328 FC(F)(F)c1cnc(NC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)cn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143798 US8969352, 59::US9611277, Example 59::US10183953, Example 59::US9845333, 59 Orexin/Hypocretin receptor type 1 Human 7.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143798 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143798&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270844 251972375 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611329 FC(F)(F)c1cnc(NC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)cn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 143798 US8969352, 59::US9611277, Example 59::US10183953, Example 59::US9845333, 59 Orexin receptor type 2 Human 192 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143798 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143798&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270844 251972375 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611330 FC(F)(F)c1cnc(NC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 314885 US10183953, Example 60::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 60 Orexin/Hypocretin receptor type 1 Rat 20.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314885 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314885&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270845 383541704 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611331 FC(F)(F)c1cnc(NC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 314885 US10183953, Example 60::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 60 Orexin/Hypocretin receptor type 1 Human 12.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314885 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314885&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270845 383541704 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611332 FC(F)(F)c1cnc(NC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 314885 US10183953, Example 60::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 60 Orexin receptor type 2 Human 617 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314885 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314885&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270845 383541704 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611333 Cc1ccc(c(n1)C(=O)N1CC2CC(Nc3cnc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C20H19F3N8O/c1-11-2-3-14(31-26-4-5-27-31)18(28-11)19(32)30-10-12-6-13(15(30)7-12)29-17-9-24-16(8-25-17)20(21,22)23/h2-5,8-9,12-13,15H,6-7,10H2,1H3,(H,25,29) KDLOCZKQRNORJA-UHFFFAOYSA-N 314886 US10183953, Example 61::(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 61 Orexin/Hypocretin receptor type 1 Rat 15.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314886 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314886&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270846 383541705 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611334 Cc1ccc(c(n1)C(=O)N1CC2CC(Nc3cnc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C20H19F3N8O/c1-11-2-3-14(31-26-4-5-27-31)18(28-11)19(32)30-10-12-6-13(15(30)7-12)29-17-9-24-16(8-25-17)20(21,22)23/h2-5,8-9,12-13,15H,6-7,10H2,1H3,(H,25,29) KDLOCZKQRNORJA-UHFFFAOYSA-N 314886 US10183953, Example 61::(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 61 Orexin/Hypocretin receptor type 1 Human 19.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314886 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314886&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270846 383541705 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611335 Cc1ccc(c(n1)C(=O)N1CC2CC(Nc3cnc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C20H19F3N8O/c1-11-2-3-14(31-26-4-5-27-31)18(28-11)19(32)30-10-12-6-13(15(30)7-12)29-17-9-24-16(8-25-17)20(21,22)23/h2-5,8-9,12-13,15H,6-7,10H2,1H3,(H,25,29) KDLOCZKQRNORJA-UHFFFAOYSA-N 314886 US10183953, Example 61::(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 61 Orexin receptor type 2 Human 248 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314886 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314886&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270846 383541705 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611336 Cc1ccc(c(n1)C(=O)N1CC2CC(Nc3ncc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C20H19F3N8O/c1-11-2-3-15(31-26-4-5-27-31)17(28-11)18(32)30-10-12-6-14(16(30)7-12)29-19-24-8-13(9-25-19)20(21,22)23/h2-5,8-9,12,14,16H,6-7,10H2,1H3,(H,24,25,29) BLGUJDDADBTVBG-UHFFFAOYSA-N 314887 US10183953, Example 62::(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 62 Orexin/Hypocretin receptor type 1 Rat 28.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314887 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314887&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 90454380 383541706 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611337 Cc1ccc(c(n1)C(=O)N1CC2CC(Nc3ncc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C20H19F3N8O/c1-11-2-3-15(31-26-4-5-27-31)17(28-11)18(32)30-10-12-6-14(16(30)7-12)29-19-24-8-13(9-25-19)20(21,22)23/h2-5,8-9,12,14,16H,6-7,10H2,1H3,(H,24,25,29) BLGUJDDADBTVBG-UHFFFAOYSA-N 314887 US10183953, Example 62::(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 62 Orexin/Hypocretin receptor type 1 Human 19.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314887 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314887&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 90454380 383541706 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611338 Cc1ccc(c(n1)C(=O)N1CC2CC(Nc3ncc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C20H19F3N8O/c1-11-2-3-15(31-26-4-5-27-31)17(28-11)18(32)30-10-12-6-14(16(30)7-12)29-19-24-8-13(9-25-19)20(21,22)23/h2-5,8-9,12,14,16H,6-7,10H2,1H3,(H,24,25,29) BLGUJDDADBTVBG-UHFFFAOYSA-N 314887 US10183953, Example 62::(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 62 Orexin receptor type 2 Human 569 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314887 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314887&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 90454380 383541706 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611339 Fc1cccc(C(=O)N2CC3CC(Nc4ccc(cn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C23H19F4N5O/c24-16-4-1-3-15(20(16)21-28-7-2-8-29-21)22(33)32-12-13-9-17(18(32)10-13)31-19-6-5-14(11-30-19)23(25,26)27/h1-8,11,13,17-18H,9-10,12H2,(H,30,31) MKBACMGUFQWKQP-UHFFFAOYSA-N 314889 US10183953, Example 66::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 66 Orexin/Hypocretin receptor type 1 Rat 2.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314889 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314889&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270942 383541708 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611340 Fc1cccc(C(=O)N2CC3CC(Nc4ccc(cn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C23H19F4N5O/c24-16-4-1-3-15(20(16)21-28-7-2-8-29-21)22(33)32-12-13-9-17(18(32)10-13)31-19-6-5-14(11-30-19)23(25,26)27/h1-8,11,13,17-18H,9-10,12H2,(H,30,31) MKBACMGUFQWKQP-UHFFFAOYSA-N 314889 US10183953, Example 66::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 66 Orexin/Hypocretin receptor type 1 Human 5.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314889 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314889&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270942 383541708 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611341 Fc1cccc(C(=O)N2CC3CC(Nc4ccc(cn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C23H19F4N5O/c24-16-4-1-3-15(20(16)21-28-7-2-8-29-21)22(33)32-12-13-9-17(18(32)10-13)31-19-6-5-14(11-30-19)23(25,26)27/h1-8,11,13,17-18H,9-10,12H2,(H,30,31) MKBACMGUFQWKQP-UHFFFAOYSA-N 314889 US10183953, Example 66::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 66 Orexin receptor type 2 Human 181 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314889 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314889&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270942 383541708 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611342 Fc1cccc(C(=O)N2CC3CC(Nc4cnc(cn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C22H18F4N6O/c23-14-4-1-3-13(19(14)20-27-5-2-6-28-20)21(33)32-11-12-7-15(16(32)8-12)31-18-10-29-17(9-30-18)22(24,25)26/h1-6,9-10,12,15-16H,7-8,11H2,(H,30,31) HVTPZBKKIPJUMP-UHFFFAOYSA-N 314890 US10183953, Example 67::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 67 Orexin/Hypocretin receptor type 1 Rat 7.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314890 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314890&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270943 383541709 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611343 Fc1cccc(C(=O)N2CC3CC(Nc4cnc(cn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C22H18F4N6O/c23-14-4-1-3-13(19(14)20-27-5-2-6-28-20)21(33)32-11-12-7-15(16(32)8-12)31-18-10-29-17(9-30-18)22(24,25)26/h1-6,9-10,12,15-16H,7-8,11H2,(H,30,31) HVTPZBKKIPJUMP-UHFFFAOYSA-N 314890 US10183953, Example 67::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 67 Orexin/Hypocretin receptor type 1 Human 7.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314890 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314890&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270943 383541709 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611344 Fc1cccc(C(=O)N2CC3CC(Nc4cnc(cn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C22H18F4N6O/c23-14-4-1-3-13(19(14)20-27-5-2-6-28-20)21(33)32-11-12-7-15(16(32)8-12)31-18-10-29-17(9-30-18)22(24,25)26/h1-6,9-10,12,15-16H,7-8,11H2,(H,30,31) HVTPZBKKIPJUMP-UHFFFAOYSA-N 314890 US10183953, Example 67::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 67 Orexin receptor type 2 Human 264 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314890 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314890&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270943 383541709 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611345 Fc1cccc(C(=O)N2CC3CC(Nc4ncc(cn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C22H18F4N6O/c23-15-4-1-3-14(18(15)19-27-5-2-6-28-19)20(33)32-11-12-7-16(17(32)8-12)31-21-29-9-13(10-30-21)22(24,25)26/h1-6,9-10,12,16-17H,7-8,11H2,(H,29,30,31) OKURLOIOWNPCQX-UHFFFAOYSA-N 314891 US10183953, Example 68::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 68 Orexin/Hypocretin receptor type 1 Rat 7.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314891 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314891&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270944 383541710 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611346 Fc1cccc(C(=O)N2CC3CC(Nc4ncc(cn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C22H18F4N6O/c23-15-4-1-3-14(18(15)19-27-5-2-6-28-19)20(33)32-11-12-7-16(17(32)8-12)31-21-29-9-13(10-30-21)22(24,25)26/h1-6,9-10,12,16-17H,7-8,11H2,(H,29,30,31) OKURLOIOWNPCQX-UHFFFAOYSA-N 314891 US10183953, Example 68::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 68 Orexin/Hypocretin receptor type 1 Human 8.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314891 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314891&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86270944 383541710 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611347 Fc1cccc(C(=O)N2CC3CC(Nc4ncc(cn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C22H18F4N6O/c23-15-4-1-3-14(18(15)19-27-5-2-6-28-19)20(33)32-11-12-7-16(17(32)8-12)31-21-29-9-13(10-30-21)22(24,25)26/h1-6,9-10,12,16-17H,7-8,11H2,(H,29,30,31) OKURLOIOWNPCQX-UHFFFAOYSA-N 314891 US10183953, Example 68::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 68 Orexin receptor type 2 Human 612 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314891 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314891&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86270944 383541710 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611348 Fc1cccc(C(=O)N2CC3CCC2C(C3)Oc2ccc(cn2)C(F)(F)F)c1-c1ncccn1 |TLB:16:14:11.12:9.8,THB:6:8:14.15:11.12| 314892 (3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 248::US10183953, Example 73::US9611277, Example 73 Orexin/Hypocretin receptor type 1 Rat 8.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314892 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314892&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271039 383541711 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611349 Fc1cccc(C(=O)N2CC3CCC2C(C3)Oc2ccc(cn2)C(F)(F)F)c1-c1ncccn1 |TLB:16:14:11.12:9.8,THB:6:8:14.15:11.12| 314892 (3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 248::US10183953, Example 73::US9611277, Example 73 Orexin/Hypocretin receptor type 1 Human 11.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314892 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314892&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271039 383541711 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611350 Fc1cccc(C(=O)N2CC3CCC2C(C3)Oc2ccc(cn2)C(F)(F)F)c1-c1ncccn1 |TLB:16:14:11.12:9.8,THB:6:8:14.15:11.12| 314892 (3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 248::US10183953, Example 73::US9611277, Example 73 Orexin receptor type 2 Human 575 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314892 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314892&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271039 383541711 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611351 Fc1cccc(C(=O)N2CC3CCC2C(C3)Oc2cnc(cn2)C(F)(F)F)c1-c1ncccn1 |TLB:16:14:11.12:9.8,THB:6:8:14.15:11.12| 314893 US10183953, Example 74::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 74 Orexin/Hypocretin receptor type 1 Rat 16.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314893 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314893&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271040 383541712 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611352 Fc1cccc(C(=O)N2CC3CCC2C(C3)Oc2cnc(cn2)C(F)(F)F)c1-c1ncccn1 |TLB:16:14:11.12:9.8,THB:6:8:14.15:11.12| 314893 US10183953, Example 74::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 74 Orexin/Hypocretin receptor type 1 Human 16.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314893 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314893&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271040 383541712 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611353 Fc1cccc(C(=O)N2CC3CCC2C(C3)Oc2cnc(cn2)C(F)(F)F)c1-c1ncccn1 |TLB:16:14:11.12:9.8,THB:6:8:14.15:11.12| 314893 US10183953, Example 74::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 74 Orexin receptor type 2 Human 1800 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314893 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314893&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271040 383541712 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611354 Cc1ccc(c(n1)C(=O)N1CC2CCC1C(C2)Oc1ccc(cn1)C(F)(F)F)-n1nccn1 |TLB:17:15:12.13:10.9,THB:7:9:15.16:12.13| 314894 US10183953, Example 76::(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 76 Orexin/Hypocretin receptor type 1 Rat 4.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314894 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314894&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271132 383541713 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611355 Cc1ccc(c(n1)C(=O)N1CC2CCC1C(C2)Oc1ccc(cn1)C(F)(F)F)-n1nccn1 |TLB:17:15:12.13:10.9,THB:7:9:15.16:12.13| 314894 US10183953, Example 76::(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 76 Orexin/Hypocretin receptor type 1 Human 3.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314894 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314894&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271132 383541713 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611356 Cc1ccc(c(n1)C(=O)N1CC2CCC1C(C2)Oc1ccc(cn1)C(F)(F)F)-n1nccn1 |TLB:17:15:12.13:10.9,THB:7:9:15.16:12.13| 314894 US10183953, Example 76::(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 76 Orexin receptor type 2 Human 211 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314894 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314894&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271132 383541713 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611357 Cc1ccc(c(n1)C(=O)N1CC2CCC1C(C2)Oc1cnc(cn1)C(F)(F)F)-n1nccn1 |TLB:17:15:12.13:10.9,THB:7:9:15.16:12.13| 314895 US10183953, Example 77::(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 77 Orexin/Hypocretin receptor type 1 Rat 9.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314895 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314895&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271133 383541714 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611358 Cc1ccc(c(n1)C(=O)N1CC2CCC1C(C2)Oc1cnc(cn1)C(F)(F)F)-n1nccn1 |TLB:17:15:12.13:10.9,THB:7:9:15.16:12.13| 314895 US10183953, Example 77::(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 77 Orexin/Hypocretin receptor type 1 Human 13.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314895 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314895&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271133 383541714 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611359 Cc1ccc(c(n1)C(=O)N1CC2CCC1C(C2)Oc1cnc(cn1)C(F)(F)F)-n1nccn1 |TLB:17:15:12.13:10.9,THB:7:9:15.16:12.13| 314895 US10183953, Example 77::(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 77 Orexin receptor type 2 Human 1700 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314895 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314895&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271133 383541714 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611360 Fc1cccc(C(=O)N2CC3CCC2C(C3)Nc2cnc(cn2)C(F)(F)F)c1-c1ncccn1 |TLB:16:14:11.12:9.8,THB:6:8:14.15:11.12| 314897 (3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 276::US9611277, Example 257::US10183953, Example 80::US9611277, Example 80 Orexin/Hypocretin receptor type 1 Rat 9.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314897 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314897&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271136 383541716 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611361 Fc1cccc(C(=O)N2CC3CCC2C(C3)Nc2cnc(cn2)C(F)(F)F)c1-c1ncccn1 |TLB:16:14:11.12:9.8,THB:6:8:14.15:11.12| 314897 (3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 276::US9611277, Example 257::US10183953, Example 80::US9611277, Example 80 Orexin/Hypocretin receptor type 1 Human 7.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314897 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314897&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271136 383541716 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611362 Fc1cccc(C(=O)N2CC3CCC2C(C3)Nc2cnc(cn2)C(F)(F)F)c1-c1ncccn1 |TLB:16:14:11.12:9.8,THB:6:8:14.15:11.12| 314897 (3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 276::US9611277, Example 257::US10183953, Example 80::US9611277, Example 80 Orexin receptor type 2 Human 456 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314897 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314897&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271136 383541716 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611363 Cc1ccc(c(n1)C(=O)N1CC2CCC1C(C2)Nc1cnc(cn1)C(F)(F)F)-n1nccn1 |TLB:17:15:12.13:10.9,THB:7:9:15.16:12.13| 314898 US9611277, Example 252::(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US10183953, Example 83::US9611277, Example 83 Orexin/Hypocretin receptor type 1 Rat 8.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314898 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314898&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271234 383541717 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611364 Cc1ccc(c(n1)C(=O)N1CC2CCC1C(C2)Nc1cnc(cn1)C(F)(F)F)-n1nccn1 |TLB:17:15:12.13:10.9,THB:7:9:15.16:12.13| 314898 US9611277, Example 252::(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US10183953, Example 83::US9611277, Example 83 Orexin/Hypocretin receptor type 1 Human 5.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314898 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314898&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271234 383541717 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611365 Cc1ccc(c(n1)C(=O)N1CC2CCC1C(C2)Nc1cnc(cn1)C(F)(F)F)-n1nccn1 |TLB:17:15:12.13:10.9,THB:7:9:15.16:12.13| 314898 US9611277, Example 252::(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US10183953, Example 83::US9611277, Example 83 Orexin receptor type 2 Human 289 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314898 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314898&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271234 383541717 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611366 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C23H18F4N4O2/c24-16-4-1-3-15(20(16)21-28-7-2-8-29-21)22(32)31-12-13-9-17(31)18(10-13)33-19-6-5-14(11-30-19)23(25,26)27/h1-8,11,13,17-18H,9-10,12H2 HUKWIAXQBOHZIX-UHFFFAOYSA-N 143750 US8969352, 27::US8969352, 11::US9611277, Example 86::US10183953, Example 86::US9845333, 27 Orexin/Hypocretin receptor type 1 Rat 6.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143750 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143750&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271787 251972337 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611367 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C23H18F4N4O2/c24-16-4-1-3-15(20(16)21-28-7-2-8-29-21)22(32)31-12-13-9-17(31)18(10-13)33-19-6-5-14(11-30-19)23(25,26)27/h1-8,11,13,17-18H,9-10,12H2 HUKWIAXQBOHZIX-UHFFFAOYSA-N 143750 US8969352, 27::US8969352, 11::US9611277, Example 86::US10183953, Example 86::US9845333, 27 Orexin/Hypocretin receptor type 1 Human 6.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143750 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143750&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271787 251972337 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611368 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C23H18F4N4O2/c24-16-4-1-3-15(20(16)21-28-7-2-8-29-21)22(32)31-12-13-9-17(31)18(10-13)33-19-6-5-14(11-30-19)23(25,26)27/h1-8,11,13,17-18H,9-10,12H2 HUKWIAXQBOHZIX-UHFFFAOYSA-N 143750 US8969352, 27::US8969352, 11::US9611277, Example 86::US10183953, Example 86::US9845333, 27 Orexin receptor type 2 Human 910 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143750 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143750&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271787 251972337 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611369 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C23H18F4N4O2/c24-16-4-1-3-15(20(16)21-28-7-2-8-29-21)22(32)31-12-13-9-17(31)18(10-13)33-19-6-5-14(11-30-19)23(25,26)27/h1-8,11,13,17-18H,9-10,12H2 HUKWIAXQBOHZIX-UHFFFAOYSA-N 143750 US8969352, 27::US8969352, 11::US9611277, Example 86::US10183953, Example 86::US9845333, 27 Orexin/Hypocretin receptor type 1 Rat 7.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143750 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143750&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271787 251972337 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611370 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C23H18F4N4O2/c24-16-4-1-3-15(20(16)21-28-7-2-8-29-21)22(32)31-12-13-9-17(31)18(10-13)33-19-6-5-14(11-30-19)23(25,26)27/h1-8,11,13,17-18H,9-10,12H2 HUKWIAXQBOHZIX-UHFFFAOYSA-N 143750 US8969352, 27::US8969352, 11::US9611277, Example 86::US10183953, Example 86::US9845333, 27 Orexin/Hypocretin receptor type 1 Human 9.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143750 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143750&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271787 251972337 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611371 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C23H18F4N4O2/c24-16-4-1-3-15(20(16)21-28-7-2-8-29-21)22(32)31-12-13-9-17(31)18(10-13)33-19-6-5-14(11-30-19)23(25,26)27/h1-8,11,13,17-18H,9-10,12H2 HUKWIAXQBOHZIX-UHFFFAOYSA-N 143750 US8969352, 27::US8969352, 11::US9611277, Example 86::US10183953, Example 86::US9845333, 27 Orexin receptor type 2 Human 946 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143750 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143750&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271787 251972337 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611372 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2cccnc2-n2nccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 314904 US10183953, Example 87::(2-(2H-1,2,3-triazol-2-yl)pyridin-3-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 87 Orexin/Hypocretin receptor type 1 Rat 156 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314904 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314904&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637439 383541723 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611373 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2cccnc2-n2nccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 314904 US10183953, Example 87::(2-(2H-1,2,3-triazol-2-yl)pyridin-3-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 87 Orexin/Hypocretin receptor type 1 Human 211 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314904 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314904&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637439 383541723 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611374 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2cccnc2-n2nccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 314904 US10183953, Example 87::(2-(2H-1,2,3-triazol-2-yl)pyridin-3-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 87 Orexin receptor type 2 Human >10000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314904 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314904&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637439 383541723 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611375 Cc1cnc(c(c1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H19F3N6O2/c1-12-6-15(19(26-9-12)30-27-4-5-28-30)20(31)29-11-13-7-16(29)17(8-13)32-18-3-2-14(10-25-18)21(22,23)24/h2-6,9-10,13,16-17H,7-8,11H2,1H3 SZPDVLGCBZREQA-UHFFFAOYSA-N 314905 US10183953, Example 88::(5-methyl-2-(2H-1,2,3-triazol-2-yl)pyridin-3-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 88 Orexin/Hypocretin receptor type 1 Rat 45.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314905 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314905&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637537 383541724 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611376 Cc1cnc(c(c1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H19F3N6O2/c1-12-6-15(19(26-9-12)30-27-4-5-28-30)20(31)29-11-13-7-16(29)17(8-13)32-18-3-2-14(10-25-18)21(22,23)24/h2-6,9-10,13,16-17H,7-8,11H2,1H3 SZPDVLGCBZREQA-UHFFFAOYSA-N 314905 US10183953, Example 88::(5-methyl-2-(2H-1,2,3-triazol-2-yl)pyridin-3-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 88 Orexin/Hypocretin receptor type 1 Human 36.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314905 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314905&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637537 383541724 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611377 Cc1cnc(c(c1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H19F3N6O2/c1-12-6-15(19(26-9-12)30-27-4-5-28-30)20(31)29-11-13-7-16(29)17(8-13)32-18-3-2-14(10-25-18)21(22,23)24/h2-6,9-10,13,16-17H,7-8,11H2,1H3 SZPDVLGCBZREQA-UHFFFAOYSA-N 314905 US10183953, Example 88::(5-methyl-2-(2H-1,2,3-triazol-2-yl)pyridin-3-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 88 Orexin receptor type 2 Human >10000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314905 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314905&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637537 383541724 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611378 Fc1cnc(nc1)-c1ccccc1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H18F4N4O2/c24-15-10-29-21(30-11-15)16-3-1-2-4-17(16)22(32)31-12-13-7-18(31)19(8-13)33-20-6-5-14(9-28-20)23(25,26)27/h1-6,9-11,13,18-19H,7-8,12H2 XIANVXLHVLHZCY-UHFFFAOYSA-N 314906 US10183953, Example 89::(2-(5-fluoropyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 89 Orexin/Hypocretin receptor type 1 Rat 18.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314906 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314906&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637538 383541725 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611379 Fc1cnc(nc1)-c1ccccc1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H18F4N4O2/c24-15-10-29-21(30-11-15)16-3-1-2-4-17(16)22(32)31-12-13-7-18(31)19(8-13)33-20-6-5-14(9-28-20)23(25,26)27/h1-6,9-11,13,18-19H,7-8,12H2 XIANVXLHVLHZCY-UHFFFAOYSA-N 314906 US10183953, Example 89::(2-(5-fluoropyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 89 Orexin/Hypocretin receptor type 1 Human 8.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314906 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314906&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637538 383541725 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611380 Fc1cnc(nc1)-c1ccccc1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H18F4N4O2/c24-15-10-29-21(30-11-15)16-3-1-2-4-17(16)22(32)31-12-13-7-18(31)19(8-13)33-20-6-5-14(9-28-20)23(25,26)27/h1-6,9-11,13,18-19H,7-8,12H2 XIANVXLHVLHZCY-UHFFFAOYSA-N 314906 US10183953, Example 89::(2-(5-fluoropyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 89 Orexin receptor type 2 Human 1100 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314906 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314906&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637538 383541725 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611381 Fc1cnc(nc1)-c1c(F)cccc1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:21:20:16.17:33,14:16:20.19:33| InChI=1S/C23H17F5N4O2/c24-14-9-30-21(31-10-14)20-15(2-1-3-16(20)25)22(33)32-11-12-6-17(32)18(7-12)34-19-5-4-13(8-29-19)23(26,27)28/h1-5,8-10,12,17-18H,6-7,11H2 RFQXMXBLMXGNTK-UHFFFAOYSA-N 314907 US10183953, Example 90::(3-fluoro-2-(5-fluoropyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 90 Orexin/Hypocretin receptor type 1 Rat 15.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314907 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314907&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637604 383541726 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611382 Fc1cnc(nc1)-c1c(F)cccc1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:21:20:16.17:33,14:16:20.19:33| InChI=1S/C23H17F5N4O2/c24-14-9-30-21(31-10-14)20-15(2-1-3-16(20)25)22(33)32-11-12-6-17(32)18(7-12)34-19-5-4-13(8-29-19)23(26,27)28/h1-5,8-10,12,17-18H,6-7,11H2 RFQXMXBLMXGNTK-UHFFFAOYSA-N 314907 US10183953, Example 90::(3-fluoro-2-(5-fluoropyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 90 Orexin/Hypocretin receptor type 1 Human 19.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314907 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314907&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637604 383541726 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611383 Fc1cnc(nc1)-c1c(F)cccc1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:21:20:16.17:33,14:16:20.19:33| InChI=1S/C23H17F5N4O2/c24-14-9-30-21(31-10-14)20-15(2-1-3-16(20)25)22(33)32-11-12-6-17(32)18(7-12)34-19-5-4-13(8-29-19)23(26,27)28/h1-5,8-10,12,17-18H,6-7,11H2 RFQXMXBLMXGNTK-UHFFFAOYSA-N 314907 US10183953, Example 90::(3-fluoro-2-(5-fluoropyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 90 Orexin receptor type 2 Human 2150 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314907 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314907&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637604 383541726 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611384 Cc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-c1ncc(F)cn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C24H20F4N4O2/c1-13-3-2-4-17(21(13)22-30-10-16(25)11-31-22)23(33)32-12-14-7-18(32)19(8-14)34-20-6-5-15(9-29-20)24(26,27)28/h2-6,9-11,14,18-19H,7-8,12H2,1H3 SGWSCQKIMSCPCJ-UHFFFAOYSA-N 314911 US10183953, Example 91::(2-(5-fluoropyrimidin-2-yl)-3-methylphenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 91 Orexin/Hypocretin receptor type 1 Rat 8.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314911 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314911&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637607 383541730 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611385 Cc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-c1ncc(F)cn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C24H20F4N4O2/c1-13-3-2-4-17(21(13)22-30-10-16(25)11-31-22)23(33)32-12-14-7-18(32)19(8-14)34-20-6-5-15(9-29-20)24(26,27)28/h2-6,9-11,14,18-19H,7-8,12H2,1H3 SGWSCQKIMSCPCJ-UHFFFAOYSA-N 314911 US10183953, Example 91::(2-(5-fluoropyrimidin-2-yl)-3-methylphenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 91 Orexin/Hypocretin receptor type 1 Human 6.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314911 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314911&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637607 383541730 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611386 Cc1cccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c1-c1ncc(F)cn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C24H20F4N4O2/c1-13-3-2-4-17(21(13)22-30-10-16(25)11-31-22)23(33)32-12-14-7-18(32)19(8-14)34-20-6-5-15(9-29-20)24(26,27)28/h2-6,9-11,14,18-19H,7-8,12H2,1H3 SGWSCQKIMSCPCJ-UHFFFAOYSA-N 314911 US10183953, Example 91::(2-(5-fluoropyrimidin-2-yl)-3-methylphenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 91 Orexin receptor type 2 Human 331 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314911 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314911&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637607 383541730 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611387 Cc1ccc(-c2ncccn2)c(n1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H20F3N5O2/c1-13-3-5-16(21-27-7-2-8-28-21)20(30-13)22(32)31-12-14-9-17(31)18(10-14)33-19-6-4-15(11-29-19)23(24,25)26/h2-8,11,14,17-18H,9-10,12H2,1H3 VFLRRGBPHSLIQK-UHFFFAOYSA-N 314912 US10183953, Example 92::(6-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 92 Orexin/Hypocretin receptor type 1 Rat 13.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314912 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314912&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637695 383541731 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611388 Cc1ccc(-c2ncccn2)c(n1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H20F3N5O2/c1-13-3-5-16(21-27-7-2-8-28-21)20(30-13)22(32)31-12-14-9-17(31)18(10-14)33-19-6-4-15(11-29-19)23(24,25)26/h2-8,11,14,17-18H,9-10,12H2,1H3 VFLRRGBPHSLIQK-UHFFFAOYSA-N 314912 US10183953, Example 92::(6-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 92 Orexin/Hypocretin receptor type 1 Human 19.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314912 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314912&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637695 383541731 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611389 Cc1ccc(-c2ncccn2)c(n1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H20F3N5O2/c1-13-3-5-16(21-27-7-2-8-28-21)20(30-13)22(32)31-12-14-9-17(31)18(10-14)33-19-6-4-15(11-29-19)23(24,25)26/h2-8,11,14,17-18H,9-10,12H2,1H3 VFLRRGBPHSLIQK-UHFFFAOYSA-N 314912 US10183953, Example 92::(6-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 92 Orexin receptor type 2 Human 362 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314912 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314912&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637695 383541731 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611390 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2nccnc2-c2ccccc2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 314913 US10183953, Example 93::(3-phenylpyrazin-2-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 93 Orexin/Hypocretin receptor type 1 Rat 125 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314913 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314913&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637444 383541732 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611391 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2nccnc2-c2ccccc2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 314913 US10183953, Example 93::(3-phenylpyrazin-2-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 93 Orexin/Hypocretin receptor type 1 Human 76.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314913 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314913&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637444 383541732 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611392 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2nccnc2-c2ccccc2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 314913 US10183953, Example 93::(3-phenylpyrazin-2-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 93 Orexin receptor type 2 Human 3100 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314913 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314913&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637444 383541732 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611393 Fc1cccc(C(=O)N2CC3CC(Oc4cccc(n4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C23H18F4N4O2/c24-15-5-1-4-14(20(15)21-28-8-3-9-29-21)22(32)31-12-13-10-16(31)17(11-13)33-19-7-2-6-18(30-19)23(25,26)27/h1-9,13,16-17H,10-12H2 BMVIINOQMUXBCV-UHFFFAOYSA-N 314914 US10183953, Example 94::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((6-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 94 Orexin/Hypocretin receptor type 1 Rat 35.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314914 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314914&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637397 383541733 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611394 Fc1cccc(C(=O)N2CC3CC(Oc4cccc(n4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C23H18F4N4O2/c24-15-5-1-4-14(20(15)21-28-8-3-9-29-21)22(32)31-12-13-10-16(31)17(11-13)33-19-7-2-6-18(30-19)23(25,26)27/h1-9,13,16-17H,10-12H2 BMVIINOQMUXBCV-UHFFFAOYSA-N 314914 US10183953, Example 94::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((6-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 94 Orexin/Hypocretin receptor type 1 Human 30.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314914 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314914&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637397 383541733 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611395 Fc1cccc(C(=O)N2CC3CC(Oc4cccc(n4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C23H18F4N4O2/c24-15-5-1-4-14(20(15)21-28-8-3-9-29-21)22(32)31-12-13-10-16(31)17(11-13)33-19-7-2-6-18(30-19)23(25,26)27/h1-9,13,16-17H,10-12H2 BMVIINOQMUXBCV-UHFFFAOYSA-N 314914 US10183953, Example 94::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((6-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 94 Orexin receptor type 2 Human 848 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314914 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314914&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637397 383541733 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611396 Fc1cccc(C(=O)N2CC3CC(Oc4cc(ccn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C23H18F4N4O2/c24-16-4-1-3-15(20(16)21-29-6-2-7-30-21)22(32)31-12-13-9-17(31)18(10-13)33-19-11-14(5-8-28-19)23(25,26)27/h1-8,11,13,17-18H,9-10,12H2 ZVTYOYFWFRJRNO-UHFFFAOYSA-N 314915 US10183953, Example 95::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((4-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 95 Orexin/Hypocretin receptor type 1 Rat 29.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314915 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314915&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637445 383541734 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611397 Fc1cccc(C(=O)N2CC3CC(Oc4cc(ccn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C23H18F4N4O2/c24-16-4-1-3-15(20(16)21-29-6-2-7-30-21)22(32)31-12-13-9-17(31)18(10-13)33-19-11-14(5-8-28-19)23(25,26)27/h1-8,11,13,17-18H,9-10,12H2 ZVTYOYFWFRJRNO-UHFFFAOYSA-N 314915 US10183953, Example 95::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((4-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 95 Orexin/Hypocretin receptor type 1 Human 37.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314915 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314915&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637445 383541734 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611398 Fc1cccc(C(=O)N2CC3CC(Oc4cc(ccn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C23H18F4N4O2/c24-16-4-1-3-15(20(16)21-29-6-2-7-30-21)22(32)31-12-13-9-17(31)18(10-13)33-19-11-14(5-8-28-19)23(25,26)27/h1-8,11,13,17-18H,9-10,12H2 ZVTYOYFWFRJRNO-UHFFFAOYSA-N 314915 US10183953, Example 95::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((4-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 95 Orexin receptor type 2 Human 137 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314915 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314915&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637445 383541734 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611399 Fc1cccc(C(=O)N2CC3CC(Oc4ncccc4C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C23H18F4N4O2/c24-16-6-1-4-14(19(16)20-28-8-3-9-29-20)22(32)31-12-13-10-17(31)18(11-13)33-21-15(23(25,26)27)5-2-7-30-21/h1-9,13,17-18H,10-12H2 UMUZOQATVFXSBE-UHFFFAOYSA-N 314917 US10183953, Example 96::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((3-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 96 Orexin/Hypocretin receptor type 1 Rat 320 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314917 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314917&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637559 383541736 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611400 Fc1cccc(C(=O)N2CC3CC(Oc4ncccc4C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C23H18F4N4O2/c24-16-6-1-4-14(19(16)20-28-8-3-9-29-20)22(32)31-12-13-10-17(31)18(11-13)33-21-15(23(25,26)27)5-2-7-30-21/h1-9,13,17-18H,10-12H2 UMUZOQATVFXSBE-UHFFFAOYSA-N 314917 US10183953, Example 96::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((3-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 96 Orexin receptor type 2 Human 1700 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314917 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314917&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637559 383541736 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611401 Fc1cc(cnc1OC1CC2CC1N(C2)C(=O)c1ccccc1-n1nccn1)C(F)(F)F |TLB:15:13:8.9:11,THB:7:8:13.14:11| 314918 US10183953, Example 97::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4R,6R)-6-((3-fluoro-5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 97 Orexin/Hypocretin receptor type 1 Rat 21.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314918 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314918&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637398 383541737 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611402 Fc1cc(cnc1OC1CC2CC1N(C2)C(=O)c1ccccc1-n1nccn1)C(F)(F)F |TLB:15:13:8.9:11,THB:7:8:13.14:11| 314918 US10183953, Example 97::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4R,6R)-6-((3-fluoro-5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 97 Orexin/Hypocretin receptor type 1 Human 15.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314918 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314918&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637398 383541737 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611403 Fc1cc(cnc1OC1CC2CC1N(C2)C(=O)c1ccccc1-n1nccn1)C(F)(F)F |TLB:15:13:8.9:11,THB:7:8:13.14:11| 314918 US10183953, Example 97::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4R,6R)-6-((3-fluoro-5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 97 Orexin receptor type 2 Human 1100 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314918 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314918&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637398 383541737 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611404 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ncc(cc3F)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:27,7:9:13.12:27| InChI=1S/C21H18F4N6O2/c1-11-2-3-15(31-27-4-5-28-31)18(29-11)20(32)30-10-12-6-16(30)17(7-12)33-19-14(22)8-13(9-26-19)21(23,24)25/h2-5,8-9,12,16-17H,6-7,10H2,1H3 MPKCPHHHUVZGIC-UHFFFAOYSA-N 314919 US10183953, Example 98::(1S,4R,6R)-6-((3-fluoro-5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)methanone::US9611277, Example 98 Orexin/Hypocretin receptor type 1 Rat 37.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314919 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314919&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637400 383541738 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611405 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ncc(cc3F)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:27,7:9:13.12:27| InChI=1S/C21H18F4N6O2/c1-11-2-3-15(31-27-4-5-28-31)18(29-11)20(32)30-10-12-6-16(30)17(7-12)33-19-14(22)8-13(9-26-19)21(23,24)25/h2-5,8-9,12,16-17H,6-7,10H2,1H3 MPKCPHHHUVZGIC-UHFFFAOYSA-N 314919 US10183953, Example 98::(1S,4R,6R)-6-((3-fluoro-5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)methanone::US9611277, Example 98 Orexin/Hypocretin receptor type 1 Human 28.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314919 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314919&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637400 383541738 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611406 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ncc(cc3F)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:27,7:9:13.12:27| InChI=1S/C21H18F4N6O2/c1-11-2-3-15(31-27-4-5-28-31)18(29-11)20(32)30-10-12-6-16(30)17(7-12)33-19-14(22)8-13(9-26-19)21(23,24)25/h2-5,8-9,12,16-17H,6-7,10H2,1H3 MPKCPHHHUVZGIC-UHFFFAOYSA-N 314919 US10183953, Example 98::(1S,4R,6R)-6-((3-fluoro-5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)methanone::US9611277, Example 98 Orexin receptor type 2 Human 1200 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314919 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314919&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637400 383541738 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611407 Fc1cc(cnc1OC1CC2CC1N(C2)C(=O)c1ccccc1-c1ncccn1)C(F)(F)F |TLB:15:13:8.9:11,THB:7:8:13.14:11| 314920 US10183953, Example 99::((1S,4R,6R)-6-((3-fluoro-5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 99 Orexin/Hypocretin receptor type 1 Rat 11.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314920 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314920&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637557 383541739 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611408 Fc1cc(cnc1OC1CC2CC1N(C2)C(=O)c1ccccc1-c1ncccn1)C(F)(F)F |TLB:15:13:8.9:11,THB:7:8:13.14:11| 314920 US10183953, Example 99::((1S,4R,6R)-6-((3-fluoro-5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 99 Orexin/Hypocretin receptor type 1 Human 10.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314920 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314920&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637557 383541739 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611409 Fc1cc(cnc1OC1CC2CC1N(C2)C(=O)c1ccccc1-c1ncccn1)C(F)(F)F |TLB:15:13:8.9:11,THB:7:8:13.14:11| 314920 US10183953, Example 99::((1S,4R,6R)-6-((3-fluoro-5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 99 Orexin receptor type 2 Human 725 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314920 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314920&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637557 383541739 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611410 Fc1cc(cnc1OC1CC2CC1N(C2)C(=O)c1cccc(F)c1-c1ncccn1)C(F)(F)F |TLB:15:13:8.9:11,THB:7:8:13.14:11| 314921 US10183953, Example 100::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((3-fluoro-5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 100 Orexin/Hypocretin receptor type 1 Rat 13.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314921 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314921&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637814 383541740 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611411 Fc1cc(cnc1OC1CC2CC1N(C2)C(=O)c1cccc(F)c1-c1ncccn1)C(F)(F)F |TLB:15:13:8.9:11,THB:7:8:13.14:11| 314921 US10183953, Example 100::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((3-fluoro-5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 100 Orexin/Hypocretin receptor type 1 Human 12.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314921 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314921&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637814 383541740 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611412 Fc1cc(cnc1OC1CC2CC1N(C2)C(=O)c1cccc(F)c1-c1ncccn1)C(F)(F)F |TLB:15:13:8.9:11,THB:7:8:13.14:11| 314921 US10183953, Example 100::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((3-fluoro-5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 100 Orexin receptor type 2 Human 1600 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314921 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314921&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637814 383541740 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611413 Cc1ccc(OC2CC3CC2N(C3)C(=O)c2cccc(F)c2-c2ncccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 314922 US10183953, Example 101::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-methylpyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 101 Orexin/Hypocretin receptor type 1 Rat 26.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314922 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314922&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 90452162 383541741 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611414 Cc1ccc(OC2CC3CC2N(C3)C(=O)c2cccc(F)c2-c2ncccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 314922 US10183953, Example 101::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-methylpyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 101 Orexin/Hypocretin receptor type 1 Human 11.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314922 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314922&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 90452162 383541741 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611415 Cc1ccc(OC2CC3CC2N(C3)C(=O)c2cccc(F)c2-c2ncccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 314922 US10183953, Example 101::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-methylpyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 101 Orexin receptor type 2 Human 710 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314922 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314922&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 90452162 383541741 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611416 O=C(N1CC2CC(Oc3ccccn3)C1C2)c1ccccc1-n1nccn1 |TLB:7:6:2.3:15,1:2:6.5:15| InChI=1S/C20H19N5O2/c26-20(15-5-1-2-6-16(15)25-22-9-10-23-25)24-13-14-11-17(24)18(12-14)27-19-7-3-4-8-21-19/h1-10,14,17-18H,11-13H2 HSPNFRNGEFXLDT-UHFFFAOYSA-N 314923 US10183953, Example 102::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4R,6R)-6-(pyridin-2-yloxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 102 Orexin/Hypocretin receptor type 1 Rat 404 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314923 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314923&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637399 383541742 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611417 O=C(N1CC2CC(Oc3ccccn3)C1C2)c1ccccc1-n1nccn1 |TLB:7:6:2.3:15,1:2:6.5:15| InChI=1S/C20H19N5O2/c26-20(15-5-1-2-6-16(15)25-22-9-10-23-25)24-13-14-11-17(24)18(12-14)27-19-7-3-4-8-21-19/h1-10,14,17-18H,11-13H2 HSPNFRNGEFXLDT-UHFFFAOYSA-N 314923 US10183953, Example 102::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4R,6R)-6-(pyridin-2-yloxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 102 Orexin receptor type 2 Human 1600 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314923 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314923&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637399 383541742 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611418 Cc1ccc(C(=O)N2CC3CC(Oc4ccccn4)C2C3)c(n1)-n1nccn1 |TLB:12:11:7.8:20,5:7:11.10:20| InChI=1S/C20H20N6O2/c1-13-5-6-15(19(24-13)26-22-8-9-23-26)20(27)25-12-14-10-16(25)17(11-14)28-18-4-2-3-7-21-18/h2-9,14,16-17H,10-12H2,1H3 ZPEIRGTYFIWCEM-UHFFFAOYSA-N 314924 US10183953, Example 103::(6-methyl-2-(2H-1,2,3-triazol-2-yl)pyridin-3-yl)((1S,4R,6R)-6-(pyridin-2-yloxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 103 Orexin/Hypocretin receptor type 1 Rat >10000 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314924 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314924&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637605 383541743 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611419 Cc1ccc(C(=O)N2CC3CC(Oc4ccccn4)C2C3)c(n1)-n1nccn1 |TLB:12:11:7.8:20,5:7:11.10:20| InChI=1S/C20H20N6O2/c1-13-5-6-15(19(24-13)26-22-8-9-23-26)20(27)25-12-14-10-16(25)17(11-14)28-18-4-2-3-7-21-18/h2-9,14,16-17H,10-12H2,1H3 ZPEIRGTYFIWCEM-UHFFFAOYSA-N 314924 US10183953, Example 103::(6-methyl-2-(2H-1,2,3-triazol-2-yl)pyridin-3-yl)((1S,4R,6R)-6-(pyridin-2-yloxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 103 Orexin receptor type 2 Human >10000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314924 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314924&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637605 383541743 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611420 Fc1cccc(C(=O)N2CC3CC(Oc4ccccn4)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:21,6:8:12.11:21| InChI=1S/C22H19FN4O2/c23-16-6-3-5-15(20(16)21-25-9-4-10-26-21)22(28)27-13-14-11-17(27)18(12-14)29-19-7-1-2-8-24-19/h1-10,14,17-18H,11-13H2 NRWSCYDVSMLPPG-UHFFFAOYSA-N 314925 US10183953, Example 104::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-(pyridin-2-yloxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 104 Orexin/Hypocretin receptor type 1 Rat 497 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314925 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314925&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637401 383541744 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611421 Fc1cccc(C(=O)N2CC3CC(Oc4ccccn4)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:21,6:8:12.11:21| InChI=1S/C22H19FN4O2/c23-16-6-3-5-15(20(16)21-25-9-4-10-26-21)22(28)27-13-14-11-17(27)18(12-14)29-19-7-1-2-8-24-19/h1-10,14,17-18H,11-13H2 NRWSCYDVSMLPPG-UHFFFAOYSA-N 314925 US10183953, Example 104::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-(pyridin-2-yloxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 104 Orexin receptor type 2 Human 5000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314925 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314925&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637401 383541744 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611422 Cc1ccc(C(=O)N2CC3CC(Oc4ccc(Br)cn4)C2C3)c(n1)-n1nccn1 |TLB:12:11:7.8:21,5:7:11.10:21| InChI=1S/C20H19BrN6O2/c1-12-2-4-15(19(25-12)27-23-6-7-24-27)20(28)26-11-13-8-16(26)17(9-13)29-18-5-3-14(21)10-22-18/h2-7,10,13,16-17H,8-9,11H2,1H3 BBAWWLVBZCGTPR-UHFFFAOYSA-N 314926 US10183953, Example 105::((1S,4R,6R)-6-((5-bromopyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(6-methyl-2-(2H-1,2,3-triazol-2-yl)pyridin-3-yl)methanone::US9611277, Example 105 Orexin/Hypocretin receptor type 1 Rat 119 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314926 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314926&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637608 383541745 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611423 Cc1ccc(C(=O)N2CC3CC(Oc4ccc(Br)cn4)C2C3)c(n1)-n1nccn1 |TLB:12:11:7.8:21,5:7:11.10:21| InChI=1S/C20H19BrN6O2/c1-12-2-4-15(19(25-12)27-23-6-7-24-27)20(28)26-11-13-8-16(26)17(9-13)29-18-5-3-14(21)10-22-18/h2-7,10,13,16-17H,8-9,11H2,1H3 BBAWWLVBZCGTPR-UHFFFAOYSA-N 314926 US10183953, Example 105::((1S,4R,6R)-6-((5-bromopyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(6-methyl-2-(2H-1,2,3-triazol-2-yl)pyridin-3-yl)methanone::US9611277, Example 105 Orexin/Hypocretin receptor type 1 Human 337 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314926 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314926&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637608 383541745 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611424 Cc1ccc(C(=O)N2CC3CC(Oc4ccc(Br)cn4)C2C3)c(n1)-n1nccn1 |TLB:12:11:7.8:21,5:7:11.10:21| InChI=1S/C20H19BrN6O2/c1-12-2-4-15(19(25-12)27-23-6-7-24-27)20(28)26-11-13-8-16(26)17(9-13)29-18-5-3-14(21)10-22-18/h2-7,10,13,16-17H,8-9,11H2,1H3 BBAWWLVBZCGTPR-UHFFFAOYSA-N 314926 US10183953, Example 105::((1S,4R,6R)-6-((5-bromopyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(6-methyl-2-(2H-1,2,3-triazol-2-yl)pyridin-3-yl)methanone::US9611277, Example 105 Orexin receptor type 2 Human >10000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314926 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314926&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637608 383541745 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611425 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(Br)cn4)C2C3)c1-n1nccn1 |TLB:13:12:8.9:22,6:8:12.11:22| InChI=1S/C20H17BrFN5O2/c21-13-4-5-18(23-10-13)29-17-9-12-8-16(17)26(11-12)20(28)14-2-1-3-15(22)19(14)27-24-6-7-25-27/h1-7,10,12,16-17H,8-9,11H2 IKRKJQANDJSOOF-UHFFFAOYSA-N 314927 US10183953, Example 106::((1S,4R,6R)-6-((5-bromopyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone::US9611277, Example 106 Orexin/Hypocretin receptor type 1 Rat 3.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314927 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314927&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637816 383541746 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611426 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(Br)cn4)C2C3)c1-n1nccn1 |TLB:13:12:8.9:22,6:8:12.11:22| InChI=1S/C20H17BrFN5O2/c21-13-4-5-18(23-10-13)29-17-9-12-8-16(17)26(11-12)20(28)14-2-1-3-15(22)19(14)27-24-6-7-25-27/h1-7,10,12,16-17H,8-9,11H2 IKRKJQANDJSOOF-UHFFFAOYSA-N 314927 US10183953, Example 106::((1S,4R,6R)-6-((5-bromopyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone::US9611277, Example 106 Orexin/Hypocretin receptor type 1 Human 4.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314927 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314927&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637816 383541746 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611427 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(Br)cn4)C2C3)c1-n1nccn1 |TLB:13:12:8.9:22,6:8:12.11:22| InChI=1S/C20H17BrFN5O2/c21-13-4-5-18(23-10-13)29-17-9-12-8-16(17)26(11-12)20(28)14-2-1-3-15(22)19(14)27-24-6-7-25-27/h1-7,10,12,16-17H,8-9,11H2 IKRKJQANDJSOOF-UHFFFAOYSA-N 314927 US10183953, Example 106::((1S,4R,6R)-6-((5-bromopyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone::US9611277, Example 106 Orexin receptor type 2 Human 436 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314927 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314927&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637816 383541746 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611428 Fc1ccc(C(=O)N2CC3CC(Oc4ccc(Br)cn4)C2C3)c(c1)-n1nccn1 |TLB:12:11:7.8:21,5:7:11.10:21| InChI=1S/C20H17BrFN5O2/c21-13-1-4-19(23-10-13)29-18-8-12-7-17(18)26(11-12)20(28)15-3-2-14(22)9-16(15)27-24-5-6-25-27/h1-6,9-10,12,17-18H,7-8,11H2 SMONOAFNYGZSPI-UHFFFAOYSA-N 314928 US10183953, Example 107::((1S,4R,6R)-6-((5-bromopyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(4-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone::US9611277, Example 107 Orexin/Hypocretin receptor type 1 Rat 16.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314928 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314928&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637402 383541747 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611429 Fc1ccc(C(=O)N2CC3CC(Oc4ccc(Br)cn4)C2C3)c(c1)-n1nccn1 |TLB:12:11:7.8:21,5:7:11.10:21| InChI=1S/C20H17BrFN5O2/c21-13-1-4-19(23-10-13)29-18-8-12-7-17(18)26(11-12)20(28)15-3-2-14(22)9-16(15)27-24-5-6-25-27/h1-6,9-10,12,17-18H,7-8,11H2 SMONOAFNYGZSPI-UHFFFAOYSA-N 314928 US10183953, Example 107::((1S,4R,6R)-6-((5-bromopyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(4-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone::US9611277, Example 107 Orexin/Hypocretin receptor type 1 Human 26.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314928 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314928&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637402 383541747 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611430 Fc1ccc(C(=O)N2CC3CC(Oc4ccc(Br)cn4)C2C3)c(c1)-n1nccn1 |TLB:12:11:7.8:21,5:7:11.10:21| InChI=1S/C20H17BrFN5O2/c21-13-1-4-19(23-10-13)29-18-8-12-7-17(18)26(11-12)20(28)15-3-2-14(22)9-16(15)27-24-5-6-25-27/h1-6,9-10,12,17-18H,7-8,11H2 SMONOAFNYGZSPI-UHFFFAOYSA-N 314928 US10183953, Example 107::((1S,4R,6R)-6-((5-bromopyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(4-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone::US9611277, Example 107 Orexin receptor type 2 Human 1960 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314928 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314928&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637402 383541747 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611431 Fc1ccc(c(c1)C(=O)N1CC2CC(Oc3ccc(Br)cn3)C1C2)-n1nccn1 |TLB:14:13:9.10:23,7:9:13.12:23| InChI=1S/C20H17BrFN5O2/c21-13-1-4-19(23-10-13)29-18-8-12-7-17(18)26(11-12)20(28)15-9-14(22)2-3-16(15)27-24-5-6-25-27/h1-6,9-10,12,17-18H,7-8,11H2 LVMZNJMKNSCSRE-UHFFFAOYSA-N 314929 US10183953, Example 108::((1S,4R,6R)-6-((5-bromopyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone::US9611277, Example 108 Orexin/Hypocretin receptor type 1 Rat 8.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314929 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314929&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637560 383541748 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611432 Fc1ccc(c(c1)C(=O)N1CC2CC(Oc3ccc(Br)cn3)C1C2)-n1nccn1 |TLB:14:13:9.10:23,7:9:13.12:23| InChI=1S/C20H17BrFN5O2/c21-13-1-4-19(23-10-13)29-18-8-12-7-17(18)26(11-12)20(28)15-9-14(22)2-3-16(15)27-24-5-6-25-27/h1-6,9-10,12,17-18H,7-8,11H2 LVMZNJMKNSCSRE-UHFFFAOYSA-N 314929 US10183953, Example 108::((1S,4R,6R)-6-((5-bromopyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone::US9611277, Example 108 Orexin/Hypocretin receptor type 1 Human 31.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314929 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314929&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637560 383541748 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611433 Fc1ccc(c(c1)C(=O)N1CC2CC(Oc3ccc(Br)cn3)C1C2)-n1nccn1 |TLB:14:13:9.10:23,7:9:13.12:23| InChI=1S/C20H17BrFN5O2/c21-13-1-4-19(23-10-13)29-18-8-12-7-17(18)26(11-12)20(28)15-9-14(22)2-3-16(15)27-24-5-6-25-27/h1-6,9-10,12,17-18H,7-8,11H2 LVMZNJMKNSCSRE-UHFFFAOYSA-N 314929 US10183953, Example 108::((1S,4R,6R)-6-((5-bromopyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone::US9611277, Example 108 Orexin receptor type 2 Human 776 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314929 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314929&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637560 383541748 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611434 Fc1cccc(c1C(=O)N1CC2CC(Oc3ccc(Br)cn3)C1C2)-n1nccn1 |TLB:14:13:9.10:23,7:9:13.12:23| InChI=1S/C20H17BrFN5O2/c21-13-4-5-18(23-10-13)29-17-9-12-8-16(17)26(11-12)20(28)19-14(22)2-1-3-15(19)27-24-6-7-25-27/h1-7,10,12,16-17H,8-9,11H2 MRACDQSYDZOLOK-UHFFFAOYSA-N 314930 US10183953, Example 109::((1S,4R,6R)-6-((5-bromopyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(2-fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl)methanone::US9611277, Example 109 Orexin/Hypocretin receptor type 1 Rat 6.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314930 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314930&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637561 383541749 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611435 Fc1cccc(c1C(=O)N1CC2CC(Oc3ccc(Br)cn3)C1C2)-n1nccn1 |TLB:14:13:9.10:23,7:9:13.12:23| InChI=1S/C20H17BrFN5O2/c21-13-4-5-18(23-10-13)29-17-9-12-8-16(17)26(11-12)20(28)19-14(22)2-1-3-15(19)27-24-6-7-25-27/h1-7,10,12,16-17H,8-9,11H2 MRACDQSYDZOLOK-UHFFFAOYSA-N 314930 US10183953, Example 109::((1S,4R,6R)-6-((5-bromopyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(2-fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl)methanone::US9611277, Example 109 Orexin/Hypocretin receptor type 1 Human 5.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314930 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314930&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637561 383541749 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611436 Fc1cccc(c1C(=O)N1CC2CC(Oc3ccc(Br)cn3)C1C2)-n1nccn1 |TLB:14:13:9.10:23,7:9:13.12:23| InChI=1S/C20H17BrFN5O2/c21-13-4-5-18(23-10-13)29-17-9-12-8-16(17)26(11-12)20(28)19-14(22)2-1-3-15(19)27-24-6-7-25-27/h1-7,10,12,16-17H,8-9,11H2 MRACDQSYDZOLOK-UHFFFAOYSA-N 314930 US10183953, Example 109::((1S,4R,6R)-6-((5-bromopyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(2-fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl)methanone::US9611277, Example 109 Orexin receptor type 2 Human 442 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314930 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314930&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637561 383541749 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611437 Fc1ccc(C(=O)N2CC3CC(Oc4ccc(Br)cn4)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:21,5:7:11.10:21| InChI=1S/C22H18BrFN4O2/c23-14-2-5-20(27-11-14)30-19-9-13-8-18(19)28(12-13)22(29)16-4-3-15(24)10-17(16)21-25-6-1-7-26-21/h1-7,10-11,13,18-19H,8-9,12H2 IUILCANMCVXZBC-UHFFFAOYSA-N 314931 US10183953, Example 110::((1S,4R,6R)-6-((5-bromopyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(4-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 110 Orexin/Hypocretin receptor type 1 Rat 6.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314931 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314931&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637562 383541750 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611438 Fc1ccc(C(=O)N2CC3CC(Oc4ccc(Br)cn4)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:21,5:7:11.10:21| InChI=1S/C22H18BrFN4O2/c23-14-2-5-20(27-11-14)30-19-9-13-8-18(19)28(12-13)22(29)16-4-3-15(24)10-17(16)21-25-6-1-7-26-21/h1-7,10-11,13,18-19H,8-9,12H2 IUILCANMCVXZBC-UHFFFAOYSA-N 314931 US10183953, Example 110::((1S,4R,6R)-6-((5-bromopyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(4-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 110 Orexin/Hypocretin receptor type 1 Human 11.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314931 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314931&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637562 383541750 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611439 Fc1ccc(C(=O)N2CC3CC(Oc4ccc(Br)cn4)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:21,5:7:11.10:21| InChI=1S/C22H18BrFN4O2/c23-14-2-5-20(27-11-14)30-19-9-13-8-18(19)28(12-13)22(29)16-4-3-15(24)10-17(16)21-25-6-1-7-26-21/h1-7,10-11,13,18-19H,8-9,12H2 IUILCANMCVXZBC-UHFFFAOYSA-N 314931 US10183953, Example 110::((1S,4R,6R)-6-((5-bromopyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(4-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 110 Orexin receptor type 2 Human 1200 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314931 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314931&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637562 383541750 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611440 Fc1ccc(-c2ncccn2)c(c1)C(=O)N1CC2CC(Oc3ccc(Br)cn3)C1C2 |TLB:20:19:15.16:29,13:15:19.18:29| InChI=1S/C22H18BrFN4O2/c23-14-2-5-20(27-11-14)30-19-9-13-8-18(19)28(12-13)22(29)17-10-15(24)3-4-16(17)21-25-6-1-7-26-21/h1-7,10-11,13,18-19H,8-9,12H2 BXBJEADATQUMMN-UHFFFAOYSA-N 314932 ((1S,4R,6R)-6-((5-bromopyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(5-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 111 Orexin/Hypocretin receptor type 1 Rat 5.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314932 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314932&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637446 383541751 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611441 Fc1ccc(-c2ncccn2)c(c1)C(=O)N1CC2CC(Oc3ccc(Br)cn3)C1C2 |TLB:20:19:15.16:29,13:15:19.18:29| InChI=1S/C22H18BrFN4O2/c23-14-2-5-20(27-11-14)30-19-9-13-8-18(19)28(12-13)22(29)17-10-15(24)3-4-16(17)21-25-6-1-7-26-21/h1-7,10-11,13,18-19H,8-9,12H2 BXBJEADATQUMMN-UHFFFAOYSA-N 314932 ((1S,4R,6R)-6-((5-bromopyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(5-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 111 Orexin/Hypocretin receptor type 1 Human 5.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314932 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314932&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637446 383541751 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611442 Fc1ccc(-c2ncccn2)c(c1)C(=O)N1CC2CC(Oc3ccc(Br)cn3)C1C2 |TLB:20:19:15.16:29,13:15:19.18:29| InChI=1S/C22H18BrFN4O2/c23-14-2-5-20(27-11-14)30-19-9-13-8-18(19)28(12-13)22(29)17-10-15(24)3-4-16(17)21-25-6-1-7-26-21/h1-7,10-11,13,18-19H,8-9,12H2 BXBJEADATQUMMN-UHFFFAOYSA-N 314932 ((1S,4R,6R)-6-((5-bromopyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(5-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 111 Orexin receptor type 2 Human 458 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314932 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314932&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637446 383541751 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611443 Clc1ccc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 314933 US10183953, Example 112::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4R,6R)-6-((5-chloropyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 112 Orexin/Hypocretin receptor type 1 Rat 8.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314933 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314933&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637611 383541752 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611444 Clc1ccc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 314933 US10183953, Example 112::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4R,6R)-6-((5-chloropyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 112 Orexin/Hypocretin receptor type 1 Human 10.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314933 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314933&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637611 383541752 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611445 Clc1ccc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 314933 US10183953, Example 112::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4R,6R)-6-((5-chloropyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 112 Orexin receptor type 2 Human 459 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314933 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314933&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637611 383541752 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611446 Fc1ccc(c(c1)C(=O)N1CC2CC(Oc3ccc(Cl)cn3)C1C2)-n1nccn1 |TLB:14:13:9.10:23,7:9:13.12:23| InChI=1S/C20H17ClFN5O2/c21-13-1-4-19(23-10-13)29-18-8-12-7-17(18)26(11-12)20(28)15-9-14(22)2-3-16(15)27-24-5-6-25-27/h1-6,9-10,12,17-18H,7-8,11H2 ACOGCBSETDFIIN-UHFFFAOYSA-N 314934 US10183953, Example 113::((1S,4R,6R)-6-((5-chloropyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone::US9611277, Example 113 Orexin/Hypocretin receptor type 1 Rat 17.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314934 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314934&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637612 383541753 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611447 Fc1ccc(c(c1)C(=O)N1CC2CC(Oc3ccc(Cl)cn3)C1C2)-n1nccn1 |TLB:14:13:9.10:23,7:9:13.12:23| InChI=1S/C20H17ClFN5O2/c21-13-1-4-19(23-10-13)29-18-8-12-7-17(18)26(11-12)20(28)15-9-14(22)2-3-16(15)27-24-5-6-25-27/h1-6,9-10,12,17-18H,7-8,11H2 ACOGCBSETDFIIN-UHFFFAOYSA-N 314934 US10183953, Example 113::((1S,4R,6R)-6-((5-chloropyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone::US9611277, Example 113 Orexin/Hypocretin receptor type 1 Human 14.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314934 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314934&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637612 383541753 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611448 Fc1ccc(c(c1)C(=O)N1CC2CC(Oc3ccc(Cl)cn3)C1C2)-n1nccn1 |TLB:14:13:9.10:23,7:9:13.12:23| InChI=1S/C20H17ClFN5O2/c21-13-1-4-19(23-10-13)29-18-8-12-7-17(18)26(11-12)20(28)15-9-14(22)2-3-16(15)27-24-5-6-25-27/h1-6,9-10,12,17-18H,7-8,11H2 ACOGCBSETDFIIN-UHFFFAOYSA-N 314934 US10183953, Example 113::((1S,4R,6R)-6-((5-chloropyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone::US9611277, Example 113 Orexin receptor type 2 Human 984 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314934 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314934&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637612 383541753 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611449 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc(Cl)cn3)C1C2)-n1nccn1 |TLB:14:13:9.10:23,7:9:13.12:23| InChI=1S/C20H19ClN6O2/c1-12-2-4-15(27-23-6-7-24-27)19(25-12)20(28)26-11-13-8-16(26)17(9-13)29-18-5-3-14(21)10-22-18/h2-7,10,13,16-17H,8-9,11H2,1H3 QTYIVVNDNOEBGA-UHFFFAOYSA-N 314935 US10183953, Example 114::((1S,4R,6R)-6-((5-chloropyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)methanone::US9611277, Example 114 Orexin/Hypocretin receptor type 1 Rat 11.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314935 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314935&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637752 383541754 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611450 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc(Cl)cn3)C1C2)-n1nccn1 |TLB:14:13:9.10:23,7:9:13.12:23| InChI=1S/C20H19ClN6O2/c1-12-2-4-15(27-23-6-7-24-27)19(25-12)20(28)26-11-13-8-16(26)17(9-13)29-18-5-3-14(21)10-22-18/h2-7,10,13,16-17H,8-9,11H2,1H3 QTYIVVNDNOEBGA-UHFFFAOYSA-N 314935 US10183953, Example 114::((1S,4R,6R)-6-((5-chloropyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)methanone::US9611277, Example 114 Orexin/Hypocretin receptor type 1 Human 23.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314935 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314935&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637752 383541754 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611451 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc(Cl)cn3)C1C2)-n1nccn1 |TLB:14:13:9.10:23,7:9:13.12:23| InChI=1S/C20H19ClN6O2/c1-12-2-4-15(27-23-6-7-24-27)19(25-12)20(28)26-11-13-8-16(26)17(9-13)29-18-5-3-14(21)10-22-18/h2-7,10,13,16-17H,8-9,11H2,1H3 QTYIVVNDNOEBGA-UHFFFAOYSA-N 314935 US10183953, Example 114::((1S,4R,6R)-6-((5-chloropyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)methanone::US9611277, Example 114 Orexin receptor type 2 Human 668 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314935 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314935&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637752 383541754 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611452 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(Cl)cn4)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:22,6:8:12.11:22| InChI=1S/C22H18ClFN4O2/c23-14-5-6-19(27-11-14)30-18-10-13-9-17(18)28(12-13)22(29)15-3-1-4-16(24)20(15)21-25-7-2-8-26-21/h1-8,11,13,17-18H,9-10,12H2 HTDSVXBXPJNEDB-UHFFFAOYSA-N 314936 US10183953, Example 115::((1S,4R,6R)-6-((5-chloropyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 115 Orexin/Hypocretin receptor type 1 Rat 7.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314936 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314936&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637609 383541755 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611453 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(Cl)cn4)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:22,6:8:12.11:22| InChI=1S/C22H18ClFN4O2/c23-14-5-6-19(27-11-14)30-18-10-13-9-17(18)28(12-13)22(29)15-3-1-4-16(24)20(15)21-25-7-2-8-26-21/h1-8,11,13,17-18H,9-10,12H2 HTDSVXBXPJNEDB-UHFFFAOYSA-N 314936 US10183953, Example 115::((1S,4R,6R)-6-((5-chloropyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 115 Orexin/Hypocretin receptor type 1 Human 8.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314936 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314936&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637609 383541755 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611454 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(Cl)cn4)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:22,6:8:12.11:22| InChI=1S/C22H18ClFN4O2/c23-14-5-6-19(27-11-14)30-18-10-13-9-17(18)28(12-13)22(29)15-3-1-4-16(24)20(15)21-25-7-2-8-26-21/h1-8,11,13,17-18H,9-10,12H2 HTDSVXBXPJNEDB-UHFFFAOYSA-N 314936 US10183953, Example 115::((1S,4R,6R)-6-((5-chloropyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 115 Orexin receptor type 2 Human 852 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314936 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314936&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637609 383541755 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611455 Fc1cnc(nc1)-c1ccccc1C(=O)N1CC2CC(Oc3ccc(Cl)cn3)C1C2 |TLB:20:19:15.16:29,13:15:19.18:29| InChI=1S/C22H18ClFN4O2/c23-14-5-6-20(25-9-14)30-19-8-13-7-18(19)28(12-13)22(29)17-4-2-1-3-16(17)21-26-10-15(24)11-27-21/h1-6,9-11,13,18-19H,7-8,12H2 SLPQSTVMMGCCCM-UHFFFAOYSA-N 314937 US10183953, Example 116::((1S,4R,6R)-6-((5-chloropyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(2-(5-fluoropyrimidin-2-yl)phenyl)methanone::US9611277, Example 116 Orexin/Hypocretin receptor type 1 Rat 11.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314937 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314937&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637403 383541756 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611456 Fc1cnc(nc1)-c1ccccc1C(=O)N1CC2CC(Oc3ccc(Cl)cn3)C1C2 |TLB:20:19:15.16:29,13:15:19.18:29| InChI=1S/C22H18ClFN4O2/c23-14-5-6-20(25-9-14)30-19-8-13-7-18(19)28(12-13)22(29)17-4-2-1-3-16(17)21-26-10-15(24)11-27-21/h1-6,9-11,13,18-19H,7-8,12H2 SLPQSTVMMGCCCM-UHFFFAOYSA-N 314937 US10183953, Example 116::((1S,4R,6R)-6-((5-chloropyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(2-(5-fluoropyrimidin-2-yl)phenyl)methanone::US9611277, Example 116 Orexin/Hypocretin receptor type 1 Human 12.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314937 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314937&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637403 383541756 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611457 Fc1cnc(nc1)-c1ccccc1C(=O)N1CC2CC(Oc3ccc(Cl)cn3)C1C2 |TLB:20:19:15.16:29,13:15:19.18:29| InChI=1S/C22H18ClFN4O2/c23-14-5-6-20(25-9-14)30-19-8-13-7-18(19)28(12-13)22(29)17-4-2-1-3-16(17)21-26-10-15(24)11-27-21/h1-6,9-11,13,18-19H,7-8,12H2 SLPQSTVMMGCCCM-UHFFFAOYSA-N 314937 US10183953, Example 116::((1S,4R,6R)-6-((5-chloropyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(2-(5-fluoropyrimidin-2-yl)phenyl)methanone::US9611277, Example 116 Orexin receptor type 2 Human 939 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314937 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314937&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637403 383541756 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611458 Fc1cnc(nc1)-c1c(F)cccc1C(=O)N1CC2CC(Oc3ccc(Cl)cn3)C1C2 |TLB:21:20:16.17:30,14:16:20.19:30| InChI=1S/C22H17ClF2N4O2/c23-13-4-5-19(26-8-13)31-18-7-12-6-17(18)29(11-12)22(30)15-2-1-3-16(25)20(15)21-27-9-14(24)10-28-21/h1-5,8-10,12,17-18H,6-7,11H2 SNUPJQDDCFLBBP-UHFFFAOYSA-N 314938 US10183953, Example 117::((1S,4R,6R)-6-((5-chloropyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(5-fluoropyrimidin-2-yl)phenyl)methanone::US9611277, Example 117 Orexin/Hypocretin receptor type 1 Rat 16.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314938 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314938&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637826 383541757 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611459 Fc1cnc(nc1)-c1c(F)cccc1C(=O)N1CC2CC(Oc3ccc(Cl)cn3)C1C2 |TLB:21:20:16.17:30,14:16:20.19:30| InChI=1S/C22H17ClF2N4O2/c23-13-4-5-19(26-8-13)31-18-7-12-6-17(18)29(11-12)22(30)15-2-1-3-16(25)20(15)21-27-9-14(24)10-28-21/h1-5,8-10,12,17-18H,6-7,11H2 SNUPJQDDCFLBBP-UHFFFAOYSA-N 314938 US10183953, Example 117::((1S,4R,6R)-6-((5-chloropyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(5-fluoropyrimidin-2-yl)phenyl)methanone::US9611277, Example 117 Orexin/Hypocretin receptor type 1 Human 28.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314938 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314938&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637826 383541757 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611460 Fc1cnc(nc1)-c1c(F)cccc1C(=O)N1CC2CC(Oc3ccc(Cl)cn3)C1C2 |TLB:21:20:16.17:30,14:16:20.19:30| InChI=1S/C22H17ClF2N4O2/c23-13-4-5-19(26-8-13)31-18-7-12-6-17(18)29(11-12)22(30)15-2-1-3-16(25)20(15)21-27-9-14(24)10-28-21/h1-5,8-10,12,17-18H,6-7,11H2 SNUPJQDDCFLBBP-UHFFFAOYSA-N 314938 US10183953, Example 117::((1S,4R,6R)-6-((5-chloropyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(5-fluoropyrimidin-2-yl)phenyl)methanone::US9611277, Example 117 Orexin receptor type 2 Human 1600 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314938 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314938&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637826 383541757 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611461 Fc1ccc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 314939 US10183953, Example 118::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4R,6R)-6-((5-fluoropyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 118 Orexin/Hypocretin receptor type 1 Rat 133 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314939 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314939&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637448 383541758 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611462 Fc1ccc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 314939 US10183953, Example 118::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4R,6R)-6-((5-fluoropyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 118 Orexin/Hypocretin receptor type 1 Human 105 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314939 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314939&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637448 383541758 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611463 Fc1ccc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 314939 US10183953, Example 118::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4R,6R)-6-((5-fluoropyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 118 Orexin receptor type 2 Human 1600 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314939 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314939&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637448 383541758 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611464 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc(F)cn3)C1C2)-n1nccn1 |TLB:14:13:9.10:23,7:9:13.12:23| InChI=1S/C20H19FN6O2/c1-12-2-4-15(27-23-6-7-24-27)19(25-12)20(28)26-11-13-8-16(26)17(9-13)29-18-5-3-14(21)10-22-18/h2-7,10,13,16-17H,8-9,11H2,1H3 AKJLDZHUQCXFJL-UHFFFAOYSA-N 314940 US10183953, Example 119::((1S,4R,6R)-6-((5-fluoropyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)methanone::US9611277, Example 119 Orexin/Hypocretin receptor type 1 Rat 262 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314940 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314940&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637594 383541759 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611465 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc(F)cn3)C1C2)-n1nccn1 |TLB:14:13:9.10:23,7:9:13.12:23| InChI=1S/C20H19FN6O2/c1-12-2-4-15(27-23-6-7-24-27)19(25-12)20(28)26-11-13-8-16(26)17(9-13)29-18-5-3-14(21)10-22-18/h2-7,10,13,16-17H,8-9,11H2,1H3 AKJLDZHUQCXFJL-UHFFFAOYSA-N 314940 US10183953, Example 119::((1S,4R,6R)-6-((5-fluoropyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)methanone::US9611277, Example 119 Orexin receptor type 2 Human 3600 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314940 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314940&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637594 383541759 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611466 Fc1ccc(OC2CC3CC2N(C3)C(=O)c2cccc(F)c2-c2ncccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 314941 US10183953, Example 120::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-fluoropyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 120 Orexin/Hypocretin receptor type 1 Rat 60.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314941 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314941&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637449 383541760 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611467 Fc1ccc(OC2CC3CC2N(C3)C(=O)c2cccc(F)c2-c2ncccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 314941 US10183953, Example 120::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-fluoropyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 120 Orexin/Hypocretin receptor type 1 Human 111 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314941 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314941&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637449 383541760 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611468 Fc1ccc(OC2CC3CC2N(C3)C(=O)c2cccc(F)c2-c2ncccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 314941 US10183953, Example 120::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-fluoropyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 120 Orexin receptor type 2 Human 4100 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314941 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314941&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637449 383541760 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611469 FC(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:15:13:8.9:11,THB:7:8:13.14:11| 314942 US10183953, Example 121::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4R,6R)-6-((5-(difluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 121 Orexin/Hypocretin receptor type 1 Rat 10.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314942 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314942&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637404 383541761 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611470 FC(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:15:13:8.9:11,THB:7:8:13.14:11| 314942 US10183953, Example 121::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4R,6R)-6-((5-(difluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 121 Orexin/Hypocretin receptor type 1 Human 11.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314942 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314942&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637404 383541761 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611471 FC(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:15:13:8.9:11,THB:7:8:13.14:11| 314942 US10183953, Example 121::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4R,6R)-6-((5-(difluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 121 Orexin receptor type 2 Human 50.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314942 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314942&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637404 383541761 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611472 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:25,7:9:13.12:25| InChI=1S/C21H20F2N6O2/c1-12-2-4-15(29-25-6-7-26-29)19(27-12)21(30)28-11-13-8-16(28)17(9-13)31-18-5-3-14(10-24-18)20(22)23/h2-7,10,13,16-17,20H,8-9,11H2,1H3 FPVWQZKZLYHJBA-UHFFFAOYSA-N 314943 US10183953, Example 122::((1S,4R,6R)-6-((5-(difluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)methanone::US9611277, Example 122 Orexin/Hypocretin receptor type 1 Rat 28.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314943 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314943&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637615 383541762 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611473 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:25,7:9:13.12:25| InChI=1S/C21H20F2N6O2/c1-12-2-4-15(29-25-6-7-26-29)19(27-12)21(30)28-11-13-8-16(28)17(9-13)31-18-5-3-14(10-24-18)20(22)23/h2-7,10,13,16-17,20H,8-9,11H2,1H3 FPVWQZKZLYHJBA-UHFFFAOYSA-N 314943 US10183953, Example 122::((1S,4R,6R)-6-((5-(difluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)methanone::US9611277, Example 122 Orexin/Hypocretin receptor type 1 Human 30.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314943 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314943&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637615 383541762 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611474 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:25,7:9:13.12:25| InChI=1S/C21H20F2N6O2/c1-12-2-4-15(29-25-6-7-26-29)19(27-12)21(30)28-11-13-8-16(28)17(9-13)31-18-5-3-14(10-24-18)20(22)23/h2-7,10,13,16-17,20H,8-9,11H2,1H3 FPVWQZKZLYHJBA-UHFFFAOYSA-N 314943 US10183953, Example 122::((1S,4R,6R)-6-((5-(difluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)methanone::US9611277, Example 122 Orexin receptor type 2 Human 218 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314943 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314943&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637615 383541762 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611475 FC(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2cccc(F)c2-c2ncccn2)nc1 |TLB:15:13:8.9:11,THB:7:8:13.14:11| 314944 US10183953, Example 123::((1S,4R,6R)-6-((5-(difluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 123 Orexin/Hypocretin receptor type 1 Rat 11.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314944 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314944&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637617 383541763 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611476 FC(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2cccc(F)c2-c2ncccn2)nc1 |TLB:15:13:8.9:11,THB:7:8:13.14:11| 314944 US10183953, Example 123::((1S,4R,6R)-6-((5-(difluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 123 Orexin/Hypocretin receptor type 1 Human 10.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314944 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314944&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637617 383541763 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611477 FC(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2cccc(F)c2-c2ncccn2)nc1 |TLB:15:13:8.9:11,THB:7:8:13.14:11| 314944 US10183953, Example 123::((1S,4R,6R)-6-((5-(difluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 123 Orexin receptor type 2 Human 149 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314944 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314944&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637617 383541763 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611478 Fc1ccc(c(c1)C(=O)N1CC2CC(Oc3cnc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C20H16F4N6O2/c21-12-1-2-14(30-27-3-4-28-30)13(7-12)19(31)29-10-11-5-15(29)16(6-11)32-18-9-25-17(8-26-18)20(22,23)24/h1-4,7-9,11,15-16H,5-6,10H2 IXTVGOOAYRBFSB-UHFFFAOYSA-N 314945 US10183953, Example 124::(5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 124 Orexin/Hypocretin receptor type 1 Rat 200 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314945 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314945&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637456 383541764 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611479 Fc1ccc(c(c1)C(=O)N1CC2CC(Oc3cnc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C20H16F4N6O2/c21-12-1-2-14(30-27-3-4-28-30)13(7-12)19(31)29-10-11-5-15(29)16(6-11)32-18-9-25-17(8-26-18)20(22,23)24/h1-4,7-9,11,15-16H,5-6,10H2 IXTVGOOAYRBFSB-UHFFFAOYSA-N 314945 US10183953, Example 124::(5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 124 Orexin/Hypocretin receptor type 1 Human 109 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314945 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314945&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637456 383541764 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611480 Fc1ccc(c(c1)C(=O)N1CC2CC(Oc3cnc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C20H16F4N6O2/c21-12-1-2-14(30-27-3-4-28-30)13(7-12)19(31)29-10-11-5-15(29)16(6-11)32-18-9-25-17(8-26-18)20(22,23)24/h1-4,7-9,11,15-16H,5-6,10H2 IXTVGOOAYRBFSB-UHFFFAOYSA-N 314945 US10183953, Example 124::(5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 124 Orexin receptor type 2 Human 4500 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314945 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314945&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637456 383541764 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611481 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3cnc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C20H18F3N7O2/c1-11-2-3-13(30-26-4-5-27-30)18(28-11)19(31)29-10-12-6-14(29)15(7-12)32-17-9-24-16(8-25-17)20(21,22)23/h2-5,8-9,12,14-15H,6-7,10H2,1H3 CKWUPZSHHCLQII-UHFFFAOYSA-N 143743 US8969352, 2::US9611277, Example 125::US10183953, Example 2::US9845333, 2 Orexin/Hypocretin receptor type 1 Rat 220 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143743 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143743&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271695 251972330 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611482 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3cnc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C20H18F3N7O2/c1-11-2-3-13(30-26-4-5-27-30)18(28-11)19(31)29-10-12-6-14(29)15(7-12)32-17-9-24-16(8-25-17)20(21,22)23/h2-5,8-9,12,14-15H,6-7,10H2,1H3 CKWUPZSHHCLQII-UHFFFAOYSA-N 143743 US8969352, 2::US9611277, Example 125::US10183953, Example 2::US9845333, 2 Orexin/Hypocretin receptor type 1 Human 88.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143743 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143743&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271695 251972330 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611483 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3cnc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C20H18F3N7O2/c1-11-2-3-13(30-26-4-5-27-30)18(28-11)19(31)29-10-12-6-14(29)15(7-12)32-17-9-24-16(8-25-17)20(21,22)23/h2-5,8-9,12,14-15H,6-7,10H2,1H3 CKWUPZSHHCLQII-UHFFFAOYSA-N 143743 US8969352, 2::US9611277, Example 125::US10183953, Example 2::US9845333, 2 Orexin receptor type 2 Human 5500 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143743 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143743&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271695 251972330 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611484 Fc1cccc(C(=O)N2CC3CC(Oc4cnc(cn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C22H17F4N5O2/c23-14-4-1-3-13(19(14)20-27-5-2-6-28-20)21(32)31-11-12-7-15(31)16(8-12)33-18-10-29-17(9-30-18)22(24,25)26/h1-6,9-10,12,15-16H,7-8,11H2 FSDXAFQWIRNYLV-UHFFFAOYSA-N 314947 US10183953, Example 126::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 126 Orexin/Hypocretin receptor type 1 Rat 27.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314947 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314947&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637616 383541766 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611485 Fc1cccc(C(=O)N2CC3CC(Oc4cnc(cn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C22H17F4N5O2/c23-14-4-1-3-13(19(14)20-27-5-2-6-28-20)21(32)31-11-12-7-15(31)16(8-12)33-18-10-29-17(9-30-18)22(24,25)26/h1-6,9-10,12,15-16H,7-8,11H2 FSDXAFQWIRNYLV-UHFFFAOYSA-N 314947 US10183953, Example 126::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 126 Orexin/Hypocretin receptor type 1 Human 22.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314947 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314947&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637616 383541766 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611486 Fc1cccc(C(=O)N2CC3CC(Oc4cnc(cn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C22H17F4N5O2/c23-14-4-1-3-13(19(14)20-27-5-2-6-28-20)21(32)31-11-12-7-15(31)16(8-12)33-18-10-29-17(9-30-18)22(24,25)26/h1-6,9-10,12,15-16H,7-8,11H2 FSDXAFQWIRNYLV-UHFFFAOYSA-N 314947 US10183953, Example 126::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 126 Orexin receptor type 2 Human 4200 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314947 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314947&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637616 383541766 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611487 Fc1ccc(C(=O)N2CC3CC(Oc4cnc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C22H17F4N5O2/c23-13-2-3-14(15(8-13)20-27-4-1-5-28-20)21(32)31-11-12-6-16(31)17(7-12)33-19-10-29-18(9-30-19)22(24,25)26/h1-5,8-10,12,16-17H,6-7,11H2 WKTBBFGPEXQHKB-UHFFFAOYSA-N 314948 US10183953, Example 127::(4-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 127 Orexin/Hypocretin receptor type 1 Rat 116 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314948 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314948&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637832 383541767 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611488 Fc1ccc(C(=O)N2CC3CC(Oc4cnc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C22H17F4N5O2/c23-13-2-3-14(15(8-13)20-27-4-1-5-28-20)21(32)31-11-12-6-16(31)17(7-12)33-19-10-29-18(9-30-19)22(24,25)26/h1-5,8-10,12,16-17H,6-7,11H2 WKTBBFGPEXQHKB-UHFFFAOYSA-N 314948 US10183953, Example 127::(4-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 127 Orexin/Hypocretin receptor type 1 Human 143 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314948 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314948&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637832 383541767 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611489 Fc1ccc(C(=O)N2CC3CC(Oc4cnc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C22H17F4N5O2/c23-13-2-3-14(15(8-13)20-27-4-1-5-28-20)21(32)31-11-12-6-16(31)17(7-12)33-19-10-29-18(9-30-19)22(24,25)26/h1-5,8-10,12,16-17H,6-7,11H2 WKTBBFGPEXQHKB-UHFFFAOYSA-N 314948 US10183953, Example 127::(4-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 127 Orexin receptor type 2 Human >10000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314948 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314948&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637832 383541767 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611490 Fc1ccc(-c2ncccn2)c(c1)C(=O)N1CC2CC(Oc3cnc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C22H17F4N5O2/c23-13-2-3-14(20-27-4-1-5-28-20)15(8-13)21(32)31-11-12-6-16(31)17(7-12)33-19-10-29-18(9-30-19)22(24,25)26/h1-5,8-10,12,16-17H,6-7,11H2 NZLIWNHRTLECAK-UHFFFAOYSA-N 314949 US10183953, Example 128::(5-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 128 Orexin/Hypocretin receptor type 1 Rat 69.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314949 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314949&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637754 383541768 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611491 Fc1ccc(-c2ncccn2)c(c1)C(=O)N1CC2CC(Oc3cnc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C22H17F4N5O2/c23-13-2-3-14(20-27-4-1-5-28-20)15(8-13)21(32)31-11-12-6-16(31)17(7-12)33-19-10-29-18(9-30-19)22(24,25)26/h1-5,8-10,12,16-17H,6-7,11H2 NZLIWNHRTLECAK-UHFFFAOYSA-N 314949 US10183953, Example 128::(5-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 128 Orexin/Hypocretin receptor type 1 Human 62.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314949 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314949&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637754 383541768 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611492 Fc1ccc(-c2ncccn2)c(c1)C(=O)N1CC2CC(Oc3cnc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C22H17F4N5O2/c23-13-2-3-14(20-27-4-1-5-28-20)15(8-13)21(32)31-11-12-6-16(31)17(7-12)33-19-10-29-18(9-30-19)22(24,25)26/h1-5,8-10,12,16-17H,6-7,11H2 NZLIWNHRTLECAK-UHFFFAOYSA-N 314949 US10183953, Example 128::(5-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 128 Orexin receptor type 2 Human 3800 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314949 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314949&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637754 383541768 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611493 Fc1cccc(-c2ncccn2)c1C(=O)N1CC2CC(Oc3cnc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C22H17F4N5O2/c23-14-4-1-3-13(20-27-5-2-6-28-20)19(14)21(32)31-11-12-7-15(31)16(8-12)33-18-10-29-17(9-30-18)22(24,25)26/h1-6,9-10,12,15-16H,7-8,11H2 CCUGNZGBCBKQGZ-UHFFFAOYSA-N 314950 US10183953, Example 129::(2-fluoro-6-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 129 Orexin/Hypocretin receptor type 1 Rat 53.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314950 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314950&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637613 383541769 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611494 Fc1cccc(-c2ncccn2)c1C(=O)N1CC2CC(Oc3cnc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C22H17F4N5O2/c23-14-4-1-3-13(20-27-5-2-6-28-20)19(14)21(32)31-11-12-7-15(31)16(8-12)33-18-10-29-17(9-30-18)22(24,25)26/h1-6,9-10,12,15-16H,7-8,11H2 CCUGNZGBCBKQGZ-UHFFFAOYSA-N 314950 US10183953, Example 129::(2-fluoro-6-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 129 Orexin/Hypocretin receptor type 1 Human 47.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314950 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314950&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637613 383541769 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611495 Fc1cccc(-c2ncccn2)c1C(=O)N1CC2CC(Oc3cnc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C22H17F4N5O2/c23-14-4-1-3-13(20-27-5-2-6-28-20)19(14)21(32)31-11-12-7-15(31)16(8-12)33-18-10-29-17(9-30-18)22(24,25)26/h1-6,9-10,12,15-16H,7-8,11H2 CCUGNZGBCBKQGZ-UHFFFAOYSA-N 314950 US10183953, Example 129::(2-fluoro-6-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 129 Orexin receptor type 2 Human 4400 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314950 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314950&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637613 383541769 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611496 FC(F)(F)c1cnc(OC2CC3CC2N(C3)C(=O)c2ccccc2-c2ncccn2)cn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 314951 US10183953, Example 130::(2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 130 Orexin/Hypocretin receptor type 1 Rat 29.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314951 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314951&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637405 383541770 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611497 FC(F)(F)c1cnc(OC2CC3CC2N(C3)C(=O)c2ccccc2-c2ncccn2)cn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 314951 US10183953, Example 130::(2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 130 Orexin/Hypocretin receptor type 1 Human 27.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314951 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314951&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637405 383541770 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611498 FC(F)(F)c1cnc(OC2CC3CC2N(C3)C(=O)c2ccccc2-c2ncccn2)cn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 314951 US10183953, Example 130::(2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 130 Orexin receptor type 2 Human 3500 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314951 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314951&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637405 383541770 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611499 Cc1cnc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 314952 US10183953, Example 131::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4R,6R)-6-((5-methylpyrimidin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 131 Orexin/Hypocretin receptor type 1 Rat 140 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314952 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314952&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637840 383541771 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611500 Cc1cnc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 314952 US10183953, Example 131::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4R,6R)-6-((5-methylpyrimidin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 131 Orexin/Hypocretin receptor type 1 Human 132 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314952 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314952&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637840 383541771 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611501 Cc1cnc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 314952 US10183953, Example 131::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4R,6R)-6-((5-methylpyrimidin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 131 Orexin receptor type 2 Human 2200 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314952 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314952&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637840 383541771 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611502 Cc1cnc(OC2CC3CC2N(C3)C(=O)c2nc(C)ccc2-n2nccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 314953 US10183953, Example 132::(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)((1S,4R,6R)-6-((5-methylpyrimidin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 132 Orexin/Hypocretin receptor type 1 Rat 425 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314953 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314953&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637406 383541772 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611503 Cc1cnc(OC2CC3CC2N(C3)C(=O)c2nc(C)ccc2-n2nccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 314953 US10183953, Example 132::(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)((1S,4R,6R)-6-((5-methylpyrimidin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 132 Orexin receptor type 2 Human 6800 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314953 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314953&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637406 383541772 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611504 Cc1cnc(OC2CC3CC2N(C3)C(=O)c2cccc(F)c2-c2ncccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 314954 US10183953, Example 133::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-methylpyrimidin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 133 Orexin/Hypocretin receptor type 1 Rat 60.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314954 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314954&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637841 383541773 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611505 Cc1cnc(OC2CC3CC2N(C3)C(=O)c2cccc(F)c2-c2ncccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 314954 US10183953, Example 133::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-methylpyrimidin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 133 Orexin/Hypocretin receptor type 1 Human 102 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314954 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314954&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637841 383541773 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611506 Cc1cnc(OC2CC3CC2N(C3)C(=O)c2cccc(F)c2-c2ncccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 314954 US10183953, Example 133::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-methylpyrimidin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 133 Orexin receptor type 2 Human 4200 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314954 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314954&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637841 383541773 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611507 Cc1cnc(OC2CC3CC2N(C3)C(=O)c2ncc(C)cc2-c2ncccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 314955 US10183953, Example 134::(5-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4R,6R)-6-((5-methylpyrimidin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 134 Orexin/Hypocretin receptor type 1 Rat 668 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314955 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314955&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637851 383541774 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611508 Cc1cnc(OC2CC3CC2N(C3)C(=O)c2ncc(C)cc2-c2ncccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 314955 US10183953, Example 134::(5-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4R,6R)-6-((5-methylpyrimidin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 134 Orexin receptor type 2 Human >10000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314955 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314955&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637851 383541774 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611509 CCc1cnc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:14:12:7.8:10,THB:6:7:12.13:10| 314956 US10183953, Example 135::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4R,6R)-6-((5-ethylpyrimidin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 135 Orexin/Hypocretin receptor type 1 Rat 61.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314956 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314956&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637564 383541775 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611510 CCc1cnc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:14:12:7.8:10,THB:6:7:12.13:10| 314956 US10183953, Example 135::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4R,6R)-6-((5-ethylpyrimidin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 135 Orexin/Hypocretin receptor type 1 Human 100.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314956 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314956&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637564 383541775 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611511 CCc1cnc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:14:12:7.8:10,THB:6:7:12.13:10| 314956 US10183953, Example 135::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4R,6R)-6-((5-ethylpyrimidin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 135 Orexin receptor type 2 Human 1200 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314956 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314956&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637564 383541775 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611512 CCc1cnc(OC2CC3CC2N(C3)C(=O)c2nc(C)ccc2-n2nccn2)nc1 |TLB:14:12:7.8:10,THB:6:7:12.13:10| 314957 US10183953, Example 136::((1S,4R,6R)-6-((5-ethylpyrimidin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)methanone::US9611277, Example 136 Orexin/Hypocretin receptor type 1 Rat 380 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314957 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314957&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637459 383541776 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611513 CCc1cnc(OC2CC3CC2N(C3)C(=O)c2nc(C)ccc2-n2nccn2)nc1 |TLB:14:12:7.8:10,THB:6:7:12.13:10| 314957 US10183953, Example 136::((1S,4R,6R)-6-((5-ethylpyrimidin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)methanone::US9611277, Example 136 Orexin receptor type 2 Human 4700 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314957 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314957&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637459 383541776 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611514 CCc1cnc(OC2CC3CC2N(C3)C(=O)c2cccc(F)c2-c2ncccn2)nc1 |TLB:14:12:7.8:10,THB:6:7:12.13:10| 314958 US10183953, Example 137::((1S,4R,6R)-6-((5-ethylpyrimidin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 137 Orexin/Hypocretin receptor type 1 Rat 39.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314958 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314958&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637464 383541777 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611515 CCc1cnc(OC2CC3CC2N(C3)C(=O)c2cccc(F)c2-c2ncccn2)nc1 |TLB:14:12:7.8:10,THB:6:7:12.13:10| 314958 US10183953, Example 137::((1S,4R,6R)-6-((5-ethylpyrimidin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 137 Orexin/Hypocretin receptor type 1 Human 65.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314958 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314958&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637464 383541777 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611516 CCc1cnc(OC2CC3CC2N(C3)C(=O)c2cccc(F)c2-c2ncccn2)nc1 |TLB:14:12:7.8:10,THB:6:7:12.13:10| 314958 US10183953, Example 137::((1S,4R,6R)-6-((5-ethylpyrimidin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 137 Orexin receptor type 2 Human 1700 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314958 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314958&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637464 383541777 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611517 CCc1cnc(OC2CC3CC2N(C3)C(=O)c2nc(C)ccc2-c2ncccn2)nc1 |TLB:14:12:7.8:10,THB:6:7:12.13:10| 314959 US10183953, Example 138::((1S,4R,6R)-6-((5-ethylpyrimidin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(6-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)methanone::US9611277, Example 138 Orexin/Hypocretin receptor type 1 Rat 300 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314959 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314959&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637565 383541778 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611518 CCc1cnc(OC2CC3CC2N(C3)C(=O)c2nc(C)ccc2-c2ncccn2)nc1 |TLB:14:12:7.8:10,THB:6:7:12.13:10| 314959 US10183953, Example 138::((1S,4R,6R)-6-((5-ethylpyrimidin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(6-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)methanone::US9611277, Example 138 Orexin receptor type 2 Human 2700 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314959 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314959&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637565 383541778 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611519 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 314960 US10183953, Example 139::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4R,6R)-6-((6-(trifluoromethyl)pyridazin-3-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 139 Orexin/Hypocretin receptor type 1 Rat 208 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314960 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314960&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637633 383541779 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611520 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 314960 US10183953, Example 139::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4R,6R)-6-((6-(trifluoromethyl)pyridazin-3-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 139 Orexin/Hypocretin receptor type 1 Human 150 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314960 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314960&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637633 383541779 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611521 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 314960 US10183953, Example 139::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4R,6R)-6-((6-(trifluoromethyl)pyridazin-3-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 139 Orexin receptor type 2 Human 3700 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314960 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314960&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637633 383541779 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611522 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc(nn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C20H18F3N7O2/c1-11-2-3-13(30-24-6-7-25-30)18(26-11)19(31)29-10-12-8-14(29)15(9-12)32-17-5-4-16(27-28-17)20(21,22)23/h2-7,12,14-15H,8-10H2,1H3 RFYNPCVTQIOEBU-UHFFFAOYSA-N 314961 US10183953, Example 140::(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)((1S,4R,6R)-6-((6-(trifluoromethyl)pyridazin-3-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 140 Orexin/Hypocretin receptor type 1 Rat 330 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314961 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314961&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637467 383541780 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611523 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc(nn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C20H18F3N7O2/c1-11-2-3-13(30-24-6-7-25-30)18(26-11)19(31)29-10-12-8-14(29)15(9-12)32-17-5-4-16(27-28-17)20(21,22)23/h2-7,12,14-15H,8-10H2,1H3 RFYNPCVTQIOEBU-UHFFFAOYSA-N 314961 US10183953, Example 140::(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)((1S,4R,6R)-6-((6-(trifluoromethyl)pyridazin-3-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 140 Orexin receptor type 2 Human 7700 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314961 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314961&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637467 383541780 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611524 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(nn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C22H17F4N5O2/c23-14-4-1-3-13(19(14)20-27-7-2-8-28-20)21(32)31-11-12-9-15(31)16(10-12)33-18-6-5-17(29-30-18)22(24,25)26/h1-8,12,15-16H,9-11H2 ZFCYESHCPYTKHK-UHFFFAOYSA-N 314962 US10183953, Example 141::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((6-(trifluoromethyl)pyridazin-3-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 141 Orexin/Hypocretin receptor type 1 Rat 208 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314962 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314962&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637462 383541781 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611525 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(nn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C22H17F4N5O2/c23-14-4-1-3-13(19(14)20-27-7-2-8-28-20)21(32)31-11-12-9-15(31)16(10-12)33-18-6-5-17(29-30-18)22(24,25)26/h1-8,12,15-16H,9-11H2 ZFCYESHCPYTKHK-UHFFFAOYSA-N 314962 US10183953, Example 141::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((6-(trifluoromethyl)pyridazin-3-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 141 Orexin/Hypocretin receptor type 1 Human 348 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314962 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314962&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637462 383541781 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611526 Fc1cccc(C(=O)N2CC3CC(Oc4ccc(nn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C22H17F4N5O2/c23-14-4-1-3-13(19(14)20-27-7-2-8-28-20)21(32)31-11-12-9-15(31)16(10-12)33-18-6-5-17(29-30-18)22(24,25)26/h1-8,12,15-16H,9-11H2 ZFCYESHCPYTKHK-UHFFFAOYSA-N 314962 US10183953, Example 141::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((6-(trifluoromethyl)pyridazin-3-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 141 Orexin receptor type 2 Human >10000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314962 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314962&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637462 383541781 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611527 Cc1ccc(-c2ncccn2)c(n1)C(=O)N1CC2CC(Oc3ccc(nn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C22H19F3N6O2/c1-12-3-4-14(20-26-7-2-8-27-20)19(28-12)21(32)31-11-13-9-15(31)16(10-13)33-18-6-5-17(29-30-18)22(23,24)25/h2-8,13,15-16H,9-11H2,1H3 FFFLGKLFZPHJQO-UHFFFAOYSA-N 314963 US10183953, Example 142::(6-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4R,6R)-6-((6-(trifluoromethyl)pyridazin-3-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 142 Orexin/Hypocretin receptor type 1 Rat 376 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314963 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314963&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637463 383541782 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611528 Cc1ccc(-c2ncccn2)c(n1)C(=O)N1CC2CC(Oc3ccc(nn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C22H19F3N6O2/c1-12-3-4-14(20-26-7-2-8-27-20)19(28-12)21(32)31-11-13-9-15(31)16(10-13)33-18-6-5-17(29-30-18)22(23,24)25/h2-8,13,15-16H,9-11H2,1H3 FFFLGKLFZPHJQO-UHFFFAOYSA-N 314963 US10183953, Example 142::(6-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4R,6R)-6-((6-(trifluoromethyl)pyridazin-3-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 142 Orexin receptor type 2 Human 7900 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314963 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314963&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637463 383541782 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611529 Cc1ccc(C(=O)N2CC3CC(Nc4ccc(cn4)C(F)(F)F)C2C3)c(n1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H20F3N7O/c1-12-2-4-15(19(28-12)31-26-6-7-27-31)20(32)30-11-13-8-16(17(30)9-13)29-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,16-17H,8-9,11H2,1H3,(H,25,29) KRQUNZNRVOVSNP-UHFFFAOYSA-N 314964 US10183953, Example 143::(6-methyl-2-(2H-1,2,3-triazol-2-yl)pyridin-3-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 143 Orexin/Hypocretin receptor type 1 Rat 24.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314964 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314964&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637407 383541783 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611530 Cc1ccc(C(=O)N2CC3CC(Nc4ccc(cn4)C(F)(F)F)C2C3)c(n1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H20F3N7O/c1-12-2-4-15(19(28-12)31-26-6-7-27-31)20(32)30-11-13-8-16(17(30)9-13)29-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,16-17H,8-9,11H2,1H3,(H,25,29) KRQUNZNRVOVSNP-UHFFFAOYSA-N 314964 US10183953, Example 143::(6-methyl-2-(2H-1,2,3-triazol-2-yl)pyridin-3-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 143 Orexin/Hypocretin receptor type 1 Human 34.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314964 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314964&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637407 383541783 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611531 Cc1ccc(C(=O)N2CC3CC(Nc4ccc(cn4)C(F)(F)F)C2C3)c(n1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H20F3N7O/c1-12-2-4-15(19(28-12)31-26-6-7-27-31)20(32)30-11-13-8-16(17(30)9-13)29-18-5-3-14(10-25-18)21(22,23)24/h2-7,10,13,16-17H,8-9,11H2,1H3,(H,25,29) KRQUNZNRVOVSNP-UHFFFAOYSA-N 314964 US10183953, Example 143::(6-methyl-2-(2H-1,2,3-triazol-2-yl)pyridin-3-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 143 Orexin receptor type 2 Human 7300 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314964 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314964&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637407 383541783 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611532 Fc1cccc(C(=O)N2CC3CC(Nc4ccc(cn4)C(F)(F)F)C2C3)c1-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C21H18F4N6O/c22-15-3-1-2-14(19(15)31-27-6-7-28-31)20(32)30-11-12-8-16(17(30)9-12)29-18-5-4-13(10-26-18)21(23,24)25/h1-7,10,12,16-17H,8-9,11H2,(H,26,29) BXGAQSCKCCBJHO-UHFFFAOYSA-N 314965 US10183953, Example 144::(3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 144 Orexin/Hypocretin receptor type 1 Rat 3.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314965 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314965&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637466 383541784 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611533 Fc1cccc(C(=O)N2CC3CC(Nc4ccc(cn4)C(F)(F)F)C2C3)c1-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C21H18F4N6O/c22-15-3-1-2-14(19(15)31-27-6-7-28-31)20(32)30-11-12-8-16(17(30)9-12)29-18-5-4-13(10-26-18)21(23,24)25/h1-7,10,12,16-17H,8-9,11H2,(H,26,29) BXGAQSCKCCBJHO-UHFFFAOYSA-N 314965 US10183953, Example 144::(3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 144 Orexin/Hypocretin receptor type 1 Human 3.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314965 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314965&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637466 383541784 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611534 Fc1cccc(C(=O)N2CC3CC(Nc4ccc(cn4)C(F)(F)F)C2C3)c1-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C21H18F4N6O/c22-15-3-1-2-14(19(15)31-27-6-7-28-31)20(32)30-11-12-8-16(17(30)9-12)29-18-5-4-13(10-26-18)21(23,24)25/h1-7,10,12,16-17H,8-9,11H2,(H,26,29) BXGAQSCKCCBJHO-UHFFFAOYSA-N 314965 US10183953, Example 144::(3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 144 Orexin receptor type 2 Human 133 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314965 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314965&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637466 383541784 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611535 Fc1ccc(C(=O)N2CC3CC(Nc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H18F4N6O/c22-14-2-3-15(17(9-14)31-27-5-6-28-31)20(32)30-11-12-7-16(18(30)8-12)29-19-4-1-13(10-26-19)21(23,24)25/h1-6,9-10,12,16,18H,7-8,11H2,(H,26,29) NACKMCVHDTYAJJ-UHFFFAOYSA-N 314966 US10183953, Example 145::(4-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 145 Orexin/Hypocretin receptor type 1 Rat 17.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314966 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314966&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637765 383541785 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611536 Fc1ccc(C(=O)N2CC3CC(Nc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H18F4N6O/c22-14-2-3-15(17(9-14)31-27-5-6-28-31)20(32)30-11-12-7-16(18(30)8-12)29-19-4-1-13(10-26-19)21(23,24)25/h1-6,9-10,12,16,18H,7-8,11H2,(H,26,29) NACKMCVHDTYAJJ-UHFFFAOYSA-N 314966 US10183953, Example 145::(4-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 145 Orexin/Hypocretin receptor type 1 Human 7.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314966 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314966&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637765 383541785 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611537 Fc1ccc(C(=O)N2CC3CC(Nc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H18F4N6O/c22-14-2-3-15(17(9-14)31-27-5-6-28-31)20(32)30-11-12-7-16(18(30)8-12)29-19-4-1-13(10-26-19)21(23,24)25/h1-6,9-10,12,16,18H,7-8,11H2,(H,26,29) NACKMCVHDTYAJJ-UHFFFAOYSA-N 314966 US10183953, Example 145::(4-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 145 Orexin receptor type 2 Human 934 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314966 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314966&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637765 383541785 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611538 Fc1cccc(c1C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H18F4N6O/c22-14-2-1-3-16(31-27-6-7-28-31)19(14)20(32)30-11-12-8-15(17(30)9-12)29-18-5-4-13(10-26-18)21(23,24)25/h1-7,10,12,15,17H,8-9,11H2,(H,26,29) BBSRUMBWTMTJBM-UHFFFAOYSA-N 314967 US10183953, Example 146::(2-fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 146 Orexin/Hypocretin receptor type 1 Rat 6.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314967 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314967&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637763 383541786 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611539 Fc1cccc(c1C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H18F4N6O/c22-14-2-1-3-16(31-27-6-7-28-31)19(14)20(32)30-11-12-8-15(17(30)9-12)29-18-5-4-13(10-26-18)21(23,24)25/h1-7,10,12,15,17H,8-9,11H2,(H,26,29) BBSRUMBWTMTJBM-UHFFFAOYSA-N 314967 US10183953, Example 146::(2-fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 146 Orexin/Hypocretin receptor type 1 Human 3.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314967 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314967&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637763 383541786 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611540 Fc1cccc(c1C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C21H18F4N6O/c22-14-2-1-3-16(31-27-6-7-28-31)19(14)20(32)30-11-12-8-15(17(30)9-12)29-18-5-4-13(10-26-18)21(23,24)25/h1-7,10,12,15,17H,8-9,11H2,(H,26,29) BBSRUMBWTMTJBM-UHFFFAOYSA-N 314967 US10183953, Example 146::(2-fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 146 Orexin receptor type 2 Human 150 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314967 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314967&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637763 383541786 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611541 Fc1cccc(-c2ncccn2)c1C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H19F4N5O/c24-16-4-1-3-15(21-28-7-2-8-29-21)20(16)22(33)32-12-13-9-17(18(32)10-13)31-19-6-5-14(11-30-19)23(25,26)27/h1-8,11,13,17-18H,9-10,12H2,(H,30,31) KGHATKLNJXKIRR-UHFFFAOYSA-N 314968 US10183953, Example 147::(2-fluoro-6-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 147 Orexin/Hypocretin receptor type 1 Rat 5.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314968 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314968&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637622 383541787 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611542 Fc1cccc(-c2ncccn2)c1C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H19F4N5O/c24-16-4-1-3-15(21-28-7-2-8-29-21)20(16)22(33)32-12-13-9-17(18(32)10-13)31-19-6-5-14(11-30-19)23(25,26)27/h1-8,11,13,17-18H,9-10,12H2,(H,30,31) KGHATKLNJXKIRR-UHFFFAOYSA-N 314968 US10183953, Example 147::(2-fluoro-6-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 147 Orexin/Hypocretin receptor type 1 Human 6.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314968 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314968&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637622 383541787 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611543 Fc1cccc(-c2ncccn2)c1C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H19F4N5O/c24-16-4-1-3-15(21-28-7-2-8-29-21)20(16)22(33)32-12-13-9-17(18(32)10-13)31-19-6-5-14(11-30-19)23(25,26)27/h1-8,11,13,17-18H,9-10,12H2,(H,30,31) KGHATKLNJXKIRR-UHFFFAOYSA-N 314968 US10183953, Example 147::(2-fluoro-6-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 147 Orexin receptor type 2 Human 190 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314968 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314968&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637622 383541787 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611544 FC(F)(F)c1ccc(NC2CC3CC2N(C3)C(=O)c2ccccc2-c2ncccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 314969 US10183953, Example 148::(2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 148 Orexin/Hypocretin receptor type 1 Rat 3.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314969 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314969&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637853 383541788 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611545 FC(F)(F)c1ccc(NC2CC3CC2N(C3)C(=O)c2ccccc2-c2ncccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 314969 US10183953, Example 148::(2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 148 Orexin/Hypocretin receptor type 1 Human 5.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314969 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314969&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637853 383541788 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611546 FC(F)(F)c1ccc(NC2CC3CC2N(C3)C(=O)c2ccccc2-c2ncccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 314969 US10183953, Example 148::(2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 148 Orexin receptor type 2 Human 189 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314969 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314969&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637853 383541788 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611547 Cc1cnc(C(=O)N2CC3CC(Nc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C23H21F3N6O/c1-13-7-16(21-27-5-2-6-28-21)20(30-10-13)22(33)32-12-14-8-17(18(32)9-14)31-19-4-3-15(11-29-19)23(24,25)26/h2-7,10-11,14,17-18H,8-9,12H2,1H3,(H,29,31) FNMGBLJFQZWUMX-UHFFFAOYSA-N 314970 US10183953, Example 149::(5-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 149 Orexin/Hypocretin receptor type 1 Rat 14.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314970 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314970&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637618 383541789 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611548 Cc1cnc(C(=O)N2CC3CC(Nc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C23H21F3N6O/c1-13-7-16(21-27-5-2-6-28-21)20(30-10-13)22(33)32-12-14-8-17(18(32)9-14)31-19-4-3-15(11-29-19)23(24,25)26/h2-7,10-11,14,17-18H,8-9,12H2,1H3,(H,29,31) FNMGBLJFQZWUMX-UHFFFAOYSA-N 314970 US10183953, Example 149::(5-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 149 Orexin/Hypocretin receptor type 1 Human 7.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314970 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314970&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637618 383541789 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611549 Cc1cnc(C(=O)N2CC3CC(Nc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C23H21F3N6O/c1-13-7-16(21-27-5-2-6-28-21)20(30-10-13)22(33)32-12-14-8-17(18(32)9-14)31-19-4-3-15(11-29-19)23(24,25)26/h2-7,10-11,14,17-18H,8-9,12H2,1H3,(H,29,31) FNMGBLJFQZWUMX-UHFFFAOYSA-N 314970 US10183953, Example 149::(5-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 149 Orexin receptor type 2 Human 4600 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314970 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314970&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637618 383541789 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611550 Cc1ccc(-c2ncccn2)c(n1)C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H21F3N6O/c1-13-3-5-16(21-27-7-2-8-28-21)20(30-13)22(33)32-12-14-9-17(18(32)10-14)31-19-6-4-15(11-29-19)23(24,25)26/h2-8,11,14,17-18H,9-10,12H2,1H3,(H,29,31) DWFVOORHDDCKKL-UHFFFAOYSA-N 314971 US10183953, Example 150::(6-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 150 Orexin/Hypocretin receptor type 1 Rat 13.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314971 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314971&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637591 383541790 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611551 Cc1ccc(-c2ncccn2)c(n1)C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H21F3N6O/c1-13-3-5-16(21-27-7-2-8-28-21)20(30-13)22(33)32-12-14-9-17(18(32)10-14)31-19-6-4-15(11-29-19)23(24,25)26/h2-8,11,14,17-18H,9-10,12H2,1H3,(H,29,31) DWFVOORHDDCKKL-UHFFFAOYSA-N 314971 US10183953, Example 150::(6-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 150 Orexin/Hypocretin receptor type 1 Human 9.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314971 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314971&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637591 383541790 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611552 Cc1ccc(-c2ncccn2)c(n1)C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H21F3N6O/c1-13-3-5-16(21-27-7-2-8-28-21)20(30-13)22(33)32-12-14-9-17(18(32)10-14)31-19-6-4-15(11-29-19)23(24,25)26/h2-8,11,14,17-18H,9-10,12H2,1H3,(H,29,31) DWFVOORHDDCKKL-UHFFFAOYSA-N 314971 US10183953, Example 150::(6-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 150 Orexin receptor type 2 Human 88.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314971 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314971&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637591 383541790 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611553 Cc1cnc(-c2ncccn2)c(c1)C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H21F3N6O/c1-13-7-16(20(30-10-13)21-27-5-2-6-28-21)22(33)32-12-14-8-17(18(32)9-14)31-19-4-3-15(11-29-19)23(24,25)26/h2-7,10-11,14,17-18H,8-9,12H2,1H3,(H,29,31) VXNFOIYCRLUTLB-UHFFFAOYSA-N 314972 US10183953, Example 151::(5-methyl-2-(pyrimidin-2-yl)pyridin-3-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 151 Orexin/Hypocretin receptor type 1 Rat 21.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314972 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314972&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637654 383541791 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611554 Cc1cnc(-c2ncccn2)c(c1)C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H21F3N6O/c1-13-7-16(20(30-10-13)21-27-5-2-6-28-21)22(33)32-12-14-8-17(18(32)9-14)31-19-4-3-15(11-29-19)23(24,25)26/h2-7,10-11,14,17-18H,8-9,12H2,1H3,(H,29,31) VXNFOIYCRLUTLB-UHFFFAOYSA-N 314972 US10183953, Example 151::(5-methyl-2-(pyrimidin-2-yl)pyridin-3-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 151 Orexin/Hypocretin receptor type 1 Human 47.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314972 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314972&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637654 383541791 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611555 Cc1cnc(-c2ncccn2)c(c1)C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H21F3N6O/c1-13-7-16(20(30-10-13)21-27-5-2-6-28-21)22(33)32-12-14-8-17(18(32)9-14)31-19-4-3-15(11-29-19)23(24,25)26/h2-7,10-11,14,17-18H,8-9,12H2,1H3,(H,29,31) VXNFOIYCRLUTLB-UHFFFAOYSA-N 314972 US10183953, Example 151::(5-methyl-2-(pyrimidin-2-yl)pyridin-3-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 151 Orexin receptor type 2 Human 5100 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314972 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314972&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637654 383541791 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611556 Cc1noc(n1)-c1cc(F)ccc1C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C22H19F4N5O2/c1-11-28-20(33-30-11)16-8-14(23)3-4-15(16)21(32)31-10-12-6-17(18(31)7-12)29-19-5-2-13(9-27-19)22(24,25)26/h2-5,8-9,12,17-18H,6-7,10H2,1H3,(H,27,29) WWELVUMHRMQNJZ-UHFFFAOYSA-N 314973 US10183953, Example 152::(4-fluoro-2-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 152 Orexin/Hypocretin receptor type 1 Rat 30.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314973 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314973&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637593 383541792 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611557 Cc1noc(n1)-c1cc(F)ccc1C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C22H19F4N5O2/c1-11-28-20(33-30-11)16-8-14(23)3-4-15(16)21(32)31-10-12-6-17(18(31)7-12)29-19-5-2-13(9-27-19)22(24,25)26/h2-5,8-9,12,17-18H,6-7,10H2,1H3,(H,27,29) WWELVUMHRMQNJZ-UHFFFAOYSA-N 314973 US10183953, Example 152::(4-fluoro-2-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 152 Orexin/Hypocretin receptor type 1 Human 16.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314973 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314973&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637593 383541792 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611558 Cc1noc(n1)-c1cc(F)ccc1C(=O)N1CC2CC(Nc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C22H19F4N5O2/c1-11-28-20(33-30-11)16-8-14(23)3-4-15(16)21(32)31-10-12-6-17(18(31)7-12)29-19-5-2-13(9-27-19)22(24,25)26/h2-5,8-9,12,17-18H,6-7,10H2,1H3,(H,27,29) WWELVUMHRMQNJZ-UHFFFAOYSA-N 314973 US10183953, Example 152::(4-fluoro-2-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 152 Orexin receptor type 2 Human 1600 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314973 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314973&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637593 383541792 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611559 CN(C1CC2CC1N(C2)C(=O)c1ccccc1-n1nccn1)c1ccc(cn1)C(F)(F)F |TLB:9:7:2.3:5,THB:1:2:7.8:5| 314974 US10183953, Example 153::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-(methyl(5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 153 Orexin/Hypocretin receptor type 1 Rat 3.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314974 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314974&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637470 383541793 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611560 CN(C1CC2CC1N(C2)C(=O)c1ccccc1-n1nccn1)c1ccc(cn1)C(F)(F)F |TLB:9:7:2.3:5,THB:1:2:7.8:5| 314974 US10183953, Example 153::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-(methyl(5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 153 Orexin/Hypocretin receptor type 1 Human 3.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314974 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314974&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637470 383541793 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611561 CN(C1CC2CC1N(C2)C(=O)c1ccccc1-n1nccn1)c1ccc(cn1)C(F)(F)F |TLB:9:7:2.3:5,THB:1:2:7.8:5| 314974 US10183953, Example 153::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-(methyl(5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 153 Orexin receptor type 2 Human 342 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314974 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314974&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637470 383541793 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611562 CN(C1CC2CC1N(C2)C(=O)c1cccc(F)c1-n1nccn1)c1ccc(cn1)C(F)(F)F |TLB:9:7:2.3:5,THB:1:2:7.8:5| 314975 US10183953, Example 154::(3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-(methyl(5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 154 Orexin/Hypocretin receptor type 1 Rat 4.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314975 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314975&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637409 383541794 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611563 CN(C1CC2CC1N(C2)C(=O)c1cccc(F)c1-n1nccn1)c1ccc(cn1)C(F)(F)F |TLB:9:7:2.3:5,THB:1:2:7.8:5| 314975 US10183953, Example 154::(3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-(methyl(5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 154 Orexin/Hypocretin receptor type 1 Human 6.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314975 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314975&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637409 383541794 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611564 CN(C1CC2CC1N(C2)C(=O)c1cccc(F)c1-n1nccn1)c1ccc(cn1)C(F)(F)F |TLB:9:7:2.3:5,THB:1:2:7.8:5| 314975 US10183953, Example 154::(3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-(methyl(5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 154 Orexin receptor type 2 Human 329 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314975 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314975&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637409 383541794 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611565 CN(C1CC2CC1N(C2)C(=O)c1cc(F)ccc1-n1nccn1)c1ccc(cn1)C(F)(F)F |TLB:9:7:2.3:5,THB:1:2:7.8:5| 314976 US10183953, Example 155::(5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-(methyl(5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 155 Orexin/Hypocretin receptor type 1 Rat 5.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314976 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314976&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637408 383541795 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611566 CN(C1CC2CC1N(C2)C(=O)c1cc(F)ccc1-n1nccn1)c1ccc(cn1)C(F)(F)F |TLB:9:7:2.3:5,THB:1:2:7.8:5| 314976 US10183953, Example 155::(5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-(methyl(5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 155 Orexin/Hypocretin receptor type 1 Human 3.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314976 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314976&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637408 383541795 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611567 CN(C1CC2CC1N(C2)C(=O)c1cc(F)ccc1-n1nccn1)c1ccc(cn1)C(F)(F)F |TLB:9:7:2.3:5,THB:1:2:7.8:5| 314976 US10183953, Example 155::(5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-(methyl(5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 155 Orexin receptor type 2 Human 303 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314976 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314976&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637408 383541795 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611568 CN(C1CC2CC1N(C2)C(=O)c1nc(C)ccc1-n1nccn1)c1ccc(cn1)C(F)(F)F |TLB:9:7:2.3:5,THB:1:2:7.8:5| 314977 US10183953, Example 156::((1S,4S,6R)-6-(methyl(5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)methanone::US9611277, Example 156 Orexin/Hypocretin receptor type 1 Rat 7.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314977 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314977&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637678 383541796 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611569 CN(C1CC2CC1N(C2)C(=O)c1nc(C)ccc1-n1nccn1)c1ccc(cn1)C(F)(F)F |TLB:9:7:2.3:5,THB:1:2:7.8:5| 314977 US10183953, Example 156::((1S,4S,6R)-6-(methyl(5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)methanone::US9611277, Example 156 Orexin/Hypocretin receptor type 1 Human 5.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314977 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314977&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637678 383541796 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611570 CN(C1CC2CC1N(C2)C(=O)c1nc(C)ccc1-n1nccn1)c1ccc(cn1)C(F)(F)F |TLB:9:7:2.3:5,THB:1:2:7.8:5| 314977 US10183953, Example 156::((1S,4S,6R)-6-(methyl(5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)methanone::US9611277, Example 156 Orexin receptor type 2 Human 274 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314977 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314977&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637678 383541796 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611571 CN(C1CC2CC1N(C2)C(=O)c1cccc(F)c1-c1ncccn1)c1ccc(cn1)C(F)(F)F |TLB:9:7:2.3:5,THB:1:2:7.8:5| 314978 US10183953, Example 157::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-(methyl(5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 157 Orexin/Hypocretin receptor type 1 Rat 6.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314978 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314978&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637592 383541797 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611572 CN(C1CC2CC1N(C2)C(=O)c1cccc(F)c1-c1ncccn1)c1ccc(cn1)C(F)(F)F |TLB:9:7:2.3:5,THB:1:2:7.8:5| 314978 US10183953, Example 157::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-(methyl(5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 157 Orexin/Hypocretin receptor type 1 Human 3.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314978 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314978&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637592 383541797 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611573 CN(C1CC2CC1N(C2)C(=O)c1cccc(F)c1-c1ncccn1)c1ccc(cn1)C(F)(F)F |TLB:9:7:2.3:5,THB:1:2:7.8:5| 314978 US10183953, Example 157::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-(methyl(5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 157 Orexin receptor type 2 Human 351 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314978 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314978&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637592 383541797 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611574 CN(C1CC2CC1N(C2)C(=O)c1cc(F)ccc1-c1ncccn1)c1ccc(cn1)C(F)(F)F |TLB:9:7:2.3:5,THB:1:2:7.8:5| 314979 US10183953, Example 158::(5-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-(methyl(5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 158 Orexin/Hypocretin receptor type 1 Rat 5.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314979 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314979&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637766 383541798 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611575 CN(C1CC2CC1N(C2)C(=O)c1cc(F)ccc1-c1ncccn1)c1ccc(cn1)C(F)(F)F |TLB:9:7:2.3:5,THB:1:2:7.8:5| 314979 US10183953, Example 158::(5-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-(methyl(5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 158 Orexin/Hypocretin receptor type 1 Human 2.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314979 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314979&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637766 383541798 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611576 CN(C1CC2CC1N(C2)C(=O)c1cc(F)ccc1-c1ncccn1)c1ccc(cn1)C(F)(F)F |TLB:9:7:2.3:5,THB:1:2:7.8:5| 314979 US10183953, Example 158::(5-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-(methyl(5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 158 Orexin receptor type 2 Human 340 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314979 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314979&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637766 383541798 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611577 CN(C1CC2CC1N(C2)C(=O)c1c(F)cccc1-c1ncccn1)c1ccc(cn1)C(F)(F)F |TLB:9:7:2.3:5,THB:1:2:7.8:5| 314980 US10183953, Example 159::(2-fluoro-6-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-(methyl(5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 159 Orexin/Hypocretin receptor type 1 Rat 6.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314980 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314980&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637623 383541799 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611578 CN(C1CC2CC1N(C2)C(=O)c1c(F)cccc1-c1ncccn1)c1ccc(cn1)C(F)(F)F |TLB:9:7:2.3:5,THB:1:2:7.8:5| 314980 US10183953, Example 159::(2-fluoro-6-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-(methyl(5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 159 Orexin/Hypocretin receptor type 1 Human 4.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314980 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314980&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637623 383541799 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611579 CN(C1CC2CC1N(C2)C(=O)c1c(F)cccc1-c1ncccn1)c1ccc(cn1)C(F)(F)F |TLB:9:7:2.3:5,THB:1:2:7.8:5| 314980 US10183953, Example 159::(2-fluoro-6-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-(methyl(5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 159 Orexin receptor type 2 Human 209 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314980 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314980&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637623 383541799 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611580 CCN(C1CC2CC1N(C2)C(=O)c1cccc(F)c1-c1ncccn1)c1ccc(cn1)C(F)(F)F |TLB:10:8:3.4:6,THB:2:3:8.9:6| 314981 US10183953, Example 160::(2-fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 160 Orexin/Hypocretin receptor type 1 Rat 9.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314981 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314981&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637473 383541800 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611581 CCN(C1CC2CC1N(C2)C(=O)c1cccc(F)c1-c1ncccn1)c1ccc(cn1)C(F)(F)F |TLB:10:8:3.4:6,THB:2:3:8.9:6| 314981 US10183953, Example 160::(2-fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 160 Orexin/Hypocretin receptor type 1 Human 6.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314981 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314981&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637473 383541800 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611582 CCN(C1CC2CC1N(C2)C(=O)c1cccc(F)c1-c1ncccn1)c1ccc(cn1)C(F)(F)F |TLB:10:8:3.4:6,THB:2:3:8.9:6| 314981 US10183953, Example 160::(2-fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 160 Orexin receptor type 2 Human 208 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314981 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314981&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637473 383541800 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611583 Fc1cccc(C(=O)N2CC3CC(C2C3)N(CC2CC2)c2ccc(cn2)C(F)(F)F)c1-c1ncccn1 |TLB:15:12:8.9:14,6:8:12.11:14| InChI=1S/C27H25F4N5O/c28-20-4-1-3-19(24(20)25-32-9-2-10-33-25)26(37)36-15-17-11-21(22(36)12-17)35(14-16-5-6-16)23-8-7-18(13-34-23)27(29,30)31/h1-4,7-10,13,16-17,21-22H,5-6,11-12,14-15H2 NJPIQHUTFPVYIK-UHFFFAOYSA-N 314982 US10183953, Example 161::((1S,4S,6R)-6-((cyclopropylmethyl)(5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 161 Orexin/Hypocretin receptor type 1 Rat 14.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314982 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314982&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637627 383541801 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611584 Fc1cccc(C(=O)N2CC3CC(C2C3)N(CC2CC2)c2ccc(cn2)C(F)(F)F)c1-c1ncccn1 |TLB:15:12:8.9:14,6:8:12.11:14| InChI=1S/C27H25F4N5O/c28-20-4-1-3-19(24(20)25-32-9-2-10-33-25)26(37)36-15-17-11-21(22(36)12-17)35(14-16-5-6-16)23-8-7-18(13-34-23)27(29,30)31/h1-4,7-10,13,16-17,21-22H,5-6,11-12,14-15H2 NJPIQHUTFPVYIK-UHFFFAOYSA-N 314982 US10183953, Example 161::((1S,4S,6R)-6-((cyclopropylmethyl)(5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 161 Orexin/Hypocretin receptor type 1 Human 5.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314982 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314982&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637627 383541801 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611585 Fc1cccc(C(=O)N2CC3CC(C2C3)N(CC2CC2)c2ccc(cn2)C(F)(F)F)c1-c1ncccn1 |TLB:15:12:8.9:14,6:8:12.11:14| InChI=1S/C27H25F4N5O/c28-20-4-1-3-19(24(20)25-32-9-2-10-33-25)26(37)36-15-17-11-21(22(36)12-17)35(14-16-5-6-16)23-8-7-18(13-34-23)27(29,30)31/h1-4,7-10,13,16-17,21-22H,5-6,11-12,14-15H2 NJPIQHUTFPVYIK-UHFFFAOYSA-N 314982 US10183953, Example 161::((1S,4S,6R)-6-((cyclopropylmethyl)(5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 161 Orexin receptor type 2 Human 384 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314982 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314982&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637627 383541801 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611586 CC(=O)N(C1CC2CC1N(C2)C(=O)c1cccc(F)c1-c1ncccn1)c1ccc(cn1)C(F)(F)F |TLB:3:4:9.10:7,THB:11:9:4.5:7| 314983 US10183953, Example 162::N-((1S,4R,6R)-2-(3-fluoro-2-(pyrimidin-2-yl)benzoyl)-2-azabicyclo[2.2.1]heptan-6-yl)-N-(5-(trifluoromethyl)pyridin-2-yl)acetamide::US9611277, Example 162 Orexin/Hypocretin receptor type 1 Rat >10000 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314983 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314983&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637475 383541802 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611587 CC(=O)N(C1CC2CC1N(C2)C(=O)c1cccc(F)c1-c1ncccn1)c1ccc(cn1)C(F)(F)F |TLB:3:4:9.10:7,THB:11:9:4.5:7| 314983 US10183953, Example 162::N-((1S,4R,6R)-2-(3-fluoro-2-(pyrimidin-2-yl)benzoyl)-2-azabicyclo[2.2.1]heptan-6-yl)-N-(5-(trifluoromethyl)pyridin-2-yl)acetamide::US9611277, Example 162 Orexin receptor type 2 Human >10000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314983 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314983&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637475 383541802 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611588 COCCN(C1CC2CC1N(C2)C(=O)c1cccc(F)c1-c1ncccn1)c1ccc(cn1)C(F)(F)F |TLB:12:10:5.6:8,THB:4:5:10.11:8| 314984 US10183953, Example 163::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((2-methoxyethyl)(5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 163 Orexin/Hypocretin receptor type 1 Rat 19.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314984 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314984&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637761 383541803 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611589 COCCN(C1CC2CC1N(C2)C(=O)c1cccc(F)c1-c1ncccn1)c1ccc(cn1)C(F)(F)F |TLB:12:10:5.6:8,THB:4:5:10.11:8| 314984 US10183953, Example 163::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((2-methoxyethyl)(5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 163 Orexin/Hypocretin receptor type 1 Human 12.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314984 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314984&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637761 383541803 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611590 COCCN(C1CC2CC1N(C2)C(=O)c1cccc(F)c1-c1ncccn1)c1ccc(cn1)C(F)(F)F |TLB:12:10:5.6:8,THB:4:5:10.11:8| 314984 US10183953, Example 163::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((2-methoxyethyl)(5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 163 Orexin receptor type 2 Human 962 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314984 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314984&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637761 383541803 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611591 Brc1ccc(NC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 314985 US10183953, Example 166::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-bromopyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 166 Orexin/Hypocretin receptor type 1 Rat 2.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314985 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314985&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637410 383541804 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611592 Brc1ccc(NC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 314985 US10183953, Example 166::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-bromopyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 166 Orexin/Hypocretin receptor type 1 Human 4.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314985 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314985&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637410 383541804 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611593 Brc1ccc(NC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 314985 US10183953, Example 166::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-bromopyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 166 Orexin receptor type 2 Human 236 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314985 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314985&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637410 383541804 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611594 Fc1cccc(C(=O)N2CC3CC(Nc4ccc(Br)cn4)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:22,6:8:12.11:22| InChI=1S/C22H19BrFN5O/c23-14-5-6-19(27-11-14)28-17-9-13-10-18(17)29(12-13)22(30)15-3-1-4-16(24)20(15)21-25-7-2-8-26-21/h1-8,11,13,17-18H,9-10,12H2,(H,27,28) XXINOWMVAYQKLJ-UHFFFAOYSA-N 314986 US10183953, Example 167::((1S,4S,6R)-6-((5-bromopyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 167 Orexin/Hypocretin receptor type 1 Rat 2.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314986 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314986&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637624 383541805 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611595 Fc1cccc(C(=O)N2CC3CC(Nc4ccc(Br)cn4)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:22,6:8:12.11:22| InChI=1S/C22H19BrFN5O/c23-14-5-6-19(27-11-14)28-17-9-13-10-18(17)29(12-13)22(30)15-3-1-4-16(24)20(15)21-25-7-2-8-26-21/h1-8,11,13,17-18H,9-10,12H2,(H,27,28) XXINOWMVAYQKLJ-UHFFFAOYSA-N 314986 US10183953, Example 167::((1S,4S,6R)-6-((5-bromopyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 167 Orexin/Hypocretin receptor type 1 Human 6.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314986 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314986&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637624 383541805 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611596 Fc1cccc(C(=O)N2CC3CC(Nc4ccc(Br)cn4)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:22,6:8:12.11:22| InChI=1S/C22H19BrFN5O/c23-14-5-6-19(27-11-14)28-17-9-13-10-18(17)29(12-13)22(30)15-3-1-4-16(24)20(15)21-25-7-2-8-26-21/h1-8,11,13,17-18H,9-10,12H2,(H,27,28) XXINOWMVAYQKLJ-UHFFFAOYSA-N 314986 US10183953, Example 167::((1S,4S,6R)-6-((5-bromopyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 167 Orexin receptor type 2 Human 239 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314986 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314986&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637624 383541805 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611597 Fc1cccc(-c2ncccn2)c1C(=O)N1CC2CC(Nc3ccc(Br)cn3)C1C2 |TLB:20:19:15.16:29,13:15:19.18:29| InChI=1S/C22H19BrFN5O/c23-14-5-6-19(27-11-14)28-17-9-13-10-18(17)29(12-13)22(30)20-15(3-1-4-16(20)24)21-25-7-2-8-26-21/h1-8,11,13,17-18H,9-10,12H2,(H,27,28) PGRFCBWNHDMEMV-UHFFFAOYSA-N 314987 US10183953, Example 168::((1S,4S,6R)-6-((5-bromopyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(2-fluoro-6-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 168 Orexin/Hypocretin receptor type 1 Rat 2.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314987 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314987&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637648 383541806 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611598 Fc1cccc(-c2ncccn2)c1C(=O)N1CC2CC(Nc3ccc(Br)cn3)C1C2 |TLB:20:19:15.16:29,13:15:19.18:29| InChI=1S/C22H19BrFN5O/c23-14-5-6-19(27-11-14)28-17-9-13-10-18(17)29(12-13)22(30)20-15(3-1-4-16(20)24)21-25-7-2-8-26-21/h1-8,11,13,17-18H,9-10,12H2,(H,27,28) PGRFCBWNHDMEMV-UHFFFAOYSA-N 314987 US10183953, Example 168::((1S,4S,6R)-6-((5-bromopyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(2-fluoro-6-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 168 Orexin/Hypocretin receptor type 1 Human 4.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314987 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314987&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637648 383541806 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611599 Fc1cccc(-c2ncccn2)c1C(=O)N1CC2CC(Nc3ccc(Br)cn3)C1C2 |TLB:20:19:15.16:29,13:15:19.18:29| InChI=1S/C22H19BrFN5O/c23-14-5-6-19(27-11-14)28-17-9-13-10-18(17)29(12-13)22(30)20-15(3-1-4-16(20)24)21-25-7-2-8-26-21/h1-8,11,13,17-18H,9-10,12H2,(H,27,28) PGRFCBWNHDMEMV-UHFFFAOYSA-N 314987 US10183953, Example 168::((1S,4S,6R)-6-((5-bromopyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(2-fluoro-6-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 168 Orexin receptor type 2 Human 351 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314987 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314987&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637648 383541806 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611600 Clc1ccc(NC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 314988 US10183953, Example 169::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-chloropyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 169 Orexin/Hypocretin receptor type 1 Rat 3.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314988 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314988&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637411 383541807 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611601 Clc1ccc(NC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 314988 US10183953, Example 169::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-chloropyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 169 Orexin/Hypocretin receptor type 1 Human 4.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314988 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314988&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637411 383541807 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611602 Clc1ccc(NC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 314988 US10183953, Example 169::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-chloropyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 169 Orexin receptor type 2 Human 285 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314988 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314988&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637411 383541807 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611603 Fc1cccc(C(=O)N2CC3CC(Nc4ccc(Cl)cn4)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:22,6:8:12.11:22| InChI=1S/C22H19ClFN5O/c23-14-5-6-19(27-11-14)28-17-9-13-10-18(17)29(12-13)22(30)15-3-1-4-16(24)20(15)21-25-7-2-8-26-21/h1-8,11,13,17-18H,9-10,12H2,(H,27,28) BVFVSYKYGCTVQL-UHFFFAOYSA-N 314989 US10183953, Example 170::((1S,4S,6R)-6-((5-chloropyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 170 Orexin/Hypocretin receptor type 1 Rat 4.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314989 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314989&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637626 383541808 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611604 Fc1cccc(C(=O)N2CC3CC(Nc4ccc(Cl)cn4)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:22,6:8:12.11:22| InChI=1S/C22H19ClFN5O/c23-14-5-6-19(27-11-14)28-17-9-13-10-18(17)29(12-13)22(30)15-3-1-4-16(24)20(15)21-25-7-2-8-26-21/h1-8,11,13,17-18H,9-10,12H2,(H,27,28) BVFVSYKYGCTVQL-UHFFFAOYSA-N 314989 US10183953, Example 170::((1S,4S,6R)-6-((5-chloropyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 170 Orexin/Hypocretin receptor type 1 Human 12.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314989 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314989&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637626 383541808 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611605 Fc1cccc(C(=O)N2CC3CC(Nc4ccc(Cl)cn4)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:22,6:8:12.11:22| InChI=1S/C22H19ClFN5O/c23-14-5-6-19(27-11-14)28-17-9-13-10-18(17)29(12-13)22(30)15-3-1-4-16(24)20(15)21-25-7-2-8-26-21/h1-8,11,13,17-18H,9-10,12H2,(H,27,28) BVFVSYKYGCTVQL-UHFFFAOYSA-N 314989 US10183953, Example 170::((1S,4S,6R)-6-((5-chloropyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 170 Orexin receptor type 2 Human 321 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314989 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314989&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637626 383541808 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611606 Fc1ccc(C(=O)N2CC3CC(Nc4ccc(Cl)cn4)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:21,5:7:11.10:21| InChI=1S/C22H19ClFN5O/c23-14-2-5-20(27-11-14)28-18-8-13-9-19(18)29(12-13)22(30)16-4-3-15(24)10-17(16)21-25-6-1-7-26-21/h1-7,10-11,13,18-19H,8-9,12H2,(H,27,28) MAGAJAMUAVLXIX-UHFFFAOYSA-N 314990 US10183953, Example 171::((1S,4S,6R)-6-((5-chloropyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(4-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 171 Orexin/Hypocretin receptor type 1 Rat 27.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314990 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314990&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637544 383541809 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611607 Fc1ccc(C(=O)N2CC3CC(Nc4ccc(Cl)cn4)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:21,5:7:11.10:21| InChI=1S/C22H19ClFN5O/c23-14-2-5-20(27-11-14)28-18-8-13-9-19(18)29(12-13)22(30)16-4-3-15(24)10-17(16)21-25-6-1-7-26-21/h1-7,10-11,13,18-19H,8-9,12H2,(H,27,28) MAGAJAMUAVLXIX-UHFFFAOYSA-N 314990 US10183953, Example 171::((1S,4S,6R)-6-((5-chloropyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(4-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 171 Orexin/Hypocretin receptor type 1 Human 25.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314990 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314990&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637544 383541809 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611608 Fc1ccc(C(=O)N2CC3CC(Nc4ccc(Cl)cn4)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:21,5:7:11.10:21| InChI=1S/C22H19ClFN5O/c23-14-2-5-20(27-11-14)28-18-8-13-9-19(18)29(12-13)22(30)16-4-3-15(24)10-17(16)21-25-6-1-7-26-21/h1-7,10-11,13,18-19H,8-9,12H2,(H,27,28) MAGAJAMUAVLXIX-UHFFFAOYSA-N 314990 US10183953, Example 171::((1S,4S,6R)-6-((5-chloropyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(4-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 171 Orexin receptor type 2 Human 1900 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314990 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314990&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637544 383541809 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611609 Fc1ccc(-c2ncccn2)c(c1)C(=O)N1CC2CC(Nc3ccc(Cl)cn3)C1C2 |TLB:20:19:15.16:29,13:15:19.18:29| InChI=1S/C22H19ClFN5O/c23-14-2-5-20(27-11-14)28-18-8-13-9-19(18)29(12-13)22(30)17-10-15(24)3-4-16(17)21-25-6-1-7-26-21/h1-7,10-11,13,18-19H,8-9,12H2,(H,27,28) GYQNTAWIWKHANR-UHFFFAOYSA-N 314991 US10183953, Example 172::((1S,4S,6R)-6-((5-chloropyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(5-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 172 Orexin/Hypocretin receptor type 1 Rat 8.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314991 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314991&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637549 383541810 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611610 Fc1ccc(-c2ncccn2)c(c1)C(=O)N1CC2CC(Nc3ccc(Cl)cn3)C1C2 |TLB:20:19:15.16:29,13:15:19.18:29| InChI=1S/C22H19ClFN5O/c23-14-2-5-20(27-11-14)28-18-8-13-9-19(18)29(12-13)22(30)17-10-15(24)3-4-16(17)21-25-6-1-7-26-21/h1-7,10-11,13,18-19H,8-9,12H2,(H,27,28) GYQNTAWIWKHANR-UHFFFAOYSA-N 314991 US10183953, Example 172::((1S,4S,6R)-6-((5-chloropyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(5-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 172 Orexin/Hypocretin receptor type 1 Human 7.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314991 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314991&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637549 383541810 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611611 Fc1ccc(-c2ncccn2)c(c1)C(=O)N1CC2CC(Nc3ccc(Cl)cn3)C1C2 |TLB:20:19:15.16:29,13:15:19.18:29| InChI=1S/C22H19ClFN5O/c23-14-2-5-20(27-11-14)28-18-8-13-9-19(18)29(12-13)22(30)17-10-15(24)3-4-16(17)21-25-6-1-7-26-21/h1-7,10-11,13,18-19H,8-9,12H2,(H,27,28) GYQNTAWIWKHANR-UHFFFAOYSA-N 314991 US10183953, Example 172::((1S,4S,6R)-6-((5-chloropyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(5-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 172 Orexin receptor type 2 Human 400 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314991 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314991&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637549 383541810 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611612 FC(F)c1ccc(NC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:15:13:8.9:11,THB:7:8:13.14:11| 314992 US10183953, Example 173::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(difluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 173 Orexin/Hypocretin receptor type 1 Rat 55.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314992 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314992&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637545 383541811 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611613 FC(F)c1ccc(NC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:15:13:8.9:11,THB:7:8:13.14:11| 314992 US10183953, Example 173::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(difluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 173 Orexin/Hypocretin receptor type 1 Human 33.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314992 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314992&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637545 383541811 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611614 FC(F)c1ccc(NC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:15:13:8.9:11,THB:7:8:13.14:11| 314992 US10183953, Example 173::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(difluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 173 Orexin receptor type 2 Human 264 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314992 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314992&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637545 383541811 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611615 FC(F)c1ccc(NC2CC3CC2N(C3)C(=O)c2cccc(F)c2-c2ncccn2)nc1 |TLB:15:13:8.9:11,THB:7:8:13.14:11| 314993 US10183953, Example 174::((1S,4S,6R)-6-((5-(difluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 174 Orexin/Hypocretin receptor type 1 Rat 18.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314993 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314993&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637546 383541812 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611616 FC(F)c1ccc(NC2CC3CC2N(C3)C(=O)c2cccc(F)c2-c2ncccn2)nc1 |TLB:15:13:8.9:11,THB:7:8:13.14:11| 314993 US10183953, Example 174::((1S,4S,6R)-6-((5-(difluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 174 Orexin/Hypocretin receptor type 1 Human 15.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314993 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314993&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637546 383541812 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611617 FC(F)c1ccc(NC2CC3CC2N(C3)C(=O)c2cccc(F)c2-c2ncccn2)nc1 |TLB:15:13:8.9:11,THB:7:8:13.14:11| 314993 US10183953, Example 174::((1S,4S,6R)-6-((5-(difluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 174 Orexin receptor type 2 Human 230 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314993 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314993&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637546 383541812 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611618 COc1ccc(NC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:14:12:7.8:10,THB:6:7:12.13:10| 314994 US10183953, Example 175::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-methoxypyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 175 Orexin/Hypocretin receptor type 1 Rat 170 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314994 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314994&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637857 383541813 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611619 COc1ccc(NC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:14:12:7.8:10,THB:6:7:12.13:10| 314994 US10183953, Example 175::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-methoxypyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 175 Orexin/Hypocretin receptor type 1 Human 191 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314994 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314994&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637857 383541813 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611620 COc1ccc(NC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:14:12:7.8:10,THB:6:7:12.13:10| 314994 US10183953, Example 175::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-methoxypyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 175 Orexin receptor type 2 Human 844 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314994 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314994&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637857 383541813 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611621 COc1ccc(NC2CC3CC2N(C3)C(=O)c2cccc(F)c2-c2ncccn2)nc1 |TLB:14:12:7.8:10,THB:6:7:12.13:10| 314995 US10183953, Example 176::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-methoxypyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 176 Orexin/Hypocretin receptor type 1 Rat 56.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314995 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314995&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637412 383541814 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611622 COc1ccc(NC2CC3CC2N(C3)C(=O)c2cccc(F)c2-c2ncccn2)nc1 |TLB:14:12:7.8:10,THB:6:7:12.13:10| 314995 US10183953, Example 176::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-methoxypyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 176 Orexin/Hypocretin receptor type 1 Human 52.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314995 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314995&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637412 383541814 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611623 COc1ccc(NC2CC3CC2N(C3)C(=O)c2cccc(F)c2-c2ncccn2)nc1 |TLB:14:12:7.8:10,THB:6:7:12.13:10| 314995 US10183953, Example 176::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-methoxypyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 176 Orexin receptor type 2 Human 1300 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314995 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314995&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637412 383541814 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611624 Fc1cc(cnc1NC1CC2CC1N(C2)C(=O)c1ccccc1-n1nccn1)C(F)(F)F |TLB:15:13:8.9:11,THB:7:8:13.14:11| 314996 US10183953, Example 177::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((3-fluoro-5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 177 Orexin/Hypocretin receptor type 1 Rat 3.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314996 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314996&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637579 383541815 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611625 Fc1cc(cnc1NC1CC2CC1N(C2)C(=O)c1ccccc1-n1nccn1)C(F)(F)F |TLB:15:13:8.9:11,THB:7:8:13.14:11| 314996 US10183953, Example 177::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((3-fluoro-5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 177 Orexin/Hypocretin receptor type 1 Human 3.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314996 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314996&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637579 383541815 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611626 Fc1cc(cnc1NC1CC2CC1N(C2)C(=O)c1ccccc1-n1nccn1)C(F)(F)F |TLB:15:13:8.9:11,THB:7:8:13.14:11| 314996 US10183953, Example 177::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((3-fluoro-5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 177 Orexin receptor type 2 Human 200 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314996 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314996&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637579 383541815 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611627 Cc1ccc(c(n1)C(=O)N1CC2CC(Nc3ncc(cc3F)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:27,7:9:13.12:27| InChI=1S/C21H19F4N7O/c1-11-2-3-16(32-27-4-5-28-32)18(29-11)20(33)31-10-12-6-15(17(31)7-12)30-19-14(22)8-13(9-26-19)21(23,24)25/h2-5,8-9,12,15,17H,6-7,10H2,1H3,(H,26,30) BKCZBZAATSMBGQ-UHFFFAOYSA-N 314997 US10183953, Example 178::((1S,4S,6R)-6-((3-fluoro-5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)methanone::US9611277, Example 178 Orexin/Hypocretin receptor type 1 Rat 6.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314997 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314997&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637476 383541816 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611628 Cc1ccc(c(n1)C(=O)N1CC2CC(Nc3ncc(cc3F)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:27,7:9:13.12:27| InChI=1S/C21H19F4N7O/c1-11-2-3-16(32-27-4-5-28-32)18(29-11)20(33)31-10-12-6-15(17(31)7-12)30-19-14(22)8-13(9-26-19)21(23,24)25/h2-5,8-9,12,15,17H,6-7,10H2,1H3,(H,26,30) BKCZBZAATSMBGQ-UHFFFAOYSA-N 314997 US10183953, Example 178::((1S,4S,6R)-6-((3-fluoro-5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)methanone::US9611277, Example 178 Orexin/Hypocretin receptor type 1 Human 8.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314997 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314997&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637476 383541816 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611629 Cc1ccc(c(n1)C(=O)N1CC2CC(Nc3ncc(cc3F)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:27,7:9:13.12:27| InChI=1S/C21H19F4N7O/c1-11-2-3-16(32-27-4-5-28-32)18(29-11)20(33)31-10-12-6-15(17(31)7-12)30-19-14(22)8-13(9-26-19)21(23,24)25/h2-5,8-9,12,15,17H,6-7,10H2,1H3,(H,26,30) BKCZBZAATSMBGQ-UHFFFAOYSA-N 314997 US10183953, Example 178::((1S,4S,6R)-6-((3-fluoro-5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)methanone::US9611277, Example 178 Orexin receptor type 2 Human 112 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314997 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314997&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637476 383541816 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611630 Fc1cc(cnc1NC1CC2CC1N(C2)C(=O)c1cccc(F)c1-c1ncccn1)C(F)(F)F |TLB:15:13:8.9:11,THB:7:8:13.14:11| 314998 US10183953, Example 179::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((3-fluoro-5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 179 Orexin/Hypocretin receptor type 1 Rat 5.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314998 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314998&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637413 383541817 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611631 Fc1cc(cnc1NC1CC2CC1N(C2)C(=O)c1cccc(F)c1-c1ncccn1)C(F)(F)F |TLB:15:13:8.9:11,THB:7:8:13.14:11| 314998 US10183953, Example 179::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((3-fluoro-5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 179 Orexin/Hypocretin receptor type 1 Human 5.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314998 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314998&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637413 383541817 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611632 Fc1cc(cnc1NC1CC2CC1N(C2)C(=O)c1cccc(F)c1-c1ncccn1)C(F)(F)F |TLB:15:13:8.9:11,THB:7:8:13.14:11| 314998 US10183953, Example 179::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((3-fluoro-5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 179 Orexin receptor type 2 Human 217 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314998 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314998&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637413 383541817 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611633 FC(F)c1cnc(NC2CC3CC2N(C3)C(=O)c2ccccc2-c2ncc(F)cn2)c(F)c1 |TLB:15:13:8.9:11,THB:7:8:13.14:11| 314999 ((1S,4S,6R)-6-((3-fluoro-5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(2-(5-fluoropyrimidin-2-yl)phenyl)methanone::US9611277, Example 180 Orexin/Hypocretin receptor type 1 Rat 6.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314999 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314999&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 138106832 383541818 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611634 FC(F)c1cnc(NC2CC3CC2N(C3)C(=O)c2ccccc2-c2ncc(F)cn2)c(F)c1 |TLB:15:13:8.9:11,THB:7:8:13.14:11| 314999 ((1S,4S,6R)-6-((3-fluoro-5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(2-(5-fluoropyrimidin-2-yl)phenyl)methanone::US9611277, Example 180 Orexin/Hypocretin receptor type 1 Human 5.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314999 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314999&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 138106832 383541818 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611635 FC(F)c1cnc(NC2CC3CC2N(C3)C(=O)c2ccccc2-c2ncc(F)cn2)c(F)c1 |TLB:15:13:8.9:11,THB:7:8:13.14:11| 314999 ((1S,4S,6R)-6-((3-fluoro-5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(2-(5-fluoropyrimidin-2-yl)phenyl)methanone::US9611277, Example 180 Orexin receptor type 2 Human 380 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314999 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314999&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 138106832 383541818 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611636 Cc1ccc(c(n1)C(=O)N1CC2CC(Nc3nc4ccccc4o3)C1C2)-n1nccn1 |TLB:14:13:9.10:25,7:9:13.12:25| InChI=1S/C22H21N7O2/c1-13-6-7-17(29-23-8-9-24-29)20(25-13)21(30)28-12-14-10-16(18(28)11-14)27-22-26-15-4-2-3-5-19(15)31-22/h2-9,14,16,18H,10-12H2,1H3,(H,26,27) JKCPIJFLIHIICL-UHFFFAOYSA-N 315000 US10183953, Example 181::((1S,4S,6R)-6-(benzo[d]oxazol-2-ylamino)-2-azabicyclo[2.2.1]heptan-2-yl)(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)methanone::US9611277, Example 181 Orexin/Hypocretin receptor type 1 Rat 5.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315000 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315000&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637625 383541819 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611637 Cc1ccc(c(n1)C(=O)N1CC2CC(Nc3nc4ccccc4o3)C1C2)-n1nccn1 |TLB:14:13:9.10:25,7:9:13.12:25| InChI=1S/C22H21N7O2/c1-13-6-7-17(29-23-8-9-24-29)20(25-13)21(30)28-12-14-10-16(18(28)11-14)27-22-26-15-4-2-3-5-19(15)31-22/h2-9,14,16,18H,10-12H2,1H3,(H,26,27) JKCPIJFLIHIICL-UHFFFAOYSA-N 315000 US10183953, Example 181::((1S,4S,6R)-6-(benzo[d]oxazol-2-ylamino)-2-azabicyclo[2.2.1]heptan-2-yl)(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)methanone::US9611277, Example 181 Orexin/Hypocretin receptor type 1 Human 8.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315000 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315000&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637625 383541819 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611638 Cc1ccc(c(n1)C(=O)N1CC2CC(Nc3nc4ccccc4o3)C1C2)-n1nccn1 |TLB:14:13:9.10:25,7:9:13.12:25| InChI=1S/C22H21N7O2/c1-13-6-7-17(29-23-8-9-24-29)20(25-13)21(30)28-12-14-10-16(18(28)11-14)27-22-26-15-4-2-3-5-19(15)31-22/h2-9,14,16,18H,10-12H2,1H3,(H,26,27) JKCPIJFLIHIICL-UHFFFAOYSA-N 315000 US10183953, Example 181::((1S,4S,6R)-6-(benzo[d]oxazol-2-ylamino)-2-azabicyclo[2.2.1]heptan-2-yl)(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)methanone::US9611277, Example 181 Orexin receptor type 2 Human 163 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315000 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315000&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637625 383541819 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611639 Fc1cccc(C(=O)N2CC3CC(Nc4nc5ccccc5o4)C2C3)c1-n1nccn1 |TLB:13:12:8.9:24,6:8:12.11:24| InChI=1S/C22H19FN6O2/c23-15-5-3-4-14(20(15)29-24-8-9-25-29)21(30)28-12-13-10-17(18(28)11-13)27-22-26-16-6-1-2-7-19(16)31-22/h1-9,13,17-18H,10-12H2,(H,26,27) PXDWETVKDHRZFI-UHFFFAOYSA-N 315001 US10183953, Example 182::((1S,4S,6R)-6-(benzo[d]oxazol-2-ylamino)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone::US9611277, Example 182 Orexin/Hypocretin receptor type 1 Rat 3.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315001 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315001&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637634 383541820 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611640 Fc1cccc(C(=O)N2CC3CC(Nc4nc5ccccc5o4)C2C3)c1-n1nccn1 |TLB:13:12:8.9:24,6:8:12.11:24| InChI=1S/C22H19FN6O2/c23-15-5-3-4-14(20(15)29-24-8-9-25-29)21(30)28-12-13-10-17(18(28)11-13)27-22-26-16-6-1-2-7-19(16)31-22/h1-9,13,17-18H,10-12H2,(H,26,27) PXDWETVKDHRZFI-UHFFFAOYSA-N 315001 US10183953, Example 182::((1S,4S,6R)-6-(benzo[d]oxazol-2-ylamino)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone::US9611277, Example 182 Orexin/Hypocretin receptor type 1 Human 4.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315001 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315001&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637634 383541820 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611641 Fc1cccc(C(=O)N2CC3CC(Nc4nc5ccccc5o4)C2C3)c1-n1nccn1 |TLB:13:12:8.9:24,6:8:12.11:24| InChI=1S/C22H19FN6O2/c23-15-5-3-4-14(20(15)29-24-8-9-25-29)21(30)28-12-13-10-17(18(28)11-13)27-22-26-16-6-1-2-7-19(16)31-22/h1-9,13,17-18H,10-12H2,(H,26,27) PXDWETVKDHRZFI-UHFFFAOYSA-N 315001 US10183953, Example 182::((1S,4S,6R)-6-(benzo[d]oxazol-2-ylamino)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone::US9611277, Example 182 Orexin receptor type 2 Human 218 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315001 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315001&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637634 383541820 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611642 Fc1cccc(C(=O)N2CC3CC(Nc4nc5ccccc5o4)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:24,6:8:12.11:24| InChI=1S/C24H20FN5O2/c25-16-6-3-5-15(21(16)22-26-9-4-10-27-22)23(31)30-13-14-11-18(19(30)12-14)29-24-28-17-7-1-2-8-20(17)32-24/h1-10,14,18-19H,11-13H2,(H,28,29) WVASWRMPEASFSN-UHFFFAOYSA-N 315002 US10183953, Example 183::((1S,4S,6R)-6-(benzo[d]oxazol-2-ylamino)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 183 Orexin/Hypocretin receptor type 1 Rat 5.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315002 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315002&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637477 383541821 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611643 Fc1cccc(C(=O)N2CC3CC(Nc4nc5ccccc5o4)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:24,6:8:12.11:24| InChI=1S/C24H20FN5O2/c25-16-6-3-5-15(21(16)22-26-9-4-10-27-22)23(31)30-13-14-11-18(19(30)12-14)29-24-28-17-7-1-2-8-20(17)32-24/h1-10,14,18-19H,11-13H2,(H,28,29) WVASWRMPEASFSN-UHFFFAOYSA-N 315002 US10183953, Example 183::((1S,4S,6R)-6-(benzo[d]oxazol-2-ylamino)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 183 Orexin/Hypocretin receptor type 1 Human 7.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315002 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315002&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637477 383541821 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611644 Fc1cccc(C(=O)N2CC3CC(Nc4nc5ccccc5o4)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:24,6:8:12.11:24| InChI=1S/C24H20FN5O2/c25-16-6-3-5-15(21(16)22-26-9-4-10-27-22)23(31)30-13-14-11-18(19(30)12-14)29-24-28-17-7-1-2-8-20(17)32-24/h1-10,14,18-19H,11-13H2,(H,28,29) WVASWRMPEASFSN-UHFFFAOYSA-N 315002 US10183953, Example 183::((1S,4S,6R)-6-(benzo[d]oxazol-2-ylamino)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 183 Orexin receptor type 2 Human 206 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315002 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315002&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637477 383541821 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611645 Cc1ccc(NC2CC3CC2N(C3)C(=O)c2cccc(F)c2-c2ncccn2)cc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 315003 US10183953, Example 184::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-(p-tolylamino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 184 Orexin/Hypocretin receptor type 1 Rat 13.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315003 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315003&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637478 383541822 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611646 Cc1ccc(NC2CC3CC2N(C3)C(=O)c2cccc(F)c2-c2ncccn2)cc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 315003 US10183953, Example 184::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-(p-tolylamino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 184 Orexin/Hypocretin receptor type 1 Human 15.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315003 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315003&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637478 383541822 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611647 Cc1ccc(NC2CC3CC2N(C3)C(=O)c2cccc(F)c2-c2ncccn2)cc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 315003 US10183953, Example 184::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-(p-tolylamino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 184 Orexin receptor type 2 Human 337 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315003 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315003&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637478 383541822 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611648 FC(F)(F)c1ccc(NC2CC3CC2N(C3)C(=O)c2cccc3cc[nH]c23)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315004 US10183953, Example 185::(1H-indol-7-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 185 Orexin/Hypocretin receptor type 1 Rat 27.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315004 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315004&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637414 383541823 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611649 FC(F)(F)c1ccc(NC2CC3CC2N(C3)C(=O)c2cccc3cc[nH]c23)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315004 US10183953, Example 185::(1H-indol-7-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 185 Orexin/Hypocretin receptor type 1 Human 33.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315004 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315004&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637414 383541823 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611650 FC(F)(F)c1ccc(NC2CC3CC2N(C3)C(=O)c2cccc3cc[nH]c23)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315004 US10183953, Example 185::(1H-indol-7-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 185 Orexin receptor type 2 Human 146 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315004 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315004&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637414 383541823 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611651 FC(F)(F)c1ccc(NC2CC3CC2N(C3)C(=O)c2cccc3cn[nH]c23)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315005 US10183953, Example 186::(1H-indazol-7-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 186 Orexin/Hypocretin receptor type 1 Rat 123 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315005 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315005&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637480 383541824 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611652 FC(F)(F)c1ccc(NC2CC3CC2N(C3)C(=O)c2cccc3cn[nH]c23)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315005 US10183953, Example 186::(1H-indazol-7-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 186 Orexin/Hypocretin receptor type 1 Human 151 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315005 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315005&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637480 383541824 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611653 FC(F)(F)c1ccc(NC2CC3CC2N(C3)C(=O)c2cccc3cn[nH]c23)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315005 US10183953, Example 186::(1H-indazol-7-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 186 Orexin receptor type 2 Human 2700 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315005 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315005&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637480 383541824 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611654 Cc1cnc(C(=O)N2CC3CC(Nc4cnc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C20H19F3N8O/c1-11-4-15(31-27-2-3-28-31)18(26-7-11)19(32)30-10-12-5-13(14(30)6-12)29-17-9-24-16(8-25-17)20(21,22)23/h2-4,7-9,12-14H,5-6,10H2,1H3,(H,25,29) QIZBLMNXIRGQNU-UHFFFAOYSA-N 315006 US10183953, Example 187::(5-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 187 Orexin/Hypocretin receptor type 1 Rat 28.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315006 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315006&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637631 383541825 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611655 Cc1cnc(C(=O)N2CC3CC(Nc4cnc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C20H19F3N8O/c1-11-4-15(31-27-2-3-28-31)18(26-7-11)19(32)30-10-12-5-13(14(30)6-12)29-17-9-24-16(8-25-17)20(21,22)23/h2-4,7-9,12-14H,5-6,10H2,1H3,(H,25,29) QIZBLMNXIRGQNU-UHFFFAOYSA-N 315006 US10183953, Example 187::(5-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 187 Orexin/Hypocretin receptor type 1 Human 30.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315006 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315006&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637631 383541825 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611656 Cc1cnc(C(=O)N2CC3CC(Nc4cnc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C20H19F3N8O/c1-11-4-15(31-27-2-3-28-31)18(26-7-11)19(32)30-10-12-5-13(14(30)6-12)29-17-9-24-16(8-25-17)20(21,22)23/h2-4,7-9,12-14H,5-6,10H2,1H3,(H,25,29) QIZBLMNXIRGQNU-UHFFFAOYSA-N 315006 US10183953, Example 187::(5-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 187 Orexin receptor type 2 Human 1600 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315006 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315006&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637631 383541825 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611657 FC(F)(F)c1cnc(NC2CC3CC2N(C3)C(=O)c2cccnc2-n2nccn2)cn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315007 US10183953, Example 188::(2-(2H-1,2,3-triazol-2-yl)pyridin-3-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 188 Orexin/Hypocretin receptor type 1 Rat 191 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315007 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315007&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637656 383541826 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611658 FC(F)(F)c1cnc(NC2CC3CC2N(C3)C(=O)c2cccnc2-n2nccn2)cn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315007 US10183953, Example 188::(2-(2H-1,2,3-triazol-2-yl)pyridin-3-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 188 Orexin/Hypocretin receptor type 1 Human 210 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315007 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315007&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637656 383541826 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611659 FC(F)(F)c1cnc(NC2CC3CC2N(C3)C(=O)c2cccnc2-n2nccn2)cn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315007 US10183953, Example 188::(2-(2H-1,2,3-triazol-2-yl)pyridin-3-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 188 Orexin receptor type 2 Human >10000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315007 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315007&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637656 383541826 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611660 FC(F)(F)c1cnc(NC2CC3CC2N(C3)C(=O)c2ncccc2-c2ncccn2)cn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315008 US10183953, Example 189::(3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 189 Orexin/Hypocretin receptor type 1 Rat 14.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315008 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315008&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637482 383541827 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611661 FC(F)(F)c1cnc(NC2CC3CC2N(C3)C(=O)c2ncccc2-c2ncccn2)cn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315008 US10183953, Example 189::(3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 189 Orexin/Hypocretin receptor type 1 Human 11.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315008 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315008&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637482 383541827 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611662 FC(F)(F)c1cnc(NC2CC3CC2N(C3)C(=O)c2ncccc2-c2ncccn2)cn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315008 US10183953, Example 189::(3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 189 Orexin receptor type 2 Human 678 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315008 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315008&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637482 383541827 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611663 Cc1cnc(C(=O)N2CC3CC(Nc4cnc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C22H20F3N7O/c1-12-5-14(20-26-3-2-4-27-20)19(30-8-12)21(33)32-11-13-6-15(16(32)7-13)31-18-10-28-17(9-29-18)22(23,24)25/h2-5,8-10,13,15-16H,6-7,11H2,1H3,(H,29,31) VUSAAEMKACWHPJ-UHFFFAOYSA-N 315009 US10183953, Example 190::(5-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 190 Orexin/Hypocretin receptor type 1 Rat 12.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315009 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315009&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637601 383541828 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611664 Cc1cnc(C(=O)N2CC3CC(Nc4cnc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C22H20F3N7O/c1-12-5-14(20-26-3-2-4-27-20)19(30-8-12)21(33)32-11-13-6-15(16(32)7-13)31-18-10-28-17(9-29-18)22(23,24)25/h2-5,8-10,13,15-16H,6-7,11H2,1H3,(H,29,31) VUSAAEMKACWHPJ-UHFFFAOYSA-N 315009 US10183953, Example 190::(5-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 190 Orexin/Hypocretin receptor type 1 Human 12.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315009 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315009&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637601 383541828 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611665 Cc1cnc(C(=O)N2CC3CC(Nc4cnc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C22H20F3N7O/c1-12-5-14(20-26-3-2-4-27-20)19(30-8-12)21(33)32-11-13-6-15(16(32)7-13)31-18-10-28-17(9-29-18)22(23,24)25/h2-5,8-10,13,15-16H,6-7,11H2,1H3,(H,29,31) VUSAAEMKACWHPJ-UHFFFAOYSA-N 315009 US10183953, Example 190::(5-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 190 Orexin receptor type 2 Human >10000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315009 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315009&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637601 383541828 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611666 Cc1ccc(-c2ncccn2)c(n1)C(=O)N1CC2CC(Nc3cnc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C22H20F3N7O/c1-12-3-4-14(20-26-5-2-6-27-20)19(30-12)21(33)32-11-13-7-15(16(32)8-13)31-18-10-28-17(9-29-18)22(23,24)25/h2-6,9-10,13,15-16H,7-8,11H2,1H3,(H,29,31) CGNHJOCYDMNLSG-UHFFFAOYSA-N 315010 US10183953, Example 191::(6-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 191 Orexin/Hypocretin receptor type 1 Rat 15.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315010 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315010&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637416 383541829 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611667 Cc1ccc(-c2ncccn2)c(n1)C(=O)N1CC2CC(Nc3cnc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C22H20F3N7O/c1-12-3-4-14(20-26-5-2-6-27-20)19(30-12)21(33)32-11-13-7-15(16(32)8-13)31-18-10-28-17(9-29-18)22(23,24)25/h2-6,9-10,13,15-16H,7-8,11H2,1H3,(H,29,31) CGNHJOCYDMNLSG-UHFFFAOYSA-N 315010 US10183953, Example 191::(6-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 191 Orexin/Hypocretin receptor type 1 Human 13.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315010 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315010&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637416 383541829 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611668 Cc1ccc(-c2ncccn2)c(n1)C(=O)N1CC2CC(Nc3cnc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C22H20F3N7O/c1-12-3-4-14(20-26-5-2-6-27-20)19(30-12)21(33)32-11-13-7-15(16(32)8-13)31-18-10-28-17(9-29-18)22(23,24)25/h2-6,9-10,13,15-16H,7-8,11H2,1H3,(H,29,31) CGNHJOCYDMNLSG-UHFFFAOYSA-N 315010 US10183953, Example 191::(6-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 191 Orexin receptor type 2 Human 163 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315010 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315010&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637416 383541829 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611669 Fc1cccc(C(=O)N2CC3CC(Nc4cnc(cn4)C(F)(F)F)C2C3)c1-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C20H17F4N7O/c21-13-3-1-2-12(18(13)31-27-4-5-28-31)19(32)30-10-11-6-14(15(30)7-11)29-17-9-25-16(8-26-17)20(22,23)24/h1-5,8-9,11,14-15H,6-7,10H2,(H,26,29) GJJGGTQBCLKHOF-UHFFFAOYSA-N 315011 US10183953, Example 192::(3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 192 Orexin/Hypocretin receptor type 1 Rat 8.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315011 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315011&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637614 383541830 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611670 Fc1cccc(C(=O)N2CC3CC(Nc4cnc(cn4)C(F)(F)F)C2C3)c1-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C20H17F4N7O/c21-13-3-1-2-12(18(13)31-27-4-5-28-31)19(32)30-10-11-6-14(15(30)7-11)29-17-9-25-16(8-26-17)20(22,23)24/h1-5,8-9,11,14-15H,6-7,10H2,(H,26,29) GJJGGTQBCLKHOF-UHFFFAOYSA-N 315011 US10183953, Example 192::(3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 192 Orexin/Hypocretin receptor type 1 Human 7.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315011 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315011&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637614 383541830 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611671 Fc1cccc(C(=O)N2CC3CC(Nc4cnc(cn4)C(F)(F)F)C2C3)c1-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C20H17F4N7O/c21-13-3-1-2-12(18(13)31-27-4-5-28-31)19(32)30-10-11-6-14(15(30)7-11)29-17-9-25-16(8-26-17)20(22,23)24/h1-5,8-9,11,14-15H,6-7,10H2,(H,26,29) GJJGGTQBCLKHOF-UHFFFAOYSA-N 315011 US10183953, Example 192::(3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 192 Orexin receptor type 2 Human 249 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315011 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315011&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637614 383541830 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611672 Fc1ccc(C(=O)N2CC3CC(Nc4cnc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C20H17F4N7O/c21-12-1-2-13(15(7-12)31-27-3-4-28-31)19(32)30-10-11-5-14(16(30)6-11)29-18-9-25-17(8-26-18)20(22,23)24/h1-4,7-9,11,14,16H,5-6,10H2,(H,26,29) ROPPUJUSZSBGQQ-UHFFFAOYSA-N 315012 US10183953, Example 193::(4-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 193 Orexin/Hypocretin receptor type 1 Rat 40.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315012 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315012&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637638 383541831 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611673 Fc1ccc(C(=O)N2CC3CC(Nc4cnc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C20H17F4N7O/c21-12-1-2-13(15(7-12)31-27-3-4-28-31)19(32)30-10-11-5-14(16(30)6-11)29-18-9-25-17(8-26-18)20(22,23)24/h1-4,7-9,11,14,16H,5-6,10H2,(H,26,29) ROPPUJUSZSBGQQ-UHFFFAOYSA-N 315012 US10183953, Example 193::(4-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 193 Orexin/Hypocretin receptor type 1 Human 65.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315012 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315012&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637638 383541831 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611674 Fc1ccc(C(=O)N2CC3CC(Nc4cnc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C20H17F4N7O/c21-12-1-2-13(15(7-12)31-27-3-4-28-31)19(32)30-10-11-5-14(16(30)6-11)29-18-9-25-17(8-26-18)20(22,23)24/h1-4,7-9,11,14,16H,5-6,10H2,(H,26,29) ROPPUJUSZSBGQQ-UHFFFAOYSA-N 315012 US10183953, Example 193::(4-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 193 Orexin receptor type 2 Human 2000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315012 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315012&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637638 383541831 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611675 Fc1ccc(c(c1)C(=O)N1CC2CC(Nc3cnc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C20H17F4N7O/c21-12-1-2-15(31-27-3-4-28-31)13(7-12)19(32)30-10-11-5-14(16(30)6-11)29-18-9-25-17(8-26-18)20(22,23)24/h1-4,7-9,11,14,16H,5-6,10H2,(H,26,29) SLRLNNYNKDLOIV-UHFFFAOYSA-N 315013 US10183953, Example 194::((5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 194 Orexin/Hypocretin receptor type 1 Rat 8.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315013 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315013&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637856 383541832 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611676 Fc1ccc(c(c1)C(=O)N1CC2CC(Nc3cnc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C20H17F4N7O/c21-12-1-2-15(31-27-3-4-28-31)13(7-12)19(32)30-10-11-5-14(16(30)6-11)29-18-9-25-17(8-26-18)20(22,23)24/h1-4,7-9,11,14,16H,5-6,10H2,(H,26,29) SLRLNNYNKDLOIV-UHFFFAOYSA-N 315013 US10183953, Example 194::((5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 194 Orexin/Hypocretin receptor type 1 Human 8.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315013 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315013&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637856 383541832 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611677 Fc1ccc(c(c1)C(=O)N1CC2CC(Nc3cnc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C20H17F4N7O/c21-12-1-2-15(31-27-3-4-28-31)13(7-12)19(32)30-10-11-5-14(16(30)6-11)29-18-9-25-17(8-26-18)20(22,23)24/h1-4,7-9,11,14,16H,5-6,10H2,(H,26,29) SLRLNNYNKDLOIV-UHFFFAOYSA-N 315013 US10183953, Example 194::((5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 194 Orexin receptor type 2 Human 241 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315013 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315013&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637856 383541832 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611678 Fc1cccc(c1C(=O)N1CC2CC(Nc3cnc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C20H17F4N7O/c21-12-2-1-3-14(31-27-4-5-28-31)18(12)19(32)30-10-11-6-13(15(30)7-11)29-17-9-25-16(8-26-17)20(22,23)24/h1-5,8-9,11,13,15H,6-7,10H2,(H,26,29) XHMFGCWUFHDXAB-UHFFFAOYSA-N 315014 US10183953, Example 195::(2-fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 195 Orexin/Hypocretin receptor type 1 Rat 9.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315014 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315014&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637632 383541833 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611679 Fc1cccc(c1C(=O)N1CC2CC(Nc3cnc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C20H17F4N7O/c21-12-2-1-3-14(31-27-4-5-28-31)18(12)19(32)30-10-11-6-13(15(30)7-11)29-17-9-25-16(8-26-17)20(22,23)24/h1-5,8-9,11,13,15H,6-7,10H2,(H,26,29) XHMFGCWUFHDXAB-UHFFFAOYSA-N 315014 US10183953, Example 195::(2-fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 195 Orexin/Hypocretin receptor type 1 Human 8.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315014 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315014&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637632 383541833 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611680 Fc1cccc(c1C(=O)N1CC2CC(Nc3cnc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C20H17F4N7O/c21-12-2-1-3-14(31-27-4-5-28-31)18(12)19(32)30-10-11-6-13(15(30)7-11)29-17-9-25-16(8-26-17)20(22,23)24/h1-5,8-9,11,13,15H,6-7,10H2,(H,26,29) XHMFGCWUFHDXAB-UHFFFAOYSA-N 315014 US10183953, Example 195::(2-fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 195 Orexin receptor type 2 Human 199 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315014 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315014&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637632 383541833 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611681 Cc1cccc(C(=O)N2CC3CC(Nc4cnc(cn4)C(F)(F)F)C2C3)c1-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C21H20F3N7O/c1-12-3-2-4-14(19(12)31-27-5-6-28-31)20(32)30-11-13-7-15(16(30)8-13)29-18-10-25-17(9-26-18)21(22,23)24/h2-6,9-10,13,15-16H,7-8,11H2,1H3,(H,26,29) KBOYUJJQCAMZDT-UHFFFAOYSA-N 315015 US10183953, Example 196::(3-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 196 Orexin/Hypocretin receptor type 1 Rat 6.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315015 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315015&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637630 383541834 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611682 Cc1cccc(C(=O)N2CC3CC(Nc4cnc(cn4)C(F)(F)F)C2C3)c1-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C21H20F3N7O/c1-12-3-2-4-14(19(12)31-27-5-6-28-31)20(32)30-11-13-7-15(16(30)8-13)29-18-10-25-17(9-26-18)21(22,23)24/h2-6,9-10,13,15-16H,7-8,11H2,1H3,(H,26,29) KBOYUJJQCAMZDT-UHFFFAOYSA-N 315015 US10183953, Example 196::(3-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 196 Orexin/Hypocretin receptor type 1 Human 4.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315015 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315015&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637630 383541834 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611683 Cc1cccc(C(=O)N2CC3CC(Nc4cnc(cn4)C(F)(F)F)C2C3)c1-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C21H20F3N7O/c1-12-3-2-4-14(19(12)31-27-5-6-28-31)20(32)30-11-13-7-15(16(30)8-13)29-18-10-25-17(9-26-18)21(22,23)24/h2-6,9-10,13,15-16H,7-8,11H2,1H3,(H,26,29) KBOYUJJQCAMZDT-UHFFFAOYSA-N 315015 US10183953, Example 196::(3-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 196 Orexin receptor type 2 Human 60.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315015 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315015&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637630 383541834 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611684 COc1ccc(C(=O)N2CC3CC(Nc4cnc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C21H20F3N7O2/c1-33-13-2-3-14(16(8-13)31-27-4-5-28-31)20(32)30-11-12-6-15(17(30)7-12)29-19-10-25-18(9-26-19)21(22,23)24/h2-5,8-10,12,15,17H,6-7,11H2,1H3,(H,26,29) SFENYALQQRWBNG-UHFFFAOYSA-N 315016 US10183953, Example 197::(4-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 197 Orexin/Hypocretin receptor type 1 Rat 93.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315016 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315016&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637773 383541835 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611685 COc1ccc(C(=O)N2CC3CC(Nc4cnc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C21H20F3N7O2/c1-33-13-2-3-14(16(8-13)31-27-4-5-28-31)20(32)30-11-12-6-15(17(30)7-12)29-19-10-25-18(9-26-19)21(22,23)24/h2-5,8-10,12,15,17H,6-7,11H2,1H3,(H,26,29) SFENYALQQRWBNG-UHFFFAOYSA-N 315016 US10183953, Example 197::(4-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 197 Orexin/Hypocretin receptor type 1 Human 39.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315016 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315016&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637773 383541835 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611686 COc1ccc(C(=O)N2CC3CC(Nc4cnc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C21H20F3N7O2/c1-33-13-2-3-14(16(8-13)31-27-4-5-28-31)20(32)30-11-12-6-15(17(30)7-12)29-19-10-25-18(9-26-19)21(22,23)24/h2-5,8-10,12,15,17H,6-7,11H2,1H3,(H,26,29) SFENYALQQRWBNG-UHFFFAOYSA-N 315016 US10183953, Example 197::(4-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 197 Orexin receptor type 2 Human 9700 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315016 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315016&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637773 383541835 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611687 Fc1ccc(C(=O)N2CC3CC(Nc4cnc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C22H18F4N6O/c23-13-2-3-14(15(8-13)20-27-4-1-5-28-20)21(33)32-11-12-6-16(17(32)7-12)31-19-10-29-18(9-30-19)22(24,25)26/h1-5,8-10,12,16-17H,6-7,11H2,(H,30,31) XYPNUYVAPPRDPP-UHFFFAOYSA-N 315017 (4-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 227::US10183953, Example 198::US9611277, Example 198 Orexin/Hypocretin receptor type 1 Rat 11.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315017 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315017&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637417 383541836 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611688 Fc1ccc(C(=O)N2CC3CC(Nc4cnc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C22H18F4N6O/c23-13-2-3-14(15(8-13)20-27-4-1-5-28-20)21(33)32-11-12-6-16(17(32)7-12)31-19-10-29-18(9-30-19)22(24,25)26/h1-5,8-10,12,16-17H,6-7,11H2,(H,30,31) XYPNUYVAPPRDPP-UHFFFAOYSA-N 315017 (4-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 227::US10183953, Example 198::US9611277, Example 198 Orexin/Hypocretin receptor type 1 Human 9.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315017 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315017&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637417 383541836 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611689 Fc1ccc(C(=O)N2CC3CC(Nc4cnc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C22H18F4N6O/c23-13-2-3-14(15(8-13)20-27-4-1-5-28-20)21(33)32-11-12-6-16(17(32)7-12)31-19-10-29-18(9-30-19)22(24,25)26/h1-5,8-10,12,16-17H,6-7,11H2,(H,30,31) XYPNUYVAPPRDPP-UHFFFAOYSA-N 315017 (4-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 227::US10183953, Example 198::US9611277, Example 198 Orexin receptor type 2 Human 1375 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315017 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315017&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637417 383541836 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611690 Fc1ccc(-c2ncccn2)c(c1)C(=O)N1CC2CC(Nc3cnc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C22H18F4N6O/c23-13-2-3-14(20-27-4-1-5-28-20)15(8-13)21(33)32-11-12-6-16(17(32)7-12)31-19-10-29-18(9-30-19)22(24,25)26/h1-5,8-10,12,16-17H,6-7,11H2,(H,30,31) ZTFAJHQXXGQGJI-UHFFFAOYSA-N 315018 US10183953, Example 199::(5-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 199 Orexin/Hypocretin receptor type 1 Rat 6.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315018 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315018&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637651 383541837 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611691 Fc1ccc(-c2ncccn2)c(c1)C(=O)N1CC2CC(Nc3cnc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C22H18F4N6O/c23-13-2-3-14(20-27-4-1-5-28-20)15(8-13)21(33)32-11-12-6-16(17(32)7-12)31-19-10-29-18(9-30-19)22(24,25)26/h1-5,8-10,12,16-17H,6-7,11H2,(H,30,31) ZTFAJHQXXGQGJI-UHFFFAOYSA-N 315018 US10183953, Example 199::(5-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 199 Orexin/Hypocretin receptor type 1 Human 8.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315018 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315018&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637651 383541837 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611692 Fc1ccc(-c2ncccn2)c(c1)C(=O)N1CC2CC(Nc3cnc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C22H18F4N6O/c23-13-2-3-14(20-27-4-1-5-28-20)15(8-13)21(33)32-11-12-6-16(17(32)7-12)31-19-10-29-18(9-30-19)22(24,25)26/h1-5,8-10,12,16-17H,6-7,11H2,(H,30,31) ZTFAJHQXXGQGJI-UHFFFAOYSA-N 315018 US10183953, Example 199::(5-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 199 Orexin receptor type 2 Human 221 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315018 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315018&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637651 383541837 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611693 Fc1cccc(-c2ncccn2)c1C(=O)N1CC2CC(Nc3cnc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C22H18F4N6O/c23-14-4-1-3-13(20-27-5-2-6-28-20)19(14)21(33)32-11-12-7-15(16(32)8-12)31-18-10-29-17(9-30-18)22(24,25)26/h1-6,9-10,12,15-16H,7-8,11H2,(H,30,31) DUTIHKKSAPSLCY-UHFFFAOYSA-N 315019 US10183953, Example 200::(2-fluoro-6-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 200 Orexin/Hypocretin receptor type 1 Rat 7.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315019 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315019&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637676 383541838 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611694 Fc1cccc(-c2ncccn2)c1C(=O)N1CC2CC(Nc3cnc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C22H18F4N6O/c23-14-4-1-3-13(20-27-5-2-6-28-20)19(14)21(33)32-11-12-7-15(16(32)8-12)31-18-10-29-17(9-30-18)22(24,25)26/h1-6,9-10,12,15-16H,7-8,11H2,(H,30,31) DUTIHKKSAPSLCY-UHFFFAOYSA-N 315019 US10183953, Example 200::(2-fluoro-6-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 200 Orexin/Hypocretin receptor type 1 Human 6.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315019 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315019&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637676 383541838 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611695 Fc1cccc(-c2ncccn2)c1C(=O)N1CC2CC(Nc3cnc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C22H18F4N6O/c23-14-4-1-3-13(20-27-5-2-6-28-20)19(14)21(33)32-11-12-7-15(16(32)8-12)31-18-10-29-17(9-30-18)22(24,25)26/h1-6,9-10,12,15-16H,7-8,11H2,(H,30,31) DUTIHKKSAPSLCY-UHFFFAOYSA-N 315019 US10183953, Example 200::(2-fluoro-6-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 200 Orexin receptor type 2 Human 240 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315019 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315019&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637676 383541838 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611696 FC(F)(F)c1cnc(NC2CC3CC2N(C3)C(=O)c2ccccc2-c2ncccn2)cn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315020 US10183953, Example 201::(2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 201 Orexin/Hypocretin receptor type 1 Rat 6.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315020 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315020&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637859 383541839 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611697 FC(F)(F)c1cnc(NC2CC3CC2N(C3)C(=O)c2ccccc2-c2ncccn2)cn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315020 US10183953, Example 201::(2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 201 Orexin/Hypocretin receptor type 1 Human 6.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315020 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315020&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637859 383541839 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611698 FC(F)(F)c1cnc(NC2CC3CC2N(C3)C(=O)c2ccccc2-c2ncccn2)cn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315020 US10183953, Example 201::(2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 201 Orexin receptor type 2 Human 213 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315020 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315020&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637859 383541839 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611699 Fc1ccc(-c2ncco2)c(c1)C(=O)N1CC2CC(Nc3cnc(cn3)C(F)(F)F)C1C2 |TLB:19:18:14.15:31,12:14:18.17:31| InChI=1S/C21H17F4N5O2/c22-12-1-2-13(19-26-3-4-32-19)14(7-12)20(31)30-10-11-5-15(16(30)6-11)29-18-9-27-17(8-28-18)21(23,24)25/h1-4,7-9,11,15-16H,5-6,10H2,(H,28,29) QRSFHHAHMGPRSD-UHFFFAOYSA-N 315021 US10183953, Example 202::(5-fluoro-2-(oxazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 202 Orexin/Hypocretin receptor type 1 Rat 13.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315021 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315021&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637418 383541840 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611700 Fc1ccc(-c2ncco2)c(c1)C(=O)N1CC2CC(Nc3cnc(cn3)C(F)(F)F)C1C2 |TLB:19:18:14.15:31,12:14:18.17:31| InChI=1S/C21H17F4N5O2/c22-12-1-2-13(19-26-3-4-32-19)14(7-12)20(31)30-10-11-5-15(16(30)6-11)29-18-9-27-17(8-28-18)21(23,24)25/h1-4,7-9,11,15-16H,5-6,10H2,(H,28,29) QRSFHHAHMGPRSD-UHFFFAOYSA-N 315021 US10183953, Example 202::(5-fluoro-2-(oxazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 202 Orexin/Hypocretin receptor type 1 Human 13.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315021 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315021&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637418 383541840 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611701 Fc1ccc(-c2ncco2)c(c1)C(=O)N1CC2CC(Nc3cnc(cn3)C(F)(F)F)C1C2 |TLB:19:18:14.15:31,12:14:18.17:31| InChI=1S/C21H17F4N5O2/c22-12-1-2-13(19-26-3-4-32-19)14(7-12)20(31)30-10-11-5-15(16(30)6-11)29-18-9-27-17(8-28-18)21(23,24)25/h1-4,7-9,11,15-16H,5-6,10H2,(H,28,29) QRSFHHAHMGPRSD-UHFFFAOYSA-N 315021 US10183953, Example 202::(5-fluoro-2-(oxazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 202 Orexin receptor type 2 Human 302 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315021 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315021&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637418 383541840 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611702 Fc1cnc(nc1)-c1ccccc1C(=O)N1CC2CC(Nc3cnc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C22H18F4N6O/c23-13-7-29-20(30-8-13)14-3-1-2-4-15(14)21(33)32-11-12-5-16(17(32)6-12)31-19-10-27-18(9-28-19)22(24,25)26/h1-4,7-10,12,16-17H,5-6,11H2,(H,28,31) QGYXSTLYCRZUEO-UHFFFAOYSA-N 315022 US10183953, Example 203::(2-(5-fluoropyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 203 Orexin/Hypocretin receptor type 1 Rat 9.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315022 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315022&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637862 383541841 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611703 Fc1cnc(nc1)-c1ccccc1C(=O)N1CC2CC(Nc3cnc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C22H18F4N6O/c23-13-7-29-20(30-8-13)14-3-1-2-4-15(14)21(33)32-11-12-5-16(17(32)6-12)31-19-10-27-18(9-28-19)22(24,25)26/h1-4,7-10,12,16-17H,5-6,11H2,(H,28,31) QGYXSTLYCRZUEO-UHFFFAOYSA-N 315022 US10183953, Example 203::(2-(5-fluoropyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 203 Orexin/Hypocretin receptor type 1 Human 9.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315022 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315022&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637862 383541841 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611704 Fc1cnc(nc1)-c1ccccc1C(=O)N1CC2CC(Nc3cnc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C22H18F4N6O/c23-13-7-29-20(30-8-13)14-3-1-2-4-15(14)21(33)32-11-12-5-16(17(32)6-12)31-19-10-27-18(9-28-19)22(24,25)26/h1-4,7-10,12,16-17H,5-6,11H2,(H,28,31) QGYXSTLYCRZUEO-UHFFFAOYSA-N 315022 US10183953, Example 203::(2-(5-fluoropyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 203 Orexin receptor type 2 Human 545 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315022 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315022&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637862 383541841 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611705 Fc1cnc(nc1)-c1c(F)cccc1C(=O)N1CC2CC(Nc3cnc(cn3)C(F)(F)F)C1C2 |TLB:21:20:16.17:33,14:16:20.19:33| InChI=1S/C22H17F5N6O/c23-12-6-30-20(31-7-12)19-13(2-1-3-14(19)24)21(34)33-10-11-4-15(16(33)5-11)32-18-9-28-17(8-29-18)22(25,26)27/h1-3,6-9,11,15-16H,4-5,10H2,(H,29,32) DKCBWFSLAZBMOX-UHFFFAOYSA-N 315023 US10183953, Example 204::(3-fluoro-2-(5-fluoropyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 204 Orexin/Hypocretin receptor type 1 Rat 9.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315023 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315023&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637555 383541842 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611706 Fc1cnc(nc1)-c1c(F)cccc1C(=O)N1CC2CC(Nc3cnc(cn3)C(F)(F)F)C1C2 |TLB:21:20:16.17:33,14:16:20.19:33| InChI=1S/C22H17F5N6O/c23-12-6-30-20(31-7-12)19-13(2-1-3-14(19)24)21(34)33-10-11-4-15(16(33)5-11)32-18-9-28-17(8-29-18)22(25,26)27/h1-3,6-9,11,15-16H,4-5,10H2,(H,29,32) DKCBWFSLAZBMOX-UHFFFAOYSA-N 315023 US10183953, Example 204::(3-fluoro-2-(5-fluoropyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 204 Orexin/Hypocretin receptor type 1 Human 9.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315023 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315023&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637555 383541842 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611707 Fc1cnc(nc1)-c1c(F)cccc1C(=O)N1CC2CC(Nc3cnc(cn3)C(F)(F)F)C1C2 |TLB:21:20:16.17:33,14:16:20.19:33| InChI=1S/C22H17F5N6O/c23-12-6-30-20(31-7-12)19-13(2-1-3-14(19)24)21(34)33-10-11-4-15(16(33)5-11)32-18-9-28-17(8-29-18)22(25,26)27/h1-3,6-9,11,15-16H,4-5,10H2,(H,29,32) DKCBWFSLAZBMOX-UHFFFAOYSA-N 315023 US10183953, Example 204::(3-fluoro-2-(5-fluoropyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 204 Orexin receptor type 2 Human 960 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315023 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315023&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637555 383541842 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611708 FC(F)(F)c1cnc(NC2CC3CC2N(C3)C(=O)c2nccnc2-c2ccccc2)cn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315024 US10183953, Example 205::(3-phenylpyrazin-2-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 205 Orexin/Hypocretin receptor type 1 Rat 51.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315024 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315024&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637558 383541843 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611709 FC(F)(F)c1cnc(NC2CC3CC2N(C3)C(=O)c2nccnc2-c2ccccc2)cn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315024 US10183953, Example 205::(3-phenylpyrazin-2-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 205 Orexin/Hypocretin receptor type 1 Human 35.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315024 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315024&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637558 383541843 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611710 FC(F)(F)c1cnc(NC2CC3CC2N(C3)C(=O)c2nccnc2-c2ccccc2)cn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315024 US10183953, Example 205::(3-phenylpyrazin-2-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 205 Orexin receptor type 2 Human 846 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315024 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315024&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637558 383541843 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611711 FC(F)(F)c1cnc(NC2CC3CC2N(C3)C(=O)c2ccccc2-c2ccccc2)cn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315025 US10183953, Example 206::[1,1′-biphenyl]-2-yl((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 206 Orexin/Hypocretin receptor type 1 Rat 8.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315025 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315025&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637554 383541844 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611712 FC(F)(F)c1cnc(NC2CC3CC2N(C3)C(=O)c2ccccc2-c2ccccc2)cn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315025 US10183953, Example 206::[1,1′-biphenyl]-2-yl((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 206 Orexin/Hypocretin receptor type 1 Human 10.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315025 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315025&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637554 383541844 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611713 FC(F)(F)c1cnc(NC2CC3CC2N(C3)C(=O)c2ccccc2-c2ccccc2)cn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315025 US10183953, Example 206::[1,1′-biphenyl]-2-yl((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 206 Orexin receptor type 2 Human 103 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315025 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315025&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637554 383541844 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611714 FC(F)(F)c1cnc(NC2CC3CC2N(C3)C(=O)c2occc2-c2ccccc2)cn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315026 US10183953, Example 207::(3-phenylfuran-2-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 207 Orexin/Hypocretin receptor type 1 Rat 143 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315026 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315026&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637553 383541845 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611715 FC(F)(F)c1cnc(NC2CC3CC2N(C3)C(=O)c2occc2-c2ccccc2)cn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315026 US10183953, Example 207::(3-phenylfuran-2-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 207 Orexin/Hypocretin receptor type 1 Human 127 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315026 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315026&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637553 383541845 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611716 FC(F)(F)c1cnc(NC2CC3CC2N(C3)C(=O)c2occc2-c2ccccc2)cn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315026 US10183953, Example 207::(3-phenylfuran-2-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 207 Orexin receptor type 2 Human 611 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315026 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315026&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637553 383541845 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611717 CN(C1CC2CC1N(C2)C(=O)c1cccc(F)c1-c1ncccn1)c1cnc(cn1)C(F)(F)F |TLB:1:2:7.8:5,THB:9:7:2.3:5| 315027 US10183953, Example 208::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-(methyl(5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 208 Orexin/Hypocretin receptor type 1 Rat 7.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315027 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315027&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637873 383541846 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611718 CN(C1CC2CC1N(C2)C(=O)c1cccc(F)c1-c1ncccn1)c1cnc(cn1)C(F)(F)F |TLB:1:2:7.8:5,THB:9:7:2.3:5| 315027 US10183953, Example 208::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-(methyl(5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 208 Orexin/Hypocretin receptor type 1 Human 6.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315027 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315027&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637873 383541846 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611719 CN(C1CC2CC1N(C2)C(=O)c1cccc(F)c1-c1ncccn1)c1cnc(cn1)C(F)(F)F |TLB:1:2:7.8:5,THB:9:7:2.3:5| 315027 US10183953, Example 208::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-(methyl(5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 208 Orexin receptor type 2 Human 846 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315027 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315027&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637873 383541846 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611720 CN(C1CC2CC1N(C2)C(=O)c1cc(F)ccc1-c1ncccn1)c1cnc(cn1)C(F)(F)F |TLB:1:2:7.8:5,THB:9:7:2.3:5| 315028 US10183953, Example 209::(5-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-(methyl(5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 209 Orexin/Hypocretin receptor type 1 Rat 9.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315028 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315028&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637483 383541847 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611721 CN(C1CC2CC1N(C2)C(=O)c1cc(F)ccc1-c1ncccn1)c1cnc(cn1)C(F)(F)F |TLB:1:2:7.8:5,THB:9:7:2.3:5| 315028 US10183953, Example 209::(5-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-(methyl(5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 209 Orexin/Hypocretin receptor type 1 Human 5.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315028 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315028&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637483 383541847 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611722 CN(C1CC2CC1N(C2)C(=O)c1cc(F)ccc1-c1ncccn1)c1cnc(cn1)C(F)(F)F |TLB:1:2:7.8:5,THB:9:7:2.3:5| 315028 US10183953, Example 209::(5-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-(methyl(5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 209 Orexin receptor type 2 Human 753 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315028 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315028&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637483 383541847 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611723 CN(C1CC2CC1N(C2)C(=O)c1ccccc1-c1ncccn1)c1cnc(cn1)C(F)(F)F |TLB:1:2:7.8:5,THB:9:7:2.3:5| 315029 US10183953, Example 210::((1S,4S,6R)-6-(methyl(5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 210 Orexin/Hypocretin receptor type 1 Rat 6.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315029 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315029&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637419 383541848 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611724 CN(C1CC2CC1N(C2)C(=O)c1ccccc1-c1ncccn1)c1cnc(cn1)C(F)(F)F |TLB:1:2:7.8:5,THB:9:7:2.3:5| 315029 US10183953, Example 210::((1S,4S,6R)-6-(methyl(5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 210 Orexin/Hypocretin receptor type 1 Human 5.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315029 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315029&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637419 383541848 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611725 CN(C1CC2CC1N(C2)C(=O)c1ccccc1-c1ncccn1)c1cnc(cn1)C(F)(F)F |TLB:1:2:7.8:5,THB:9:7:2.3:5| 315029 US10183953, Example 210::((1S,4S,6R)-6-(methyl(5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 210 Orexin receptor type 2 Human 502 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315029 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315029&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637419 383541848 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611726 Fc1cccc(C(=O)N2CC3CC(C2C3)N(CC2CC2)c2cnc(cn2)C(F)(F)F)c1-c1ncccn1 |TLB:15:12:8.9:14,6:8:12.11:14| InChI=1S/C26H24F4N6O/c27-18-4-1-3-17(23(18)24-31-7-2-8-32-24)25(37)36-14-16-9-19(20(36)10-16)35(13-15-5-6-15)22-12-33-21(11-34-22)26(28,29)30/h1-4,7-8,11-12,15-16,19-20H,5-6,9-10,13-14H2 KZEDWEBGNZEIRI-UHFFFAOYSA-N 315030 US10183953, Example 211::((1S,4S,6R)-6-((cyclopropylmethyl)(5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 211 Orexin/Hypocretin receptor type 1 Rat 31.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315030 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315030&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637644 383541849 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611727 Fc1cccc(C(=O)N2CC3CC(C2C3)N(CC2CC2)c2cnc(cn2)C(F)(F)F)c1-c1ncccn1 |TLB:15:12:8.9:14,6:8:12.11:14| InChI=1S/C26H24F4N6O/c27-18-4-1-3-17(23(18)24-31-7-2-8-32-24)25(37)36-14-16-9-19(20(36)10-16)35(13-15-5-6-15)22-12-33-21(11-34-22)26(28,29)30/h1-4,7-8,11-12,15-16,19-20H,5-6,9-10,13-14H2 KZEDWEBGNZEIRI-UHFFFAOYSA-N 315030 US10183953, Example 211::((1S,4S,6R)-6-((cyclopropylmethyl)(5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 211 Orexin/Hypocretin receptor type 1 Human 16.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315030 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315030&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637644 383541849 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611728 Fc1cccc(C(=O)N2CC3CC(C2C3)N(CC2CC2)c2cnc(cn2)C(F)(F)F)c1-c1ncccn1 |TLB:15:12:8.9:14,6:8:12.11:14| InChI=1S/C26H24F4N6O/c27-18-4-1-3-17(23(18)24-31-7-2-8-32-24)25(37)36-14-16-9-19(20(36)10-16)35(13-15-5-6-15)22-12-33-21(11-34-22)26(28,29)30/h1-4,7-8,11-12,15-16,19-20H,5-6,9-10,13-14H2 KZEDWEBGNZEIRI-UHFFFAOYSA-N 315030 US10183953, Example 211::((1S,4S,6R)-6-((cyclopropylmethyl)(5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 211 Orexin receptor type 2 Human 1300 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315030 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315030&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637644 383541849 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611729 Fc1cccc(C(=O)N2CC3CC(Nc4cnc(Cl)cn4)C2C3)c1-n1nccn1 |TLB:13:12:8.9:22,6:8:12.11:22| InChI=1S/C19H17ClFN7O/c20-16-8-23-17(9-22-16)26-14-6-11-7-15(14)27(10-11)19(29)12-2-1-3-13(21)18(12)28-24-4-5-25-28/h1-5,8-9,11,14-15H,6-7,10H2,(H,23,26) HYVMYNYGNAPXGW-UHFFFAOYSA-N 315031 US10183953, Example 212::((1S,4S,6R)-6-((5-chloropyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone::US9611277, Example 212 Orexin/Hypocretin receptor type 1 Rat 14.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315031 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315031&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637653 383541850 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611730 Fc1cccc(C(=O)N2CC3CC(Nc4cnc(Cl)cn4)C2C3)c1-n1nccn1 |TLB:13:12:8.9:22,6:8:12.11:22| InChI=1S/C19H17ClFN7O/c20-16-8-23-17(9-22-16)26-14-6-11-7-15(14)27(10-11)19(29)12-2-1-3-13(21)18(12)28-24-4-5-25-28/h1-5,8-9,11,14-15H,6-7,10H2,(H,23,26) HYVMYNYGNAPXGW-UHFFFAOYSA-N 315031 US10183953, Example 212::((1S,4S,6R)-6-((5-chloropyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone::US9611277, Example 212 Orexin/Hypocretin receptor type 1 Human 9.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315031 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315031&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637653 383541850 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611731 Fc1cccc(C(=O)N2CC3CC(Nc4cnc(Cl)cn4)C2C3)c1-n1nccn1 |TLB:13:12:8.9:22,6:8:12.11:22| InChI=1S/C19H17ClFN7O/c20-16-8-23-17(9-22-16)26-14-6-11-7-15(14)27(10-11)19(29)12-2-1-3-13(21)18(12)28-24-4-5-25-28/h1-5,8-9,11,14-15H,6-7,10H2,(H,23,26) HYVMYNYGNAPXGW-UHFFFAOYSA-N 315031 US10183953, Example 212::((1S,4S,6R)-6-((5-chloropyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone::US9611277, Example 212 Orexin receptor type 2 Human 607 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315031 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315031&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637653 383541850 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611732 Fc1ccc(c(c1)C(=O)N1CC2CC(Nc3cnc(Cl)cn3)C1C2)-n1nccn1 |TLB:14:13:9.10:23,7:9:13.12:23| InChI=1S/C19H17ClFN7O/c20-17-8-23-18(9-22-17)26-14-5-11-6-16(14)27(10-11)19(29)13-7-12(21)1-2-15(13)28-24-3-4-25-28/h1-4,7-9,11,14,16H,5-6,10H2,(H,23,26) SCIDCNXCCXNFGG-UHFFFAOYSA-N 315032 US10183953, Example 213::1S,4S,6R)-6-((5-chloropyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone::US9611277, Example 213 Orexin/Hypocretin receptor type 1 Rat 39.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315032 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315032&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637572 383541851 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611733 Fc1ccc(c(c1)C(=O)N1CC2CC(Nc3cnc(Cl)cn3)C1C2)-n1nccn1 |TLB:14:13:9.10:23,7:9:13.12:23| InChI=1S/C19H17ClFN7O/c20-17-8-23-18(9-22-17)26-14-5-11-6-16(14)27(10-11)19(29)13-7-12(21)1-2-15(13)28-24-3-4-25-28/h1-4,7-9,11,14,16H,5-6,10H2,(H,23,26) SCIDCNXCCXNFGG-UHFFFAOYSA-N 315032 US10183953, Example 213::1S,4S,6R)-6-((5-chloropyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone::US9611277, Example 213 Orexin/Hypocretin receptor type 1 Human 31.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315032 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315032&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637572 383541851 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611734 Fc1ccc(c(c1)C(=O)N1CC2CC(Nc3cnc(Cl)cn3)C1C2)-n1nccn1 |TLB:14:13:9.10:23,7:9:13.12:23| InChI=1S/C19H17ClFN7O/c20-17-8-23-18(9-22-17)26-14-5-11-6-16(14)27(10-11)19(29)13-7-12(21)1-2-15(13)28-24-3-4-25-28/h1-4,7-9,11,14,16H,5-6,10H2,(H,23,26) SCIDCNXCCXNFGG-UHFFFAOYSA-N 315032 US10183953, Example 213::1S,4S,6R)-6-((5-chloropyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone::US9611277, Example 213 Orexin receptor type 2 Human 871 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315032 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315032&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637572 383541851 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611735 Fc1cccc(C(=O)N2CC3CC(Nc4cnc(Cl)cn4)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:22,6:8:12.11:22| InChI=1S/C21H18ClFN6O/c22-17-9-27-18(10-26-17)28-15-7-12-8-16(15)29(11-12)21(30)13-3-1-4-14(23)19(13)20-24-5-2-6-25-20/h1-6,9-10,12,15-16H,7-8,11H2,(H,27,28) NVSKMGRKNKNTIA-UHFFFAOYSA-N 315033 US10183953, Example 214::((1S,4S,6R)-6-((5-chloropyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 214 Orexin/Hypocretin receptor type 1 Rat 13.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315033 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315033&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637649 383541852 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611736 Fc1cccc(C(=O)N2CC3CC(Nc4cnc(Cl)cn4)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:22,6:8:12.11:22| InChI=1S/C21H18ClFN6O/c22-17-9-27-18(10-26-17)28-15-7-12-8-16(15)29(11-12)21(30)13-3-1-4-14(23)19(13)20-24-5-2-6-25-20/h1-6,9-10,12,15-16H,7-8,11H2,(H,27,28) NVSKMGRKNKNTIA-UHFFFAOYSA-N 315033 US10183953, Example 214::((1S,4S,6R)-6-((5-chloropyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 214 Orexin/Hypocretin receptor type 1 Human 14.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315033 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315033&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637649 383541852 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611737 Fc1cccc(C(=O)N2CC3CC(Nc4cnc(Cl)cn4)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:22,6:8:12.11:22| InChI=1S/C21H18ClFN6O/c22-17-9-27-18(10-26-17)28-15-7-12-8-16(15)29(11-12)21(30)13-3-1-4-14(23)19(13)20-24-5-2-6-25-20/h1-6,9-10,12,15-16H,7-8,11H2,(H,27,28) NVSKMGRKNKNTIA-UHFFFAOYSA-N 315033 US10183953, Example 214::((1S,4S,6R)-6-((5-chloropyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 214 Orexin receptor type 2 Human 708 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315033 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315033&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637649 383541852 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611738 Clc1cnc(NC2CC3CC2N(C3)C(=O)c2ccccc2-c2ncccn2)cn1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 315034 US10183953, Example 215::((1S,4S,6R)-6-((5-chloropyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 215 Orexin/Hypocretin receptor type 1 Rat 12.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315034 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315034&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637778 383541853 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611739 Clc1cnc(NC2CC3CC2N(C3)C(=O)c2ccccc2-c2ncccn2)cn1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 315034 US10183953, Example 215::((1S,4S,6R)-6-((5-chloropyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 215 Orexin/Hypocretin receptor type 1 Human 13.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315034 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315034&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637778 383541853 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611740 Clc1cnc(NC2CC3CC2N(C3)C(=O)c2ccccc2-c2ncccn2)cn1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 315034 US10183953, Example 215::((1S,4S,6R)-6-((5-chloropyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 215 Orexin receptor type 2 Human 435 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315034 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315034&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637778 383541853 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611741 Fc1cnc(nc1)-c1c(F)cccc1C(=O)N1CC2CC(Nc3cnc(Cl)cn3)C1C2 |TLB:21:20:16.17:30,14:16:20.19:30| InChI=1S/C21H17ClF2N6O/c22-17-8-26-18(9-25-17)29-15-4-11-5-16(15)30(10-11)21(31)13-2-1-3-14(24)19(13)20-27-6-12(23)7-28-20/h1-3,6-9,11,15-16H,4-5,10H2,(H,26,29) SSMCZWIIHVXVQM-UHFFFAOYSA-N 315035 US10183953, Example 216::((1S,4S,6R)-6-((5-chloropyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(5-fluoropyrimidin-2-yl)phenyl)methanone::US9611277, Example 216 Orexin/Hypocretin receptor type 1 Rat 9.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315035 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315035&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637420 383541854 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611742 Fc1cnc(nc1)-c1c(F)cccc1C(=O)N1CC2CC(Nc3cnc(Cl)cn3)C1C2 |TLB:21:20:16.17:30,14:16:20.19:30| InChI=1S/C21H17ClF2N6O/c22-17-8-26-18(9-25-17)29-15-4-11-5-16(15)30(10-11)21(31)13-2-1-3-14(24)19(13)20-27-6-12(23)7-28-20/h1-3,6-9,11,15-16H,4-5,10H2,(H,26,29) SSMCZWIIHVXVQM-UHFFFAOYSA-N 315035 US10183953, Example 216::((1S,4S,6R)-6-((5-chloropyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(5-fluoropyrimidin-2-yl)phenyl)methanone::US9611277, Example 216 Orexin/Hypocretin receptor type 1 Human 9.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315035 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315035&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637420 383541854 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611743 Fc1cnc(nc1)-c1c(F)cccc1C(=O)N1CC2CC(Nc3cnc(Cl)cn3)C1C2 |TLB:21:20:16.17:30,14:16:20.19:30| InChI=1S/C21H17ClF2N6O/c22-17-8-26-18(9-25-17)29-15-4-11-5-16(15)30(10-11)21(31)13-2-1-3-14(24)19(13)20-27-6-12(23)7-28-20/h1-3,6-9,11,15-16H,4-5,10H2,(H,26,29) SSMCZWIIHVXVQM-UHFFFAOYSA-N 315035 US10183953, Example 216::((1S,4S,6R)-6-((5-chloropyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(5-fluoropyrimidin-2-yl)phenyl)methanone::US9611277, Example 216 Orexin receptor type 2 Human 500 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315035 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315035&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637420 383541854 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611744 Cc1cnc(NC2CC3CC2N(C3)C(=O)c2cccc(F)c2-n2nccn2)cn1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 315036 US10183953, Example 217::(3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-methylpyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 217 Orexin/Hypocretin receptor type 1 Rat 12.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315036 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315036&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637421 383541855 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611745 Cc1cnc(NC2CC3CC2N(C3)C(=O)c2cccc(F)c2-n2nccn2)cn1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 315036 US10183953, Example 217::(3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-methylpyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 217 Orexin/Hypocretin receptor type 1 Human 29.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315036 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315036&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637421 383541855 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611746 Cc1cnc(NC2CC3CC2N(C3)C(=O)c2cccc(F)c2-n2nccn2)cn1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 315036 US10183953, Example 217::(3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-methylpyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 217 Orexin receptor type 2 Human 390 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315036 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315036&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637421 383541855 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611747 Cc1cnc(NC2CC3CC2N(C3)C(=O)c2cc(F)ccc2-n2nccn2)cn1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 315037 US10183953, Example 218::(5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-methylpyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 218 Orexin/Hypocretin receptor type 1 Rat 31.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315037 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315037&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637652 383541856 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611748 Cc1cnc(NC2CC3CC2N(C3)C(=O)c2cc(F)ccc2-n2nccn2)cn1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 315037 US10183953, Example 218::(5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-methylpyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 218 Orexin/Hypocretin receptor type 1 Human 49.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315037 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315037&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637652 383541856 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611749 Cc1cnc(NC2CC3CC2N(C3)C(=O)c2cc(F)ccc2-n2nccn2)cn1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 315037 US10183953, Example 218::(5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-methylpyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 218 Orexin receptor type 2 Human 490 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315037 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315037&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637652 383541856 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611750 Cc1cnc(NC2CC3CC2N(C3)C(=O)c2cccc(F)c2-c2ncccn2)cn1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 315038 US10183953, Example 219::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-methylpyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 219 Orexin/Hypocretin receptor type 1 Rat 20.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315038 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315038&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 90452202 383541857 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611751 Cc1cnc(NC2CC3CC2N(C3)C(=O)c2cccc(F)c2-c2ncccn2)cn1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 315038 US10183953, Example 219::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-methylpyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 219 Orexin/Hypocretin receptor type 1 Human 27.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315038 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315038&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 90452202 383541857 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611752 Cc1cnc(NC2CC3CC2N(C3)C(=O)c2cccc(F)c2-c2ncccn2)cn1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 315038 US10183953, Example 219::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-methylpyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 219 Orexin receptor type 2 Human 480 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315038 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315038&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 90452202 383541857 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611753 Cc1cnc(NC2CC3CC2N(C3)C(=O)c2ccccc2-c2ncccn2)cn1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 315039 US10183953, Example 220::((1S,4S,6R)-6-((5-methylpyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 220 Orexin/Hypocretin receptor type 1 Rat 11.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315039 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315039&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637486 383541858 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611754 Cc1cnc(NC2CC3CC2N(C3)C(=O)c2ccccc2-c2ncccn2)cn1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 315039 US10183953, Example 220::((1S,4S,6R)-6-((5-methylpyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 220 Orexin/Hypocretin receptor type 1 Human 17.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315039 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315039&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637486 383541858 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611755 Cc1cnc(NC2CC3CC2N(C3)C(=O)c2ccccc2-c2ncccn2)cn1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 315039 US10183953, Example 220::((1S,4S,6R)-6-((5-methylpyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 220 Orexin receptor type 2 Human 284 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315039 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315039&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637486 383541858 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611756 Cc1cnc(NC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)cn1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 315040 US10183953, Example 221::methyl 5-(((1S,4S,6R)-2-(2-(2H-1,2,3-triazol-2-yl)benzoyl)-2-azabicyclo[2.2.1]heptan-6-yl)amino)pyrazine-2-carboxylate::US9611277, Example 221 Orexin/Hypocretin receptor type 1 Rat 2100 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315040 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315040&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 90452196 383541859 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611757 Cc1cnc(NC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)cn1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 315040 US10183953, Example 221::methyl 5-(((1S,4S,6R)-2-(2-(2H-1,2,3-triazol-2-yl)benzoyl)-2-azabicyclo[2.2.1]heptan-6-yl)amino)pyrazine-2-carboxylate::US9611277, Example 221 Orexin receptor type 2 Human 3000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315040 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315040&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 90452196 383541859 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611758 FC(F)(F)c1cnc(NC2CC3CC2N(C3)C(=O)c2cccnc2-n2nccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315041 US10183953, Example 222::(2-(2H-1,2,3-triazol-2-yl)pyridin-3-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 222 Orexin/Hypocretin receptor type 1 Rat 261 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315041 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315041&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637003 383541860 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611759 FC(F)(F)c1cnc(NC2CC3CC2N(C3)C(=O)c2cccnc2-n2nccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315041 US10183953, Example 222::(2-(2H-1,2,3-triazol-2-yl)pyridin-3-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 222 Orexin receptor type 2 Human >10000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315041 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315041&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637003 383541860 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611760 Fc1cccc(C(=O)N2CC3CC(Nc4ncc(cn4)C(F)(F)F)C2C3)c1-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C20H17F4N7O/c21-14-3-1-2-13(17(14)31-27-4-5-28-31)18(32)30-10-11-6-15(16(30)7-11)29-19-25-8-12(9-26-19)20(22,23)24/h1-5,8-9,11,15-16H,6-7,10H2,(H,25,26,29) FEHKWGGDLFXOPG-UHFFFAOYSA-N 315042 US10183953, Example 223::(3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 223 Orexin/Hypocretin receptor type 1 Rat 11.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315042 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315042&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637658 383541861 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611761 Fc1cccc(C(=O)N2CC3CC(Nc4ncc(cn4)C(F)(F)F)C2C3)c1-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C20H17F4N7O/c21-14-3-1-2-13(17(14)31-27-4-5-28-31)18(32)30-10-11-6-15(16(30)7-11)29-19-25-8-12(9-26-19)20(22,23)24/h1-5,8-9,11,15-16H,6-7,10H2,(H,25,26,29) FEHKWGGDLFXOPG-UHFFFAOYSA-N 315042 US10183953, Example 223::(3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 223 Orexin/Hypocretin receptor type 1 Human 6.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315042 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315042&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637658 383541861 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611762 Fc1cccc(C(=O)N2CC3CC(Nc4ncc(cn4)C(F)(F)F)C2C3)c1-n1nccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C20H17F4N7O/c21-14-3-1-2-13(17(14)31-27-4-5-28-31)18(32)30-10-11-6-15(16(30)7-11)29-19-25-8-12(9-26-19)20(22,23)24/h1-5,8-9,11,15-16H,6-7,10H2,(H,25,26,29) FEHKWGGDLFXOPG-UHFFFAOYSA-N 315042 US10183953, Example 223::(3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 223 Orexin receptor type 2 Human 619 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315042 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315042&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637658 383541861 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611763 Fc1ccc(C(=O)N2CC3CC(Nc4ncc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C20H17F4N7O/c21-13-1-2-14(16(7-13)31-27-3-4-28-31)18(32)30-10-11-5-15(17(30)6-11)29-19-25-8-12(9-26-19)20(22,23)24/h1-4,7-9,11,15,17H,5-6,10H2,(H,25,26,29) JUPUVZVBPVXPRH-UHFFFAOYSA-N 315043 US10183953, Example 224::(4-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 224 Orexin/Hypocretin receptor type 1 Rat 37.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315043 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315043&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637606 383541862 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611764 Fc1ccc(C(=O)N2CC3CC(Nc4ncc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C20H17F4N7O/c21-13-1-2-14(16(7-13)31-27-3-4-28-31)18(32)30-10-11-5-15(17(30)6-11)29-19-25-8-12(9-26-19)20(22,23)24/h1-4,7-9,11,15,17H,5-6,10H2,(H,25,26,29) JUPUVZVBPVXPRH-UHFFFAOYSA-N 315043 US10183953, Example 224::(4-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 224 Orexin/Hypocretin receptor type 1 Human 33.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315043 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315043&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637606 383541862 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611765 Fc1ccc(C(=O)N2CC3CC(Nc4ncc(cn4)C(F)(F)F)C2C3)c(c1)-n1nccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C20H17F4N7O/c21-13-1-2-14(16(7-13)31-27-3-4-28-31)18(32)30-10-11-5-15(17(30)6-11)29-19-25-8-12(9-26-19)20(22,23)24/h1-4,7-9,11,15,17H,5-6,10H2,(H,25,26,29) JUPUVZVBPVXPRH-UHFFFAOYSA-N 315043 US10183953, Example 224::(4-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 224 Orexin receptor type 2 Human 1900 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315043 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315043&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637606 383541862 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611766 Fc1ccc(c(c1)C(=O)N1CC2CC(Nc3ncc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C20H17F4N7O/c21-13-1-2-16(31-27-3-4-28-31)14(7-13)18(32)30-10-11-5-15(17(30)6-11)29-19-25-8-12(9-26-19)20(22,23)24/h1-4,7-9,11,15,17H,5-6,10H2,(H,25,26,29) MYQUUCSKQSIWLS-UHFFFAOYSA-N 315044 US10183953, Example 225::(5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 225 Orexin/Hypocretin receptor type 1 Rat 20.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315044 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315044&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637684 383541863 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611767 Fc1ccc(c(c1)C(=O)N1CC2CC(Nc3ncc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C20H17F4N7O/c21-13-1-2-16(31-27-3-4-28-31)14(7-13)18(32)30-10-11-5-15(17(30)6-11)29-19-25-8-12(9-26-19)20(22,23)24/h1-4,7-9,11,15,17H,5-6,10H2,(H,25,26,29) MYQUUCSKQSIWLS-UHFFFAOYSA-N 315044 US10183953, Example 225::(5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 225 Orexin/Hypocretin receptor type 1 Human 16.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315044 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315044&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637684 383541863 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611768 Fc1ccc(c(c1)C(=O)N1CC2CC(Nc3ncc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C20H17F4N7O/c21-13-1-2-16(31-27-3-4-28-31)14(7-13)18(32)30-10-11-5-15(17(30)6-11)29-19-25-8-12(9-26-19)20(22,23)24/h1-4,7-9,11,15,17H,5-6,10H2,(H,25,26,29) MYQUUCSKQSIWLS-UHFFFAOYSA-N 315044 US10183953, Example 225::(5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 225 Orexin receptor type 2 Human 800 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315044 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315044&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637684 383541863 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611769 Fc1cccc(c1C(=O)N1CC2CC(Nc3ncc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C20H17F4N7O/c21-13-2-1-3-15(31-27-4-5-28-31)17(13)18(32)30-10-11-6-14(16(30)7-11)29-19-25-8-12(9-26-19)20(22,23)24/h1-5,8-9,11,14,16H,6-7,10H2,(H,25,26,29) YIKVBNMFYWSYAV-UHFFFAOYSA-N 315045 US10183953, Example 226::(2-fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 226 Orexin/Hypocretin receptor type 1 Rat 17.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315045 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315045&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637487 383541864 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611770 Fc1cccc(c1C(=O)N1CC2CC(Nc3ncc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C20H17F4N7O/c21-13-2-1-3-15(31-27-4-5-28-31)17(13)18(32)30-10-11-6-14(16(30)7-11)29-19-25-8-12(9-26-19)20(22,23)24/h1-5,8-9,11,14,16H,6-7,10H2,(H,25,26,29) YIKVBNMFYWSYAV-UHFFFAOYSA-N 315045 US10183953, Example 226::(2-fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 226 Orexin/Hypocretin receptor type 1 Human 19.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315045 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315045&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637487 383541864 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611771 Fc1cccc(c1C(=O)N1CC2CC(Nc3ncc(cn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C20H17F4N7O/c21-13-2-1-3-15(31-27-4-5-28-31)17(13)18(32)30-10-11-6-14(16(30)7-11)29-19-25-8-12(9-26-19)20(22,23)24/h1-5,8-9,11,14,16H,6-7,10H2,(H,25,26,29) YIKVBNMFYWSYAV-UHFFFAOYSA-N 315045 US10183953, Example 226::(2-fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 226 Orexin receptor type 2 Human 874 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315045 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315045&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637487 383541864 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611772 Fc1ccc(C(=O)N2CC3CC(Nc4cnc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C22H18F4N6O/c23-13-2-3-14(15(8-13)20-27-4-1-5-28-20)21(33)32-11-12-6-16(17(32)7-12)31-19-10-29-18(9-30-19)22(24,25)26/h1-5,8-10,12,16-17H,6-7,11H2,(H,30,31) XYPNUYVAPPRDPP-UHFFFAOYSA-N 315017 (4-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 227::US10183953, Example 198::US9611277, Example 198 Orexin/Hypocretin receptor type 1 Rat 12.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315017 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315017&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637417 383541836 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611773 Fc1ccc(C(=O)N2CC3CC(Nc4cnc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C22H18F4N6O/c23-13-2-3-14(15(8-13)20-27-4-1-5-28-20)21(33)32-11-12-6-16(17(32)7-12)31-19-10-29-18(9-30-19)22(24,25)26/h1-5,8-10,12,16-17H,6-7,11H2,(H,30,31) XYPNUYVAPPRDPP-UHFFFAOYSA-N 315017 (4-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 227::US10183953, Example 198::US9611277, Example 198 Orexin/Hypocretin receptor type 1 Human 13.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315017 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315017&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637417 383541836 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611774 Fc1ccc(C(=O)N2CC3CC(Nc4cnc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C22H18F4N6O/c23-13-2-3-14(15(8-13)20-27-4-1-5-28-20)21(33)32-11-12-6-16(17(32)7-12)31-19-10-29-18(9-30-19)22(24,25)26/h1-5,8-10,12,16-17H,6-7,11H2,(H,30,31) XYPNUYVAPPRDPP-UHFFFAOYSA-N 315017 (4-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 227::US10183953, Example 198::US9611277, Example 198 Orexin receptor type 2 Human 3100 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315017 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315017&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637417 383541836 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611775 Fc1ccc(-c2ncccn2)c(c1)C(=O)N1CC2CC(Nc3ncc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C22H18F4N6O/c23-14-2-3-15(19-27-4-1-5-28-19)16(8-14)20(33)32-11-12-6-17(18(32)7-12)31-21-29-9-13(10-30-21)22(24,25)26/h1-5,8-10,12,17-18H,6-7,11H2,(H,29,30,31) CYFAFDVISGNXDC-UHFFFAOYSA-N 315047 US10183953, Example 228::(5-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 228 Orexin/Hypocretin receptor type 1 Rat 11.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315047 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315047&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637027 383541865 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611776 Fc1ccc(-c2ncccn2)c(c1)C(=O)N1CC2CC(Nc3ncc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C22H18F4N6O/c23-14-2-3-15(19-27-4-1-5-28-19)16(8-14)20(33)32-11-12-6-17(18(32)7-12)31-21-29-9-13(10-30-21)22(24,25)26/h1-5,8-10,12,17-18H,6-7,11H2,(H,29,30,31) CYFAFDVISGNXDC-UHFFFAOYSA-N 315047 US10183953, Example 228::(5-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 228 Orexin/Hypocretin receptor type 1 Human 9.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315047 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315047&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637027 383541865 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611777 Fc1ccc(-c2ncccn2)c(c1)C(=O)N1CC2CC(Nc3ncc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C22H18F4N6O/c23-14-2-3-15(19-27-4-1-5-28-19)16(8-14)20(33)32-11-12-6-17(18(32)7-12)31-21-29-9-13(10-30-21)22(24,25)26/h1-5,8-10,12,17-18H,6-7,11H2,(H,29,30,31) CYFAFDVISGNXDC-UHFFFAOYSA-N 315047 US10183953, Example 228::(5-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 228 Orexin receptor type 2 Human 544 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315047 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315047&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637027 383541865 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611778 Fc1cccc(-c2ncccn2)c1C(=O)N1CC2CC(Nc3ncc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C22H18F4N6O/c23-15-4-1-3-14(19-27-5-2-6-28-19)18(15)20(33)32-11-12-7-16(17(32)8-12)31-21-29-9-13(10-30-21)22(24,25)26/h1-6,9-10,12,16-17H,7-8,11H2,(H,29,30,31) FMQHXPFWYUHTFI-UHFFFAOYSA-N 315048 US10183953, Example 229::(2-fluoro-6-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 229 Orexin/Hypocretin receptor type 1 Rat 9.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315048 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315048&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637636 383541866 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611779 Fc1cccc(-c2ncccn2)c1C(=O)N1CC2CC(Nc3ncc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C22H18F4N6O/c23-15-4-1-3-14(19-27-5-2-6-28-19)18(15)20(33)32-11-12-7-16(17(32)8-12)31-21-29-9-13(10-30-21)22(24,25)26/h1-6,9-10,12,16-17H,7-8,11H2,(H,29,30,31) FMQHXPFWYUHTFI-UHFFFAOYSA-N 315048 US10183953, Example 229::(2-fluoro-6-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 229 Orexin/Hypocretin receptor type 1 Human 11.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315048 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315048&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637636 383541866 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611780 Fc1cccc(-c2ncccn2)c1C(=O)N1CC2CC(Nc3ncc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C22H18F4N6O/c23-15-4-1-3-14(19-27-5-2-6-28-19)18(15)20(33)32-11-12-7-16(17(32)8-12)31-21-29-9-13(10-30-21)22(24,25)26/h1-6,9-10,12,16-17H,7-8,11H2,(H,29,30,31) FMQHXPFWYUHTFI-UHFFFAOYSA-N 315048 US10183953, Example 229::(2-fluoro-6-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 229 Orexin receptor type 2 Human 724 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315048 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315048&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637636 383541866 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611781 FC(F)(F)c1cnc(NC2CC3CC2N(C3)C(=O)c2ccccc2-c2ncccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315049 US10183953, Example 230::(2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 230 Orexin/Hypocretin receptor type 1 Rat 4.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315049 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315049&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637875 383541867 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611782 FC(F)(F)c1cnc(NC2CC3CC2N(C3)C(=O)c2ccccc2-c2ncccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315049 US10183953, Example 230::(2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 230 Orexin/Hypocretin receptor type 1 Human 4.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315049 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315049&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637875 383541867 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611783 FC(F)(F)c1cnc(NC2CC3CC2N(C3)C(=O)c2ccccc2-c2ncccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315049 US10183953, Example 230::(2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 230 Orexin receptor type 2 Human 470 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315049 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315049&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637875 383541867 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611784 Fc1cnc(nc1)-c1ccccc1C(=O)N1CC2CC(Nc3ncc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C22H18F4N6O/c23-14-9-27-19(28-10-14)15-3-1-2-4-16(15)20(33)32-11-12-5-17(18(32)6-12)31-21-29-7-13(8-30-21)22(24,25)26/h1-4,7-10,12,17-18H,5-6,11H2,(H,29,30,31) OPAGHPHGZOYGCG-UHFFFAOYSA-N 315050 US10183953, Example 231::(2-(5-fluoropyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 231 Orexin/Hypocretin receptor type 1 Rat 9.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315050 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315050&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637787 383541868 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611785 Fc1cnc(nc1)-c1ccccc1C(=O)N1CC2CC(Nc3ncc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C22H18F4N6O/c23-14-9-27-19(28-10-14)15-3-1-2-4-16(15)20(33)32-11-12-5-17(18(32)6-12)31-21-29-7-13(8-30-21)22(24,25)26/h1-4,7-10,12,17-18H,5-6,11H2,(H,29,30,31) OPAGHPHGZOYGCG-UHFFFAOYSA-N 315050 US10183953, Example 231::(2-(5-fluoropyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 231 Orexin/Hypocretin receptor type 1 Human 12.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315050 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315050&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637787 383541868 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611786 Fc1cnc(nc1)-c1ccccc1C(=O)N1CC2CC(Nc3ncc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C22H18F4N6O/c23-14-9-27-19(28-10-14)15-3-1-2-4-16(15)20(33)32-11-12-5-17(18(32)6-12)31-21-29-7-13(8-30-21)22(24,25)26/h1-4,7-10,12,17-18H,5-6,11H2,(H,29,30,31) OPAGHPHGZOYGCG-UHFFFAOYSA-N 315050 US10183953, Example 231::(2-(5-fluoropyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 231 Orexin receptor type 2 Human 1300 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315050 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315050&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637787 383541868 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611787 Fc1cccc(-c2ncco2)c1C(=O)N1CC2CC(Nc3ncc(cn3)C(F)(F)F)C1C2 |TLB:19:18:14.15:31,12:14:18.17:31| InChI=1S/C21H17F4N5O2/c22-14-3-1-2-13(18-26-4-5-32-18)17(14)19(31)30-10-11-6-15(16(30)7-11)29-20-27-8-12(9-28-20)21(23,24)25/h1-5,8-9,11,15-16H,6-7,10H2,(H,27,28,29) JBKVBYLQXQCZGK-UHFFFAOYSA-N 315051 US10183953, Example 232::(2-fluoro-6-(oxazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 232 Orexin/Hypocretin receptor type 1 Rat 24.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315051 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315051&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637488 383541869 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611788 Fc1cccc(-c2ncco2)c1C(=O)N1CC2CC(Nc3ncc(cn3)C(F)(F)F)C1C2 |TLB:19:18:14.15:31,12:14:18.17:31| InChI=1S/C21H17F4N5O2/c22-14-3-1-2-13(18-26-4-5-32-18)17(14)19(31)30-10-11-6-15(16(30)7-11)29-20-27-8-12(9-28-20)21(23,24)25/h1-5,8-9,11,15-16H,6-7,10H2,(H,27,28,29) JBKVBYLQXQCZGK-UHFFFAOYSA-N 315051 US10183953, Example 232::(2-fluoro-6-(oxazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 232 Orexin/Hypocretin receptor type 1 Human 25.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315051 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315051&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637488 383541869 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611789 Fc1cccc(-c2ncco2)c1C(=O)N1CC2CC(Nc3ncc(cn3)C(F)(F)F)C1C2 |TLB:19:18:14.15:31,12:14:18.17:31| InChI=1S/C21H17F4N5O2/c22-14-3-1-2-13(18-26-4-5-32-18)17(14)19(31)30-10-11-6-15(16(30)7-11)29-20-27-8-12(9-28-20)21(23,24)25/h1-5,8-9,11,15-16H,6-7,10H2,(H,27,28,29) JBKVBYLQXQCZGK-UHFFFAOYSA-N 315051 US10183953, Example 232::(2-fluoro-6-(oxazol-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 232 Orexin receptor type 2 Human 1352 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315051 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315051&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637488 383541869 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611790 CCOc1ccc(C)nc1C(=O)N1CC2CC(Nc3ncc(cn3)C(F)(F)F)C1C2 |TLB:17:16:12.13:29,10:12:16.15:29| InChI=1S/C20H22F3N5O2/c1-3-30-16-5-4-11(2)26-17(16)18(29)28-10-12-6-14(15(28)7-12)27-19-24-8-13(9-25-19)20(21,22)23/h4-5,8-9,12,14-15H,3,6-7,10H2,1-2H3,(H,24,25,27) VBIGBXMZFFCHHN-UHFFFAOYSA-N 315052 US10183953, Example 233::(3-ethoxy-6-methylpyridin-2-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 233 Orexin/Hypocretin receptor type 1 Rat 280 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315052 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315052&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637662 383541870 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611791 CCOc1ccc(C)nc1C(=O)N1CC2CC(Nc3ncc(cn3)C(F)(F)F)C1C2 |TLB:17:16:12.13:29,10:12:16.15:29| InChI=1S/C20H22F3N5O2/c1-3-30-16-5-4-11(2)26-17(16)18(29)28-10-12-6-14(15(28)7-12)27-19-24-8-13(9-25-19)20(21,22)23/h4-5,8-9,12,14-15H,3,6-7,10H2,1-2H3,(H,24,25,27) VBIGBXMZFFCHHN-UHFFFAOYSA-N 315052 US10183953, Example 233::(3-ethoxy-6-methylpyridin-2-yl)((1S,4S,6R)-6-((5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 233 Orexin receptor type 2 Human 1100 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315052 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315052&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637662 383541870 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611792 Fc1cccc(C(=O)N2CC3CC(Nc4ncc(Cl)cn4)C2C3)c1-n1nccn1 |TLB:13:12:8.9:22,6:8:12.11:22| InChI=1S/C19H17ClFN7O/c20-12-8-22-19(23-9-12)26-15-6-11-7-16(15)27(10-11)18(29)13-2-1-3-14(21)17(13)28-24-4-5-25-28/h1-5,8-9,11,15-16H,6-7,10H2,(H,22,23,26) ICNXAMJXGBVNKI-UHFFFAOYSA-N 315053 US10183953, Example 234::((1S,4S,6R)-6-((5-chloropyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone::US9611277, Example 234 Orexin/Hypocretin receptor type 1 Rat 17.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315053 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315053&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637422 383541871 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611793 Fc1cccc(C(=O)N2CC3CC(Nc4ncc(Cl)cn4)C2C3)c1-n1nccn1 |TLB:13:12:8.9:22,6:8:12.11:22| InChI=1S/C19H17ClFN7O/c20-12-8-22-19(23-9-12)26-15-6-11-7-16(15)27(10-11)18(29)13-2-1-3-14(21)17(13)28-24-4-5-25-28/h1-5,8-9,11,15-16H,6-7,10H2,(H,22,23,26) ICNXAMJXGBVNKI-UHFFFAOYSA-N 315053 US10183953, Example 234::((1S,4S,6R)-6-((5-chloropyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone::US9611277, Example 234 Orexin/Hypocretin receptor type 1 Human 12.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315053 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315053&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637422 383541871 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611794 Fc1cccc(C(=O)N2CC3CC(Nc4ncc(Cl)cn4)C2C3)c1-n1nccn1 |TLB:13:12:8.9:22,6:8:12.11:22| InChI=1S/C19H17ClFN7O/c20-12-8-22-19(23-9-12)26-15-6-11-7-16(15)27(10-11)18(29)13-2-1-3-14(21)17(13)28-24-4-5-25-28/h1-5,8-9,11,15-16H,6-7,10H2,(H,22,23,26) ICNXAMJXGBVNKI-UHFFFAOYSA-N 315053 US10183953, Example 234::((1S,4S,6R)-6-((5-chloropyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone::US9611277, Example 234 Orexin receptor type 2 Human 827 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315053 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315053&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637422 383541871 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611795 Fc1ccc(c(c1)C(=O)N1CC2CC(Nc3ncc(Cl)cn3)C1C2)-n1nccn1 |TLB:14:13:9.10:23,7:9:13.12:23| InChI=1S/C19H17ClFN7O/c20-12-8-22-19(23-9-12)26-15-5-11-6-17(15)27(10-11)18(29)14-7-13(21)1-2-16(14)28-24-3-4-25-28/h1-4,7-9,11,15,17H,5-6,10H2,(H,22,23,26) QIVUNYIDXNJLLQ-UHFFFAOYSA-N 315054 US10183953, Example 235::((1S,4S,6R)-6-((5-chloropyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone::US9611277, Example 235 Orexin/Hypocretin receptor type 1 Rat 36.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315054 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315054&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637423 383541872 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611796 Fc1ccc(c(c1)C(=O)N1CC2CC(Nc3ncc(Cl)cn3)C1C2)-n1nccn1 |TLB:14:13:9.10:23,7:9:13.12:23| InChI=1S/C19H17ClFN7O/c20-12-8-22-19(23-9-12)26-15-5-11-6-17(15)27(10-11)18(29)14-7-13(21)1-2-16(14)28-24-3-4-25-28/h1-4,7-9,11,15,17H,5-6,10H2,(H,22,23,26) QIVUNYIDXNJLLQ-UHFFFAOYSA-N 315054 US10183953, Example 235::((1S,4S,6R)-6-((5-chloropyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone::US9611277, Example 235 Orexin/Hypocretin receptor type 1 Human 41.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315054 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315054&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637423 383541872 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611797 Fc1ccc(c(c1)C(=O)N1CC2CC(Nc3ncc(Cl)cn3)C1C2)-n1nccn1 |TLB:14:13:9.10:23,7:9:13.12:23| InChI=1S/C19H17ClFN7O/c20-12-8-22-19(23-9-12)26-15-5-11-6-17(15)27(10-11)18(29)14-7-13(21)1-2-16(14)28-24-3-4-25-28/h1-4,7-9,11,15,17H,5-6,10H2,(H,22,23,26) QIVUNYIDXNJLLQ-UHFFFAOYSA-N 315054 US10183953, Example 235::((1S,4S,6R)-6-((5-chloropyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone::US9611277, Example 235 Orexin receptor type 2 Human 1300 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315054 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315054&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637423 383541872 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611798 Fc1cccc(C(=O)N2CC3CC(Nc4ncc(Cl)cn4)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:22,6:8:12.11:22| InChI=1S/C21H18ClFN6O/c22-13-9-26-21(27-10-13)28-16-7-12-8-17(16)29(11-12)20(30)14-3-1-4-15(23)18(14)19-24-5-2-6-25-19/h1-6,9-10,12,16-17H,7-8,11H2,(H,26,27,28) LDUPXGSSMPJWFT-UHFFFAOYSA-N 315055 US10183953, Example 236::((1S,4S,6R)-6-((5-chloropyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 236 Orexin/Hypocretin receptor type 1 Rat 10.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315055 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315055&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637785 383541873 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611799 Fc1cccc(C(=O)N2CC3CC(Nc4ncc(Cl)cn4)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:22,6:8:12.11:22| InChI=1S/C21H18ClFN6O/c22-13-9-26-21(27-10-13)28-16-7-12-8-17(16)29(11-12)20(30)14-3-1-4-15(23)18(14)19-24-5-2-6-25-19/h1-6,9-10,12,16-17H,7-8,11H2,(H,26,27,28) LDUPXGSSMPJWFT-UHFFFAOYSA-N 315055 US10183953, Example 236::((1S,4S,6R)-6-((5-chloropyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 236 Orexin/Hypocretin receptor type 1 Human 9.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315055 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315055&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637785 383541873 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611800 Fc1cccc(C(=O)N2CC3CC(Nc4ncc(Cl)cn4)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:22,6:8:12.11:22| InChI=1S/C21H18ClFN6O/c22-13-9-26-21(27-10-13)28-16-7-12-8-17(16)29(11-12)20(30)14-3-1-4-15(23)18(14)19-24-5-2-6-25-19/h1-6,9-10,12,16-17H,7-8,11H2,(H,26,27,28) LDUPXGSSMPJWFT-UHFFFAOYSA-N 315055 US10183953, Example 236::((1S,4S,6R)-6-((5-chloropyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 236 Orexin receptor type 2 Human 1020 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315055 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315055&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637785 383541873 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611801 Fc1ccc(C(=O)N2CC3CC(Nc4ncc(Cl)cn4)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:21,5:7:11.10:21| InChI=1S/C21H18ClFN6O/c22-13-9-26-21(27-10-13)28-17-6-12-7-18(17)29(11-12)20(30)15-3-2-14(23)8-16(15)19-24-4-1-5-25-19/h1-5,8-10,12,17-18H,6-7,11H2,(H,26,27,28) YHMXIJSFCKICMR-UHFFFAOYSA-N 315056 US10183953, Example 237::((1S,4S,6R)-6-((5-chloropyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(4-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 237 Orexin/Hypocretin receptor type 1 Rat 32.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315056 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315056&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637663 383541874 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611802 Fc1ccc(C(=O)N2CC3CC(Nc4ncc(Cl)cn4)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:21,5:7:11.10:21| InChI=1S/C21H18ClFN6O/c22-13-9-26-21(27-10-13)28-17-6-12-7-18(17)29(11-12)20(30)15-3-2-14(23)8-16(15)19-24-4-1-5-25-19/h1-5,8-10,12,17-18H,6-7,11H2,(H,26,27,28) YHMXIJSFCKICMR-UHFFFAOYSA-N 315056 US10183953, Example 237::((1S,4S,6R)-6-((5-chloropyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(4-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 237 Orexin/Hypocretin receptor type 1 Human 13.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315056 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315056&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637663 383541874 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611803 Fc1ccc(C(=O)N2CC3CC(Nc4ncc(Cl)cn4)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:21,5:7:11.10:21| InChI=1S/C21H18ClFN6O/c22-13-9-26-21(27-10-13)28-17-6-12-7-18(17)29(11-12)20(30)15-3-2-14(23)8-16(15)19-24-4-1-5-25-19/h1-5,8-10,12,17-18H,6-7,11H2,(H,26,27,28) YHMXIJSFCKICMR-UHFFFAOYSA-N 315056 US10183953, Example 237::((1S,4S,6R)-6-((5-chloropyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(4-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 237 Orexin receptor type 2 Human 1900 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315056 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315056&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637663 383541874 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611804 CN(C1CC2CC1N(C2)C(=O)c1cc(F)ccc1-c1ncccn1)c1ncc(Cl)cn1 |TLB:1:2:7.8:5,THB:9:7:2.3:5| 315057 US10183953, Example 238::((1S,4S,6R)-6-((5-chloropyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(5-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 238 Orexin/Hypocretin receptor type 1 Rat 20.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315057 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315057&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637990 383541875 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611805 CN(C1CC2CC1N(C2)C(=O)c1cc(F)ccc1-c1ncccn1)c1ncc(Cl)cn1 |TLB:1:2:7.8:5,THB:9:7:2.3:5| 315057 US10183953, Example 238::((1S,4S,6R)-6-((5-chloropyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(5-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 238 Orexin/Hypocretin receptor type 1 Human 8.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315057 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315057&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637990 383541875 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611806 CN(C1CC2CC1N(C2)C(=O)c1cc(F)ccc1-c1ncccn1)c1ncc(Cl)cn1 |TLB:1:2:7.8:5,THB:9:7:2.3:5| 315057 US10183953, Example 238::((1S,4S,6R)-6-((5-chloropyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(5-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 238 Orexin receptor type 2 Human 991 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315057 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315057&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637990 383541875 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611807 Fc1cccc(-c2ncccn2)c1C(=O)N1CC2CC(Nc3ncc(Cl)cn3)C1C2 |TLB:20:19:15.16:29,13:15:19.18:29| InChI=1S/C21H18ClFN6O/c22-13-9-26-21(27-10-13)28-16-7-12-8-17(16)29(11-12)20(30)18-14(3-1-4-15(18)23)19-24-5-2-6-25-19/h1-6,9-10,12,16-17H,7-8,11H2,(H,26,27,28) ISLKYUABZVUDCV-UHFFFAOYSA-N 315058 US10183953, Example 239::((1S,4S,6R)-6-((5-chloropyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(2-fluoro-6-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 239 Orexin/Hypocretin receptor type 1 Rat 23.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315058 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315058&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637669 383541876 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611808 Fc1cccc(-c2ncccn2)c1C(=O)N1CC2CC(Nc3ncc(Cl)cn3)C1C2 |TLB:20:19:15.16:29,13:15:19.18:29| InChI=1S/C21H18ClFN6O/c22-13-9-26-21(27-10-13)28-16-7-12-8-17(16)29(11-12)20(30)18-14(3-1-4-15(18)23)19-24-5-2-6-25-19/h1-6,9-10,12,16-17H,7-8,11H2,(H,26,27,28) ISLKYUABZVUDCV-UHFFFAOYSA-N 315058 US10183953, Example 239::((1S,4S,6R)-6-((5-chloropyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(2-fluoro-6-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 239 Orexin/Hypocretin receptor type 1 Human 41.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315058 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315058&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637669 383541876 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611809 Fc1cccc(-c2ncccn2)c1C(=O)N1CC2CC(Nc3ncc(Cl)cn3)C1C2 |TLB:20:19:15.16:29,13:15:19.18:29| InChI=1S/C21H18ClFN6O/c22-13-9-26-21(27-10-13)28-16-7-12-8-17(16)29(11-12)20(30)18-14(3-1-4-15(18)23)19-24-5-2-6-25-19/h1-6,9-10,12,16-17H,7-8,11H2,(H,26,27,28) ISLKYUABZVUDCV-UHFFFAOYSA-N 315058 US10183953, Example 239::((1S,4S,6R)-6-((5-chloropyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(2-fluoro-6-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 239 Orexin receptor type 2 Human 726 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315058 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315058&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637669 383541876 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611810 Clc1cnc(NC2CC3CC2N(C3)C(=O)c2ccccc2-c2ncccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 315059 US10183953, Example 240::((1S,4S,6R)-6-((5-chloropyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 240 Orexin/Hypocretin receptor type 1 Rat 17.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315059 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315059&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637428 383541877 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611811 Clc1cnc(NC2CC3CC2N(C3)C(=O)c2ccccc2-c2ncccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 315059 US10183953, Example 240::((1S,4S,6R)-6-((5-chloropyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 240 Orexin/Hypocretin receptor type 1 Human 12.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315059 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315059&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637428 383541877 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611812 Clc1cnc(NC2CC3CC2N(C3)C(=O)c2ccccc2-c2ncccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 315059 US10183953, Example 240::((1S,4S,6R)-6-((5-chloropyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 240 Orexin receptor type 2 Human 831 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315059 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315059&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637428 383541877 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611813 CN(C1CC2CC1N(C2)C(=O)c1ccccc1-c1ncc(F)cn1)c1ncc(Cl)cn1 |TLB:1:2:7.8:5,THB:9:7:2.3:5| 315060 US10183953, Example 241::((1S,4S,6R)-6-((5-chloropyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(2-(5-fluoropyrimidin-2-yl)phenyl)methanone::US9611277, Example 241 Orexin/Hypocretin receptor type 1 Rat 21.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315060 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315060&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637991 383541878 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611814 CN(C1CC2CC1N(C2)C(=O)c1ccccc1-c1ncc(F)cn1)c1ncc(Cl)cn1 |TLB:1:2:7.8:5,THB:9:7:2.3:5| 315060 US10183953, Example 241::((1S,4S,6R)-6-((5-chloropyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(2-(5-fluoropyrimidin-2-yl)phenyl)methanone::US9611277, Example 241 Orexin/Hypocretin receptor type 1 Human 12.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315060 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315060&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637991 383541878 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611815 CN(C1CC2CC1N(C2)C(=O)c1ccccc1-c1ncc(F)cn1)c1ncc(Cl)cn1 |TLB:1:2:7.8:5,THB:9:7:2.3:5| 315060 US10183953, Example 241::((1S,4S,6R)-6-((5-chloropyrimidin-2-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)(2-(5-fluoropyrimidin-2-yl)phenyl)methanone::US9611277, Example 241 Orexin receptor type 2 Human 971 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315060 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315060&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637991 383541878 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611816 FC(F)(F)c1ccc(NC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315061 US10183953, Example 242::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((6-(trifluoromethyl)pyridazin-3-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 242 Orexin/Hypocretin receptor type 1 Rat 89.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315061 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315061&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637797 383541879 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611817 FC(F)(F)c1ccc(NC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315061 US10183953, Example 242::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((6-(trifluoromethyl)pyridazin-3-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 242 Orexin/Hypocretin receptor type 1 Human 113 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315061 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315061&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637797 383541879 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611818 FC(F)(F)c1ccc(NC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315061 US10183953, Example 242::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((6-(trifluoromethyl)pyridazin-3-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 242 Orexin receptor type 2 Human 2100 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315061 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315061&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637797 383541879 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611819 Cc1ccc(c(n1)C(=O)N1CC2CC(Nc3ccc(nn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C20H19F3N8O/c1-11-2-3-14(31-24-6-7-25-31)18(26-11)19(32)30-10-12-8-13(15(30)9-12)27-17-5-4-16(28-29-17)20(21,22)23/h2-7,12-13,15H,8-10H2,1H3,(H,27,29) GICZBPIOKMBLJO-UHFFFAOYSA-N 315062 US10183953, Example 243::(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)((1S,4S,6R)-6-((6-(trifluoromethyl)pyridazin-3-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 243 Orexin/Hypocretin receptor type 1 Rat 112 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315062 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315062&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637628 383541880 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611820 Cc1ccc(c(n1)C(=O)N1CC2CC(Nc3ccc(nn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C20H19F3N8O/c1-11-2-3-14(31-24-6-7-25-31)18(26-11)19(32)30-10-12-8-13(15(30)9-12)27-17-5-4-16(28-29-17)20(21,22)23/h2-7,12-13,15H,8-10H2,1H3,(H,27,29) GICZBPIOKMBLJO-UHFFFAOYSA-N 315062 US10183953, Example 243::(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)((1S,4S,6R)-6-((6-(trifluoromethyl)pyridazin-3-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 243 Orexin/Hypocretin receptor type 1 Human 131 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315062 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315062&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637628 383541880 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611821 Cc1ccc(c(n1)C(=O)N1CC2CC(Nc3ccc(nn3)C(F)(F)F)C1C2)-n1nccn1 |TLB:14:13:9.10:26,7:9:13.12:26| InChI=1S/C20H19F3N8O/c1-11-2-3-14(31-24-6-7-25-31)18(26-11)19(32)30-10-12-8-13(15(30)9-12)27-17-5-4-16(28-29-17)20(21,22)23/h2-7,12-13,15H,8-10H2,1H3,(H,27,29) GICZBPIOKMBLJO-UHFFFAOYSA-N 315062 US10183953, Example 243::(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)((1S,4S,6R)-6-((6-(trifluoromethyl)pyridazin-3-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 243 Orexin receptor type 2 Human 1800 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315062 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315062&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637628 383541880 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611822 Cc1ccc(-c2ncccn2)c(n1)C(=O)N1CC2CC(Nc3ccc(nn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C22H20F3N7O/c1-12-3-4-14(20-26-7-2-8-27-20)19(28-12)21(33)32-11-13-9-15(16(32)10-13)29-18-6-5-17(30-31-18)22(23,24)25/h2-8,13,15-16H,9-11H2,1H3,(H,29,31) ONEFDKAQBPZMAW-UHFFFAOYSA-N 315063 US10183953, Example 244::(6-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4S,6R)-6-((6-(trifluoromethyl)pyridazin-3-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 244 Orexin/Hypocretin receptor type 1 Rat 114 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315063 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315063&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637650 383541881 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611823 Cc1ccc(-c2ncccn2)c(n1)C(=O)N1CC2CC(Nc3ccc(nn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C22H20F3N7O/c1-12-3-4-14(20-26-7-2-8-27-20)19(28-12)21(33)32-11-13-9-15(16(32)10-13)29-18-6-5-17(30-31-18)22(23,24)25/h2-8,13,15-16H,9-11H2,1H3,(H,29,31) ONEFDKAQBPZMAW-UHFFFAOYSA-N 315063 US10183953, Example 244::(6-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4S,6R)-6-((6-(trifluoromethyl)pyridazin-3-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 244 Orexin/Hypocretin receptor type 1 Human 143 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315063 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315063&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637650 383541881 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611824 Cc1ccc(-c2ncccn2)c(n1)C(=O)N1CC2CC(Nc3ccc(nn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C22H20F3N7O/c1-12-3-4-14(20-26-7-2-8-27-20)19(28-12)21(33)32-11-13-9-15(16(32)10-13)29-18-6-5-17(30-31-18)22(23,24)25/h2-8,13,15-16H,9-11H2,1H3,(H,29,31) ONEFDKAQBPZMAW-UHFFFAOYSA-N 315063 US10183953, Example 244::(6-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4S,6R)-6-((6-(trifluoromethyl)pyridazin-3-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 244 Orexin receptor type 2 Human 1700 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315063 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315063&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637650 383541881 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611825 Fc1cccc(C(=O)N2CC3CC(Nc4ccc(nn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C22H18F4N6O/c23-14-4-1-3-13(19(14)20-27-7-2-8-28-20)21(33)32-11-12-9-15(16(32)10-12)29-18-6-5-17(30-31-18)22(24,25)26/h1-8,12,15-16H,9-11H2,(H,29,31) MPKQYFFBTXDIDP-UHFFFAOYSA-N 315064 US10183953, Example 245::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((6-(trifluoromethyl)pyridazin-3-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 245 Orexin/Hypocretin receptor type 1 Rat 65.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315064 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315064&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637637 383541882 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611826 Fc1cccc(C(=O)N2CC3CC(Nc4ccc(nn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C22H18F4N6O/c23-14-4-1-3-13(19(14)20-27-7-2-8-28-20)21(33)32-11-12-9-15(16(32)10-12)29-18-6-5-17(30-31-18)22(24,25)26/h1-8,12,15-16H,9-11H2,(H,29,31) MPKQYFFBTXDIDP-UHFFFAOYSA-N 315064 US10183953, Example 245::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((6-(trifluoromethyl)pyridazin-3-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 245 Orexin/Hypocretin receptor type 1 Human 53.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315064 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315064&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637637 383541882 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611827 Fc1cccc(C(=O)N2CC3CC(Nc4ccc(nn4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C22H18F4N6O/c23-14-4-1-3-13(19(14)20-27-7-2-8-28-20)21(33)32-11-12-9-15(16(32)10-12)29-18-6-5-17(30-31-18)22(24,25)26/h1-8,12,15-16H,9-11H2,(H,29,31) MPKQYFFBTXDIDP-UHFFFAOYSA-N 315064 US10183953, Example 245::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((6-(trifluoromethyl)pyridazin-3-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 245 Orexin receptor type 2 Human 4300 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315064 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315064&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637637 383541882 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611828 FC(F)(F)c1ccc(NC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)cn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315065 US10183953, Example 246::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((6-(trifluoromethyl)pyridin-3-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 246 Orexin/Hypocretin receptor type 1 Rat 194 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315065 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315065&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637566 383541883 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611829 FC(F)(F)c1ccc(NC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)cn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315065 US10183953, Example 246::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((6-(trifluoromethyl)pyridin-3-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 246 Orexin/Hypocretin receptor type 1 Human 155 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315065 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315065&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637566 383541883 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611830 FC(F)(F)c1ccc(NC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)cn1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315065 US10183953, Example 246::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4S,6R)-6-((6-(trifluoromethyl)pyridin-3-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 246 Orexin receptor type 2 Human 843 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315065 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315065&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637566 383541883 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611831 Fc1cccc(C(=O)N2CC3CC(Nc4ccc(nc4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C23H19F4N5O/c24-16-4-1-3-15(20(16)21-28-7-2-8-29-21)22(33)32-12-13-9-17(18(32)10-13)31-14-5-6-19(30-11-14)23(25,26)27/h1-8,11,13,17-18,31H,9-10,12H2 ANELYGOMGGJEQF-UHFFFAOYSA-N 315066 US10183953, Example 247::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((6-(trifluoromethyl)pyridin-3-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 247 Orexin/Hypocretin receptor type 1 Rat 26.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315066 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315066&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637492 383541884 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611832 Fc1cccc(C(=O)N2CC3CC(Nc4ccc(nc4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C23H19F4N5O/c24-16-4-1-3-15(20(16)21-28-7-2-8-29-21)22(33)32-12-13-9-17(18(32)10-13)31-14-5-6-19(30-11-14)23(25,26)27/h1-8,11,13,17-18,31H,9-10,12H2 ANELYGOMGGJEQF-UHFFFAOYSA-N 315066 US10183953, Example 247::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((6-(trifluoromethyl)pyridin-3-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 247 Orexin/Hypocretin receptor type 1 Human 31.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315066 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315066&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637492 383541884 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611833 Fc1cccc(C(=O)N2CC3CC(Nc4ccc(nc4)C(F)(F)F)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C23H19F4N5O/c24-16-4-1-3-15(20(16)21-28-7-2-8-29-21)22(33)32-12-13-9-17(18(32)10-13)31-14-5-6-19(30-11-14)23(25,26)27/h1-8,11,13,17-18,31H,9-10,12H2 ANELYGOMGGJEQF-UHFFFAOYSA-N 315066 US10183953, Example 247::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((6-(trifluoromethyl)pyridin-3-yl)amino)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 247 Orexin receptor type 2 Human 939 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315066 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315066&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637492 383541884 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611834 Fc1cccc(C(=O)N2CC3CCC2C(C3)Oc2ccc(cn2)C(F)(F)F)c1-c1ncccn1 |TLB:16:14:11.12:9.8,THB:6:8:14.15:11.12| 314892 (3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 248::US10183953, Example 73::US9611277, Example 73 Orexin/Hypocretin receptor type 1 Rat 11.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314892 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314892&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271039 383541711 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611835 Fc1cccc(C(=O)N2CC3CCC2C(C3)Oc2ccc(cn2)C(F)(F)F)c1-c1ncccn1 |TLB:16:14:11.12:9.8,THB:6:8:14.15:11.12| 314892 (3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 248::US10183953, Example 73::US9611277, Example 73 Orexin/Hypocretin receptor type 1 Human 14.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314892 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314892&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271039 383541711 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611836 Fc1cccc(C(=O)N2CC3CCC2C(C3)Oc2ccc(cn2)C(F)(F)F)c1-c1ncccn1 |TLB:16:14:11.12:9.8,THB:6:8:14.15:11.12| 314892 (3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 248::US10183953, Example 73::US9611277, Example 73 Orexin receptor type 2 Human 467 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314892 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314892&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271039 383541711 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611837 Fc1cccc(C(=O)N2CC3CCC2C(C3)Oc2ccc(cn2)C(F)(F)F)c1-n1nccn1 |TLB:16:14:11.12:9.8,THB:6:8:14.15:11.12| 315068 US10183953, Example 249::(R/S)-(3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)(6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 249 Orexin/Hypocretin receptor type 1 Rat 8.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315068 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315068&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117631521 383541885 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611838 Fc1cccc(C(=O)N2CC3CCC2C(C3)Oc2ccc(cn2)C(F)(F)F)c1-n1nccn1 |TLB:16:14:11.12:9.8,THB:6:8:14.15:11.12| 315068 US10183953, Example 249::(R/S)-(3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)(6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 249 Orexin/Hypocretin receptor type 1 Human 15.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315068 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315068&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117631521 383541885 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611839 Fc1cccc(C(=O)N2CC3CCC2C(C3)Oc2ccc(cn2)C(F)(F)F)c1-n1nccn1 |TLB:16:14:11.12:9.8,THB:6:8:14.15:11.12| 315068 US10183953, Example 249::(R/S)-(3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)(6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 249 Orexin receptor type 2 Human 758 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315068 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315068&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117631521 383541885 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611840 Fc1ccc(C(=O)N2CC3CCC2C(C3)Oc2ccc(cn2)C(F)(F)F)c(c1)-c1ncccn1 |TLB:15:13:10.11:8.7,THB:5:7:13.14:10.11| 315069 US9611277, Example 259::(R/S)-(4-fluoro-2-(pyrimidin-2-yl)phenyl)(6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US10183953, Example 259::US9611277, Example 250 Orexin/Hypocretin receptor type 1 Rat 22.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315069 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315069&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117630824 383541886 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611841 Fc1ccc(C(=O)N2CC3CCC2C(C3)Oc2ccc(cn2)C(F)(F)F)c(c1)-c1ncccn1 |TLB:15:13:10.11:8.7,THB:5:7:13.14:10.11| 315069 US9611277, Example 259::(R/S)-(4-fluoro-2-(pyrimidin-2-yl)phenyl)(6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US10183953, Example 259::US9611277, Example 250 Orexin/Hypocretin receptor type 1 Human 24.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315069 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315069&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117630824 383541886 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611842 Fc1ccc(C(=O)N2CC3CCC2C(C3)Oc2ccc(cn2)C(F)(F)F)c(c1)-c1ncccn1 |TLB:15:13:10.11:8.7,THB:5:7:13.14:10.11| 315069 US9611277, Example 259::(R/S)-(4-fluoro-2-(pyrimidin-2-yl)phenyl)(6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US10183953, Example 259::US9611277, Example 250 Orexin receptor type 2 Human 1800 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315069 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315069&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117630824 383541886 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611843 Fc1cnc(nc1)-c1ccccc1C(=O)N1CC2CCC1C(C2)Oc1ccc(cn1)C(F)(F)F |TLB:23:21:18.19:16.15,THB:13:15:21.22:18.19| 315070 US9611277, Example 262::(R/S)-(2-(5-fluoropyrimidin-2-yl)phenyl)(6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US10183953, Example 262::US9611277, Example 251 Orexin/Hypocretin receptor type 1 Rat 18.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315070 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315070&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117636958 383541887 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611844 Fc1cnc(nc1)-c1ccccc1C(=O)N1CC2CCC1C(C2)Oc1ccc(cn1)C(F)(F)F |TLB:23:21:18.19:16.15,THB:13:15:21.22:18.19| 315070 US9611277, Example 262::(R/S)-(2-(5-fluoropyrimidin-2-yl)phenyl)(6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US10183953, Example 262::US9611277, Example 251 Orexin/Hypocretin receptor type 1 Human 11.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315070 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315070&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117636958 383541887 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611845 Fc1cnc(nc1)-c1ccccc1C(=O)N1CC2CCC1C(C2)Oc1ccc(cn1)C(F)(F)F |TLB:23:21:18.19:16.15,THB:13:15:21.22:18.19| 315070 US9611277, Example 262::(R/S)-(2-(5-fluoropyrimidin-2-yl)phenyl)(6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US10183953, Example 262::US9611277, Example 251 Orexin receptor type 2 Human 760 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315070 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315070&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117636958 383541887 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611846 Cc1ccc(c(n1)C(=O)N1CC2CCC1C(C2)Nc1cnc(cn1)C(F)(F)F)-n1nccn1 |TLB:17:15:12.13:10.9,THB:7:9:15.16:12.13| 314898 US9611277, Example 252::(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US10183953, Example 83::US9611277, Example 83 Orexin/Hypocretin receptor type 1 Rat 13.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314898 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314898&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271234 383541717 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611847 Cc1ccc(c(n1)C(=O)N1CC2CCC1C(C2)Nc1cnc(cn1)C(F)(F)F)-n1nccn1 |TLB:17:15:12.13:10.9,THB:7:9:15.16:12.13| 314898 US9611277, Example 252::(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US10183953, Example 83::US9611277, Example 83 Orexin/Hypocretin receptor type 1 Human 14.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314898 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314898&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271234 383541717 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611848 Cc1ccc(c(n1)C(=O)N1CC2CCC1C(C2)Nc1cnc(cn1)C(F)(F)F)-n1nccn1 |TLB:17:15:12.13:10.9,THB:7:9:15.16:12.13| 314898 US9611277, Example 252::(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US10183953, Example 83::US9611277, Example 83 Orexin receptor type 2 Human 312 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314898 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314898&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271234 383541717 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611849 Cc1ccc(c(n1)C(=O)N1CC2CCC1C(C2)Nc1cnc(cn1)C(F)(F)F)-n1nccn1 |THB:17:15:12.13:10.9,7:9:15.16:12.13| 315072 (R/S)-(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)(6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 253 Orexin/Hypocretin receptor type 1 Rat >10000 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315072 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315072&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271234 383541888 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611850 Cc1ccc(c(n1)C(=O)N1CC2CCC1C(C2)Nc1cnc(cn1)C(F)(F)F)-n1nccn1 |THB:17:15:12.13:10.9,7:9:15.16:12.13| 315072 (R/S)-(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)(6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 253 Orexin receptor type 2 Human >10000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315072 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315072&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271234 383541888 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611851 FC(F)(F)c1cnc(NC2CC3CCC2N(C3)C(=O)c2ccccc2-n2nccn2)cn1 |TLB:17:15:9.10:12.13,THB:8:9:12.13:16.15| 315073 (R/S)-(2-(2H-1,2,3-triazol-2-yl)phenyl)(6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 275::US10183953, Example 275::US9611277, Example 254 Orexin/Hypocretin receptor type 1 Rat 12.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315073 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315073&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117631409 383541889 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611852 FC(F)(F)c1cnc(NC2CC3CCC2N(C3)C(=O)c2ccccc2-n2nccn2)cn1 |TLB:17:15:9.10:12.13,THB:8:9:12.13:16.15| 315073 (R/S)-(2-(2H-1,2,3-triazol-2-yl)phenyl)(6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 275::US10183953, Example 275::US9611277, Example 254 Orexin/Hypocretin receptor type 1 Human 10.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315073 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315073&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117631409 383541889 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611853 FC(F)(F)c1cnc(NC2CC3CCC2N(C3)C(=O)c2ccccc2-n2nccn2)cn1 |TLB:17:15:9.10:12.13,THB:8:9:12.13:16.15| 315073 (R/S)-(2-(2H-1,2,3-triazol-2-yl)phenyl)(6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 275::US10183953, Example 275::US9611277, Example 254 Orexin receptor type 2 Human 307 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315073 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315073&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117631409 383541889 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611854 Fc1cccc(C(=O)N2CC3CCC2C(C3)Nc2cnc(cn2)C(F)(F)F)c1-n1nccn1 |TLB:16:14:11.12:9.8,THB:6:8:14.15:11.12| 315074 US9611277, Example 274::(R/S)-(3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)(6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US10183953, Example 274::US9611277, Example 255 Orexin/Hypocretin receptor type 1 Rat 12.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315074 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315074&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117631519 383541890 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611855 Fc1cccc(C(=O)N2CC3CCC2C(C3)Nc2cnc(cn2)C(F)(F)F)c1-n1nccn1 |TLB:16:14:11.12:9.8,THB:6:8:14.15:11.12| 315074 US9611277, Example 274::(R/S)-(3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)(6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US10183953, Example 274::US9611277, Example 255 Orexin/Hypocretin receptor type 1 Human 11.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315074 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315074&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117631519 383541890 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611856 Fc1cccc(C(=O)N2CC3CCC2C(C3)Nc2cnc(cn2)C(F)(F)F)c1-n1nccn1 |TLB:16:14:11.12:9.8,THB:6:8:14.15:11.12| 315074 US9611277, Example 274::(R/S)-(3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)(6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US10183953, Example 274::US9611277, Example 255 Orexin receptor type 2 Human 1000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315074 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315074&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117631519 383541890 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611857 Cc1cccc(C(=O)N2CC3CCC2C(C3)Nc2cnc(cn2)C(F)(F)F)c1-n1nccn1 |TLB:16:14:11.12:9.8,THB:6:8:14.15:11.12| 315075 US10183953, Example 257::(R/S)-(3-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)(6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 256 Orexin/Hypocretin receptor type 1 Rat 20.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315075 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315075&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117631658 383541891 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611858 Cc1cccc(C(=O)N2CC3CCC2C(C3)Nc2cnc(cn2)C(F)(F)F)c1-n1nccn1 |TLB:16:14:11.12:9.8,THB:6:8:14.15:11.12| 315075 US10183953, Example 257::(R/S)-(3-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)(6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 256 Orexin/Hypocretin receptor type 1 Human 10.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315075 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315075&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117631658 383541891 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611859 Cc1cccc(C(=O)N2CC3CCC2C(C3)Nc2cnc(cn2)C(F)(F)F)c1-n1nccn1 |TLB:16:14:11.12:9.8,THB:6:8:14.15:11.12| 315075 US10183953, Example 257::(R/S)-(3-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)(6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 256 Orexin receptor type 2 Human 348 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315075 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315075&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117631658 383541891 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611860 Fc1cccc(C(=O)N2CC3CCC2C(C3)Nc2cnc(cn2)C(F)(F)F)c1-c1ncccn1 |TLB:16:14:11.12:9.8,THB:6:8:14.15:11.12| 314897 (3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 276::US9611277, Example 257::US10183953, Example 80::US9611277, Example 80 Orexin/Hypocretin receptor type 1 Rat 21.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314897 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314897&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271136 383541716 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611861 Fc1cccc(C(=O)N2CC3CCC2C(C3)Nc2cnc(cn2)C(F)(F)F)c1-c1ncccn1 |TLB:16:14:11.12:9.8,THB:6:8:14.15:11.12| 314897 (3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 276::US9611277, Example 257::US10183953, Example 80::US9611277, Example 80 Orexin/Hypocretin receptor type 1 Human 24.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314897 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314897&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271136 383541716 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611862 Fc1cccc(C(=O)N2CC3CCC2C(C3)Nc2cnc(cn2)C(F)(F)F)c1-c1ncccn1 |TLB:16:14:11.12:9.8,THB:6:8:14.15:11.12| 314897 (3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 276::US9611277, Example 257::US10183953, Example 80::US9611277, Example 80 Orexin receptor type 2 Human 741 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314897 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314897&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271136 383541716 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611863 Fc1ccc(C(=O)N2CC3CCC2C(C3)Nc2cnc(cn2)C(F)(F)F)c(c1)-c1ncccn1 |TLB:15:13:10.11:8.7,THB:5:7:13.14:10.11| 315077 (R/S)-(4-fluoro-2-(pyrimidin-2-yl)phenyl)(6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 277::US10183953, Example 277::US9611277, Example 258 Orexin/Hypocretin receptor type 1 Rat 26.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315077 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315077&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117631641 383541892 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611864 Fc1ccc(C(=O)N2CC3CCC2C(C3)Nc2cnc(cn2)C(F)(F)F)c(c1)-c1ncccn1 |TLB:15:13:10.11:8.7,THB:5:7:13.14:10.11| 315077 (R/S)-(4-fluoro-2-(pyrimidin-2-yl)phenyl)(6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 277::US10183953, Example 277::US9611277, Example 258 Orexin/Hypocretin receptor type 1 Human 17.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315077 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315077&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117631641 383541892 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611865 Fc1ccc(C(=O)N2CC3CCC2C(C3)Nc2cnc(cn2)C(F)(F)F)c(c1)-c1ncccn1 |TLB:15:13:10.11:8.7,THB:5:7:13.14:10.11| 315077 (R/S)-(4-fluoro-2-(pyrimidin-2-yl)phenyl)(6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 277::US10183953, Example 277::US9611277, Example 258 Orexin receptor type 2 Human 2600 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315077 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315077&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117631641 383541892 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611866 Fc1ccc(C(=O)N2CC3CCC2C(C3)Oc2ccc(cn2)C(F)(F)F)c(c1)-c1ncccn1 |TLB:15:13:10.11:8.7,THB:5:7:13.14:10.11| 315069 US9611277, Example 259::(R/S)-(4-fluoro-2-(pyrimidin-2-yl)phenyl)(6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US10183953, Example 259::US9611277, Example 250 Orexin/Hypocretin receptor type 1 Rat 16.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315069 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315069&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117630824 383541886 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611867 Fc1ccc(C(=O)N2CC3CCC2C(C3)Oc2ccc(cn2)C(F)(F)F)c(c1)-c1ncccn1 |TLB:15:13:10.11:8.7,THB:5:7:13.14:10.11| 315069 US9611277, Example 259::(R/S)-(4-fluoro-2-(pyrimidin-2-yl)phenyl)(6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US10183953, Example 259::US9611277, Example 250 Orexin/Hypocretin receptor type 1 Human 19.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315069 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315069&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117630824 383541886 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611868 Fc1ccc(C(=O)N2CC3CCC2C(C3)Oc2ccc(cn2)C(F)(F)F)c(c1)-c1ncccn1 |TLB:15:13:10.11:8.7,THB:5:7:13.14:10.11| 315069 US9611277, Example 259::(R/S)-(4-fluoro-2-(pyrimidin-2-yl)phenyl)(6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US10183953, Example 259::US9611277, Example 250 Orexin receptor type 2 Human 865 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315069 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315069&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117630824 383541886 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611869 Fc1ccc(-c2ncccn2)c(c1)C(=O)N1CC2CCC1C(C2)Oc1ccc(cn1)C(F)(F)F |TLB:23:21:18.19:16.15,THB:13:15:21.22:18.19| 315079 US10183953, Example 260::(5-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 260 Orexin/Hypocretin receptor type 1 Rat 11.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315079 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315079&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117636956 383541893 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611870 Fc1ccc(-c2ncccn2)c(c1)C(=O)N1CC2CCC1C(C2)Oc1ccc(cn1)C(F)(F)F |TLB:23:21:18.19:16.15,THB:13:15:21.22:18.19| 315079 US10183953, Example 260::(5-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 260 Orexin/Hypocretin receptor type 1 Human 10.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315079 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315079&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117636956 383541893 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611871 Fc1ccc(-c2ncccn2)c(c1)C(=O)N1CC2CCC1C(C2)Oc1ccc(cn1)C(F)(F)F |TLB:23:21:18.19:16.15,THB:13:15:21.22:18.19| 315079 US10183953, Example 260::(5-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 260 Orexin receptor type 2 Human 294 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315079 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315079&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117636956 383541893 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611872 Fc1cccc(-c2ncccn2)c1C(=O)N1CC2CCC1C(C2)Oc1ccc(cn1)C(F)(F)F |TLB:23:21:18.19:16.15,THB:13:15:21.22:18.19| 315080 US10183953, Example 261::(2-fluoro-6-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 261 Orexin/Hypocretin receptor type 1 Rat 21.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315080 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315080&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637885 383541894 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611873 Fc1cccc(-c2ncccn2)c1C(=O)N1CC2CCC1C(C2)Oc1ccc(cn1)C(F)(F)F |TLB:23:21:18.19:16.15,THB:13:15:21.22:18.19| 315080 US10183953, Example 261::(2-fluoro-6-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 261 Orexin/Hypocretin receptor type 1 Human 9.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315080 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315080&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637885 383541894 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611874 Fc1cccc(-c2ncccn2)c1C(=O)N1CC2CCC1C(C2)Oc1ccc(cn1)C(F)(F)F |TLB:23:21:18.19:16.15,THB:13:15:21.22:18.19| 315080 US10183953, Example 261::(2-fluoro-6-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 261 Orexin receptor type 2 Human 400 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315080 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315080&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637885 383541894 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611875 Fc1cnc(nc1)-c1ccccc1C(=O)N1CC2CCC1C(C2)Oc1ccc(cn1)C(F)(F)F |TLB:23:21:18.19:16.15,THB:13:15:21.22:18.19| 315070 US9611277, Example 262::(R/S)-(2-(5-fluoropyrimidin-2-yl)phenyl)(6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US10183953, Example 262::US9611277, Example 251 Orexin/Hypocretin receptor type 1 Rat 10.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315070 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315070&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117636958 383541887 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611876 Fc1cnc(nc1)-c1ccccc1C(=O)N1CC2CCC1C(C2)Oc1ccc(cn1)C(F)(F)F |TLB:23:21:18.19:16.15,THB:13:15:21.22:18.19| 315070 US9611277, Example 262::(R/S)-(2-(5-fluoropyrimidin-2-yl)phenyl)(6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US10183953, Example 262::US9611277, Example 251 Orexin/Hypocretin receptor type 1 Human 10.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315070 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315070&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117636958 383541887 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611877 Fc1cnc(nc1)-c1ccccc1C(=O)N1CC2CCC1C(C2)Oc1ccc(cn1)C(F)(F)F |TLB:23:21:18.19:16.15,THB:13:15:21.22:18.19| 315070 US9611277, Example 262::(R/S)-(2-(5-fluoropyrimidin-2-yl)phenyl)(6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US10183953, Example 262::US9611277, Example 251 Orexin receptor type 2 Human 550 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315070 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315070&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117636958 383541887 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611878 Fc1cnc(nc1)-c1c(F)cccc1C(=O)N1CC2CCC1C(C2)Oc1ccc(cn1)C(F)(F)F |TLB:24:22:19.20:17.16,THB:14:16:22.23:19.20| 315082 US10183953, Example 263::(3-fluoro-2-(5-fluoropyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 263 Orexin/Hypocretin receptor type 1 Rat 11.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315082 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315082&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637426 383541895 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611879 Fc1cnc(nc1)-c1c(F)cccc1C(=O)N1CC2CCC1C(C2)Oc1ccc(cn1)C(F)(F)F |TLB:24:22:19.20:17.16,THB:14:16:22.23:19.20| 315082 US10183953, Example 263::(3-fluoro-2-(5-fluoropyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 263 Orexin/Hypocretin receptor type 1 Human 9.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315082 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315082&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637426 383541895 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611880 Fc1cnc(nc1)-c1c(F)cccc1C(=O)N1CC2CCC1C(C2)Oc1ccc(cn1)C(F)(F)F |TLB:24:22:19.20:17.16,THB:14:16:22.23:19.20| 315082 US10183953, Example 263::(3-fluoro-2-(5-fluoropyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 263 Orexin receptor type 2 Human 1100 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315082 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315082&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637426 383541895 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611881 Cc1cnc(C(=O)N2CC3CCC2C(C3)Oc2ccc(cn2)C(F)(F)F)c(c1)-c1ncccn1 |TLB:15:13:10.11:8.7,THB:5:7:13.14:10.11| 315083 US10183953, Example 264::(5-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 264 Orexin/Hypocretin receptor type 1 Rat 10.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315083 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315083&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637494 383541896 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611882 Cc1cnc(C(=O)N2CC3CCC2C(C3)Oc2ccc(cn2)C(F)(F)F)c(c1)-c1ncccn1 |TLB:15:13:10.11:8.7,THB:5:7:13.14:10.11| 315083 US10183953, Example 264::(5-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 264 Orexin/Hypocretin receptor type 1 Human 16.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315083 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315083&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637494 383541896 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611883 Cc1cnc(C(=O)N2CC3CCC2C(C3)Oc2ccc(cn2)C(F)(F)F)c(c1)-c1ncccn1 |TLB:15:13:10.11:8.7,THB:5:7:13.14:10.11| 315083 US10183953, Example 264::(5-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 264 Orexin receptor type 2 Human >10000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315083 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315083&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637494 383541896 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611884 Cc1ccc(-c2ncccn2)c(n1)C(=O)N1CC2CCC1C(C2)Oc1ccc(cn1)C(F)(F)F |TLB:23:21:18.19:16.15,THB:13:15:21.22:18.19| 315084 US10183953, Example 265::(6-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 265 Orexin/Hypocretin receptor type 1 Rat 14.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315084 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315084&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637645 383541897 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611885 Cc1ccc(-c2ncccn2)c(n1)C(=O)N1CC2CCC1C(C2)Oc1ccc(cn1)C(F)(F)F |TLB:23:21:18.19:16.15,THB:13:15:21.22:18.19| 315084 US10183953, Example 265::(6-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 265 Orexin/Hypocretin receptor type 1 Human 19.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315084 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315084&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637645 383541897 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611886 Cc1ccc(-c2ncccn2)c(n1)C(=O)N1CC2CCC1C(C2)Oc1ccc(cn1)C(F)(F)F |TLB:23:21:18.19:16.15,THB:13:15:21.22:18.19| 315084 US10183953, Example 265::(6-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 265 Orexin receptor type 2 Human 306 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315084 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315084&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637645 383541897 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611887 Fc1cc(cnc1OC1CC2CCC1N(C2)C(=O)c1cccc(F)c1-c1ncccn1)C(F)(F)F |TLB:16:14:8.9:11.12,THB:7:8:11.12:15.14| 315085 US10183953, Example 266::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((3-fluoro-5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 266 Orexin/Hypocretin receptor type 1 Rat 11.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315085 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315085&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117636955 383541898 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611888 Fc1cc(cnc1OC1CC2CCC1N(C2)C(=O)c1cccc(F)c1-c1ncccn1)C(F)(F)F |TLB:16:14:8.9:11.12,THB:7:8:11.12:15.14| 315085 US10183953, Example 266::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((3-fluoro-5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 266 Orexin/Hypocretin receptor type 1 Human 11.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315085 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315085&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117636955 383541898 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611889 Fc1cc(cnc1OC1CC2CCC1N(C2)C(=O)c1cccc(F)c1-c1ncccn1)C(F)(F)F |TLB:16:14:8.9:11.12,THB:7:8:11.12:15.14| 315085 US10183953, Example 266::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((3-fluoro-5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 266 Orexin receptor type 2 Human 654 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315085 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315085&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117636955 383541898 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611890 Cc1ccc(OC2CC3CCC2N(C3)C(=O)c2cccc(F)c2-c2ncccn2)nc1 |TLB:14:12:6.7:9.10,THB:5:6:9.10:13.12| 315086 US10183953, Example 267::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-methylpyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 267 Orexin/Hypocretin receptor type 1 Rat 26.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315086 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315086&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 90452207 383541899 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611891 Cc1ccc(OC2CC3CCC2N(C3)C(=O)c2cccc(F)c2-c2ncccn2)nc1 |TLB:14:12:6.7:9.10,THB:5:6:9.10:13.12| 315086 US10183953, Example 267::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-methylpyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 267 Orexin/Hypocretin receptor type 1 Human 19.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315086 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315086&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 90452207 383541899 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611892 Cc1ccc(OC2CC3CCC2N(C3)C(=O)c2cccc(F)c2-c2ncccn2)nc1 |TLB:14:12:6.7:9.10,THB:5:6:9.10:13.12| 315086 US10183953, Example 267::(3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-methylpyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 267 Orexin receptor type 2 Human 1100 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315086 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315086&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 90452207 383541899 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611893 Brc1ccc(OC2CC3CCC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:14:12:6.7:9.10,THB:5:6:9.10:13.12| 315087 US10183953, Example 268::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4R,6R)-6-((5-bromopyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 268 Orexin/Hypocretin receptor type 1 Rat 5.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315087 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315087&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637670 383541900 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611894 Brc1ccc(OC2CC3CCC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:14:12:6.7:9.10,THB:5:6:9.10:13.12| 315087 US10183953, Example 268::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4R,6R)-6-((5-bromopyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 268 Orexin/Hypocretin receptor type 1 Human 4.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315087 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315087&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637670 383541900 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611895 Brc1ccc(OC2CC3CCC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:14:12:6.7:9.10,THB:5:6:9.10:13.12| 315087 US10183953, Example 268::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4R,6R)-6-((5-bromopyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 268 Orexin receptor type 2 Human 200 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315087 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315087&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637670 383541900 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611896 Fc1cccc(C(=O)N2CC3CCC2C(C3)Oc2ccc(Br)cn2)c1-c1ncccn1 |TLB:16:14:11.12:9.8,THB:6:8:14.15:11.12| 315088 US10183953, Example 269::((1S,4R,6R)-6-((5-bromopyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 269 Orexin/Hypocretin receptor type 1 Rat 4.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315088 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315088&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637884 383541901 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611897 Fc1cccc(C(=O)N2CC3CCC2C(C3)Oc2ccc(Br)cn2)c1-c1ncccn1 |TLB:16:14:11.12:9.8,THB:6:8:14.15:11.12| 315088 US10183953, Example 269::((1S,4R,6R)-6-((5-bromopyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 269 Orexin/Hypocretin receptor type 1 Human 5.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315088 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315088&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637884 383541901 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611898 Fc1cccc(C(=O)N2CC3CCC2C(C3)Oc2ccc(Br)cn2)c1-c1ncccn1 |TLB:16:14:11.12:9.8,THB:6:8:14.15:11.12| 315088 US10183953, Example 269::((1S,4R,6R)-6-((5-bromopyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 269 Orexin receptor type 2 Human 363 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315088 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315088&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637884 383541901 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611899 Clc1ccc(OC2CC3CCC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:14:12:6.7:9.10,THB:5:6:9.10:13.12| 315089 US10183953, Example 270::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4R,6R)-6-((5-chloropyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 270 Orexin/Hypocretin receptor type 1 Rat 4.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315089 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315089&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637891 383541902 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611900 Clc1ccc(OC2CC3CCC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:14:12:6.7:9.10,THB:5:6:9.10:13.12| 315089 US10183953, Example 270::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4R,6R)-6-((5-chloropyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 270 Orexin/Hypocretin receptor type 1 Human 3.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315089 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315089&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637891 383541902 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611901 Clc1ccc(OC2CC3CCC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:14:12:6.7:9.10,THB:5:6:9.10:13.12| 315089 US10183953, Example 270::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4R,6R)-6-((5-chloropyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 270 Orexin receptor type 2 Human 200 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315089 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315089&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637891 383541902 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611902 Fc1cccc(C(=O)N2CC3CCC2C(C3)Oc2ccc(Cl)cn2)c1-c1ncccn1 |TLB:16:14:11.12:9.8,THB:6:8:14.15:11.12| 315090 US10183953, Example 271::((1S,4R,6R)-6-((5-chloropyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 271 Orexin/Hypocretin receptor type 1 Rat 7.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315090 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315090&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637892 383541903 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611903 Fc1cccc(C(=O)N2CC3CCC2C(C3)Oc2ccc(Cl)cn2)c1-c1ncccn1 |TLB:16:14:11.12:9.8,THB:6:8:14.15:11.12| 315090 US10183953, Example 271::((1S,4R,6R)-6-((5-chloropyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 271 Orexin/Hypocretin receptor type 1 Human 8.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315090 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315090&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637892 383541903 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611904 Fc1cccc(C(=O)N2CC3CCC2C(C3)Oc2ccc(Cl)cn2)c1-c1ncccn1 |TLB:16:14:11.12:9.8,THB:6:8:14.15:11.12| 315090 US10183953, Example 271::((1S,4R,6R)-6-((5-chloropyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 271 Orexin receptor type 2 Human 452 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315090 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315090&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637892 383541903 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611905 Fc1cnc(nc1)-c1ccccc1C(=O)N1CC2CCC1C(C2)Oc1cnc(cn1)C(F)(F)F |TLB:23:21:18.19:16.15,THB:13:15:21.22:18.19| 315091 US10183953, Example 272::(2-(5-fluoropyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 272 Orexin/Hypocretin receptor type 1 Rat 23.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315091 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315091&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637425 383541904 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611906 Fc1cnc(nc1)-c1ccccc1C(=O)N1CC2CCC1C(C2)Oc1cnc(cn1)C(F)(F)F |TLB:23:21:18.19:16.15,THB:13:15:21.22:18.19| 315091 US10183953, Example 272::(2-(5-fluoropyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 272 Orexin/Hypocretin receptor type 1 Human 11.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315091 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315091&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637425 383541904 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611907 Fc1cnc(nc1)-c1ccccc1C(=O)N1CC2CCC1C(C2)Oc1cnc(cn1)C(F)(F)F |TLB:23:21:18.19:16.15,THB:13:15:21.22:18.19| 315091 US10183953, Example 272::(2-(5-fluoropyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 272 Orexin receptor type 2 Human 1400 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315091 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315091&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637425 383541904 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611908 Fc1cnc(nc1)-c1c(F)cccc1C(=O)N1CC2CCC1C(C2)Oc1cnc(cn1)C(F)(F)F |TLB:24:22:19.20:17.16,THB:14:16:22.23:19.20| 315092 US10183953, Example 273::(3-fluoro-2-(5-fluoropyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 273 Orexin/Hypocretin receptor type 1 Rat 44.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315092 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315092&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637568 383541905 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611909 Fc1cnc(nc1)-c1c(F)cccc1C(=O)N1CC2CCC1C(C2)Oc1cnc(cn1)C(F)(F)F |TLB:24:22:19.20:17.16,THB:14:16:22.23:19.20| 315092 US10183953, Example 273::(3-fluoro-2-(5-fluoropyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 273 Orexin/Hypocretin receptor type 1 Human 16.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315092 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315092&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637568 383541905 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611910 Fc1cnc(nc1)-c1c(F)cccc1C(=O)N1CC2CCC1C(C2)Oc1cnc(cn1)C(F)(F)F |TLB:24:22:19.20:17.16,THB:14:16:22.23:19.20| 315092 US10183953, Example 273::(3-fluoro-2-(5-fluoropyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 273 Orexin receptor type 2 Human 3800 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315092 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315092&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637568 383541905 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611911 Fc1cccc(C(=O)N2CC3CCC2C(C3)Nc2cnc(cn2)C(F)(F)F)c1-n1nccn1 |TLB:16:14:11.12:9.8,THB:6:8:14.15:11.12| 315074 US9611277, Example 274::(R/S)-(3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)(6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US10183953, Example 274::US9611277, Example 255 Orexin/Hypocretin receptor type 1 Rat 11.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315074 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315074&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117631519 383541890 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611912 Fc1cccc(C(=O)N2CC3CCC2C(C3)Nc2cnc(cn2)C(F)(F)F)c1-n1nccn1 |TLB:16:14:11.12:9.8,THB:6:8:14.15:11.12| 315074 US9611277, Example 274::(R/S)-(3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)(6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US10183953, Example 274::US9611277, Example 255 Orexin/Hypocretin receptor type 1 Human 8.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315074 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315074&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117631519 383541890 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611913 Fc1cccc(C(=O)N2CC3CCC2C(C3)Nc2cnc(cn2)C(F)(F)F)c1-n1nccn1 |TLB:16:14:11.12:9.8,THB:6:8:14.15:11.12| 315074 US9611277, Example 274::(R/S)-(3-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)(6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US10183953, Example 274::US9611277, Example 255 Orexin receptor type 2 Human 534 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315074 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315074&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117631519 383541890 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611914 FC(F)(F)c1cnc(NC2CC3CCC2N(C3)C(=O)c2ccccc2-n2nccn2)cn1 |TLB:17:15:9.10:12.13,THB:8:9:12.13:16.15| 315073 (R/S)-(2-(2H-1,2,3-triazol-2-yl)phenyl)(6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 275::US10183953, Example 275::US9611277, Example 254 Orexin/Hypocretin receptor type 1 Rat 8.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315073 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315073&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117631409 383541889 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611915 FC(F)(F)c1cnc(NC2CC3CCC2N(C3)C(=O)c2ccccc2-n2nccn2)cn1 |TLB:17:15:9.10:12.13,THB:8:9:12.13:16.15| 315073 (R/S)-(2-(2H-1,2,3-triazol-2-yl)phenyl)(6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 275::US10183953, Example 275::US9611277, Example 254 Orexin/Hypocretin receptor type 1 Human 5.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315073 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315073&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117631409 383541889 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611916 FC(F)(F)c1cnc(NC2CC3CCC2N(C3)C(=O)c2ccccc2-n2nccn2)cn1 |TLB:17:15:9.10:12.13,THB:8:9:12.13:16.15| 315073 (R/S)-(2-(2H-1,2,3-triazol-2-yl)phenyl)(6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 275::US10183953, Example 275::US9611277, Example 254 Orexin receptor type 2 Human 175 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315073 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315073&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117631409 383541889 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611917 Fc1cccc(C(=O)N2CC3CCC2C(C3)Nc2cnc(cn2)C(F)(F)F)c1-c1ncccn1 |TLB:16:14:11.12:9.8,THB:6:8:14.15:11.12| 314897 (3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 276::US9611277, Example 257::US10183953, Example 80::US9611277, Example 80 Orexin/Hypocretin receptor type 1 Rat 2700 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314897 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314897&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271136 383541716 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611918 Fc1cccc(C(=O)N2CC3CCC2C(C3)Nc2cnc(cn2)C(F)(F)F)c1-c1ncccn1 |TLB:16:14:11.12:9.8,THB:6:8:14.15:11.12| 314897 (3-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 276::US9611277, Example 257::US10183953, Example 80::US9611277, Example 80 Orexin receptor type 2 Human >10000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314897 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314897&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271136 383541716 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611919 Fc1ccc(C(=O)N2CC3CCC2C(C3)Nc2cnc(cn2)C(F)(F)F)c(c1)-c1ncccn1 |TLB:15:13:10.11:8.7,THB:5:7:13.14:10.11| 315077 (R/S)-(4-fluoro-2-(pyrimidin-2-yl)phenyl)(6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 277::US10183953, Example 277::US9611277, Example 258 Orexin/Hypocretin receptor type 1 Rat 17.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315077 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315077&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117631641 383541892 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611920 Fc1ccc(C(=O)N2CC3CCC2C(C3)Nc2cnc(cn2)C(F)(F)F)c(c1)-c1ncccn1 |TLB:15:13:10.11:8.7,THB:5:7:13.14:10.11| 315077 (R/S)-(4-fluoro-2-(pyrimidin-2-yl)phenyl)(6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 277::US10183953, Example 277::US9611277, Example 258 Orexin/Hypocretin receptor type 1 Human 15.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315077 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315077&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117631641 383541892 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611921 Fc1ccc(C(=O)N2CC3CCC2C(C3)Nc2cnc(cn2)C(F)(F)F)c(c1)-c1ncccn1 |TLB:15:13:10.11:8.7,THB:5:7:13.14:10.11| 315077 (R/S)-(4-fluoro-2-(pyrimidin-2-yl)phenyl)(6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 277::US10183953, Example 277::US9611277, Example 258 Orexin receptor type 2 Human 998 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315077 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315077&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117631641 383541892 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611922 Fc1ccc(-c2ncccn2)c(c1)C(=O)N1CC2CCC1C(C2)Nc1cnc(cn1)C(F)(F)F |TLB:23:21:18.19:16.15,THB:13:15:21.22:18.19| 315097 US10183953, Example 278::(5-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 278 Orexin/Hypocretin receptor type 1 Rat 14.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315097 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315097&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637496 383541906 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611923 Fc1ccc(-c2ncccn2)c(c1)C(=O)N1CC2CCC1C(C2)Nc1cnc(cn1)C(F)(F)F |TLB:23:21:18.19:16.15,THB:13:15:21.22:18.19| 315097 US10183953, Example 278::(5-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 278 Orexin/Hypocretin receptor type 1 Human 7.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315097 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315097&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637496 383541906 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611924 Fc1ccc(-c2ncccn2)c(c1)C(=O)N1CC2CCC1C(C2)Nc1cnc(cn1)C(F)(F)F |TLB:23:21:18.19:16.15,THB:13:15:21.22:18.19| 315097 US10183953, Example 278::(5-fluoro-2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 278 Orexin receptor type 2 Human 243 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315097 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315097&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637496 383541906 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611925 Fc1cccc(-c2ncccn2)c1C(=O)N1CC2CCC1C(C2)Nc1cnc(cn1)C(F)(F)F |TLB:23:21:18.19:16.15,THB:13:15:21.22:18.19| 315098 US10183953, Example 279::(2-fluoro-6-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 279 Orexin/Hypocretin receptor type 1 Rat 11.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315098 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315098&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637655 383541907 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611926 Fc1cccc(-c2ncccn2)c1C(=O)N1CC2CCC1C(C2)Nc1cnc(cn1)C(F)(F)F |TLB:23:21:18.19:16.15,THB:13:15:21.22:18.19| 315098 US10183953, Example 279::(2-fluoro-6-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 279 Orexin/Hypocretin receptor type 1 Human 13.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315098 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315098&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637655 383541907 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611927 Fc1cccc(-c2ncccn2)c1C(=O)N1CC2CCC1C(C2)Nc1cnc(cn1)C(F)(F)F |TLB:23:21:18.19:16.15,THB:13:15:21.22:18.19| 315098 US10183953, Example 279::(2-fluoro-6-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 279 Orexin receptor type 2 Human 177 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315098 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315098&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637655 383541907 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611928 FC(F)(F)c1cnc(NC2CC3CCC2N(C3)C(=O)c2ccccc2-c2ncccn2)cn1 |TLB:17:15:9.10:12.13,THB:8:9:12.13:16.15| 315099 US10183953, Example 280::(2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 280 Orexin/Hypocretin receptor type 1 Rat 7.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315099 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315099&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637429 383541908 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611929 FC(F)(F)c1cnc(NC2CC3CCC2N(C3)C(=O)c2ccccc2-c2ncccn2)cn1 |TLB:17:15:9.10:12.13,THB:8:9:12.13:16.15| 315099 US10183953, Example 280::(2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 280 Orexin/Hypocretin receptor type 1 Human 4.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315099 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315099&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637429 383541908 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611930 FC(F)(F)c1cnc(NC2CC3CCC2N(C3)C(=O)c2ccccc2-c2ncccn2)cn1 |TLB:17:15:9.10:12.13,THB:8:9:12.13:16.15| 315099 US10183953, Example 280::(2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)amino)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 280 Orexin receptor type 2 Human 189 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315099 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315099&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637429 383541908 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611931 Fc1cccc(C(=O)N2CC3CCC2C(C3)Oc2ncc(cc2Cl)C(F)(F)F)c1-c1ncccn1 |TLB:16:14:11.12:9.8,THB:6:8:14.15:11.12| 315100 US10183953, Example 281::((1S,4R,6R)-6-((3-chloro-5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 281 Orexin/Hypocretin receptor type 1 Rat 5.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315100 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315100&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637883 383541909 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611932 Fc1cccc(C(=O)N2CC3CCC2C(C3)Oc2ncc(cc2Cl)C(F)(F)F)c1-c1ncccn1 |TLB:16:14:11.12:9.8,THB:6:8:14.15:11.12| 315100 US10183953, Example 281::((1S,4R,6R)-6-((3-chloro-5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 281 Orexin/Hypocretin receptor type 1 Human 19.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315100 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315100&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637883 383541909 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611933 Fc1cccc(C(=O)N2CC3CCC2C(C3)Oc2ncc(cc2Cl)C(F)(F)F)c1-c1ncccn1 |TLB:16:14:11.12:9.8,THB:6:8:14.15:11.12| 315100 US10183953, Example 281::((1S,4R,6R)-6-((3-chloro-5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 281 Orexin receptor type 2 Human 336 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315100 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315100&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637883 383541909 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611934 Cc1cnc(C(=O)N2CC3CCC2C(C3)Oc2cnc(cn2)C(F)(F)F)c(c1)-c1ncccn1 |TLB:15:13:10.11:8.7,THB:5:7:13.14:10.11| 315101 US10183953, Example 282::(5-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 282 Orexin/Hypocretin receptor type 1 Rat 81.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315101 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315101&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637697 383541910 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611935 Cc1cnc(C(=O)N2CC3CCC2C(C3)Oc2cnc(cn2)C(F)(F)F)c(c1)-c1ncccn1 |TLB:15:13:10.11:8.7,THB:5:7:13.14:10.11| 315101 US10183953, Example 282::(5-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 282 Orexin/Hypocretin receptor type 1 Human 65.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315101 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315101&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637697 383541910 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611936 Cc1cnc(C(=O)N2CC3CCC2C(C3)Oc2cnc(cn2)C(F)(F)F)c(c1)-c1ncccn1 |TLB:15:13:10.11:8.7,THB:5:7:13.14:10.11| 315101 US10183953, Example 282::(5-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyrazin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)methanone::US9611277, Example 282 Orexin receptor type 2 Human >10000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315101 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315101&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637697 383541910 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611937 Cc1cnc(C(=O)N2CC3CCC2C(C3)Oc2ncc(cc2F)C(F)(F)F)c(c1)-c1ncccn1 |TLB:15:13:10.11:8.7,THB:5:7:13.14:10.11| 315102 US10183953, Example 283::((1S,4R,6R)-6-((3-fluoro-5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)(5-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)methanone::US9611277, Example 283 Orexin/Hypocretin receptor type 1 Rat 21.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315102 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315102&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637576 383541911 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611938 Cc1cnc(C(=O)N2CC3CCC2C(C3)Oc2ncc(cc2F)C(F)(F)F)c(c1)-c1ncccn1 |TLB:15:13:10.11:8.7,THB:5:7:13.14:10.11| 315102 US10183953, Example 283::((1S,4R,6R)-6-((3-fluoro-5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)(5-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)methanone::US9611277, Example 283 Orexin/Hypocretin receptor type 1 Human 27.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315102 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315102&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637576 383541911 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611939 Cc1cnc(C(=O)N2CC3CCC2C(C3)Oc2ncc(cc2F)C(F)(F)F)c(c1)-c1ncccn1 |TLB:15:13:10.11:8.7,THB:5:7:13.14:10.11| 315102 US10183953, Example 283::((1S,4R,6R)-6-((3-fluoro-5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.2]octan-2-yl)(5-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)methanone::US9611277, Example 283 Orexin receptor type 2 Human >10000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315102 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315102&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637576 383541911 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611940 Fc1cccc(C(=O)N2CC3CC(Oc4ncc(Cl)cn4)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:22,6:8:12.11:22| InChI=1S/C21H17ClFN5O2/c22-13-9-26-21(27-10-13)30-17-8-12-7-16(17)28(11-12)20(29)14-3-1-4-15(23)18(14)19-24-5-2-6-25-19/h1-6,9-10,12,16-17H,7-8,11H2 DBRGEEYSUHKXIV-UHFFFAOYSA-N 315103 US10183953, Example 284::((1S,4R,6R)-6-((5-chloropyrimidin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 284 Orexin/Hypocretin receptor type 1 Rat 45.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315103 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315103&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637575 383541912 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611941 Fc1cccc(C(=O)N2CC3CC(Oc4ncc(Cl)cn4)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:22,6:8:12.11:22| InChI=1S/C21H17ClFN5O2/c22-13-9-26-21(27-10-13)30-17-8-12-7-16(17)28(11-12)20(29)14-3-1-4-15(23)18(14)19-24-5-2-6-25-19/h1-6,9-10,12,16-17H,7-8,11H2 DBRGEEYSUHKXIV-UHFFFAOYSA-N 315103 US10183953, Example 284::((1S,4R,6R)-6-((5-chloropyrimidin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 284 Orexin/Hypocretin receptor type 1 Human 47.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315103 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315103&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637575 383541912 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611942 Fc1cccc(C(=O)N2CC3CC(Oc4ncc(Cl)cn4)C2C3)c1-c1ncccn1 |TLB:13:12:8.9:22,6:8:12.11:22| InChI=1S/C21H17ClFN5O2/c22-13-9-26-21(27-10-13)30-17-8-12-7-16(17)28(11-12)20(29)14-3-1-4-15(23)18(14)19-24-5-2-6-25-19/h1-6,9-10,12,16-17H,7-8,11H2 DBRGEEYSUHKXIV-UHFFFAOYSA-N 315103 US10183953, Example 284::((1S,4R,6R)-6-((5-chloropyrimidin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(3-fluoro-2-(pyrimidin-2-yl)phenyl)methanone::US9611277, Example 284 Orexin receptor type 2 Human 5600 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315103 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315103&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637575 383541912 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611943 Cc1ccc(-c2ncccn2)c(n1)C(=O)N1CC2CC(Oc3ncc(Cl)cn3)C1C2 |TLB:20:19:15.16:29,13:15:19.18:29| InChI=1S/C21H19ClN6O2/c1-12-3-4-15(19-23-5-2-6-24-19)18(27-12)20(29)28-11-13-7-16(28)17(8-13)30-21-25-9-14(22)10-26-21/h2-6,9-10,13,16-17H,7-8,11H2,1H3 VGBLWIQKGKFJHW-UHFFFAOYSA-N 315104 US10183953, Example 285::((1S,4R,6R)-6-((5-chloropyrimidin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(6-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)methanone::US9611277, Example 285 Orexin/Hypocretin receptor type 1 Rat 117 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315104 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315104&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637498 383541913 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611944 Cc1ccc(-c2ncccn2)c(n1)C(=O)N1CC2CC(Oc3ncc(Cl)cn3)C1C2 |TLB:20:19:15.16:29,13:15:19.18:29| InChI=1S/C21H19ClN6O2/c1-12-3-4-15(19-23-5-2-6-24-19)18(27-12)20(29)28-11-13-7-16(28)17(8-13)30-21-25-9-14(22)10-26-21/h2-6,9-10,13,16-17H,7-8,11H2,1H3 VGBLWIQKGKFJHW-UHFFFAOYSA-N 315104 US10183953, Example 285::((1S,4R,6R)-6-((5-chloropyrimidin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(6-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)methanone::US9611277, Example 285 Orexin/Hypocretin receptor type 1 Human 215 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315104 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315104&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637498 383541913 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611945 Cc1ccc(-c2ncccn2)c(n1)C(=O)N1CC2CC(Oc3ncc(Cl)cn3)C1C2 |TLB:20:19:15.16:29,13:15:19.18:29| InChI=1S/C21H19ClN6O2/c1-12-3-4-15(19-23-5-2-6-24-19)18(27-12)20(29)28-11-13-7-16(28)17(8-13)30-21-25-9-14(22)10-26-21/h2-6,9-10,13,16-17H,7-8,11H2,1H3 VGBLWIQKGKFJHW-UHFFFAOYSA-N 315104 US10183953, Example 285::((1S,4R,6R)-6-((5-chloropyrimidin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(6-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)methanone::US9611277, Example 285 Orexin receptor type 2 Human 6000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315104 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315104&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637498 383541913 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611946 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc4cccnc4n3)C1C2)-n1nccn1 |TLB:7:9:13.12:26,14:13:9.10:26| InChI=1S/C23H21N7O2/c1-14-4-6-17(30-25-9-10-26-30)21(27-14)23(31)29-13-15-11-18(29)19(12-15)32-20-7-5-16-3-2-8-24-22(16)28-20/h2-10,15,18-19H,11-13H2,1H3 FYJKRICJINHKKA-UHFFFAOYSA-N 315105 US10183953, Example 286::((1S,4R,6R)-6-((1,8-naphthyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)methanone::US9611277, Example 286 Orexin/Hypocretin receptor type 1 Rat 822 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315105 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315105&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637578 383541914 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611947 Cc1ccc(c(n1)C(=O)N1CC2CC(Oc3ccc4cccnc4n3)C1C2)-n1nccn1 |TLB:7:9:13.12:26,14:13:9.10:26| InChI=1S/C23H21N7O2/c1-14-4-6-17(30-25-9-10-26-30)21(27-14)23(31)29-13-15-11-18(29)19(12-15)32-20-7-5-16-3-2-8-24-22(16)28-20/h2-10,15,18-19H,11-13H2,1H3 FYJKRICJINHKKA-UHFFFAOYSA-N 315105 US10183953, Example 286::((1S,4R,6R)-6-((1,8-naphthyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)methanone::US9611277, Example 286 Orexin receptor type 2 Human 3100 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315105 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315105&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637578 383541914 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611948 O=C(N1CC2CC(Oc3ccc4cccnc4n3)C1C2)c1ccccc1-n1nccn1 |TLB:1:2:6.5:19,7:6:2.3:19| InChI=1S/C23H20N6O2/c30-23(17-5-1-2-6-18(17)29-25-10-11-26-29)28-14-15-12-19(28)20(13-15)31-21-8-7-16-4-3-9-24-22(16)27-21/h1-11,15,19-20H,12-14H2 ZIJHAGWLPSFFCQ-UHFFFAOYSA-N 315106 US10183953, Example 287::((1S,4R,6R)-6-((1,8-naphthyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(2-(2H-1,2,3-triazol-2-yl)phenyl)methanone::US9611277, Example 287 Orexin/Hypocretin receptor type 1 Rat 155 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315106 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315106&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637430 383541915 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611949 O=C(N1CC2CC(Oc3ccc4cccnc4n3)C1C2)c1ccccc1-n1nccn1 |TLB:1:2:6.5:19,7:6:2.3:19| InChI=1S/C23H20N6O2/c30-23(17-5-1-2-6-18(17)29-25-10-11-26-29)28-14-15-12-19(28)20(13-15)31-21-8-7-16-4-3-9-24-22(16)27-21/h1-11,15,19-20H,12-14H2 ZIJHAGWLPSFFCQ-UHFFFAOYSA-N 315106 US10183953, Example 287::((1S,4R,6R)-6-((1,8-naphthyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(2-(2H-1,2,3-triazol-2-yl)phenyl)methanone::US9611277, Example 287 Orexin/Hypocretin receptor type 1 Human 226 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315106 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315106&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637430 383541915 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611950 O=C(N1CC2CC(Oc3ccc4cccnc4n3)C1C2)c1ccccc1-n1nccn1 |TLB:1:2:6.5:19,7:6:2.3:19| InChI=1S/C23H20N6O2/c30-23(17-5-1-2-6-18(17)29-25-10-11-26-29)28-14-15-12-19(28)20(13-15)31-21-8-7-16-4-3-9-24-22(16)27-21/h1-11,15,19-20H,12-14H2 ZIJHAGWLPSFFCQ-UHFFFAOYSA-N 315106 US10183953, Example 287::((1S,4R,6R)-6-((1,8-naphthyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(2-(2H-1,2,3-triazol-2-yl)phenyl)methanone::US9611277, Example 287 Orexin receptor type 2 Human 2700 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315106 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315106&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637430 383541915 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611951 Cc1cnc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)F)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:23,5:7:11.10:23| InChI=1S/C23H21F2N5O2/c1-13-7-16(22-26-5-2-6-27-22)20(29-10-13)23(31)30-12-14-8-17(30)18(9-14)32-19-4-3-15(11-28-19)21(24)25/h2-7,10-11,14,17-18,21H,8-9,12H2,1H3 OTCZEUJANHTZCA-UHFFFAOYSA-N 315107 ((1S,4R,6R)-6-((5-(difluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(5-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)methanone::US9611277, Example 289::US10183953, Example 288::US9611277, Example 288 Orexin/Hypocretin receptor type 1 Rat 29.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315107 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315107&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637431 383541916 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611952 Cc1cnc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)F)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:23,5:7:11.10:23| InChI=1S/C23H21F2N5O2/c1-13-7-16(22-26-5-2-6-27-22)20(29-10-13)23(31)30-12-14-8-17(30)18(9-14)32-19-4-3-15(11-28-19)21(24)25/h2-7,10-11,14,17-18,21H,8-9,12H2,1H3 OTCZEUJANHTZCA-UHFFFAOYSA-N 315107 ((1S,4R,6R)-6-((5-(difluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(5-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)methanone::US9611277, Example 289::US10183953, Example 288::US9611277, Example 288 Orexin/Hypocretin receptor type 1 Human 39.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315107 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315107&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637431 383541916 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611953 Cc1cnc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)F)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:23,5:7:11.10:23| InChI=1S/C23H21F2N5O2/c1-13-7-16(22-26-5-2-6-27-22)20(29-10-13)23(31)30-12-14-8-17(30)18(9-14)32-19-4-3-15(11-28-19)21(24)25/h2-7,10-11,14,17-18,21H,8-9,12H2,1H3 OTCZEUJANHTZCA-UHFFFAOYSA-N 315107 ((1S,4R,6R)-6-((5-(difluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(5-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)methanone::US9611277, Example 289::US10183953, Example 288::US9611277, Example 288 Orexin receptor type 2 Human 5100 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315107 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315107&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637431 383541916 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611954 Cc1cnc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)F)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:23,5:7:11.10:23| InChI=1S/C23H21F2N5O2/c1-13-7-16(22-26-5-2-6-27-22)20(29-10-13)23(31)30-12-14-8-17(30)18(9-14)32-19-4-3-15(11-28-19)21(24)25/h2-7,10-11,14,17-18,21H,8-9,12H2,1H3 OTCZEUJANHTZCA-UHFFFAOYSA-N 315107 ((1S,4R,6R)-6-((5-(difluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(5-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)methanone::US9611277, Example 289::US10183953, Example 288::US9611277, Example 288 Orexin/Hypocretin receptor type 1 Rat 14.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315107 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315107&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637431 383541916 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611955 Cc1cnc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)F)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:23,5:7:11.10:23| InChI=1S/C23H21F2N5O2/c1-13-7-16(22-26-5-2-6-27-22)20(29-10-13)23(31)30-12-14-8-17(30)18(9-14)32-19-4-3-15(11-28-19)21(24)25/h2-7,10-11,14,17-18,21H,8-9,12H2,1H3 OTCZEUJANHTZCA-UHFFFAOYSA-N 315107 ((1S,4R,6R)-6-((5-(difluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(5-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)methanone::US9611277, Example 289::US10183953, Example 288::US9611277, Example 288 Orexin/Hypocretin receptor type 1 Human 24.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315107 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315107&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637431 383541916 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611956 Cc1cnc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)F)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:23,5:7:11.10:23| InChI=1S/C23H21F2N5O2/c1-13-7-16(22-26-5-2-6-27-22)20(29-10-13)23(31)30-12-14-8-17(30)18(9-14)32-19-4-3-15(11-28-19)21(24)25/h2-7,10-11,14,17-18,21H,8-9,12H2,1H3 OTCZEUJANHTZCA-UHFFFAOYSA-N 315107 ((1S,4R,6R)-6-((5-(difluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)(5-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)methanone::US9611277, Example 289::US10183953, Example 288::US9611277, Example 288 Orexin receptor type 2 Human 207 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315107 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315107&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637431 383541916 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611957 Cc1cnc(-c2ncccn2)c(c1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H20F3N5O2/c1-13-7-16(20(30-10-13)21-27-5-2-6-28-21)22(32)31-12-14-8-17(31)18(9-14)33-19-4-3-15(11-29-19)23(24,25)26/h2-7,10-11,14,17-18H,8-9,12H2,1H3 BOMYSQIORFJTDV-UHFFFAOYSA-N 315109 US10183953, Example 290::(5-methyl-2-(pyrimidin-2-yl)pyridin-3-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 290 Orexin/Hypocretin receptor type 1 Rat 97.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315109 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315109&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637807 383541917 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611958 Cc1cnc(-c2ncccn2)c(c1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H20F3N5O2/c1-13-7-16(20(30-10-13)21-27-5-2-6-28-21)22(32)31-12-14-8-17(31)18(9-14)33-19-4-3-15(11-29-19)23(24,25)26/h2-7,10-11,14,17-18H,8-9,12H2,1H3 BOMYSQIORFJTDV-UHFFFAOYSA-N 315109 US10183953, Example 290::(5-methyl-2-(pyrimidin-2-yl)pyridin-3-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 290 Orexin/Hypocretin receptor type 1 Human 188 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315109 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315109&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637807 383541917 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611959 Cc1cnc(-c2ncccn2)c(c1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C23H20F3N5O2/c1-13-7-16(20(30-10-13)21-27-5-2-6-28-21)22(32)31-12-14-8-17(31)18(9-14)33-19-4-3-15(11-29-19)23(24,25)26/h2-7,10-11,14,17-18H,8-9,12H2,1H3 BOMYSQIORFJTDV-UHFFFAOYSA-N 315109 US10183953, Example 290::(5-methyl-2-(pyrimidin-2-yl)pyridin-3-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 290 Orexin receptor type 2 Human >10000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315109 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315109&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637807 383541917 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611960 Cc1noc(n1)-c1cc(F)ccc1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C22H18F4N4O3/c1-11-28-20(33-29-11)16-8-14(23)3-4-15(16)21(31)30-10-12-6-17(30)18(7-12)32-19-5-2-13(9-27-19)22(24,25)26/h2-5,8-9,12,17-18H,6-7,10H2,1H3 QPAVSESCPPSSMR-UHFFFAOYSA-N 315110 US10183953, Example 291::(4-fluoro-2-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 291 Orexin/Hypocretin receptor type 1 Rat 43.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315110 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315110&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637668 383541918 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611961 Cc1noc(n1)-c1cc(F)ccc1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C22H18F4N4O3/c1-11-28-20(33-29-11)16-8-14(23)3-4-15(16)21(31)30-10-12-6-17(30)18(7-12)32-19-5-2-13(9-27-19)22(24,25)26/h2-5,8-9,12,17-18H,6-7,10H2,1H3 QPAVSESCPPSSMR-UHFFFAOYSA-N 315110 US10183953, Example 291::(4-fluoro-2-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 291 Orexin/Hypocretin receptor type 1 Human 82.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315110 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315110&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637668 383541918 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611962 Cc1noc(n1)-c1cc(F)ccc1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:20:19:15.16:32,13:15:19.18:32| InChI=1S/C22H18F4N4O3/c1-11-28-20(33-29-11)16-8-14(23)3-4-15(16)21(31)30-10-12-6-17(30)18(7-12)32-19-5-2-13(9-27-19)22(24,25)26/h2-5,8-9,12,17-18H,6-7,10H2,1H3 QPAVSESCPPSSMR-UHFFFAOYSA-N 315110 US10183953, Example 291::(4-fluoro-2-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 291 Orexin receptor type 2 Human 4200 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315110 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315110&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637668 383541918 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611963 Fc1cccc(-c2ncco2)c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:19:18:14.15:31,12:14:18.17:31| InChI=1S/C22H17F4N3O3/c23-15-3-1-2-14(20-27-6-7-31-20)19(15)21(30)29-11-12-8-16(29)17(9-12)32-18-5-4-13(10-28-18)22(24,25)26/h1-7,10,12,16-17H,8-9,11H2 JVDDNCZRIPYBSC-UHFFFAOYSA-N 315111 US10183953, Example 292::(2-fluoro-6-(oxazol-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 292 Orexin/Hypocretin receptor type 1 Rat 19.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315111 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315111&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637500 383541919 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611964 Fc1cccc(-c2ncco2)c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:19:18:14.15:31,12:14:18.17:31| InChI=1S/C22H17F4N3O3/c23-15-3-1-2-14(20-27-6-7-31-20)19(15)21(30)29-11-12-8-16(29)17(9-12)32-18-5-4-13(10-28-18)22(24,25)26/h1-7,10,12,16-17H,8-9,11H2 JVDDNCZRIPYBSC-UHFFFAOYSA-N 315111 US10183953, Example 292::(2-fluoro-6-(oxazol-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 292 Orexin/Hypocretin receptor type 1 Human 40.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315111 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315111&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637500 383541919 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611965 Fc1cccc(-c2ncco2)c1C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:19:18:14.15:31,12:14:18.17:31| InChI=1S/C22H17F4N3O3/c23-15-3-1-2-14(20-27-6-7-31-20)19(15)21(30)29-11-12-8-16(29)17(9-12)32-18-5-4-13(10-28-18)22(24,25)26/h1-7,10,12,16-17H,8-9,11H2 JVDDNCZRIPYBSC-UHFFFAOYSA-N 315111 US10183953, Example 292::(2-fluoro-6-(oxazol-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 292 Orexin receptor type 2 Human 673 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315111 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315111&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637500 383541919 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611966 Fc1ccc(-c2ncco2)c(c1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:19:18:14.15:31,12:14:18.17:31| InChI=1S/C22H17F4N3O3/c23-14-2-3-15(20-27-5-6-31-20)16(9-14)21(30)29-11-12-7-17(29)18(8-12)32-19-4-1-13(10-28-19)22(24,25)26/h1-6,9-10,12,17-18H,7-8,11H2 WPUHFBMNQUZAPP-UHFFFAOYSA-N 315112 US10183953, Example 293::(5-fluoro-2-(oxazol-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 293 Orexin/Hypocretin receptor type 1 Rat 16.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315112 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315112&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637699 383541920 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611967 Fc1ccc(-c2ncco2)c(c1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:19:18:14.15:31,12:14:18.17:31| InChI=1S/C22H17F4N3O3/c23-14-2-3-15(20-27-5-6-31-20)16(9-14)21(30)29-11-12-7-17(29)18(8-12)32-19-4-1-13(10-28-19)22(24,25)26/h1-6,9-10,12,17-18H,7-8,11H2 WPUHFBMNQUZAPP-UHFFFAOYSA-N 315112 US10183953, Example 293::(5-fluoro-2-(oxazol-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 293 Orexin/Hypocretin receptor type 1 Human 26.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315112 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315112&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637699 383541920 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611968 Fc1ccc(-c2ncco2)c(c1)C(=O)N1CC2CC(Oc3ccc(cn3)C(F)(F)F)C1C2 |TLB:19:18:14.15:31,12:14:18.17:31| InChI=1S/C22H17F4N3O3/c23-14-2-3-15(20-27-5-6-31-20)16(9-14)21(30)29-11-12-7-17(29)18(8-12)32-19-4-1-13(10-28-19)22(24,25)26/h1-6,9-10,12,17-18H,7-8,11H2 WPUHFBMNQUZAPP-UHFFFAOYSA-N 315112 US10183953, Example 293::(5-fluoro-2-(oxazol-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 293 Orexin receptor type 2 Human 535 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315112 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315112&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637699 383541920 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611969 Cc1cnc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-n1ccnn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H19F3N6O2/c1-12-6-16(30-5-4-27-28-30)19(26-9-12)20(31)29-11-13-7-15(29)17(8-13)32-18-3-2-14(10-25-18)21(22,23)24/h2-6,9-10,13,15,17H,7-8,11H2,1H3 WVXCDAFDLFSCMU-UHFFFAOYSA-N 315113 US10183953, Example 294::(5-methyl-3-(1H-1,2,3-triazol-1-yl)pyridin-2-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 294 Orexin/Hypocretin receptor type 1 Rat 166 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315113 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315113&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637710 383541921 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611970 Cc1cnc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-n1ccnn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H19F3N6O2/c1-12-6-16(30-5-4-27-28-30)19(26-9-12)20(31)29-11-13-7-15(29)17(8-13)32-18-3-2-14(10-25-18)21(22,23)24/h2-6,9-10,13,15,17H,7-8,11H2,1H3 WVXCDAFDLFSCMU-UHFFFAOYSA-N 315113 US10183953, Example 294::(5-methyl-3-(1H-1,2,3-triazol-1-yl)pyridin-2-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 294 Orexin/Hypocretin receptor type 1 Human 580 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315113 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315113&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637710 383541921 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611971 Cc1cnc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-n1ccnn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C21H19F3N6O2/c1-12-6-16(30-5-4-27-28-30)19(26-9-12)20(31)29-11-13-7-15(29)17(8-13)32-18-3-2-14(10-25-18)21(22,23)24/h2-6,9-10,13,15,17H,7-8,11H2,1H3 WVXCDAFDLFSCMU-UHFFFAOYSA-N 315113 US10183953, Example 294::(5-methyl-3-(1H-1,2,3-triazol-1-yl)pyridin-2-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 294 Orexin receptor type 2 Human 1400 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315113 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315113&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637710 383541921 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611972 COc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C24H21F3N4O3/c1-33-16-4-5-17(18(11-16)22-28-7-2-8-29-22)23(32)31-13-14-9-19(31)20(10-14)34-21-6-3-15(12-30-21)24(25,26)27/h2-8,11-12,14,19-20H,9-10,13H2,1H3 DSTQNGFYZOHDRW-UHFFFAOYSA-N 143751 US8969352, 12::US9611277, Example 12::US10183953, Example 12::US9845333, 12 Orexin/Hypocretin receptor type 1 Rat 19.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143751 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143751&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271788 251972338 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611973 COc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C24H21F3N4O3/c1-33-16-4-5-17(18(11-16)22-28-7-2-8-29-22)23(32)31-13-14-9-19(31)20(10-14)34-21-6-3-15(12-30-21)24(25,26)27/h2-8,11-12,14,19-20H,9-10,13H2,1H3 DSTQNGFYZOHDRW-UHFFFAOYSA-N 143751 US8969352, 12::US9611277, Example 12::US10183953, Example 12::US9845333, 12 Orexin/Hypocretin receptor type 1 Human 34.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143751 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143751&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 86271788 251972338 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611974 COc1ccc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:13:12:8.9:25,6:8:12.11:25| InChI=1S/C24H21F3N4O3/c1-33-16-4-5-17(18(11-16)22-28-7-2-8-29-22)23(32)31-13-14-9-19(31)20(10-14)34-21-6-3-15(12-30-21)24(25,26)27/h2-8,11-12,14,19-20H,9-10,13H2,1H3 DSTQNGFYZOHDRW-UHFFFAOYSA-N 143751 US8969352, 12::US9611277, Example 12::US10183953, Example 12::US9845333, 12 Orexin receptor type 2 Human 5800 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=143751 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=143751&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 86271788 251972338 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611975 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2ncccc2-c2ncccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315115 US10183953, Example 296::(3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 296 Orexin/Hypocretin receptor type 1 Rat 8.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315115 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315115&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637900 383541923 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611976 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2ncccc2-c2ncccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315115 US10183953, Example 296::(3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 296 Orexin/Hypocretin receptor type 1 Human 14.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315115 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315115&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637900 383541923 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611977 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2ncccc2-c2ncccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315115 US10183953, Example 296::(3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 296 Orexin receptor type 2 Human 474 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315115 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315115&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637900 383541923 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611978 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2ccccc2-c2ncccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315116 US10183953, Example 297::(2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 297 Orexin/Hypocretin receptor type 1 Rat 10.00 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315116 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315116&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637504 383541924 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611979 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2ccccc2-c2ncccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315116 US10183953, Example 297::(2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 297 Orexin/Hypocretin receptor type 1 Human 10.00 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315116 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315116&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637504 383541924 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611980 FC(F)(F)c1ccc(OC2CC3CC2N(C3)C(=O)c2ccccc2-c2ncccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| 315116 US10183953, Example 297::(2-(pyrimidin-2-yl)phenyl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 297 Orexin receptor type 2 Human 606 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315116 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315116&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637504 383541924 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611981 Cc1cnc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C23H20F3N5O2/c1-13-7-16(21-27-5-2-6-28-21)20(30-10-13)22(32)31-12-14-8-17(31)18(9-14)33-19-4-3-15(11-29-19)23(24,25)26/h2-7,10-11,14,17-18H,8-9,12H2,1H3 HCTFAJKZHHFKSO-UHFFFAOYSA-N 315117 US10183953, Example 298::(5-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 298 Orexin/Hypocretin receptor type 1 Rat 24.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315117 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315117&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637586 383541925 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611982 Cc1cnc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C23H20F3N5O2/c1-13-7-16(21-27-5-2-6-28-21)20(30-10-13)22(32)31-12-14-8-17(31)18(9-14)33-19-4-3-15(11-29-19)23(24,25)26/h2-7,10-11,14,17-18H,8-9,12H2,1H3 HCTFAJKZHHFKSO-UHFFFAOYSA-N 315117 US10183953, Example 298::(5-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 298 Orexin/Hypocretin receptor type 1 Human 29.0 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315117 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315117&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637586 383541925 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611983 Cc1cnc(C(=O)N2CC3CC(Oc4ccc(cn4)C(F)(F)F)C2C3)c(c1)-c1ncccn1 |TLB:12:11:7.8:24,5:7:11.10:24| InChI=1S/C23H20F3N5O2/c1-13-7-16(21-27-5-2-6-28-21)20(30-10-13)22(32)31-12-14-8-17(31)18(9-14)33-19-4-3-15(11-29-19)23(24,25)26/h2-7,10-11,14,17-18H,8-9,12H2,1H3 HCTFAJKZHHFKSO-UHFFFAOYSA-N 315117 US10183953, Example 298::(5-methyl-3-(pyrimidin-2-yl)pyridin-2-yl)((1S,4R,6R)-6-((5-(trifluoromethyl)pyridin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 298 Orexin receptor type 2 Human >10000 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315117 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315117&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637586 383541925 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 611984 Clc1cnc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 315118 US10183953, Example 300::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4R,6R)-6-((5-chloropyrimidin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 300 Orexin/Hypocretin receptor type 1 Rat 92.0 US Patent 10.7270/Q24B33D2 aid1796506 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315118 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5450&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315118&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637584 383541926 1 MEPSATPGAQPGVPTSSGEPFHLPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAVMVPQAAVMECSSVLPELANRTRLFSVCDERWADELYPKIYHSCFFFVTYLAPLGLMGMAYFQIFRKLWGPQIPGTTSALVRNWKRPSEQLEAQHQGLCTEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPSSSARHKSLSLQSRCSVSKVSEHVVLTTVTTVLS 6TQ9,6TP4,6TOT,6TOS,6TO7,4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_RAT P56718 611985 Clc1cnc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 315118 US10183953, Example 300::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4R,6R)-6-((5-chloropyrimidin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 300 Orexin/Hypocretin receptor type 1 Human 112 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315118 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315118&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 117637584 383541926 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 611986 Clc1cnc(OC2CC3CC2N(C3)C(=O)c2ccccc2-n2nccn2)nc1 |TLB:13:11:6.7:9,THB:5:6:11.12:9| 315118 US10183953, Example 300::(2-(2H-1,2,3-triazol-2-yl)phenyl)((1S,4R,6R)-6-((5-chloropyrimidin-2-yl)oxy)-2-azabicyclo[2.2.1]heptan-2-yl)methanone::US9611277, Example 300 Orexin receptor type 2 Human 3700 US Patent 10.7270/Q24B33D2 aid1796507 US9611277 Gelin, CF; Lebold, TP; Shireman, BT; Ziff, JM 4/4/2017 4/30/2019 Janssen Pharmaceutica http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315118 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315118&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 117637584 383541926 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0